>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 1; Drug: Control PTZ 2.5 mM
bLeLsbRgLsbRsbRiRsmbRgbRsbRgLsbRsbLsLsmbRgRsmbRgbRsbRsbRiLsRsbRsbRgbRs
bLsbRsbRsbRcbRgbRgbRoRgRsmbLcbRcRsmbLebLoLsmbLibRsbLobRiRgbRhbLiRsLgbL
gRsbLcbLebLebRjbRibLcLsmbRobRebLoLsmbRebLjbLobRoLsRsbLsbLibRobLoLsLgLs
mbLebLebLebRoRsmbLsLsmbLebLcLsmbRcRsRgmbRhRsRsRsmmmbRcbRgbLcbLgLobLebL
ibLsLsLsLemmbRsbRsRsmbRsLsbRsRgRsRsmmbLoReRsmbRsRebLcbLcLsmbsbRsRsLcmb
LebLibRgRgRsRsmmbRibRsLsbLsRsRibRsLeLsbRsbLsLsLgmbLsLgLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 2; Drug: Control PTZ 2.5 mM
bRsbRgbRgbRibRibRgRsmbRgbRibRibRgbRgRsmbRgbRibRgRsLsmbRgbRgbRgbRgbRgRs
mbRgRsmbRgbRgRsmbRgbRibRgbRibRibRibRiRsRgRsmmbRiRgRsRgRsmmbRiRsmbRibRi
RsmbRibRiRsmbRgbRgbRgbRgbRgbRgbRgRgRsmbRgbRibRgRsmbRgRsmbRgbRgbRibRgbR
gRsmbRgRsmbRibRibRibRibRgbRgRsmbRsRibRgbRibRiRibRhRsRiRimbRiRgbRebRgRg
bRiRgbRgRsRsRimmbRgbRiRsRimbRibRgRsmbRgbRibRgbRiLsbRiRgRsRsmmbRibRibRg
bRebRibRhRsRgRsRsmmmbRoRsmbLgbLibLoLsLsmmbRcbLgbLobLobRcbRibRgbRhbRibR
obLibRsbRsbRobRsbLgbRoRsmbRgbRibRiRgRsmbRgRsmbRgRsmbRgbRgRsmbRibRiRsmb
RgRsmbRgbRgRsmbRibRiLsbRgbRgbRiRsmbRgbRiRiRsmbRhRibRhRibRgbRebRgRsRsmm
bRgbRiRiRsmbRhRiRsRhmbRhRsmbRhRibRiRsmbRibRibRgbRgRsLsRiRsRsRimmmbRibR
ebRiRsmbRiRsmbRsbRoLsRsbLcbLobLobLhbRcbRibRgbRcbRcbLsRcbRoLsbRgRobRgRo
bRsbLibLibLsbReRiRsmbLcbLoRsbLcRsbLobLcRsLsbRebLoRsbLsLsLombRgbRgRsmbR
iRsLsmbRcbLhbRibRgbRsRiRsRgRsmmbRsRsmbRiRsRgRsmmbRibRsbRgbRibLhbLcbRcR
oRsmbLgbRgRhRsLsRsRsmmbRibRhRsLsLsRsLsmmbRobRgLsRsbLsRibRhRsmbRgRgRsmb
RobLcbLcRsbRcbRibRgbLsLoLgbLibLoRsbLiRsbLobRcLsbRcbRcRsLsmbRgRiRsRsmmb
RsLsbRcRgRsmbRoRsmbRsbRsRcRsmbRibRiRiRsRimbRiRsRiRsmmbRiReReReRebRibRo
bRcbRcRsmbLcbLoLsmbRcbLcbLcbLcRsbLhRsbRcRsmbRcbRgbRcbRiRsmbRiRsRsmmbRc
LgbLgbRhRsmbRibLgbRcRsmbLgbLoLsmbLgbLsLibLgbLobLcbLcbRsbLibRsbRibLcbRs
bRsLibRgLjbLhbLsbRjbRiRsRsmmbLgbLhbLgRoRsRsmmbLcbLcbRibLoRsbLcbLgbRobR
cbRgRsRsmmbRiReRsLsmbRobRcLsLsmbLsLcLsLsLcLsLimmmbLcbRoRobRcbLcLsRsmbL
oRsbLcbLobLcbRcRsmbLgbRcbRsRsmbRcRgRsRsmmbRebRebRebRebRsRsmbRcRsmbRebR
sRsmbRiRcbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 3; Drug: Control PTZ 2.5 mM
bLobLcLsLsmmbLcbLcRsbLobLobRiLsbRoRsmbRibLobLobRhbRibLobRibRgbLcbRcbLc
bLoLsmbLobLcbLoLsmbLobRhbLobLobLebLibLiLsLsmbRsbLcbRsbLsLsmbLoLsmbLjbL
cbLibLsbLgbRgbLibLsbLsbLiLgbLsLsLsmmbLgbLibLgbLibLgbLgbLgbLibRsbRgbRsR
sRsmmbLoLsmbRcRsmbLcbRcbLcbRobLoLsmbLobLobLhbLjbRcbLoLsmbLoLsmbLobLjbR
ibLoRsbRcRsmbRgbLgbRgbRcbLobRobRibRcbRcbRhbLhbRoRsmbLjbRcLsbLsbRibRobR
obRcRsmbLebLobLcbLoLsmbLsbLsLsmbLgbLiRsLsRsLsLiLsbLgLsLsLsmmbLhbLiLsbL
gbLsbLsLiLsbLibLgbLsRsbLgLibLgbLsbLgbLiLsLgLsLiLgbLsbLhbLcLibLcbRcbRib
LgbLibRsbLiLsLgbLgbLiLsbRebRobRhbLobRobRebRebRcbLobLsbLobLcbLcbLoRsbRo
bRebLiRsLgLhbRcbRebRsbRcbLobRobLobRcbRibLebRcbRgRhLsbLsbLeLebLhbLobLob
RcbRcRsmbRibRoLsbLjbRobLobLobLobRcRsmbRobRobRhbLobLcbLobLobLoRsbRobRcb
RcbRobRcRsmbRoRsmbLoLsmbLobLobRoLsbLcbRsbLobLobLoRsbLobRsbRcRebLibLobR
cbRoLsbLhbRibLibRcRcLsbRobRoRcbLcbLobRobRobLob

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 4; Drug: Control PTZ 2.5 mM
bLcbLcbLibLgLsbLsbLsbLsLsmbLgbRsRsmbLgbLgbRsbLibRsbLsbLibLsbRgRsmbRcbL
hLsbRjbRiLsRsbRsbLobLgbLibRsbRsbRsbLobRgRsmbRsbLhbRgbLibLiRsbLcbLgbLgb
RhbLjbRcbLsbRibLgLsbLibLibLibRsbLhRsbLgbLgbLiRsbRsbRsbLcbRcbLcbRsLsbLs
bLhRsbRgbRibRcbLcbLoRsbLibLibLibRibLgbLgbLibLcbRcbLcbLibLgbRsbLsbLgbLi
RsbRibLcLsmbRibLibRsbLiLsbLsbLgbLgbLgRsbLgbLsbLsbLgbLgbLsbLgRsbLgbLoLs
LsRimmbRibLgbLibLcRsRsmbRibLcbRhbLobRiRsmbLoRsbLiLsbLgbRgbLhbLibRibLob
LsbLsbLsbLcbLobRsbRibLsbRcbLibLoRgbRsbLsbRobRcbLibLiLsbLibRobRibLjbRhb
RoLsbLebRibRobLcbLcbLibLibRsRsmbRsbLcbLcbLibLibLibLibLobRebRhbLsbRcbRe
LsLgbRibLjbLjbLibRsbLibLgbLsbLgRgbLiLsbLibLsbLgbLgbLgbLgLsbRgbLiLgRsLe
LeLiLsbLgLsbLgbRsbLibLcbRibRibLhLsbLcbLhbLoLcbRgbRgRsmbRcLsbLsbRibRiRs
RsmmbRgbRgbRoLsbLeLsbLjbLhbRjbLobRhbLobRibLiRsbRibLcbRobRoRsmbRgbRsLsb
RibRibRibRoLsLibLgbRjRcbLgbRobLsRsRsmbRoLsLsRgmbLibLibLhbLobRibRcbLjbR
sbRibRiRiLsbRgbLgLsbLsRoRsLsRsLsmbLsbLibLiLsbLiLsbLgbRsbRjbLibRhbLhbLc
LiRsbLhRsRsmbLhbRcbRcbRibRibLiLsbLgbLgLsbLgLsbLsbRibRcbLobLibLibLgbLsb
LcbRibRcbLibLcRsbLgbLgbLsLsmbLgLsLsmbRsbLiLgLsLsLsLsmmmbLiRsLsLsLimbRg
bLibLoRsbLobLcbRibLgbLoLsmbRibLgLsbLcbLiRsbLgbRiRsmbLsRcLsbLsbRhbRgLsb
RobRiRsmbLcbRcbRobLhbRhbRcbLhbLibLiLsLiLgLgbLgbLgRsRsmbLgbRcbLobRoRsmb
RobLibLcbRjbLcLsmbLsLoLsLimbLgbLoLgbLiLsbLgbLsRsbLibLgLhLgbLcLsmbLgRsR
smbRgbLiRgLibRobRoRsRsmmbRcbLebRjbRoLsbRcRsmbRoRsmbLcbLibRiRsmbLobLibL
gbLgLsLhRsRsmbLobLobLcbLoRsbLcbLhbLgbLobLjbLcbRcbRoLsbRcbLcLoRsRsRsmmb
LcbLcbLcbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 5; Drug: Control PTZ 2.5 mM
bRgbLobRobRibLobLeLsbLcbLibLibLcbLibLgbLsbLsbLgbRcRsmbRibLjLsmbLobRsbL
gbLgbLgbLgbLgbLsbLsbLsbRsLsbLobLgbLsbLgbLgbLibLgbLsbLobLgbLiLsbLgbRhbL
ebLgbLsLsmbLgbLsLsmbLgbRsbLsbLibRjbLibRgbLibLsbRsRsmbLibLgLsbRgRsmbRsb
LiLsbRgLsbLhbLsbLsbLgbRsbLsbLgbLsbLiLsbLsbLsbLsbLsRsbLibLgbLsbRgbRgbRo
bLibLobRibLiLsbLsbLibLobRibRgbLgLsbRsLsLsmbLjLcbRhbLhbLsbLibRgLsbRsbLi
bLsbLgbLsbLsbLsLsmbLsbRsbLibLsbLsbLiLsbRsbLibRsbRsbLgbRsbRsRsmbLsbRoRs
mbLsLsmbLcbLobRhbLibRobRcRsmbRcbRibRgbLobLcbRgRsmbLsLsmbRjbLcbLhbLibRo
RsmbLebRsbLsbLsbLcbLibRhbLgLsbLsbLsbLiLsbLgbLgLsbRsbLhLsbLoLsmbRhRsmbR
ibLcbLcbLcbLhbLcLsmbRjbRcRsmbLjbLcbRebLobLobLibRsbLobRobLebRjbRcbLobRs
bRsbRibRobRcLsbRcLsRsbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 6; Drug: Control PTZ 2.5 mM
bLcbLibLgbLsbRsRsmbLobLobLhLsbLhbLibRsbRsbRsbLsbLiLsbLobLiRsLsbRsbRgbL
sbRhRsmbLgbRgRsmbRgbRobLgbLcbLibLsbLgbLhbReRsmbRobRcbRoLsbRoLsbLibLcbL
ibLcbLsLsmbRsLsbLibLsbLoRsbRebRobRsbRibLiLsbLoRsbLibLsbLsbRsbLibLsLsmb
RjRcbRobRgbRsbLsbLhbLsLsmbLibLsbLsRsbLsbLibLsbLgLsbLsbRoRsmbRsbLobLobL
iLcbLibLibRibRsRsmbRobLobLcbLobRsRsLsmbLsbRgbRobLebLibRoLsbRoRsmbRobLh
bLsRsbLcbLibRgRsmbRsbRobRobRoLjbLsbRebRcbLobRhbLcbLcbLjbsbRcbLjbRoLsbL
sbLgbRcbRiLsLsmbLsbRoLsLsmbRsbRobLjbLibLsbLibLcbRgbLibLsLiLsLsmbLgbLiL
ebLiLsbLgbLoRsbRobRcbRoLsbRoLsbLcbRobLebRcbRobLgRoLsbRgbRhLsbLgReLsbRo
bLhbLhbRoLsbRobLobRhbRiRsmbLcbLibRoRsRsmmbRibRgLsRibRgRsmbRiRsmbLsbRoR
smbRibRobsbLgRsbRsRobLebLibLhbRibRibRebReLsbLeLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bRgbRgRsmbRibRsLsbLhbRibRibRsLsbRsbRgbRibRibRgbRgbRsRsmbRgbRgbLcbLobLo
bRsRsmbLoLsmbRjbLhbRgRsmbLibLobRibLcbLcbRcbRsRsmbRsbRjRjbRibRibLcbLibL
cLsmbRhbLobRsbRjbLcbLiRsbLobRgRsmbRgbLoRsLiLcbRibRsbRsbRgRsmbRgRsmbRsL
sbRgbRibRoLsLsRhmbLsbLiLsbRibLcbLibLibLcbLibRibLibLcbRibRgbRiLsbLjbLoR
sRsRsmmbLgRsbLiLsbLgLsLsLgmbRgbLoRsbLgbLgbLgLsbRsRsmbRgbRhbLcbRcbRibLj
bLibLibLcbRibRhbLcbRebRhbLobRjbLibLibLibLibRgbLcbLcbLcLsmbLibLhbRibLiL
sLsmbLsbRsbLoLsmbRgRsmbRgRsmbRibRibRibsbLgbRgbRobLiLsbRibRsbRgbLcbRgbL
ibLiLsbLgbLoLsRsRimbLibLcbRibRoLsbLibLiLsbsbLsbLobRhbLcbRsbRsbRobLebRe
bRoLsbLibLcbRcbRoLsbLiLsLsmbLoLsmbRebRsbRiRsmbRobRobRcLsbRibRiLsbLsbRg
RsmbLjbLhbLoRibLibLobLibRgbRiRsmbLgbRcbRibRsbRibRgbLgbRgRsmbRgLsbRibLs
bRibRsbRobLibRibRsbRgbLoRsbRcbLcbLibRgbLobRgbRgbRibRoLsbRcbLobLebLcbRs
bRgbRiLsbLgbLcRsbLobRhRsmbLibLsbRsRsmbRsbRoLsLsmbRibLhbLsLsmbLgbLgLsLo
bRibRibRsbRibRoLsbLgbRsbLoRsbReRsmbRibRgbLgbLoRsbLsbRcbRhbRgbRgbRgbRob
LibRhbLcbRobRibRibLgbLgbRgbRgbRibLobRcbRibRgbRsRsmbLoRsbLsLsmbLcbsbLgb
LibRibLcRsbRsRsmbLoRgbRsRsmbLobLhbLhbRsbRibLgbLgbRhRsmbLobLobRibRhbRob
LiLsbLsRsbLhLgbLibLgLsbLibRibRibLsbRobRgbLcLsmbRgRsmbRjbLcbRibLsbRobRc
bRcbRcbRibLcbRhbLibRgbLhbLcRsbLsLsmbLoRsbLcbRibRhbRibRsRsmbRgbRibRsbRi
bRibRgbRsRsmbLgbRobLibRcbRoRsRombRcRsmbLobRobLeLsbRcbLobLobRibRiRsmbRg
bRiRiRsmbRgbLgbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsbRgbRsbRgbRsbRhbLgLsRsbRsbRobLibRibRoRsmbRsbLgbLsbLsbRsbRsRsmbRibRi
RsmbRsbRgbRsbRgbRsbRgbRsbRgbRgbRsLsbRgbLsbRibRgbRgbRsbLsRsbRiLsbLsbRsR
smbRgRsmbRsbRgLsbRgbRsbRgbRsbRsbRsRsmbRgbRsbRgbRgbRgbRgRsLsmbLsbLsbRsL
sbRgbRiLsbLsbRsbRibLgbRcLsLsmbLgbRibRibLiRsbLsbRibRibRgbLjbRcbLibRibRs
RgRsmbRsbRsbRsRsmbRsRsRsLsmmbRgbLsLsmbRgbRsbRiRgbRgRgRsmbRgRsmbRgbRsbR
gbRgbLgLsbRiRsmbRobLcbLibLsbRsbLgbRobLibRsLsbRobRiRsmbRgbRibRsbLcbLgbR
cbLobRcRsmbRobLcbRhbRsbRibLibRgRsmbRgRsmbLsbRgbRsRsmbRsbRsbRoRsRsRsmmm
bRhbLibsbRjRsmbLsLsmbRsbLibLjbLhbRebRobLibRsRsmbRsbRsRsmbRhbLgRsbRebLh
bLobRsRsRsmmbRiRiRsmbRebRoRsmbLjbRsbLcbLcbLcbLsbRobRhLsbLiLsbRcRsmbRgb
RgbLgbRsLsbRibRgRsmbRgbRsbRiLsbRiRgRgbLibLoRsbLcbRcbLobRsRsRsmmbRgRsmb
RhbRoRsmbRjbRjLsbRgbRgbLgbLsbLcbLcbRibLcbRsRsRimbRiRgLsbRgRgbRibLsbRib
LibLcbLcbRjbLobLgbLcbLibLoRsbRebLobLhbLjbRibLgbRsRibRiRsmbRsRsmbRgRsmb
RgbRibRjbLsbLhbLobRcRsmbRjbRsbLhRsbRebLoRsbLiRsbLobRgRsmbRiRsmbLcbsbRg
bRsbRiRsmbRsRsRsmmbRsbRjbRgbRgLsbRsbRibRsbRibRebLgbRiLsbRibLiRsbRsRsmb
RsRibRsRsmbRsbRsbRjbRoLsLsmbRebRgbLcbRobLjbLcbRsbRsbRgbRebRiReRibRebLo
bLcbLjbRobLobLibLcbRebRcbRibRsbRsbRsLsbRsRgRibRsbRoLsbLgbLsLgbLjbRgbLo
bLcbLoRsRsmbLebLoRsbRgRsRsRiRimmbRgRgbRsbRiRsmbRibRsbRgRsRsLsRsmmbRobR
oRsRsmmbLiRsLsbLebRiRsmbRoRsmbLcbLobRibRiRoRsmbLcbLcbRcbRoRsRgmbRiRsRg
RsmmbRsRsRgLsmbRgRsmbRiRsRgmbRcbLobReRsRimb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bsbRhbRibLgbLibLcLsmbRhbRibRsbRcbRoRsmbLeLsbLsbLsbLobRcbRcbLcLsmbLcbLs
LsmbLibRibLoLsmbLcLsmbRsbLsbLgbRjbLhbLgbLsbLsLsmbRsbLsbLiLsbRsbLgbLiLs
bRsbLibLiRgbLiLsbLgbLgLsLgLsbLgLsbLsbLsbLgLsbLgRsbLgbLgbRsbLgbLsLsmbLg
bLgbLgLsLsmbLibLgRsbLgbRgbLsbLsbLsbLgbLsLsmbRcRsmbLobLobRsbRgbLcbLobLc
bLcLsmbLcLsmbLsbLsLsmbLsLsmbLgbRjbRcLsbLjbRibLoLsmbLobRhbLibLcLsRsmbLs
LsmbLcbLcbLcLsmbLsbLobLcbRhbLcLsmbLcbRibRsbLoLsmbRibRgbLcLsmbRibLcbLoL
smbLsbRsbRibLobLsbRjbLoRsbLcbRsbRcbRsbLsbLjbRiLsbRibLgbRibRibLsbRgbLsb
RgbLcbLgbLibLgbLsbLsbLsbLgRsbLibLgLsbLsbLgLsbRsRsmbLsbLgLsLsmbLgbRsbLi
LsbRsbLsbLobLibLobLsbLiLsbLgbRsbLcLsmbRebRibRoRibLgbLgbRsLsbLsLsmbLsbL
gbLsbRsbLgLsbLgbLsbRsbLiLsbLgbRsbRsbRsLsbLoLsmbLgbLibLsbLcbLiRsLsbLoRs
RsmbRobRobLibRibRobRobLiLsbRebLcbLcRsLsbLhbLsbRsbLiLsbLibRgRsmbLsbLobR
sbLobRsbLiLsRsbRsbRiRsmbRobLcLsmbLobLhbLsbLsbRgRsmbLcbLsbRobLcbLcbLsbL
hbLsbLsbLibRebRcbRoLsbRjbLibRsbLcRsLsLsmbLibLsRsbLiLsbLsbLiLsbRsLibRsb
RobLsRsbLgbLiLsbLsbLsLsmbLgLsLsLsmmbRebLjbLobRibRibLsLsmbLsbRobReRsRom
bLobLiLsbLgbLgbLibLgbRgbRibRsbRcbLcbLcbRcbRcRsmbLcbLoRsbRgbRsRoRsmbRib
LgLsbRgRsmbRsRsmbRibLibLsbLgLsbLcLsmbLibLebLiLibLibLiLibLibLibLgbLiLsL
gbLgLebLiLsLeRebLsRsRsmbRcRsRsLsmmbLsbLgbRibRebRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcbLibLibRgRsLsmbLibLiRsbLgLsbRiLsbRgRsRsmmbRjbRcbLcbRgbRgRsmbRsbLsRs
bRibRcbRcbRcbRibRebRsbLsbLhbLgbLsLsLsmmbRgbRsbLibLobRcbRsRsmbRgbLsRsbR
ibLobRsbLsbRsbLgbLobRibRgRsmbRsbLibRibLgbLsbsbRgbLobRobRebLibRjbRgRsmb
RiRsmbLibLcbLgLsbRsLcbRcbRsbRcbRsLiLsbLsbLsbRcLsbLibRibLsbRibLobLobRjb
LibRjbLobLcbLsbRsbRcbRebLoRsbRiRsmbRgbRsbLcbLcbLibLgbRsRibRgLsbLobLobR
sbRgbLjbRibRibRibRgRgbRsbRgRgLobRgLsbRibLoRsbRebRsRsmbRebRgbLebLcbLsbR
sRsLsmbRobRibLsbRibRoLiRsRgbRibRgRhbRsRgLgRsRiRiRsmbLjbRcRsRsmmbLebLib
RebLoRsbReRgbRgbRsbLsbRsRcbLhbLobLgbLsLsmbRgbRsbLsLsmbRhbLobLobRebLsRs
RsReRhmbRebRebRebRebRebRoRsmbLobLiLebLcbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bLhbLsLsmbLgbLgbRobLibRhbRsbRibRsbLcbRjbLgbRsbLobRhbRsbLhbLobRibRibRiL
sRsbRjbLhbRibLsbLsbLgbLgbLibRibRgbRgbRgbRibRsbRibLjbLoLsmbLcbRhbRhRsmb
RobLhLsbLsbRibRsbLgbLgbLibRsbLsRsbLgbLsRoLsbRcbsbRsbLcbLhbLgbRibLobLob
LjbLgbRsbLjLgbsbLsLsmbRjbRcbRebRebLebLhbLibLgbLgbRgbLibRsbRgbLobRgbLgb
LgbRibRgbLsbRibLobRebLjbRcbRebRobRcRsmbRebLiLsbRsbLsLsmbLsbsbLiLsbRsbL
sbLgbRcbLhbRgbLsbLsbRsbLsLcbRsbRsbLibLsbLgbLgbRsbLiRsbRcbRobRobLibLsLs
mbRsLsbLcbLgbLgbLgbLsbRibRiRsRombRsRsmbRibLsbLobLibRgRsmbRsbRjRsmbLobR
sRcbLcbLcbLhbLsbRhbRsbRsbRhLsbLobLobRsbRsLsbRsbLobRjbRsbsbsbLibLgbLsbR
sbLcLsmbLgbLsbRgbLsbLcbLsbRcbRobLibLgRsbLgbsbLibLgLsbRcbRcbLibRoLsLcbL
ebLib

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsbLsbRsbRsRsRsmmbsbRgbLsRsbRsbRsbLsLsmbsbRgRsmbRiLsRiLsRgLsbLibRsbLg
LsbLsRsbRsLsbLgbRgbRoLsbRsbRibRibLsbLsbLgLsbLhbLsbRgbLgbLgbLcLoRsbRibL
sbRgbRgbLsLsRsmbRibRsLsbRsbRiLsbLibLgLsbLgLsLsmbRhbRhbRibRsbLsbLsbRibL
sbRgbRsRsmbRgbRsbLsbRsbRibRgbRsLsbRgRsmbRgbRiLsbLibRcbLiLsbRgbRibRsRsm
bRsbRsbsbRiRsmbRgbRsbRiRsmbLsRsbRsRsmbRgLsbRgbRgbRgRsmbLsRsRsmbRcLsLsm
bRobRibRsLsRsbLsbLoRsbLcbLsbLibRoLsbLibLgLsbRoLsbLiLsbRcbLjLsmbLcbRibR
hbRibLsbLjbRibLsRsbRibLsLsmbRgRsmbRgbLsRsbRgbRgbRsbRgbRhRsmbLsbsbLsbLi
bLsbRcbLibLibRgLsbRobRsbRhLsbLibRibLsbRgbRsbRjbRcbRibRcbRsRsRsRsmmmbRs
bLobLcbLgLsbLsLsmbLoRsbRgbLsbRhbLsbRibRgbRsbRibRsRsmbRsbRiRsmbRgbLsbRg
bLsRsRsLsmbRsLsbRgRsRsmmbRsbRibLjbsbRiRsmbLsbRibLsbRgbLsbRibRsbRsRsmbR
gRsmbLsbLgbRibRsbRgRsmbRsLsbRgbLsbLsbRibRsRsmbRiRsRsmmbLsbRgbRsbRiRsmb
RsbRsbRsRsmbRebLsbRgLsRsbRsRsmbRjbLsbRibRoLsbRcbLcLsmbRgbLibRsRsmbLgbL
sLsmbLgLsLsmbRsLsbLgbRsbRoLsbLcbLsLibLgLsbRjbLobRcLsbLiLsbLgbRgbRgbLgb
LibRsbLgRsbLgLsbRsbLibLcRsbLobLebLsbLibLgbLgbRsbRsbLibRsbLgLsbLsLsLsmm
bLsRsbRcbRgLsbRgbRsbRibRgbLsbRoLsbLsbLgRsbRiRsmbRsLsbRgRsmbRgbRhbLibRh
RsmbRgbLsbRibLcbRsLsbLoRsbLhbRcbRsbLcbLcbLgLsbRsRsmbLhbLiLsbRgbLobRgbR
gbLcbRjbRoLsbLsbLiLsbRoLsLsmbRibRsRsmbRgbRsRsmbRibLcbLoLsmbLcbLsbLcbLs
bLibRgLsbRsbRebRoLsRcRsmbRgbRgbRcbLcbLsLsmbRoLsbRibLgbLsbLcbRibLibRjbR
hbRobRsbRsbLibLgbLgbRgbRcbRoLsbRibLiLsbRibRgbLebLcbRgbLcLsmbLcLsmbLibR
sbRcbLoLsmbLgbRoLsbRhbLgLsbRcbRibRsbRgbLgbRcbLebRgbRobRhbRiRsmbRgbRibL
cbLcLsmbLcbRsbRoLsbRiLsbRsbRsRsRsRcmmbRhbLiLsbRhRhbLjbLobLhLsLsmbLeLsb
LibsbRgbRsbRibLjRsbRibRsRsmbRsbLsLsmbRsRsRsmmbRjRgbRibRsbRsbLsbLsbRcbR
hbRgbRsbRibLcRsRsRsmmbLoRsbLobRibLsbLgbLhLsbLsRsbRcbRgbRsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgbLsbLibLgbLibRgbLibRsbRsbLibRsbRsbLibLsbLgbLsbLgbLsbLgbLgbLgbLgRsbL
jLgLsbRjbRhbLgbRjbLcRsbRgbRsbLsbRsRsmbLiLsbRsLsbLgbLgbLgbLgLsbLgbLcLsR
gLsmbLibRsbLibRsLiLgbLiLeLeLeLebLiRsbLibLcLsmbLsRgRiRcRsmbLsbLjbRcRhRs
RembLhbLebLiRsbLebLgbLsbLoLsLsmmbLsLgbLjbLgbRsRsRsmmbRcbReLsbLsbLsLsmb
LsbLsRsLsLsmbLsLeLsbRsRsmbRsbRgbRcRsmbLobLsbLeLebLebLeLsRsbRsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgRsmbRgbRsbRsbRibRibLsLsmbRiRsmbRgbRgbRgbRgbRgRsmbRsbRgbRgRsmbRgbRgb
RibRibLgbLibRibRgbRgRsmbRgbRsbRgbRgbRgbRgRsmbRgbRgbRgbRsbRgbRgRsmbRgbR
gbRgbRsRsmbRgbRsbRsbRsRsmbRsRsmbRgLsbRgbRgRsRsRsmmmbRgRsmbRgbRgbRsRsmb
RgbRsRsmbRgbRgbRgbRgbRgbLsRgbRgbRgbRgbRgbRgbRsbRgbRgbRibRsbRsRsmbRsRsm
bRgbRgbRsbRsbLsbRiRsmbLobLiRsbRhRsmbRcbLibRcbLsbRgRsmbRsbRgRsmbRsbRgbR
gbRgbRgbRgRsmbRgbRibRibRgbRgbLoLsmbRgRsmbRgRsmbRiLsLsmbRgbRsbLjbRibRhb
RsbLobLobRiRsmbRgbLsbLsbRhbRsRsmbRgbLsbRsRsmbRsbRgbRsRsmbRsbRsRsmbRgbR
sRsmbRgRsmbRgbRgbLsRgRsmbRgRgbRgRgbRgRsmbRibRgRsmbRgbRgbRgLsbRgbRgbRgb
RgbRsbRobRoRsmbLjbRobRcRsmbLiRsbLibLsLsmbLoRsRgRgbRibLgLsbRibRebRoLsbR
ebRhLsbRiRsmbRgbLoRsbRebRgRsmbLsLsLsmmbLsbRgRsmbRcbLibRgbRibLjbRiRsRsR
smmmbRsbRgRsmbRgRsmbLsbRibLobRsRsmbLobLobLiLsbLobRsRsRsRsmmmbRebRiLsbR
gRsRiRembRiRebRgbRgbRibRiRcbRgRsmbRsRsmbRsbRgRsmbRgbRsbRsbLsbRsRsmbRgb
RoRsmbRobLobLobLoRsbRcbRcbRsbRcbRhbRiRsmbRsbLeRsRsmbLobLobRcbRoRsmbRhR
smbRcbRsRsmbRsbRgbRibRsbLsRsbsbLoRsbLobLibRsLsbRcbRcbRcbLgbRibLibLoRsb
LhbRsLiRsbLibLcbRobRoRsmbRcbRcRsmbRcRsmbRcbLibLsbLobLibRobLobRcbLhbRob
RiRsRgmbRiRsmbRgRsmbLibLoLsmbReReb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsRsbLsLsmbLsbLibLsbLsbLibRjbLibLsbLibRsRsmbLoRsLsbRgbLhbRgbLsbLsLsmb
RibRgbRsbLcbRibLobLgbLgRsbLgLsbLgbLibLcbLibRsLsbRcRsmbRibLsbRsbRsbLsLs
mbLsbLsLiLsbLsbLibLsLsmbLsbLibLsbLsbLsLsmbLsbLsbRebLobLibLibRiRgRsmbRg
bLebRjbRcRsmbLsbRibRiLsbLsLsmbRsbLsbLgbRhLsbRiRsmbLibRiLsbRgbRibLgbRsb
LjbRibRgbRsbRgbRibRibRgbLjbLobLibLgbLiRsLsbRsbRibRibRgRsmbLsbRgbRgLsbL
sLsmbRgbRgbRibRgbRgRibRgRsmbRsLsbRgbRsRgRsmbRgbLsbRibLgbRsRsmbRibRgRsm
bLgbRsbRcLsbRsbLjbRibLgbRibRcbRcbRcbRiRsRsmmbRobLhbLhRsbLcbLsbsbLiLsbL
sbLiLsRsLsbLiLgbLsLgbLgbLhbRsLgbLgLsRsbLsLgRsbLiLsLsmbLibRgbRebLobLobL
ibLhbLibLiLsbLgbLhbRsRsmbRiLsbLcbRsbLibLiLsbLeLibLebLeLsbRcbRebRsbRebL
sLjLcRebRebRsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bLibRcbRcRcbRsbRgbRobRgbRhRsmbRgbRgbLgLsbRgbRgRsRombLgLsLsmbLgbRcbLsbR
oRsLsLsmmbLebLibRcbRgRsmbRgbLsbRgbLsbRiRsmbRsbLsbLsLsmbsbRoRsRimbLsbLi
LsbLgbLibRibLcbLcbRibRibRsbRgbRgbRobRhbRsbRgbRsbRgbRibRiRsmbRsRgbRgbRg
bLibLjbRobLjbRobRcbLgLsbLibRebsbRsbRgLsbRobRjbRcLsbLhLsbLsbRsbLibRgbLg
bLibLgbLiLsbLhbLeLsLeLsLeLebLeRjbLgRibLebRoRebLobLoLeLsbLgLebLoLcRebRo
bRsbLsbRgbLeLsbRsbLobLebLoLcLsmbsbLebLgbLsbRgbLeLsLcbsbLsbLgbLjLgbsbLe
bLoLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcbLcbLcbLcLsmbLebLibLibLgLsbLgbLgLsLsmbLibLgbLibLgLsbLgLsbLgbLgbLgbL
gbLgLsbLgbLibLgbLgbLgbLsLsLsmmbLgLgbLgLsbLgLsbLiLsbLiLgLgbLibLcbRgbLsb
LgbLhbLgLsbLsbLgLsbLgbLiLsbLgbLgLsLsmbLibLgbLibLgbLibLgbLiLsLiLsbLiLsb
LsLsmbLiLsbLgbLiLgLsbLiLsbLgbLiLsLsmbLgLsbLiLibLeLcbLobLoLsLsmmbLcbLib
LsLsmbLcbRgbRobLgbLibLoLsLsmmbLsbRsbRibRiRsmbRcRsLsmbRobRibLobLcbLoRsb
LgbLobLsLsmbLgLsbLgbLobLobLsLcbLcbRgbRibRobRobLiLsbLoLsmbRsbLhbLoRsbRs
bLobRgbLsbRhbRobRcbLoLsmbRiLsbLoRsbRibLgbRobLobRobRoLsLsmbLcbRgRsRsmmb
LhLsbLibLiRsbLibLeLeLsLeLsbLsbRsRgRsmbLsLsRsLsmbLsLsmbLsLsLeRsmbReRob

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bRjbRsRcbRgbLsbRgbRsbRgbRgbRgbRsbRsbLsRgbRsbRgbRgbRcbRibRgbLgbLibRsbLi
bRsLsbLibLgLsbLgbLgbLgbLsLsmbRgbRsbLsRsbLibLgbLgRsbRjbRibRibLcbRibRsbL
ibRibRibLjbLcbLobLoRsbLgbLsLsmbLsbRhbRoRsmbRcbRcRsmbLcbLobLebLgbRgbLob
LsLgbLsLsmbLgbRsbLoLgLsLsLimbLgbRsRsmbLgbLibLsbLgLsbLobRhRsmbLsLsmbLcb
LsbLsbLobRsbRibRgbRibRgbRgbRiLsbRibLjbLoRsbRobRgbRibRgbLhbLsbLgbLgbLib
LsRsbLcRsbLobRobRsRsmbRebLgbLibLsbRebRobLobLobRebsbRgbLsLoLsmbReLsbRhb
RgRsmbLoRsbRgbLobLgbLsbLgbLsLsRsmbLsbLgbLiLsRsbLsbRebRcbRcbRcbLcbRcbRc
bRobLsbLsLsmbLsbLgbLiRsLsLsRsmbLgbLiLgbLsRjbRcbsbRsRsRgmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbRibLsbRiLsbRsRsmbRcbLiLsbRsbLibLhbLgbLiRgbLgbLsbLgbLsLsmbLsbsbsbLg
bRsLgbLgRsbLgbLgbLgRsbRsLsbLsbLsLsmbLgbLsbLgbLsLsmbLsLsmbRgbLgRsbRgbsb
LsbLgbRsbLhbLsbLsbRsbLgbLcRsRsmbRsbRibRiRsmbRcRsmbLgbLjbRsRsmbRibRhbRs
bRsRsmbRsRsmbRsRsmbRgbRsbRcRiLsbLsbLsbLsbRebLsLcbLiLsbLibRhbRgbLoLsRsm
bRoLibRibRsbLebLobRiRsRsmmbLhbRsbLebLibLsLsmbLibLibLibLiLebLeLeLsbLebL
eLgbsbLgRgbLsbRgbRsbRibRsRsmbRsbRsbRsbRsRsmbRgbLiRgRsmbRsbRcbLeLibRoLi
LsbLoLgLcLgbRsbLsLsmbRsbLibLgLsLoRgRsmbRiLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsRsRsmmbRsRgbRsRsRsmmbRsRsmbRsRsRsmmbRsRsRsmmbRgRsRsRhLgmmbRobLsbLib
RcbRgbRgbRiRsmbRsLsbRhbLjbRgRsmbRsRsmbLsbRsbRsbRsRsmbRsbRibRsbRgRsmbRs
RsmbLgbRgbRgRsmbRgRsRcLsmbLgbLgbLsbLgLsLgLsLcRsbRgbRsbRsLsbRsRsRgmbRsR
ibRsbRgRsmbRgbRgbRsbRiRsRiRsRsmmmbLsLsmbRsbRiLsLsmbLsbRcRsLsmbRsbLsRsb
RgbRsbLiLsbLibRgbLiRsbRobLsRsbsbRsbRoLsLsmbLgbLiLsbLsRsbReLsbLgbLgLsLg
LsLsmbRsbLebLcbLgbLgRsbLgbLsLsRombRgRsmbRgRsmbRsRsmbRsRsmbLsbRjRgbRcbL
gbLgbLibRjRobLibRsLsbLgLsLsmbLgbRebLhLsbLsRsbLgbLsbLgLsbLibLiLobLcbLcb
RhbRgRsmbRgRsmbRgbRgbRoLgbLsbLsLibRcbLsbRgbLgbRebRsbRebRcbLcbRjbLiLsbL
sbLibLgbRsbRoLsbLibRsbLsLgbLiRsbsbLsbLobLebRgbRiLsLsmbRsbRgbRibRsbRgbR
gbRgRsRsmmbsbsbsbRsRsmbRoRoLsLsmbRhbRsbRsRsRsmmbRgRsmbRsRsRsRsLsmmmbLs
RsRsmbLcbRcbLgbRobLsLibLsbLibsbLhbLsbRibLsbReRsmbLoLsmbRcbRsbRgbRsRoLs
LsmbLibRgbRsbRcbLsLibLcLsmbLibRoLsLsmbRgbRsbRibLsbRgbRobRjbLcLsmbRebLc
bRgbLiLsbRsbLsbRsRsmbLgbLibRobRibRcLsbLibRobRhRsmbRgbRsRsRsmmbLgbLoRsb
LoRsRsmbLiLsbRiRsmbRsRsRsRsmmmbRobRgbRebRsRiRsRsmmbRsLsbRsLsbRebRgRsmb
RibLsRsbLsRsRsmbLgbLsLgbRsbLibRcRsmbRgRsmbLjbLibLiLsLsLsmmbLsLsmbLgLsb
LoRsbRcbLhbLgbLcLsmbLcbRobRebLsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbLsbLsbLsLsmbsbRsbsbLsbLsbLgbLsbLgLsbLgbLgbLebLcbLsRsLgLobLgLsbLgbL
jbLgbLsbLgLsbLsbLgbLsbLebLoLsmbLjbLcbRgLsLsmbLhbLsLsmbLgbLsLsmbLsbLgbL
sLsmbLsbRibRobRcLsLsmbLgLsbLsbsbLsbRgbRibsbsbLsbLjbLoRsbRsbLgLhbRoLsbL
ibLgbRjbLibsbRgbRhbRebRgbLsLsmbLsbRebRobRsbLsLsmbLgbLgLsbRobRiLsbRibLs
bLsbRsRgbRibRobRiRsmbLsbLsbRobRcRsmbRebsbRiLsbRcbRsLsLsmbLobLobRsRsmbR
ibLjbRiLsbLsLsmbRoLsbRcbRoLsLsmbRibRsbLoLsmbRiRsmbLsLobLhbLsbLgbLcbRiL
sbLobRiLsLsmbLgbLgbLiLsLsmbRibLsbRgbLsLsmbRsbRsLsbRsbLsLsmbLibRjbRobLg
LsbRobRgRsmbRiRsmbRsRsRsmmbRsRsmbRoLsRcbRibRsRsmbLcbRcbLsbLoLsmbLsbLeb
RsbRsLsLsmbLsLsmbLgRsbsbRsbRobRcLsRsbLibLiLsbRsLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbLsbRsbLsbRsbLsLsmbLoRsbsbRgbLhbRsbLsbRgbLibLgLsbLsLsmbLgRsbLobLgRs
bRhbLgbRgLsbRhRsRsmmbLcbRhbRsRsmbLobLsLsmbLgbLgLsLsmbLgbLgbLgbLgRsbRoL
sbRibLsLsmbLsbLsbLsbsbLibLgLsbLgLsbLibLibRibLoLsmbRiLsbLiLsRsbRibLsbRs
LsLsmbRoRsmbRcbLsbLsLsmbLsbRsbRsRsmbLsbRsbLsLsmbRsLsRsbRsbLsRsLsbRsRsL
smbLsbsbsbsbLsRsbRsbRjbRsRsmbRgbLgRebRgbRoRsmbRoLsRsbLgbLibRobRibRobRc
RsRsmmbRhbRgbLebRobLgLcbRsRsmbLsLsmbRoLsbRebLhbLibRsbLgbLcbRgbReRsRsmm
bRcRsRsmmbRiLsbRibRebLgRsbRjbLgbRsLsLsmbRsLsbRsbLsbRibRhRsRsmmbLcbRhbL
sbLsbRsbsbRsbsbsbsbLjbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bRcbLcbRsbRsRsmbRgbRgbRgbRgRsmbRsbRoRsmbLgbRcbRcbLeLsbLsbRsLsbRiRsRsRs
mmmbRibRoRsmbRjRsmbLcbLgLsbLgbRsbLsbLiLsbLsbLibRobsbLgbLcbRgRsmbRsRiRg
RgRgRsmbRjbLsbsbLcbLoRsRsRsRgRsmmmbRgRsmbRjbLibLgRsbLgbLgLsbsbRsRsmbRi
LgbLcbRiRsmbRgbRibRgbRgRsmbRoLgbLgbLgbLsbLgLsLsLsmmbLobLcRgbRgbRibRgbR
ebRgbRiRsmbLsLsmbLsbLsLsmbLobRobLsbRibRiRibRibLgbRsRsRimbRgRsmbRiRibsb
sbLgbRgbRsbLsbLcbLoRsLsbRsLsbRiRgRsmbRjbReRibRjRsmbRgbsbsbRsbRsRsmbLjb
LgbLcbRgRgRsLjmbRibLsRiRibRiRsmbRiRgbLoLsLsmmbRebRgRsRsReRemmbRgbRiLsb
RsRsRsRsRsmmmmbRgbRsbRgbLibRcbRebRebRobLsbRgbLeLsbRgbRibLibLobRiRgRsLs
mb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bLoRsRjbLobLebLoLhbLhRcbRsbLobLebRibRgRsmbRgbRsLsbLobLiRsbRgLsbRgRsLgm
bLgbRebRebRiLsRsbRsbRgbLhbLgLsbLobLeLsLsmbLeLsLsmbLcbRgbRobLebRebLebRe
bRiLsbLsRsbRhbRgRsmbRsLsLgLsbLebRebLsRsRgLebLsbsbRoLsLsLsRsmmbRsbRsbsb
RsRsmbLhbRgRsmbRgbRobRgRsmbLibLebLebRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 25; Drug: Control PTZ 2.5 mM
bLcbLobLibLibRjbRibLsbLgRebLiLsRsbLjbRgbLobLebRgbLhbRjbRsRebRsLsbRsbLo
bLiLsbLeLsbRobLobRjbLoRsbRgbReRsmbRiRsmbLibLgbLcLsmbRsRsmbLgbLoLobLcLs
mbLsbLibRcRsmbRobLsLsLsRsmmbRsbLcbLcbLobLhbLcLsmbRcRsRcRsmmbReRgbLobRj
bRjbRibReRsmbRoRsmbRsbLsLsLsmmbLobRgbLobLoLsmbLhbLebLcbRiRsmbReRgRsmbR
gbLsLsmbLjbLcbRsbLebRobRjbLjbRebLsLsmbLgLsbRcRsmbRgbRcRsmbLhbLcbLiRsbL
gRsbLibLebRiRsmbRjbRcbRibRcRebRebRibRebRebRcRsRhmbLcRsbRcbRibRcRsRsRom
mbRjRsRsRsmmmbLcbLcLsLsLsmmmbLcLsmbLeLsLiLgRebRsRsmbRiLoLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 26; Drug: Control PTZ 2.5 mM
bRhRsRiLsRsRiRsmmbRibRibRibRiRsRsmmbRgbRiLsbLsbRgRcbLiRgbRibReRiRibRib
RibRiRsmbRgbLsbRibLcbRhRsmbRibRhLsRsLgbRgbRsRibRsRibRgbRiRsRsLsRgmmbRi
bRgbRcbRobRcbRcRiRibLsRibRgRsmbRobLiLsLsmbLgLsRsbLcbLgLsbLoRsbLcbLcLsm
bRibRhbRgRsmbRsbRiRsmbReRibRebRgbRhbRibRibRibLjLobLobLobLhbLobLcbLebLc
LsRiRhRsRsmmmbRhbRiRsRembReRsmbRibRgbRgbRgbRibRgbRibRgbRsbLebLsbLsbLcL
smbRcRsRiRsRoRgRemmbRgRsmbLobLcLsmbLsbRoRsRsmmbRobReRebRhRsReReLimbReb
RebLeRsbLoLsmbRgbRcbLcbRibRhLsbLsbRcRsmbLsbLeRsbRebRsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 27; Drug: Control PTZ 2.5 mM
bRiRsmbRobRibRhbRgRibRibLsbLgbRibRgbLsbRgbRcbLibLgbLsbLgbLcbRibRjbRcLs
bLjbRgbLsbRibRibLibLibLobLibRhLsbRgbRsbLcbLgbLgbLibRgbRjbRgbLjbLibLsbR
sbLsbLgbLgbsbLsbLgLsbRgLsbLsbLsbLsLsLsLsmmmbLibRjbLsLibLibLibRsbRibRgb
RgbRibRobRsbRcbRibLhbRibRibLsbRobLgbRgbRiRsmbLiLsbRcLsbRibRcbRgbRgbsbL
sbsbRcbRiLsbLgLsbRgRsmbRgbRcbRibRibLebRgbRsbRcbLibRoLsbRcbLgbRsbRcbLjb
LcbLibRsbLsbLibRjbRobRhLsbLsbLgbRsbRhbRibRibLibLgbLiLsbLibLsbRgbLcbRgR
smbLcbLcbLcbRsbRcRsmbRsbRcbLibRgbRoLsbRcbLsbRgbRibRgbRsbLgbRiRsRsmmbRi
LsbRgbLgbLsbRhbRsRsmbRibLsbRibRgbRsbRcbRgbLibLgbLcbRibLobLibRsbsbRsbRg
RibLgbRgbRgbRsbLsbLebLcbLibLsbRibLsbRsbRcbLsbRgbRsbRcbRjbRebRcbRibRsbR
sbRibRgRsmbRibRsbLsbLsbRgRsmbRibRibRibLgbLsbLobLiLsbLsbRsbRcbLibLeRsbL
gbLsbLibRsLsbLiRsbLsbLjbLgbLsbLibRibLiLsbLgLsbRsbLsbLsbLibRibLiRsbRsbR
sbRsLsbsbLibRgbLobLgbRsbRibRsRcbLhbLcbRgbLcRsbRgbLiRsLsRsbRsbLibRibRiL
sbLobRebRcLsbLcbLhbRsbRibRgLsbRgbRgbLcbLobLhLsbLcbLgbRjbRiLsbRgbLsLibR
ibRibRsRsmbRibLsbRibLsbLsRsbRgbRgLsLgbRgbRsbRibRgbRsbRgbLsbRgbRgbRsbLo
bRebRibLcbLjLsmbLgbLgRsbRibRobRobRcRsmbRsbRcbLsbRsbRibRgbRsbRsRsmbRibL
gbRibRsLsbRibLsbRgbLsbRsRsmbRiLsbLhbRibRsbRhbLiLsbRsbRhbRsbRiRsmbRsRsm
bRibRsbLibRcbRsbRibRibRsbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 28; Drug: Control PTZ 2.5 mM
bRiLsRsbRibRsbRiRsmbRsRsmbRgbRgbRgLsbRsRsmbLsLhbRjbRibRsbRsbRgRsmbRsbR
gbRsbRgbRgRsmbRgbRgRsRsmmbRsbRsbLeRsRsmbRsbLgLsLsmbRhRsmbRoLsRsbRcRsmb
LsbLibRsbRoLsbLcbLhbLibRibRcRsRgmbLcLsmbLibRcbLgbLsbLsLsmbLgbLibLgbLgL
sbLoRsbLsLsLsRsmmbLiLsbLiLsbLiLgLsLiLibLsLsLeLgLembLgbLsbLsLsmbLoRsbLs
LsmbLsLebLebLibLgbLsRsbRebRebRebRsRsmbRsRsmbRgbRsRsRsRsmmmbRsRsRsRsRsm
mmmbRgRsmbRsRsmbRsRsRsRsmmmbRsbRsbRsRsRsRsmmmbRcLsLsmbRobLjbLebRgbRebR
sbRgRgRsmbRsRsLsmbRsRsmbRgRsRgmbRsbRgLeLsbLgbLsLsLsmmbLsLsmbLsbLsbLsLs
mbLgbLsbLsLsLsmmbLsLebRsbLsLsLgmbLsbLebLsbLcLobRcRsmbLgLgbRsLsbRobReLs
bRibLsbRsbRoLsbRjbRcbLibRgRsmbRsRsmbRsbRgbRiRebRibRebRebRsRebRebLebLcL
smb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 29; Drug: Control PTZ 2.5 mM
bRsbRgbRibLsbRibRobRibRsbRobRcbLgbLgbRsRsmbRibLsRgbRibLhbLobRcbLobRebs
bRibLsbLibLibReRsmbRibLobLibLiLsbLsbLsbLgbLsLsmbLsbLgbRobLsLsLimbLgbLg
LsbLgbLgbLsbLgbLgbLgbLsbLgRsbLgbLsbLsbRcbLhLsRsbRibLgLsLsmbLobLjbLibLs
LsmbRibRgbLsbRcLibLebRibRsRsmbRoRsmbRobLgbRsbRsbRibLsRsbRibLsbRiLsLgbR
ibLhbLobLjbLoLsmbRebRgbRjbRsLsbRhbLibLibRsbRibRibLcbRcbRsbRsbLsLsmbLgR
sLsbRobRibRibRibRgbLsbRgbRsRsmbRgRsmbRsbRgbRgbRsbRiLgRsbLobRsbLoLsmbLc
bRibRebLjbLobLcbRibRgbLsbLjLjbRsbRsRsmbRgbLsRsbRgbRjbRhbLobLgLsbLsbLgb
RhbLsLobLsbRiLsbRsbLsbLgbRibRgbRgbRsbRgbLeLibRjbRebLcbLcbRhRsmbRhbRjbL
sRgRsRsmmbLjbLoLsLsmmbLoRsbRiLsbRhRsRsmmbsbLsLsmbLgbRebRgLsRsbLsRsbRcb
LsbRgbRgRsmbRgbLsbRibRcbRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 30; Drug: Control PTZ 2.5 mM
bRgbLibRsLsbRsbRcbLjbLcbLibLgbLgbRebRibLcbLiRsbRibRibRsbRsbRgbRsbLsbRi
bRsLsbLobLobRhbLgLsbLsbLibLgbRsbLsbLgLsbRebRebLibRibRgbLgbLhbLibRsbLib
LsbRgbLibRsbLibRgRsmbLobLobRibLcbRiRsmbRibRibRgbRsbRcbLibRsbRobLibLibR
sLcbRebLcbRibLobRgRsmbRcbRiLsbLgbRoLsbRgbLgbLibLsbLgbLibRgbLcbRhbRhbRe
bLibRsbLcbLoLsmbRibRgbRibRgRsmbRgbRsbLsbRibRcbLcbsbLobRiRsmbLsLsmbRsLc
bLcbRhbRibRsbRibRsbRgbRgbRgbRgbLgbRiLsbRoRsmbLibLgbLibRgbRobLhbLibLcbL
hbLcbLcbRhbRibRsbLibRgbRgbRsbRcbLjbRcbRibLjbLobRjbLoRsRsmbRibRobRcbLgb
RgbLgbLgRsbLgbLgLsbRsbLsbRsbLibRsbLsbLibRjbLibLobRcbRiRsmbRebRoRsmbLgb
RgbLgbRiLsbRobLibLhbLhbRgbRcbLsLsmbRiRsmbRsbRgRsmbRgbLcbLobRhbRobLgbLo
bRcRsmbLcbLsbLgbLsbRsbRebRibRjbRibRgbLobRcbRoRsmbLiLsbLhbRgbRiLsbRgbRs
bLsbLgbRiRsmbRibLsLsRsmbRgRgbRsbRgbRgbRgbRgbRgRsmbRgbRsLsbRibRgbRibLsR
cbRsbRobRiRsmbLsbRgbRobLsLsRgmbLsbLgbLgLsbLgLsLsmbLibLgRsbRebRcRsmbLhb
LobRsRsmbRhbLobRgRsmbRcbRhbLsbLebLibLgbRiRgLsbLebLoRsbRcbLcLsLsmmbLobL
iLsbRibRgLsLsmbRgbRgbRsbRgRsmbRgbRebRgbRhbRgbRgRgLsbLcRsbLcbRibLobRhbR
sRsmbRhLsbLsLsmbRiRsmbLgbRjbRebRjbRcbLobRhbLcbLiLsbLgRjbLsLgLgbLgLsbLs
bRsbLibRibRoLsbLoLsmbLcbLibRiLsbLibRibRhRsRiRgmbRgRgRiRsLsmbRgbRgRsRim
bRgRsmbRgRgbRibLgbRcRsmbLgbRibRgbsbLobLcbRgbRibRgbRiLsbLsbRiLsbRgbRgRs
mbRsbRgbRibRgRibRibRibRsbLcLsmbLcbRgbRobRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bLgbRsbRibRgbRsbRsbRgbRgbLgLsbLibLoLsmbLiLsbRsbLsbLsbRobLobLcLsLsmmbRs
bRsbRoLsbRibLobRsbRiRsmbRjbRibLobLsbLgLsRsbLsLsLgLsmbRjbRibLobLjbLsLsL
smmbLibRsbRgRsmbLgbLsLsmbLiRsbLsbLsLsLgmbLgLsbLgLsbLeLebRobRobLobLibRe
bRebRebRgRsmbRiReReLoLsLeLsmbLgbRcbLgLsbRsRsRsLgRsRoRsLsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bLobLgbLsbRsbLsbLsbLgbLsbLibRcbLsRgRsmbRsbRsRsmbRgbRsbLebLhbLgbLsbLsbL
oLsmbLgLsbLebRsbRhbRiLsbRgRgbRgbRsbRibLsbRoRsLsRsmbLgbRsbLsbLibLgbLcRs
bLsRsbLcbRsRsmbRhLsLsmbLsLsmbLibRobRcbRsRsRsRgmmbRiRsRhmbRebRobRebLeLs
bLsbLsLebRiLgLeLsLibRsRsRsLiLsLgmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bRcbLgLsbLsbLsRoRsmbLgbRgbRsRsmbRsbRgRsmbRoRsmbLibRibLgbLcbLsbLgbLibRi
bLibLsLsmbLgbLsbLgbRsbLsLgbLgbLsbLgbLsbLgbLsbLgbLgbLgbLibLiRsRgLsLsmbL
iLhLeLeLeLebLjbLsbLiLsLsLsmmbLsLgLsbLsbLgLiLsbLsbRsbRcbReLsbReRsLcRsmb
RsRsRsmmbRgbRgLsLsLsLsRgmmmbRcbRsRgbRsRgRsmbRsRsRsReLsLgmmbRiRsRsLsmmb
RiRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bRgRsmbRcRgLsbRibRcbRibLibRcRsLsmbRibLobLcLsmbRgbRibLcLsLcmbLsbLcbRcbL
cLsmbLhbLhRsbLibRsbRibLsLsmbLhbLgbLibLcLsmbRhbsbRibLjbRsbRcLsbLgRcbLcb
RcbLsbRibRgbRgbRibRgbRsRsmbRiRsmbRgbRsbLobLgLsRsbLgbLgbLgLsbRjbLibLcLs
mbRibLgbLsbLiLsbLsbLgbLgLsbLsbLgbLgRsbLgbLgbLgbLgbRsbLcbRibLibLgbRibLi
bLiRsbRgRsmbLcRsbRibRobLhbRcbRsbRgRsmbLsbRgbRobLcLsRsmbRgbRsLsbLgbLiLs
bLgbRgbLibLsLsmbLgbLibRiLsbLcbRibLsbRcbRcRsLsLsmmbRibRiRsmbRiRsLsmbRib
RcRsRsmmbLibLiLsbRgbLibRobLhbLcbRjbLibLsLsmbLiRsbLibRsbLibLgLsbLsbLgbR
gLibLgLsbRsbLibLsbLgLsbLcbRiRsmbRibLcLsmbReRsRsmmbRhRsmbRoRsRsLsmmbLcb
LiLsbLcLsmbLobLhbRobLibLobLobLiLsbLcbReRsmbRibRiLsbLsbLebLsbRcbRhbLsbL
ibLhLsbLoLsRhRsmmbRibRhbRibRgRsLsmbLsLsmbLobLobRibRgRsmbRhbRgRsLsmbRgR
smbRgbLjbLsLobLobReRsRsmmbRcbLcbRhbRcbRibLibRiLsbLsbLcbLoLsmbLobLibRcb
RcbLcLsmbLibReRoLsbRibLibLiLsbLsRsbLgLsbLgbLsbLiLgbLgLsbLhbRcbRcbRcLsb
LcbLibLiLsbLibRsRsmbRsRcbLobLhbRsRibLgRsLhbLibRgbRgbLobRiRsRsmmbRsRsmb
RobRcbLcbRjbRcLsbLcbRcbRcbRjbRoLsbLcbLoRsLsbRcRsRsmmbRiRsLsRsmbLoRsbLo
LsmbLcLsmbRibRibLcbRjbLcbRibLobRiRsLcmbLibLibRjbLibRoLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bLgbLgLsbLsLsmbLgbLgbLgbLgLsbLgbLsbLibLgbLibLsLsmbLsbLsLsmbLgbRsLsbLgb
LsLsmbLsbLibRsbLhLsbLcbLgLsbLsbRcLsbLibRgRsmbRibRoLsbRobLoLsmbLsbLgbLg
bLibLibLgLibLsLsmbLibLgbLgbLiRsbLibLgbLgbRsLsbLobLcbLgbLgLsbLiLsbLgbLi
bRcbLibLcLsmbLsLsmbLiLsRsLsbLgbLgLgLsbRobRibLgbRibReRiReRsRimbRiLsbRgb
RiRsmbRsRiLsbRgbRgbRhLsLsmbRebRgbRgbRgbLobLobLobLobLsbReRsmbRhLibRibLe
LsbRsbLsbLgbRobRobLebLibRsbRgbRibLgbLobRgbRsbLoRsbRgRsmbRsRsmbRoLsbRcb
LibRgbRsbLoRsbRsbRsbRgbLoRsbRibLgLsbLiLsbLsLsmbLobRoRsLgmbRsbRebLhbRjb
LobRiLsbLsbLsbLibLgbLsLsmbLgLsbLgLsbLgLsbLgbRsbLcbLobRgbLgLsbRsbLobLob
LobLobRsRsmbLiLsbLsbLsLsmbLibLsbLibLibLgLsbLsbRobRcbRcbLsLsmbLsbLsbRob
RobRgbRebRoRsmbLsbLibLibLgbLiLibRsbLgbLgLsbLhLsbLhbLobLobLoLsmbRobLgbR
ebLcLsmbRjbRoLsbRebLoLsmbLoLsLsLsLeLsmmmbLsbLsbRgbRoLsbRgbLobRobRoRsmb
RiLsLsmbLobLcbLobLeLgLsbLobLobRsbLobRsRsmbRobLgLsbLsbLsLsLiRombLiLsbLe
LsbLiLsbLcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bsbRebRhbRsbRgRsmbRsRsmbRgbRsRsmbRiLsbRibRsRsmbRgRsmbRgbRgbRgRsmbRgbRs
RsmbRibRibRsbRgbRgbRsbRgRsmbLsbRgbRsRsmbRobRcbRcRsmbRsbRsbRsbRcbLsbRsR
smbRsRsmbRgRsmbRiRsmbRsbRgbRsRsmbRsbRcbRcbLobLibsbRhRsmbRsbRgRsmbRobLg
bRsbLgbLhbLcRsbRebLjbLcbRiRsmbLoLsmbLcLsmbLibLobLibLsLsmbRgbLibLsbLobL
obLibRcbRoRsRsmmbLibLgLsRsRsmbsbRobLsbRsRcbRiRsmbLsRsLsbLgbLgbLoLsmbLj
bsbLhbLsbRjbLsbLhLsbLgbRgRsmbLiLsbLgbRcbLhbLibRsbRsbRibRgLsRsbRcbLcbLg
bRsbRobRsLsbLsbRobRiRsmbLebLibLgLsbLcbLibLgbRiRsmbLsbLcbRebRcbLgbLsbRs
RsmbRcLsbRgbRsbRgLsbRcRsmbRcRsmbRcbLhbLcbRsbLgbRsbLoLsmbLcbLibLgbRsbLs
bLobLcbLhbRsbLcbLebLsbLibRiRsmbRcRsmbRgbRsbLsbLgbRobRcRsRsmmbRebRcbLib
LsbLsRoRsmbLibLiLsLsmbLibRsbLgbRsbRobLhbLibRebReRsmbRibRibRibRgbRoRsmb
RcbRibRcbLgbRobRhbRebRjRsmbLibLcbLcbLibLhbRsbLhLsLsmbRgbLsLsmbRsLobLib
LgbLsbLobLcbLgbLhLsbRcbRcbRoRsmbRibRsbRoRsmbRsbLebLgbLsLsmbLgbLgLsbLsb
LsbRcRsmbRcbRcbRsLsbRibRhbRsbLsRsbsbRsbRobRgbRsbLsbRobRcbRcbRgbLcbLobL
cbRcbRobRebRhbRsbRsbLibRobRcRsRsmmbLebLsLsLsLsmmmbLobLcLsmbRoRsmbRcbLg
Lsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bLibLcbRgbRibRibRgLsbRibRsbRgRsmbRgbRobLgbRsbRsbRgbRobRibRgLsbLsRsbLib
RibLsbRgLsbRgbRsRsmbLgbRobRobLibLgbLiLsbLgbRsRsmbLibLgbLjLsLsmmbRobRib
RsbRibLsbRgbLebLgbRibLhbRebRiRsmbRsbRibRsbLobLiRsbLgbRgbLgbRjbRibRibRg
bRsbRgRsmbRsbRgbRibLgbRibLsbRgbRsbRsbRgbRsbRgbRgbLsbRsbRsbRsbRsbLsbRcL
sbRsbLobLibRgbRjRsmbRiLsbRibRsLsbRgRsmbRgbRsbRoLsbRibRibRgbLsRsbLjbLoR
sbLsbLiLsbRobRsbRibRhRsmbRsbRiLsRsbRsbRcbRibRgbRibLhbLibLobLobLhbLibRo
bRiLsbRsbRiRsmbRsbRoLsLsmbRobRsbRsRsmbRsbRibRibRiRsRsmmbRibRsbRgbRsbLo
bLgbLibLibRcbLiLsbRebRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsbRiRsRsmmbRibRsRsRsmmbRgbRsbRsbRiRcbLsbLsbLoLebLcbRibRiRsLsRsRsmmbR
sRsmbRsbRgRsmbRsbRsbRsRsRsRsmmmbRsbRsbRsRsmbRsRsRsmmbRgRsmbRsRsmbRgbRs
bRsRsRsmmbRsRsmbRsbRgbRsRsRsmmbRsbRobLjRhbRgbRsbRgRsmbRgbLobLibLibLsbL
gLsbLsbLsbLibRibLiLsbRobLiLsbLobLgbLsbRjbRgLsbLsRsRsmbRsRsmbRgbLgbRsRs
mbRgbRsbRsbRsbRsRsmbRsRsmbRgLsbRoRsRsmmbRcbRcLsbLsRsbRhRsmbRcbLoLhbRsb
LhbRjbRgbLhbLibLiLsbLoRsLsbLcbRcbLjLsmbLoRsbRibLoRsbLsRsbLsbLjLsmbsbLo
LsmbLgbRsbRoRsmbRibRgbsbRobLiLsbLsLsmbLsLsmbLobLoRsbRhbRgRsmbRsRgbRgbR
iRsmbRibRgbLobLhLsbLiLsLsmbRjbLcbLcbLiRsbLsLsmbRibRgbLoRsbRhbRhbRsbRsR
smbRsRsmbRgbRgbLsRsbRibRibRobRcbRibRoRsRsmmbRhbRiLsbRibRgRsmbRsbRsRsmb
RgRsmbLsRsbLsRsbLsRsbRhbLgbRiRsmbRgbRgbRibRsbRsbRobRibLiRsbLgLgLsbRsbR
jbLibRsbLibRsLiLhbLibLgbRgbRjRsRimbRiRsmbLsbRsRsmbRsbRgbLsRsbRsRsmbRsR
smbRgRsmbRibLoLsmbLhbRgbRebRiRsmbRsbRibRgbRgbLsLsmbRhbLsRsbRobRjbLcbLg
bLgbLsLsRsRsLsmmbsbLibRibLoLsRsLsmbLobRibRcbRobRcbRiLsbLgbLcLsmbLsLsmb
LiLsbRgbLgbLgbLsRsLsbLoLsmbLoRsLsbLobLsbRibRibLgbRgbRgbRgRsmbLsbRcbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsbLgLsbLibLsLsmbLcLsmbLcLsmbRiLsbRsbLiLsbRobLgbRibRsbRsbRgbLsRsRsmbR
sbLgbRibLsbLsbRgbRgLsbRsRsLsmbRgbRgbRiLsbLgLsbRiLsbRgbLsbRsbLhbLibLsbL
hRsbRibLcLsmbLgbLgbRibRsbLibLsbLibLsbLgbLgbRsbLiLsbLsRsbLiLsbLsbRsbLhb
LsLsmbLgbRsbLibRsbLibLgbLsbLoRsbLsbLsbLhbRobLibRibRsLsbLobRibLiLsbRobL
hbLibRsRsmbLibLsbLibRgbRcbRobLhbLcLsmbLcLsmbLsbRibRsRsmbLgbRcbRgbRgRsR
smmbLsbRsbRgRsmbLsLsmbLcLsmbLibRsbLcbRiLsbLhbRobRobLsbLgbRsbLebLibLgbL
cLsmbLsbLobRobRibLsRsbLhbLibLsLsmbLobsbsbLgbLhbLjbLgbLgbRsbLhbLjbLsLsm
bLgLsbLgbRsLibLsbLgbRobLobLibLcbLhbLsLsLsmmbLgLsbLeRsLoRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bLobLobLibLsbRiRsmbLsLsmbRibRsRsLsmbRiLsbsbRjRsmbRibRgLsRiLsbLjbLobRgb
LhbLsRsbLibLibLsbLcbLobLibLiRsRsmbRsbLgbLgbRibLgbLiLsLsmbLgbLsbLgbLgbL
ibLibLgbRibRgbRcbLsbRiLsbRgRsmbLcbRgbLoRsbRgbRgbLjbRoRsmbLobLhbLgLsbRg
bRjbLsbLibLhbLibLiLsLsmbLibLibLjbLsbLsbRiLsbRhbRobLgbLhbLjbRsbRoLsbRsb
RsbLobLeLsbLiRsbLsbLgbLgRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsbRsRsmbRsRgbsbLsLsmbLsbRgbRsRsRsmmbRibRibRiRsmbRebRobLsbLgbRhbRiLhb
LgbRgbRsRsmbLoLsmbRcbLibRiRsRsmmbLcbLibLobRhbRgbRgbRgbRsbRiLsbRgbRgbRi
RsRsmmbLsbRgbRsbRsLsbRgRgbRebRiRsmbRcbRgbRjbRibLsbRiRsmbRsRsmbRgbLgLsb
RcbLsbRibRsbRsbRgRsmbRgRsmbRgbRgbRgbRibRibRibRgbRiRsmbLibRhbRhRsmbRsbR
sbRcbRebRibRgbRoRsRsmmbRgRsmbRibRiRsmbRibRsbRgbRgbRgbLeRsbLcbRobRcbLcb
RibRgbLsLsmbRibRcbRcbLgbLobLcRsbLiLsbLibLeLsbLobLoRsbLhbRibRsbLobRgbLo
RsbRiRsmbRgRhRsmbLsbRhbRcRsmbRgRsmbLgbLiLsbLcLhbLsLsLsmmbLcbLeLsbLsbLo
RsbRgbRsbLsbRsRgRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcbRsRsmbRebRgbRiLsbLjbRoRsmbReLsbLsLsmbRcbLhLsbLibRsbLiLsbRsLsLsmbLg
LsbRsbLgLsbLgbLgbLibRgbRoRsmbRoLsbRobLhLsRsbRsbLhLsbLibRsbLsbLsRsbLibL
iLsbLsbLgbLgbLgbLgbLgbLibLgLsbLsbLgbLcLsLsmmbLsRsbLibLsbLgbLsbLgbLgbLi
bLgLsbLgbLsbLgbLgRsLsbLgbLgLsbLsbLgbLgbLibLgbLsbLgbLgLsbLsbLgbLgLsRsbL
gbLsbLgbLibLgbLibLsbLsbLsRsbLgbLibLibLgbLgbLsbLgbLgbLsbLgbLsbLgbLgLsbL
gbLgLsbLgbLsbLgbLsbLgLsbLibLsbLgbLgLsbLgbLibLgbLebLgbLhLsbLgbLgbRsbLsL
gbLsbRcbRsbRoLsbLcLsmbRibLeLsbLiLsbRgbLiLsbLsLsmbLsbLgbLsLsmbLgbLgLsbL
sLsmbLiLsbLgbLgbLgLsbLiLgbLgbLiLsbLgbLibLgLsbLibLgbLebLebLcbRhbLibLsbR
obRcRsmbRoLsbRsbRibLebRcbLhbLebLcLsmbLsLibLebLibLsbLgbLsbLgbLgLsbLsbLs
LsmbLsbLgbLsLsmbLibLgbLgLsbLibLibLibRgbLsbLibRgbLhLsbRsLsbLsbRcLsbRobR
cbRebRhbRcRsmbRhbLibLoLsLsmmbLsbLsbLcbRibLibLgbLjRoLsbLoLsmbLcLsmbLebR
jbRsbRebLcbLhbLiRsbLsbRobRobRobRhbLcLsmbLebLoLsmbLhbLsbLiLsLsmbLgbLgLs
bLgLsbLcbLsbRsbRcbRoLsbLoLsmbLcbLcbLiLsLsLgLsLsmmbLhbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbRsbLsbRsbRsbRsbRsbLsbLjbRjbLsbLhbLibRsRsRsmmbRobLhbLgLsbLgbLoRsbRc
bRsbRsbLiRsRsRsmmbRcLsbLgbRsbRgRsmbsbLsbLibLsLsmbRobLeRcbLsbLhbRsbLsbL
jLgbLibLoRsbRsbRcbLgbLsLsLsLimmbLibLsbLsLsLsLsLsmmmmbLgLsbLgLsLgbLhbRh
bLgLhLsbLibLgLsbLgbLgbLsbLsLgbLgLsLsmbLsbLsLgLgbLsLsLsmmbLgLgLsbLiLsbL
hLsLiLsbLsbLgLsLsLgLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bRibRgbRsRsmbRoLsRsbRgbRjbRebRsRsRsmmbRiRhLsbLhLsbLgbRhRoLsbLsLsLsmmbL
gbLibLsbLebReRcRsLhLiLsLgmbsbRsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbLsbLsbLgRgbRjbRjbLoRsRebLibRcRsRsmmbLsbLibLsbLibRsbLsbLgbLsbLsbLiR
sbLoRsbRgbLsbRgbRsRsLsmbRsRsRsRsmmmbRsRsRsmmbLgbRgRsmbRiRsmbRsRsRsmmbR
sbRiRgbRsbRibRgbRsRobLoRgRsmbLsLsRsmbLibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbRsbLsbRsRgRsRsRsmmmbLsbRsbRsRsmbLsbRsbRsbRsLsbRsbsbLsRsLsbRsLsbRsL
sbRgbLoRsbLsbRsbsbsbRsbRsRsmbRgbRsRsmbRiRoLcLiLsRsbLhLsbLhRsRiRsmbReRs
mbRgbRiRsmbRgbLebRibRebRgRsRiRsRimmbRgbRgbRgbRiLgRsbRsReRiRsmbRibRgRsm
bRsRsmbRgRsRsRgRiRsRsmmmmbRgRsmbRiRebRiRsmbRiRsRiRsmmbRobLsRsbRgbLebRo
bLcbRjbRsbRcbLiLsbLibLiLsbLgbLibLiLsRsLiLsbRjbRcLsbLhbLoLsLiLoLsmmbReb
LcbRobRgRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bLiLsbLgbLibLgbLgLsbRebLgbLsLibLgbLgbLgLsbRsbLgLsRsbLsLsmbLebLsbLeLsbL
gbLobRgRiLsbLsbRcbReRsmbRgbRibRjbLsRsbLsbRebRhbRibRsRsmbReLsbRebLsLsRc
mbRhbRebLsRsbRsbLibLgbRjbLsbLgRsbRjRsmbRsRgbLeLobLgbLibLgLsbLgbLsLsLgm
bLebRiRsmbLoRsRsmbRsbRgLsbRgbLcLsmbRibRebLgbLeLsLsLsmmbLiLsbRhRsRsmmbR
cbRsbLebsbRsbLiLsLsmbRcbReRsmbRsRsmbReRsmbRiRsmbRsLibRgbLjbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 144432; End: 144932;
Recording: 1-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bLibRsbLgbLiRcbRgbRgRsmbRgbRsbRgRsmbRibRsbRibLobRcbLjbLsbRjbLhLsbLgbLs
bLsbLibLgbLsbLgLsbLsbLobRoRsmbLgbLibLgbLiLsbLgRsbLgbLiRsbRgbLsLibRibRg
bLjbLsbRjbLsbRibLoLcRhRsRgmbRibRgRsmbRiRsRoLsmbLsbRsbLgbLiLgRsLsbLiLsb
LibLsbRcRsmbRibLibRgLsbRiRsmbLiLobRsRiRsmbRiRsmbReRgbLgbLsbRgbLgbLgbRs
LsbLsbLjbRibLoRsRsmbRoRebLsbRibRibRoLoRsbRcbLoRsbRobRcRgbRhLsRsbRgbLjb
LibLhbRsbLoRsbRebReRsmbRsbLjbReLsRebRsbLebLcbLgLhbLhRsbLoRsbLsRsbRobLi
bLsRgbRibLoRsRsmbLcbRhbLobLoRsbLcbLibLebRsbLeLibLcbLhbRgRsmbRhRsmbLobL
obRsRsRsmmbLobRhRsRsmmbLobLcbLoRcRebLibRcReRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 1; Drug: Control PTZ 2.5 mM
bLobRsRiRebLsLsLsLsLsmmmmbLgLsLebLgRobRebRsRibLsbLcRsbLeLcbRcbRcbRgReb
RibLgLsLsLsLsRcLsmmmbRobLsbRcbRcRsRsRgRcRcmmbLsLsLsmmbLebLsbRsRsmbRsRs
RsmmbRoLsLsLsmmbLebLcLsmbLsLebLcLcbLcLsmbRsbRgRhbLsRsRgRibRcbRsRebRobR
jbReRsRiRsRsRsmmmmbRsRsLsmbLeRgbRcLebLeLeLsbLibLgLsRsbRgbRiRsmbRoLsbLe
LsLsmbLsRgRsmbLcbRgRsRembRebLsLgbRsbRoLsRsRsmbRebRcbReLsRsRsmbReRsRsmm
bRcbRhbRgRsmbRgRcLsbLeLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 2; Drug: Control PTZ 2.5 mM
bLsbRhbRobRoLobRgRsmbRhbRibLobRgbRsRsRsmmbRgRebRebRebRgRgRsRsRsmmmbReb
RibLebLebLoRebLsRsRsRsRsRemmmbLobLoLcRgRsRsmmbRibRgRsRembRsbLebLebLsbR
eRgbRoRsRsmmbRobRoLsbLcLsLcLsLsmmmbLibRgbRgRsmbRebRcLobLcbLibLobRgRsmb
LebReLcbLsLsLsLeRsmmbLobRsbRoRoLeLebLhLibLsLsLsLsLsLsmmmmmbLsLsLsmmbRo
bLebLebLobRsRgbRsRsRsRgRsmmmbRoRsmbRiRibRsReRsRiRsmmbRiRsmbRsRsRsRsmmm
bRcRsRsRommb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 3; Drug: Control PTZ 2.5 mM
bLcLsmbRcbRcRsmbRhbRsbRiRobRcbRibRsLsLiLiRgbLiLsbLgLsbLgbRobLoLsmbLobR
gbLobRobRhbLobLobLobLobLcRebRibRsbLobLobRobRhbLjbLebLgbLobRsbRgbLobRhR
smbRgbRobRobLibLebLebLebLebLgLhLibLsbLcbLobLcbLoLcbRcRcbLcbRcRsRembLsb
LobLcbRobRcbRobRobLobRcbRiLsLsmbLcbLcLobRobLcbLebLeLsbRobLsbRcRsmbLeLo
bRobLoLobLobRcbLoLsReRsmmbRsRsRgRsRsLsRsRimmmbLoRsbLoLobRoRsRhLsRgmbLc
RgRsLcLsmmbRoRsmbLobRcbRoLobRsLsbLsRsRsRsmmbLobLebLebRhbRcbLcbLeLsbLgL
sbLebLsLsLsLsLsmmmmbRcbLebLebRobRsRiRiRsRiRgLsmbRsRsRsmmbLiRoRsRsmmbRs
RsRgmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 4; Drug: Control PTZ 2.5 mM
bRcbLhbLoRsbRcbLoLsmbLobLcbLcbRhbLgLsLsmbLibLgLsbRsbLoLsLgmbRsbRcbRcbL
cbLiLobRhbLobRobLcbRgRsmbLsLsmbLsbLibLsbLiLsbRcbLcbRobLhLcLsLsmmbLcbRh
bRhRhbLsbLobRcRoRsLsmbRhbRcbLiLebLgLeLsRcRsLsRsmbLibRebRcRsmbLebLebLgL
sLsmbLsLsLsRsLsRsmmbLgbRebRebRcbLjLsmbLsbLsbLgbRcbLobRsbRsRsRsmmbLcbLo
bRebRebLgbLsbLjbLibRobLeLsbRoRobsbRiLibRsbRsbLgLebLebLgbLsLsLsLhLsmmbL
obLobLiRjbRebLiRsbLsLsLsLsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 5; Drug: Control PTZ 2.5 mM
bLsbLsbLobRgbRsbRgbRibRcbRcbRsbRgbRsbRhbRobRcbLoLsmbLcLsmbLcLsmbLcbLsL
smbLiLsbLsbLgLsbLsRsbLiLsbLsbLsbLgbLgbLiLsbLsLiLiLeLsbLiLgLeLsbLeLsLsm
bLeLsLeLeLgLsbLeLgLiRsLsbLebRcRsRsRsmmmbRsRsLsRsmbRebLeLsbRsbLeLgLsLsm
bLsbLcReLobLgbLebLcRiLsbLgbLoLsmbLgbReRsmbLsLsmbLsbRsRsRsLsmmbLhRsbRcb
RebLcLsmbRsRcbRcbLgLobLsLibLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 6; Drug: Control PTZ 2.5 mM
bLcLsmbRcbLcbRcRsmbReRsmbRcbLebLsLcbLoRsbRhbRiRsRsRjmmbRoRcRsRsmmbRobL
ebLobLebLobLebRobRebLcRhbRsReRsmbLcRobRebLoLsLsmmbLcbLgLeLsbLcRsbLiLob
LcLsmbLcLsmbLsLgbRcLobLibLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcbsbLibLsbLsbLiLoRibLobRobRobRjRcbRsbRoLsbLobLcbLobRhbRjRsmbRibRibsb
LsLsmbLsbRjRsmbLobRobLjbLcLsLsmmbLhLsLsmbRhbLcbRobRcbRsbLcbRcLsbLcbRhb
RobLjbLhbLobRibRibRgbRiRsmbRobLgLsbRobLgbRobRobLsbRcbLcLsmbRobReRsmbRc
bRcbRibLobRobRiRsmbRgRgbRcbRoRsRiRsmmbRgRsRsmmbLcLsmbRcRsmbRsRobRoLsbR
oRoLobLibLcbRoRsRsmmbRsRoRsRsmmbRsRsmbRoRsmbLobLobLoLsRsmbLoLsLsmmbLgb
LobRoLsbLsLsRsRsmmbRcRsmbRoRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bLoRsbLhbLibLibLibLgbRebRobRjbRgbRebLibLiRsbRebLoRhRsmbLcbLoRsbLibLhbL
sbRsbRsbLcRsbLcRsbRcRsmbRcbLgbRobsbLibRebRgbRcbRhRsmbRcRsRsmmbRcLsLsmb
LcbLcbLibRsRiRiRsmbRsRsmbRobRsRsmbRhbRsbRsRsmbLcbRcbRsRsmbLhbLhRsRebRe
bRebRebRobLobReRebRibLjbLobLibLobRsbRibRiRsRsmmbLiRsbRgRebRebRebRebReb
LsbLobLobRgbLobLobLsRsbLibLgbRebRebRcRsmbRhbRobRobRsRebRebRebRebRebReb
RiLibLsLsmbLcbLcbLcLsmbRcbRcRsmbLsbRsbRcRsmbLsbRoRsmbLcLcbRgRebRgRhbLj
bRoRoLcLsmbLcbRsbLsbLiLeLeRgbRhRsmbLoLcbLcLsmbLobRsbLsLsmbRcRsmbReRebL
ibLeLcRcRsRgReLsLcmbLebLebRgbLoRsbLoLsLsLgLsLsLsLsLgLsLsLsmmmmmmmbLsLs
LsRsmmbLoLsRsmbLgLsLsmbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsbRsbLebLobLsbRibRcRcbReRsmbRsbRiRsmbLcbRiRsmbRsbRsRebRebRhRsmbLsbRe
RsmbLcbRjRsRsmmbLeLsbLobLoLsLsmmbRcbLhbRjbRebRcbRcRsmbRcbLgbRibLobLcbL
oLobRcbReRebLsbRsbRcRcbRoRsRsmmbRcbRsRgbRsReRsmbLgbLcLebsbRsRsRsmmbRoR
obReRsRsmmbLgbRsRiRgbLebRgbRsRsRsmmbRoLsbLiRhbLcLsmbRobRsbLebRobLob

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bRcLsRibLeLoRsRcRobRcLsbRebRcbLebLebLibRsbLibLeLjbLsLobLebLebRsRobLebL
ibLobLobLcRhbRebLiLgbLgbReRsRsmmbRebLcRcbRgRsmbReLsLeRebLibRcRobLob

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bRgRsmbLoLsmbRibLsbLhRsLcbLgLsbRcbRhRsRsmmbRobRcbLobRsbRcRsmbRobLcRsLs
bLobLobLiLsLsmbLsbRcbRibLiLsbLiLhLsbRsRobRibLoLibLibLgLsLsLsmmbLoRsbRc
bLoLsLombRgLsbRsRsmbRcLsbLoLsLcLhLgLembReRsmbRsRsmbRcRsRsLimmbLebLebLg
bLgLsLsLsLemmbLebLebRgRsmbRsRsmbRsRsRsRsLeRcmmmbRsRsRsmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bRgRsmbReRsmbRebRsbRibRgRsRsmmbRsbRiRsmbsbRjbRsbRsRsmbRiRsRsmmbRgbRsbR
gbRgbsbLcbLcbLibRsbsbRibsbLobLobLobRgRsmbRcbRcbRibRibRsbsbLsbRoRoRsmbR
sbRibRsbRiLsLsLsmmbLibRibLsbRoLeLhbRgbRgRsmbLjLsmbRsRsRsmmbRobRgbRoLsL
iLiRsbLsLoRsRsRoRgRsmmbLoLsLsmmbLsLsmbLgLsbLhRsbRibRgbRiLebRgbRcLobLgL
ebRsbLebLebLiLsLsLsLgLemmbRebLebLcbLebRcRgbRjbRgbRsRgRsRsRsRsRsRsRhmmm
mmmbRiRsmbsbRsbRjbLgRsLsbLobLebLebLibLsLeLsLcRsbRebLsbLsLgReRebLgbRsRs
RsRsRsRsmmmmmbLsRsRgRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bRebLiLsbLsRcRsmbRsRsRsRsmmmbLsRsRsmbRgLsRgbRiRsmbLsLhbLobRebRebLobLeb
RsbRsbRsbRsRebRibRsbLsRsRsmbLsLibRsLsLsLsLsmmmbLsLibLebRcbRebRiRsLsmbR
sRsmbRgbRcbRsbRjbLibLebRiRgRsmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bRoRsmbLgbsbLibRgbRobLcbLsLsLsLsmmmbRsbLoRsbLobLcbLibRoReRsRhmbRobLeLo
bLsbLobLhbReRsRsRgRsRsmmmmbRgRsmbLobLobRobRcRsRiRsRcReRgReRimmbLobRsRs
RsRcmmbRoRsmbRebRebReRsmbLobLgLsRsRsmbLsbRebRobsbRsbLgbLjbLobLsbLsLsRs
mbLgLibRobLobLjLeLsbRsLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bReRsmbRcbLsRsRsRsRsRcmmmbRebRhLsRsbLeLcLsRembRibLeRebRebRcbLcbLsLeRob
RcbRebLgLsLebLsLoRsbRcbLcbLeLcRsRobReRibRebRibLcLsRsmbRcRoRebLhbLoLsmb
RsReRsmbLeRsbLcLsRiLsmbRebRsLsRsRcRsRoRsmmbReRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bRoLcLibLgLcReRsRsRsmmmbLgbLeLsbLsbLsLeLsbLsbLsLeRoRsRsRsmmmbRcbLsbLcL
cbRoRsmbRsbReLobRobRgbRcLcbLibLebRebRcbRoRsmbLobRcRsmbRgRsLsRombRcbReb
LcbLebLeLsbLcbLgLsbLgLoRsbLebRcbLsRiRsRembRoRobReLgbLeLsbLebLcRsbLhbLo
bRibLibLibLcLsmbLsbLsbRebRcRsmbRhLebLebRobRebRgRobRgbLcbRcbRsLebRibLcL
smbRobLeLsLsLombLsLcRsbLsLsmbLsbLsRsLeLiLsbRgbRebRoRsmbLibsbRsRsmbLsRs
bLibRebLsbRhbRsbLsbLsLsLsmmbLiLcbLiLgLcLsmbLsRhRsRhLsmbRcbRsLgRsbReRsR
smmbLcLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bsbLgbLcbLcbRobRgRsRsLsLjLgmmbLobLib

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bLobLsbRgLgbLgLgbRjbRebLjbLoLsLeLgmbLebLebRobRobLsbRsbRebReRebRsRsRsRs
mmmbRsRsmbRsRsmbRsbRobRoRcbRoRoLsbLsbRobLgRcRsmbLsbRobLebRebRebReRcbLs
LiRiRsLsmbLsLgbLiLsbLsLeLsLobLgbLibLcRsRsmbRsbReReb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bRebRobRcRsRsmmbRgRsLsmbsbsbsbLsbRgRgbLsbReRsmbRgRsmbRiRsmbRgRsmbRgRsm
bRgbRcbRsbRsbRgbReRsmbRsbRibRibReReRcbLsbRgbRsbRsReRsLombLibRsLsLsmbRs
bRebRiRsmbLjbLsbRsbRsbRsRgRgbRebRgbRiRsRsmmbRgbRgbRsbReLoLsLsmmbLgbRiR
smbLcRsbRjbRgbRebLiLsbLgbRsbRibRsRcRsmbLsbRsRsmbRebRcReRsmbRsbReRoRsmb
RebRsbRgLsbLjbRsRsmbRsLsbRsRsRsmmbRgRhRsmbLjbRebLgbLgLsbRjbRebRibRgbRg
bLgLsLsLsmmbLgRsbRibLobLiRsLsbLgbRgbLebLibLeLcbReLeLsLebRsLsLsmbLgbLiL
sbLeLsbRsbLgbLsLgLsbLibLsbRgbLebLibRgbRgLsLibLjbLsbsbRibLebRgbRsRsmbRs
RsmbRsbLsLebLibLsLsLgLembLibLcbRsRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsRsbLjbLibLibsbLsbRjRsRsmmbLjbReRsRsmmbLgbRgRsRsRsmmmbReRsRsmmbLsLsL
smmbLsLsLsmmbLsbLsbLobReLsLiRsbLsLsmbLebRsbLsLsLsmmbLsLsLsLsLsLsmmmmmb
LsLsLsLsmmmbRiRsRsmmbLgbLiRgbReRoRobLgbLgLsLsmbLsbLsbsbLgLsRsbLsbLiLsb
LgbLgbLiLsbLgRsRsmbsbLsbLgRsbLsLsmbLsbLgLsLsmbLsLsLsLsmmmbsbLsbRjbLgbR
sLsbRsbRibLhRsbRsbLsbLsbLhRsbLgbLjbRhRsmbLsbLgbRsbsbLsbLsRsbLiLgRcRsLs
mbRgRsRsRsmmmbLsbLsLsmbLhbRgbLgbRjbRsRgbRsbRsRsmbLcRsRsmbRoRobRgRsmbLh
bLsbRsbLsLsmbRgLsbLeLsbLiRibLobReRsmbRsbRsRsmbRsRsmbLgbRsbRgRobRibRebR
oRsLembRiRsmbLjbLibLgRsbLhRsbLsbLibLgRsbRibRsLsbsbLsbLiRsRsRsmmbReRsmb
RjbLibLsRsbLiRsRjbRoRsRsmmbRcLsbLgLsbRgbLsbRsbsbLsbRsbsbLgRsbRebsbsbLc
RsbRsRsmbLsRsbLsbLibRsbLjbLgRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bRcbLhbRsbLsbLgbLsRsbLobLcbRsbLoRsbRibRebRhbRobLoLsmbLsLsmbLobsbLiLsbs
bLsbRsRsmbLsbLsRsbRsRsmbRsbLsRsbRsbLsbLsbLcLsmbRjbRjbLsbLeLsbLgbLibLib
RsbLgbLsLgbRcbLeLsLgbLibLobLsRgRsmbRhbRsbRibRibLjLsmbRjRebRobLsLsLsmmb
RjbLsLsLsmmbRcbLcbLibRebLobLsbRsbRsbLgbLsbRsRsLsLsmmbRsbsbsbRjbLsbLgbL
gbLiLgLsbRsLeLgLsbRsRhLsbRiLsLgbLcLsmbRibLcbLebLgbLiLsbRsbRibLcLgbLsLg
LsLsmbRsLgbLsLsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbRobRobLsRsbRsRsRoLsmbLobRsLsbRgbsbLsbRjbLibRgRoRsmbRgbRcbLobLcRsbR
iRsmbRoLjbLgLsbLsLsmbLsRsLebLcRsbRjbRsRoLsbRebLgbRsRsRsLsmmbLgbLsLsLsL
sLsmmmmbLjbLgLsbLsLsRsmbLsLgbLsbLgbRgbLgLsbRcbRobLsLsmbRjbLoLebRjbLeRs
bRcLsRsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bRiLsbsbLgbRsRibRobRcLobRgLsRsbLsRgbLoLsLsmmbRcbRhbRiLobRoRsRsRsLgmmmb
LsbLsbRsbsbLeRsbLobsbRoRsRsmmbRcbRsLsbRsbRsbsbsbReLiLhRoRsmbLsLgRcbReb
RcbLobLcbLcbRoRgbLoRsbLgbRsbLibLgbReRebRsRsRsLommbLsLsLsmmbLibRsbLhbRs
bRcLgRobReRsRsLsmmbsbLsbRsbLsbsbLibReRsRsRgRommbRsbRsbRsbLiRsbLgbRcLob
LgbLobRobRcLsRsbRjbLobLebLibRcRsmbRgbLobRebLsLgbRebRcbLgLsbLebRgRsRomb
LibRsbLebLobReRebRsRgRsmbsbsbLcbLibLeRoRoLsbRsLsbRoRgbRebsbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgLsbLcbRgbRsbLsbRobLsLsRsLsLsLsmmmbRsRgbLoLsLsRsmmbLibLgLsLsLiRsmbRg
LsbRebLsLsLembRsbLsbReRobRgbRsLsLsmbLgbRoRebReRsLsmbRsRsRsmmbLobRgRiRs
RsmmbLiRebRgRibLsbRjbRsbsbLgLsLsLsmmbLsLsmbLsLsLsmmbRsReLsbRebLgLgbReb
LgbRiLsbReRgLeLsLsmbRsbRsbRibRibRebRiLgRsRoLsLsmbLsLsmbRobLjbRcRibLeLo
bLgbRgbRsLgbRobRgbLoLibLobLibLgLgbReRsRsmmbRsRgbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 25; Drug: Control PTZ 2.5 mM
bRibsbRsbRsRsmbLsbLcbLcbRcbRcRsmbRebRcbReRsRcRcmbRhbRoRsmbLhbLcLsmbLgL
sLgbLcRebReRsmbRhbRgbRiRsRembLgbLobLobLgbRebLsRsRsmbRgRsmbLgRsbRiRebLo
bLebRgbRsRgbRibLsLsLsLsmmmbRsbRebLebRcLsRebReRsmbLoLsmbRcRsmbRgRsLsmbL
ebLcbRgbRsbRcbRiRsmbRgbLcbRebLgLsbLjRcRsmbRcRsRombLsLcbReRsmbRebRsbLeR
iRsmbRsRsmbLsbLobLhbLcbLsLebLebRgbRjRsLcmbLcbRgRsmbLcRcbLsLsLembLhRhRs
RsmmbRsLsLsmbLcbRebReRsRsmmbLsLsRsmbLjbRebRibLibLsRsbRgRoRgbRibRcbLsbR
ebRobLebLoRsRsmbLebLebLsLsRsmbLeLcbRebRgbLoLsmbRgbRobRsRsRsLgmmbLeLsbL
cbLcbLebLsLsLsmmbRsbLobLebLsLsLcReRsmmbRcRsmbLcbRebRsbLobLebRgbRobLebR
eRsmbLibLiLsLsmbLsbLgLsRsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 26; Drug: Control PTZ 2.5 mM
bRobRjbRoRsRcmbRcRsRsmmbRsbLeLsbLibLebLcLsmbLsLsmbLcbRsRsRsRsmmmbRoRsR
smmbLoLsmbLiLeLgbLgbLsLsLsmmbLhRsbRsRsRgRoLembRjbRgbReLsbLeLsbLebLhbLs
bLsLsLeLimbLhbLiLsbLiLgbLsLsmbRsLsLsLsReLsmmbRoRsmbReLcLsmbLgLsbLgbLsL
sLsmmbLsbLsLsLsLsLsLsmmmmmbRgbLsLsLsLsLsmmmmbLgLeLebLeLeLsLebLibLgbLgR
sbLsbRsbLgLsLsLsLsRsmmmbLsLsRsmbLsbLsLsLiReRembReRsRsmmbRgRsmbRgbRgbRi
bRebRgRsRsmmbRgRsLsmbRebRhRsmbRsbLsbRgRsmbRsRobLsbLeRebRebRgRibRgbRsbR
sRsRsmmbLsRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 27; Drug: Control PTZ 2.5 mM
bRsbLsLsmbLcbRebRiLsbRhLsbRgbsbLgbRcLsbRsbRjbLsLsLsmmbRibRsbLjbRhbLgbR
ibLjbRhbRsbLjLcbRcbLoRsbRibRebRibRoRsmbRebLobRibLibLgbLobLobLcRsbLibLh
bRhbRsbRsbLobRhbLcbLgbLsbRibLiRsbLhbRibLhbLibLcbLibLcbLhbLibRgRsmbRibR
hbLhbRgbRhbLsbLsbLcLsmbLobLobRcRsmbRoRebRibRsbReLsbRhLsbRibLoRsbRgbLhb
LibLcbLcbLibLhLsbLhbLiRsbLcbRobRhbRgbLcbRsbRibLoRsbLobLcbLoRsbRebRcbLe
bLobLcbLhbLebsbRsbLhRsbLobLobRebRoLsbRobRcbRobLcbRiRsmbRiRsmbRibRsRsmb
RsbRhbRebRcbRibRibRoLgbRebRobRcbRsbRibLoRsbLoRsbLobRhRsmbRgbLcbsbsbsbL
obRsbLcbLcbLsbLhbLobLcbLhbLcRsbRsbLibLhbLoRsbLobLcbRiRsmbRcbRcLsbRibRo
bRiLsbRsLsRsbRhRsmbRibLcLsLsmmbLcbRcbLoRsbRobRcbRcbRebRibRsLsbLsLobRsR
smbLsbLsRsbRsRsmbRobLcbLobLoRsbLcbLoLsmbRcbRobRobRhbRibsbRsbsbLsbsbsbR
oLsbRiRsmbRebLobLobLcRsbLcbLhbLsbLibLhLsbLibLcbLsbLcRsbRibLsbLoRsbLcbL
hLsbLobRebRhLsbRibRsLcbLhbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 28; Drug: Control PTZ 2.5 mM
b

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 29; Drug: Control PTZ 2.5 mM
bLoLsmbLobLcLsmbRebRsLsbLcbLcbRcbReLsbLibLgLsbRcRsmbRcRsRsmmbRebRsbLsR
sbLgbRcbRcLsbLeRsbLibLiRsbRsRcRsmbRibRcRebRgbRcRoLgbRcRsmbRsRgRsmbRcRs
RsRsLeLeRcmmmbRsLeLsbLibRobsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 30; Drug: Control PTZ 2.5 mM
bRobRcbLcbLiRsbLebRebRoLsLsmbRcbRibLcbLcbLebRhbRsLsbRibRibRgbRhLsbRhbR
sRsmbRsbLibLsbLibsbRsbRgLsbRcbRgbRcbLsbLcbRobLcbLcbReRsRhmbRebRebRebRc
bRebRsbRsbReRsRembLgbLibLgRsbLjbRgbRcbRjbLobLsLsmbLcbRsbLcbLcRsRsLsmbL
ebRsbRoRsmbRebRcbsbRcRsRgmbRhbRsLsbLsbLiLobsbRebLobLcLsmbRcLsbRcbRoRsm
bRsbRcLgLsbLsLiLsbLgbReLsbRcbLgbLebRibRobLsbLibRjbLcbLcbLhbRebRebRebRe
bRebLobLgbLsLsmbLsbsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsRsRcmbRcbRebRgbRsbRsRsRsRgmmbReLsLobRsLsbLebLobLsLibRsbRibRebRsbRcb
LcLeLsLsLiRcmbRgLgbLeLsLeLgbLgLsbLgLsRsbLsLeLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bRoRgbRgRebRebReRsmbLsRobLibReRsmbLsRgRsmbRsRsRsRsRsmmmmbRsRgRsRsmmbRs
RsRsRgmmbRgRsRsRgRsmmmbLsReLsLgLeLsbRiRsRembRobLoRebRsRjRcbLcLebLhLcRe
bRebRebRjbLjLcbLebRoRsmbRgLebLobLeLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bLjLsmbLeLsbRsRsLsmbRsbLsbLsLsLsLsRsRsmmmmbLsLsRgmbReReReRgRoRsRsmmbLs
bLgbRgRsRsRsRsRsmmmmmbRsRgRsRsmmbRsRgRsLsLsLsRsmmmbRgRsRsRsLgmmmbRsRsR
gmbRcbRsRsmbRsRsRgRsmmbRebLcLcbRebReRibRebRsRsReRgRsRsmmmbRibLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bLibRsbRgbRsRibRibRoRsmbLcLsmbRhRjbLibLobRibRhbRcbLoLobLgLsbReRgLsLsmb
LcbLeLgbLsbLibLgLsbLsbLgbLgbLcLsmbLsRibLsbLhbLiLsbRibLgLsbLiLgbLgRsbLg
LibLhbLgbRebLcbRcbRcRsLsmbRcbRhRsmbRibRibRiLsbLcbLoLsmbLcbLibLcbRebRcb
RhbRhbRiRsmbRcbLcbLcLsmbRcRsmbLhbLcLsmbLoLsmbLcbLcbRhRsmbRibRibLiLsbLo
bLcRsLsRsbRgbRsbLobLoLsmbLobLiLsRsbRoRsmbRoLsbLcbRiRsLsmbLibRoRsmbLcLs
mbRcbLibLjbsbRsRsmbRgRsmbRgbsbLoLsmbLcbRhbRibRibLsLsmbRsbRobRgbRsbRoLs
bLibRebRibLibRcbLcbRcbLobLcLgbLcbRcbLibRgbLoLsLsmmbLcbLgbLcbLcbLebRobL
oLsmbLcLsmbLoLsmbLcbLcRsbLobRoRsmbLoLobLobLcbRcbLoLsmbReRobLoRsRsmbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bLoRsbLibRoLsbRsbLoLsLsLommbLoLgLsLsmbLcbLgLsbLiLsbLsLsmbLiLgLsLcLeLgL
sLeRgbLgbLeLsLcbLeRebLgbRsbRiLebLjbLsLsmbLsLgLgLsRobRebRebLsLsLsLsLsLs
LsmmmmmmbLsLgRsbLsRsbLsbRgLiLsRobRobLebRiLgbLebRgLsbLsRsbLsbLsbRsLsbRs
bLsLsmbRsbRsbsbsbLsLsmbRsbLsLsmbsbsbsbRgRsRsRsRoLcRemmmbLebLeLebLgbLsR
sbLsLsLsmmbRjbRsLsbRcbLobLoRsRsRsLommbLobRoRoRgLebLsLsLsmmbLsbLsLsLsmm
bsbLsbLsLsmbLsbLobLebRiRobLiLebLiRobLgRcRibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bLjbRsRgRsRsLsmmbRobRobRoRsRsmmbReRsmbRoRsmbRjbRobLgLsbLiLsbLebRsbRsbL
cLsmbsbLobLobLoLsmbRobRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgbLiLsLsmbRobRibRibRgbRibRhbLsRsRsmbLcbReRsmbRgLsLsmbLibRsbRcLsbRiRs
RgmbRoLibRsRsRsRgmmbRiRsmbLobLoRsRsRsmmbRobRhbRiRsLsmbRgLsbRiRsmbLsLsR
smbLobRgRsmbRsbRiLiLhbLobLebLeLsbLgbLibRebRebRjbRebRobLsRgbLobLsbLsbLs
RsLsLebLsLcbRebLcLsmbRsLsLebLgbLsbRobLcLobRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bRoRsmbRiRsmbLoLsmbRsbLobLobRgRsRsmmbRiRsmbLgbRibLsbRibLsbRibRobRjbRcb
RibRcbRhRsRsmmbRcRsmbLsLgLsbRiRsmbRsbRcbRobRgbRcRsRsmmbRobLsRebRgbLibR
obRiRsmbRibRibRsRsmbRgbRcbsbRobLibRibRobRibLiLgbLeLgbRobRiRsmbRiRsRsmm
bRibRgRsRsmmbRiRsmbLsLoLsmbLoLsmbReRsmbRibRsRibLcLsmbLoLsLombLoRsbRsbR
sRsRsmmbLobLebLcbRibLsbLsbLoLobLoLoLobLobRsRsRsLcLgmmbLsbRoRsmbLiLsbLg
LsbLoRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcLsmbLjbLobRgbRgLsbLjbLoLsRsmbLcbLoLsmbLcLsmbLeLsLsmbLebLcLsmbRoRgRs
mbLcbRobLcbRebLjLsmbLcbLoLgLsbLibLcRsbLsLoRsbRoRsmbLebLcbRhLsLsLsmmbLi
LsLsmbLcRsLsbLcbLoLsmbLhbLhLsLsmbLgbLcbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bLiLsbLgLsbRebRsLsbRiRsmbLoLoLgbLgLgLsbRobLeLsLsmbRgLsLsmbRsbLcbRobRoR
smbLebLgbRiRsReRsmmbRgbRiRibRgRsmbLsLgbRsRsmbRcLebRgbLoLsmbLiLeLibLgbL
eLsLebLgbRcbLgbRgLsbRiLoLsRsRcmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgbLsLsLsmmbLjbLsLgbLobRobRcRsmbRibRcbRsbRcRsmbRibRibRibLgbLhLsbLoLsL
ombLcRsbRsbRiRsmbRhRsRsmmbRoRcLiLsbLsLsRsmbsbLcLsmbLsbRiRsRsmmbRcbRcbR
ibRoLoLcbLhbLcLgbRcbRgRsmbRhbRiRsmbRobRcRiRsmbRgRsmbRcLibLcbRcbLsbLgbs
bLeLsbLjbReRsRgmbRebLeRsbRcbRsbLsLsRoLsLsmmbRcRcRebRiRgRsmbRsRgRsmbRgL
sbRgbRgRebLobLsLebLsLsLsLsLhmmmbRiRsRsmmbLgbLcbRhRcbRibLiRsbLsbLgbLebR
sLsbRsRsmbRcRsmbRcbLsbRjRsmbRsbsbRsLsbLsbLsbRsbsbLsbRsLsbRsbLsbLsRsRsR
sRsmmmbLebRebRebRobLgbLsbRgRgbLoRsbRebRibRsRsRembLebRiLcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcLsmbLoLsLsmmbLcLsmbLobRsbRoRsLsmbRoRsRsmmbRsbLebLsbLibLgbLsLsmbLsLs
mbLsLsmbLsLsmbLsLsLsmmbLsbLhLebLiLsLgLibLgRsbLgLsLsmbLiRsbLsbLiLsbRjbL
iLsLsmbRobRcRsRsRsmmmbRsbRsbLsLsmbRgRsRgmbLsRsLsLsLsRsmmbRcLsLsmbLcbLh
LsLobLibLsLsLsmmbLsbLsbLgbLsLsLsLsmmmbLgLsbLibLibLgLsbLgbLgbLgbLsLsLsL
smmmbRsRsLsmbLibLeLsbLeLsbLobsbLebRsLsRsbLibLsRsbLiLsbLsLsmbLgbLsLsmbL
sbLsLiLeLsLebLsLibRsbLsbsbsbsbLcLoLcLsLgmbLsLsmbRsLsLsmbLcLsmbRibLgRiL
ebLhbLgLebRsbsbRsRsRsRsRsmmmmbLsRsbRcRoLsLobLeLeRsLgbLgbLgbLgLsLgLsbLs
LsmbLsLsmbLsLsLeRsLsmbLebLebLgbLeLsbRsbLgbLebLebLoRsbRsRsRembLgbLsbRcb
LjbRgbRcbRgbRgbRgRsmbRsbRsRsRsRsmmmbRsRgbLsLsRsmbRsRgbLebRibRsRsRsmmbL
gbLsLsmbLsbLsbLsLeLsLsmbRgRoRob

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsRgRsmbLgLsbLsbLsLsmbLiLsLsLsmmbLgLsLsLgmbLsLsmbRsRsLsmbLsLsLsmmbLhL
sRsbLobLeLeLsbLgbLiLeLhLiLsRsbRsbRobLeLebLsLsLombRibRgRsmbRiRsmbLsbRsR
gbRoLoRsReRsmbLgbLsLhLobLiLeLsbRsRsLsRsLsRcmbLhRjbRoRoReRebLsLsRsLsmbR
iRsRgmbRsLgLsbLsLsmbLsbLgbLgbRoLsLcLibLsbRoLsLsmbLoRsRsmbLgLsRoLsLebLh
bRoLoRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsLsLsLsRsmmmbLsLsRsRsmmbLcbRcbRsRsmbLebLsLsLsLgmmbLiRsLeRsbLgLsbRsLs
RsLsLsLsLsmmmbLsLsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bRibRsRsmbLcLgbRcbLobRcbLobRiLsbRebRibRobLobLsRsbLcbRcbLsRsbRibRsRgbRo
LsbLgbLibRcbRiRsmbLcbRcbLcbRgbRsbRgRsmbRhbRiLsbRgRsmbRiRsmbRibRsbLsRgL
sbLsbRgRsmbLsLsmbRgbLsbLsbLsbRebRibRibLsLsmbLgbRsbLibLcbLgbLcbsbReLsbR
cbRobRibRsRgbLiRsLhbLgLsbLgbRsLsLgbRgRsmbLsRsbRebRsRsRsRsmmmbRsRsmbLsb
LoRsbRsbRsbRhRsmbRhRsmbRsbRsRhbRhbRsRgRsRsmmbRebLsRsRsmbRjbRhbRebRsbLs
LsmbLebRebLebRebRgbLjbRebLsbReRebLjbRebLiRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bLjbLjbLoLsmbLobLsbLgLsbRsLsbLibLsbLobLoLsmbRobLibLsbLsbRgbLsbsbsbsbsb
sbLjLsLsLsLsmmmmbLoLsLsmmbRobLsbRebLsLsmbLsbLgbLobLoLsLgmbRsRsRsmmbLsb
LjbRgbLsbLsLsmbLgbRsRsRsRsLgmmmbRsRsRsRsLsmmmbRsLsRsRsRsmmbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbLcbLgbRgLsLsLsmmbRsbLgLsbRoLsbLgbLgRoLsbRobReRsLombLsbRebRgRgbRjRj
bRgRsmbLjbLgbRsLgLsLsLsmmbLsLibRebRsRgbLobRgRsmbLsRsRsmbRsRsmbRebLoRcb
RibRsbRibLebRebLgbLcLcRsLhbLiRsLgbLgbLgbLebLebLibLibRobReRgRiRgRsRsmmb
RiRsmbRgRgbRgRiLsbRibRsbLcbLeLsbLsLsLimbRobLebLibLsLcLebLebLiLsbRsLgLs
LsLsmmbLsLsLsLsmmmbRsLsLgLeRebLsLsmbLebLebLebLhLgbRcbRhRsmbRsLgbLsLsmb
RgLsbLebRcbRsLsbLobLibLebLgbRsLsLsLembRgbLeLsLsLsLsmmmbLibRsRgbRgRsRsm
mbRiRsmbRiRsmbLsRsRgbRsLgbLebRiRsmbRsRsLsLsmmbsbRiRsmbRsbRiLgLsbRsbReR
iRgRsmbRgReRcbReRoRsmbRibRiRsRsRgRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 144934; End: 145434;
Recording: 2-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgRsmbReReRebLebLgbRsbRobRoRsRiRsmmbLoLcLsmbRobRgbReRsmbLcbLeLcbRcbsb
RsbsbLeRoRsRombRjbRgbLcbRcLobLebLoLcRsbRsbRjbLcRsRsmbRsRsmbLgbRebReLsL
smbLebLeLgbRgbLibLcbLiRsbReRjbLobLebRgbLsbRobLebLgbRgbLcbReRsmbRjbRobR
cLcbRsbRobRibRibLobLcLobRibLjbRsbLjbRebLobLcLsmbRebLobLgLsLsmbLcbLeLsL
obRcbLiLsbLiLibRibLcbLoLcbRcLgRsbLhbLjbRgbRgbRcbRcbLcbLsRsRsmbLgRsbReR
sLsmbRebLoRsbLobLgLsLobRgRsRsmmbLsbLhbRgRsmbRebRebLebLgLsbLibLgbLiLsbR
cbRcbRsbLjbLebLebRebRebRebRgbRebLcbsbRebLgLsbLiLobRiRcbRgbLcLebRcLsbLc
LsmbLcLsLsmmbRsLcbLoRsRsmbRcbRcbLhRibLgRgRsmbLcbLobLiRsLoLsmbRebRebLgL
sbRcRsmbLoLebRobLeLsbLgbReRgRsRsmmbRcbRcRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 1; Drug: Control PTZ 2.5 mM
bLgLobLsRjbLiRgRcbRebRebLoReRcbLeRjbLgbRsbLcLsmbLsbLgbLebLcbLibLsLebLe
LsRsbLgLsLsmbLsbRsLsbLsbLsbRsbLsbRsbLsbLsbLsbRsbLsbLsbLebLebRibRcRebRe
bReRibRebRebRebRhbRgRebRsLsbLsbRgbRsRsRsmmbRgRsmbRgbRgbRgLsLsmbRsRsRsR
smmmbRgRsRsmmbRgbLsRgbRibRgRsmbLsLeLsbLgbLsLsmbLsLsmbRhbRsbRsRcLsLebLe
bLebRcLsLsRcmbRsRsmbRiRgbRgRsmbRsRibLibLsbLhLgbLgbRsLsbLgLsRcbReRsmbRi
bRebRsRsRsmmbRsbRsbLsbLeLsbReLsbRebRgbRsbRgbRibLsRgRsRsmmbRjbLibLsLsLs
mmbRsLcLsmbRsbRebLobLeLsLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 2; Drug: Control PTZ 2.5 mM
bRoLebLobRsRiRgRgRiRsmbRsRsRsmmbRsbRcLcbRebLgbRgbLebLeLebRsbRsbRcbLebL
ebRobLebRsRsRgRsRimmbLsbsbRibRsbLebLcbLgbRebRsbLebLebLgLsbLgLgLibLsLsL
sLgLsLsmmmbLsbRgbLebRebRcRsmbRsbLgbLgbLsLsLsLsLsmmmmbRibRebRsRsRsRsRsm
mmmbReLcbRgbRsRgRgLsLsmbRsRebLoLsmbLsLsRsLsmbRoRgbRobRebRoLebLsbLebLgL
ebLsLsLsLsLsLsLeLsLsmmmmmmbLsLiLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 3; Drug: Control PTZ 2.5 mM
bRoRebLgbLoLoReRsRcmbRoRcbRsRsRsmmbRsbRoLcbRobReRibRhbRjbLsbLoLsmbLcbR
obRgRiRjbLobRebRobLsRobRoRsRsmmbReRcbLcRoRgRcbLoLsLsLommbLsRsLsLsmbLoL
sLcLcmbRcReLsbLgbLhRcRsmbLsbRoRcLiLsbLsLsLsLhmmbLcLsmbLsLsLgLsLsmmbLcR
hbRiRobLiRsLobLebLebRoRhbRsLsbRgRsRsRsmmmbRsRsRsRsRsmmmmbRsRsmbReRcRsR
eRembRsRgRgbRebRsRsRsmmbRsRsRsRsmmmbReLsRsbLcbRsbRobRcbLcRobRsRsRsRgRs
RsRsRsRsRsmmmmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 4; Drug: Control PTZ 2.5 mM
bRoLebLsReRebRoRsmbRobLsRibLcLoRibLsbRsbRebLebLsLsLsmmbRcbLsLsmbRsLsbR
jbLcbRgbRsRgRsRiRimbRobLgbRebLcbLoLsLoRsmbReReLeLcRsbLjbLjbRgLsbRcbRsb
RsbRhRcbLcbRcbRobLoRiLsLeLsbLgLgLsLsLsLsLsmmmmbLsLsmbLcRsbLcRsbRsLsRsR
smbLsbRgRobRcRsmbLebLiLgbLsLsRsmbLsLsRsmbLcbLhLsReLsbLibLgbRcLebLebRsR
sRsRemmbRsRgRsRgRsmmbRsbLcReRobReRoRsmbRsLsLsmbRsRgRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 5; Drug: Control PTZ 2.5 mM
bRcLcbLgLcLgbLgbLsLsLsLsLsLsLoLsLsmmmmmmmbLobLsLibLsRsLsLsmbLcbLsbLcbL
oLcbRcbLcLsmbLsLebRsbLsRsbLoRcRsmbRhbReRcRsRsReRsLiLsmmmbRsRgbRsRsRsRg
mmbRsRsRgmbRsbRsbLobRgRgbRsLsbRcbLsLgbLsLsLsLsmmmbLeRsbLiLcbLsLsmbLsLs
LsLsLeRjmmmbLebRsbLobRebLhbLiLiLsRoRsmbRcbLsbLjbLcbRhRsmbReRsmbRsLsRsb
LsbLsLebLsbLebLebRsRsRsmmbRsRsRsmmbRsbRsRsRsRsRsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 6; Drug: Control PTZ 2.5 mM
bRcLsLcbLebRsRebRsLeLsbLcbRsLsLoLsLombLoRsLoLsmbLcbLcbLcbRoRcRsmbLhbRe
RsRsmmbLobLgLsbLeLsbLcbReRoRsRsmmbRobReRoLsbLcLobReRsmbLcbLcbLebLgRsLi
bLsLsLsmmbLobRebLcRsbRsbRgRebLiLsbRgLsbLebLebLgbRgbLeLhbRcbLgbReLsbRsb
LsbLeLoRsRebReReRebRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bLobRjbLibRoRsRiLeLsLsLommbReRoLgLsLsmbLsbLsLsmbRibRhbLsbRsRsmbRoRjbRc
RsRgmbLsLsmbLcLibLsLsLsmmbsbLsLsmbLsbRsbLsRsLsLsRsRsLsmmbLsbLsbRsbRsLs
bRsbRsbLcbLcbReRiRsmbRebRgbRcbRsRgLsLsLsmmbRgbLibRcbRebRobRsLsbRoLsbRi
RsmbRsRgRsmbRebLebLiLgLsbLsRsRsRsLsRommbRcRsRoLsmbRsbRcLobLeLsbLgLobLs
LsLsLsRsmmmbLeReb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bRobLhbLsbRsbLsRsLsbRsRsmbsbLsbsbLsbLsbRsbsbsbsbsbsbRcbRcRoRhbRsbRsbLc
RsRoRiRsmbLoLsLsLsLsmmmmbReRobLcLsmbLgLsLsLsLsLsLsLsmmmmmmbLsbRcbLjbRc
RsRombRcbLiLsLsmbsbLcbRoRsRsmmbRhRsmbLebLebLebLobLcbRsLsbLsbLcbRebLibR
gbRcRobRjRsmbRoLhLobRsbLebRoRsmbRcbRiLsbRsLsbRsbRcRcbRsbRsRsmbsbsbRsLs
bLcLsLcmbLcLsLsLoLommbRcbLoLobLsbsbLcbRcLsLsRiRsmmbLebLebLibRsbReRsRom
bRsbRebLgbLcLebLiRsbLsLsmbRsRoRobRoRsRsLsLsLcLcRgmmmbRgbRsRsRgRsRsRsmm
mmbRoRsRombReReLsbLcbLsbRsbLjbLeLoRoRsRsLsmmbReRsRsRommbLiLsLcLobReReb
RiRsRembLjbRsbLcRsLob

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsLgLjbLobRsLsbLsRgbRebLgbLebRoLsbRebRebRebRoRsmbLsbReRsmbLsbRsLsbLgb
ReLeRobLebRsRibRsbRobRebLgbLobLhbRsbRebLgbRibLoLsmbReRsmbLsbLeRsbRsbRs
bRsbLcbsbRgRebLebLgLcbRsRgbRgbRgbRgbLebRsRsLgmbRiRsmbRsReb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsLcRcbLsRebLgbLcLcbRcbRgbLeRebRebLebLebLebRsLsLeLsbLsbLebLebLebLibLe
bRiRsmbRsbRgRsmbLsRsRsRsLimmbRiLgbRebLgbLsbLgbLsLeLsLsmbRebLebRgbRcLsb
LcbRgbLsbRsbLgRebReLgLsbLcRsbRgbRebRcbLsbRjbRcReLiRiRoLcbLgLsbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bsbLsLcbLeLsLsmbLebLoLcbLebLebLiLgLsLgbLebLsLsLsmmbLiLsLsmbRsLebLcbLgL
sLsmbRebRgRsRsRsRsRsmmmmmbRsRgbLsLsmbRsRsRsRsLeLcRsRsRsLcmmmmmbLgbLebL
sLibLsLgLsLebRcbReRibReLcbLsLgLsLeLgLsbLebRgbRgbRgRobLsLsLembLsbLebLeb
Lib

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsRsRsRsReRsRsRsRsmmmmmmmbLobLebLcbRebLobRebRobLobLjbLeLobReLobLgLsbL
hRsRcRsLcmbLgLsbRcLsbLgLsLsmbLsLsLsLsmmmbRiLoRjLsLsmbLiLsbLhbLhbLgLeRc
RsmbRebRgRsRsRsRcLeLemmmbLsbRsbRsRsRsmmbLsLsRsmbRsbRsbLebLcbLjbLoRsbRs
bRebRoRsRsmmbRsbRebLoLobRgRibRibLjbRebRoRsmbRsRsLsmbRsRsmbRsRsmbRibRgb
LjbLgLebRsbLgbLebRoLcbLgbRgLsbLsLoLsRombRiRsmbRibLcbLcRobLgbLsLsmbsbLs
bLsLsmbsbLebLibRebLebLeLsRsRcRsRgmbRhLebLiLsbLsLsRsRsmmbLsLsmbRobReRib
LeRibLibRsbRsbRsRsmbRjbsbReRoRgbRsRsRsRsmmmbRiRobLibLgLsLsLsRsmmbRsRsR
smmbRobLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bRcbRgbLcbLsbLobRgbRsbRgbLebLiRsRsmbLsLsmbLibLsLsmbLebRcbRcbLiRsbLgLsb
RgbLebReReLgLgbRebRebRebRibReRgbRibLoLebLebLsbReRsmbReRhRsmbLsbRebReRs
mbRsReRgRsmbRebRsbLeLgLsLebRsLsbRsbLgbRsbLsRsLsbRcRsmbLgbRjbRgbRobRsbL
ebLibLgLsbRgLsbLsbLsbRsbRcRsmbLgLsLsLeRgmbRhRgbRgbLsbLsbRsbLgbLeLebLob

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bRebLoRsRsRoRgmbLobReLobLeLsbRoLsLsmbRoRsmbRsRebLcLsmbLjLjLgbReReRsLsm
bRoRebRhLeRgbLcRsRsmbRgRgReRiRsmbRiRebLsbLiLsLgLibLeLeReLsbRebsbLibLhb
LsbLhLsRsbRcbLobRcRgbRcLobLhbLeLsRsbRobLcRsRoLgLsbRsLgbLhbRgbRgRiRgbLo
LsLsRsmmbRobRsRsLsRsmbLgbLoRsbLibRsbLsbLobLhbReRgbLoLsRsmbRcRoLsbLsRsb
RjRsmbRgbLgRsRibRibRob

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsLibRibLcRsbRcbLhbLsLhLsLsmbRebLebReLgLgLcbLjbRsbRgLsbLsbReLsbLcbLgb
LobRgRcLeLsbLeReRebRibRsLsbLjbLobReLcLgLsLgLebRjbRsRgbRebLebLeRsRjbLgb
LjbLebReRsmbLeLhbLsbRcbReLcbLcbReRgRcbRibRsbRhRgRebLgbLiLsbLgbLebRhRcL
sbRgbRsbRibReRsmbRibLoRsbLcbRebRjbRsbLcbLsbLcbRebLebLgbRsbLibRgRiRsmbL
eRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bLgbRsRsmbRgbRsRebLeLsbLgbLsbRsRsRsmmbRsbRsbLsbLebLebLeLsRoRiReLsbReLs
LsLsmmbLebLgLibLsbRgbRgbRebRhRibRibLsLsLeLsmbLcLcbLobLeLebLebRibRebRob
LebLeRebLiLsRsRjbLeLobLcLeLeLeLebRcbRibLgbLjbLsbRebLobLeLeRjbLibRcbLsR
sRsmbLsbLsLsmbLebLeLcbRsReReRsLimbLhReRhbRebRsRsRsRsmmmbRsbLobLebLeLsL
cbLebLeRsbRcbRgbRsbLsbLgbRebRebRebRjRoRobsbLobLgLsLsLsmmbLcbLibLsbLiRs
bLeRobRcRsRsmmbRgRgRgbRsbLsRsbLcbLcbLiLcbLobLhLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bRoRoLibLobRiLgLsbLsLsLsLsLsLsLsLgmmmmmmbRebLgLsLsLsLsLhRiRsLsmmmmbLob
LsbRhbLsLsmbRsLsLsLsmmbRoRoRobLcLsLsmmbRsRsmbRebLsLcLsmbLsLgbRhRibRsRs
RsmmbRoRebLcbLobLsLsLsLcmmbLeLgLgRsLsRsbsbLsbLsbRsRsLsmbRsLsRsRsRoLomb
LcRsRobRsRsLsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bReRsmbReRsmbLsbRgRgRsmbReRsmbLhLsbLiRsRsmbRsRgRsRsRsLsmmmbLgbsbRsRsmb
LsLgbLgRsbLcbRgRsRsmmbRibRgRebReRebRsRsLsmbRhRsRsmmbRiRsmbReRoLobRcbLo
bRoRgbRsLsbLsLgLsLsLgmbRsLeRsRhbRgLcbLobLobLibLeRsRsmbRsRsRsRsmmmbRsRs
RsmmbLsbLebLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bLhbLgbLgbRgbRgRsLsmbRgbRgRibRgbsbRsbRsbLsbsbsbRsRsmbRsbRgRgRsRsRsmmmb
sbRsLsbLsLsmbRsbRsbLsbsbsbRsbRsbLeLcbLcLsmbRsRsmbRsbLgbLsLsLsmmbRsLsLs
LsRjmmbRsbsbLibLgbLsbsbLibLhbRsRsmbLgbRsbLsbLhbLebLcLeLsbRibRgRgbRsbRg
RsmbLsLsmbLsbLiLsLsLsLsLsLsmmmmmbRsRsmbRsbRsbRgbsbsbLgbLoLsmbLgbLgbRsb
LcbRobRsbRobLcRsbRgRsmbLcbLsRsbLsLsmbLsbLibLebRgbReLsbRobLcLsLsLsmmmbL
eLeRsbRebRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bLiRsbLgbLcbLobRoLsbReRsmbRhRgLoLgLsbLiRsbRsbRsbRsLiRsbLsbLobLsRsbLoLs
mbLcRsbLcLsLsmmbRhRsmbReLeRsLsbRsbLgbLgbRibRiRsmbRsbRgLsbRsbRgbsbReRoL
sLobLiLsbRebRsRsRsmmbLsLibLgbRcbLoRsbRiLsbLgbRgbRgLsbLebReLoLsmbLobLsL
sLsmmbLsLhRsRsmbLsbLgbRsRcLcbLoRsbRsbRcbRcbLgLsbLsbRgRgRsmbLsbReRsmbRe
bLoLhRsbLobRcRsRsmmbRoRsmbLeRoLsLsLoRsmbRhRsRsRsmmmbRebLeLsLsmbLoLobRg
bLhbLgbLsbRhRsLsRsmbLsbRsRsRsmmbLcRsRsmbLoRsRsLoRsRsmmbLibLgbReLsLcbRg
bReRsmbRoLsbRcRsLgmbRgbRoRsmbReLsbLoRsbLcbRobLsRsLsbLhbRjbRsLoLsmbReLs
bsbLjbRsbRgbRsbLsbLgLsRsLsbLsbRsbRgbRsRiRobLoRsbLsLsmbLsbLebReLoLobLsR
gb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgbLobLibLsLgbRsbLgbRobRsLsbLgLiLsbLsbLsLsmbLiLibLebLcbLibLsbsbLgRsbR
gbRiLsbLjbLeLsbLcLsLsmmbLoLsmbRhbsbLsLsRsmbsbRgbRcbRcLobLsLsmbLebLgLsb
LiLgRsRjbRjbLcLobRjbLibLcbLhbRcRsRsmmbRcLsbLgLsLsmbRiLsLobLoRsLsbLcbLe
RsbRsRsRsRsmmmbLgRsRsRsmmbLiLgLsRsRsmbLiLibLsbLhLsbRebRsbsbLsbsbRsbLsb
Rsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgRsRsmmbRsbRgbLoRsRoLsbRobRcRsLsRsmbRhLsRhRsmbLeLobLeLsLsLoLsLsRcLsm
mmbRsLsbRjbRgRsLsmbsbRiLsbLiLsbRsLsLgbRsbLsbLcRoLsbLsLsmbLiLhbLgLsLsmb
LoLsRoLsmbRcbLsRsbRcLsbRiLoLsRombsbsbLsLgbLsLoLsRoRhmbLebLsRsbLsLcbLoL
gbLebRgLsRobLeLobLsRsbRobRgbRsRsLsmbRsbLjbLhRoRobRsLsRsbsbsbLsbLsbsbLs
bsbRsLsbsbsbRsbLsLsmbLsRsbLiRsRsRsmmbRoLsbLjbLobLiRoRib

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bRoLsRoRgRsmbLibLgbLobLibsbLoRobRoRgReRcbLibLgbReRsLsmbRsbRcLsbRoRgRsR
eRsmmbRsRsLsmbRiLobLibLebRsbsbLgLsRsbsbLsbsbRsbLsbsbReLoReRsmbRgbLobRe
RebRcReRsmbRebReReRibRiRsmbRcbRgRsRsmmbRebLsLsmbLibRcbLgLsLsLsRsmmbLhb
RsRoRsmbRgRsmbLiLgLgbRoRebLsLibRoReLsLebLebLgbLgRsbLibLsbLcLsmbLgLsbsb
RobLibLsbLsbLsRsbsbLgLsLsLsmmbLebLcLsmbRgRsmbRebRcRebRgRsmbRsRsmbLcbRe
LsbLcbRiRgRsmbRebRobRebRcbReRebLgLgbLeRsRsmbLsLsLsmmbLsLsmbRsbLibsbsbs
bRsbsbsbsbsbRsbLsRsLsbsbLsbLgLsLsRsmbLgRsbLgRsbRcRsRembLiRsRoRsmbRsRcR
smbLcLsLsLsLsmmmmbLsbsbLsbLgbRobRgbRsRsmbRgbRsRsmbLjbLcLsRsmbRobLhLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbRobLcbLgbLoLsLombLhbRsbLebRgRsmbRibRibLobLeRebLebLcLgbRgbLsbRsbsbR
sRjbRsbLsbLjbLebLebLsRsbLsbLgbRsbsbsbsbRsbRgLsbLoLiRsLibRcbRsLsbRsbLeb
RibLiLsLsLombLgbLiRjbRebLobLgbLgRsbLiLsLsLcRsmbLsLsLgLsLsLsLsmmmmbLsbs
bLsRsbLsRsbsbRsbsbsbLsbLsLsmbRsLsLobRobRcbRoRsmbRsbRsRsmbRgLsRsbLebLsb
LsLgLgLsLsmbLsLgLsLsmbLsLsmbLsLsmbLebRsbLibLsLiLebLsLgRobLgbLsbLebLeLe
RoRsmbLsbLgLgLgbLgLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 25; Drug: Control PTZ 2.5 mM
bRsRhbRsbLgbRsRsRsRsRgmmmbRsbLsbLcRcbRiRsmbLsbRsRgRsmbRsRsmbRsbRsbRsbR
ebLibLsbLebLgRsbReReLsbRcbRgRsmbRsReRsmbRgRcbRhRcbRsRsmbLcRjbLeRsbLcbR
sRsRsRsRsReRgmmmmbLgbLgbLebLsLebRsbRebRebLebLibRsRebRcRsmbsbRgRebLgLcL
smbLebLcbLsLebLeLsbLebLeRsbRsbLsbLebLebRsRhLsbRcbRsbRebRjLebLsRsLsLsLe
mbLsbLibLebLgbLsbRjbLebRebReRsmbLebLgbLeRsbRsLsbRjbLobRsbLjbLebLsRsRsm
bRgbRebRcbLjbLgbLebLebLebRebRsbRebRibRsbRsbRsRsRsRsmmmbRsRsRembLiLibRs
bRcbLiReRsmbLebLeLeLeLiLeLsbRsLeLsbRsRsmbRebRgbLeRsRsmbLebRebRsRsRsmmb
RsRsRsmmbRsRebLeLcbLiLsbRebLsRsRsRsmmbRsRsReRcRsmmbRsRsRsmmbRebRcRsmbR
ebLeLoLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 26; Drug: Control PTZ 2.5 mM
bRobLeLsbLebLgbLgbLsLsLsLsLsmmmmbRsRsRsmmbLsLsmbRjbRsRobRibRgRgRsmbLoL
oRsRebRgbRsbLsRsbRsbLhbRcbRcbRsRsmbRgbRsRsRsRcmmbRiRsmbRgbRiRsRombRgLc
bLeRsbLeRsbLeLsbLeLebLgLsbLgRsbRoLsLgbRcbRgbRibRsRsmbRibLcLsmbLsLsLsmm
bLcRcRsmbRebRgRsmbRibRgRsmbRibReRebRsbRcLeLsbRgbRsbLebLebLebLgbLgbLgRs
bLsLsLsLsLsmmmmbLsLsLsLsLsmmmmbLgReLsbLsbLoLoLobLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 27; Drug: Control PTZ 2.5 mM
bRibLgbLhRcbRoLsbRiRsmbRhbRhbRoLsbRcLsbReRsmbRsbLoLsRsmbRcLsbRibLoLsmb
LcbLcbLobLoRsRsmbRcbLoRsbRoRiRsmbRiLeLebLsbLebLsLgbRobRsRsLsRsmbReRebR
ebRebRebRcbRebRebRebReRsRgmbRebRebRebLobRobRsbRgRsmbRsbRsbReRsmbLobLcL
sLsmmbRibRjbRgRsmbRsRsRsRsmmmbRgbRsRsmbRsbRjbLoLsLsmmbLobReRsRembLobLc
bRcbRebLebLobRgRsmbRcbRcRsRsmmbRcRsRsmmbRgbLcbRsRsmbLibLibRcRsmbLobRgb
RcbRcbRcRsmbLobRgLobRoRsmbRebRobLobRoRebRibLobRcbLeLsLgbLeLgLsLeLsbReb
LobReRsRhRsmmbRibReReRiRsRsRsmmmbRsbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 28; Drug: Control PTZ 2.5 mM
bLsRsLgbRsLgbRgLsbRsRgRgbRsRgbRiRsmbRsRgRsmbRgRsmbRibLgbLjbRiLsbLebLsL
smbLcbLcbLgbLeLsbRsbRsLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 29; Drug: Control PTZ 2.5 mM
bLobRhRcbLeRcLsbLobRebRebRsRebRgbRsRsmbRsRsRsmmbRgbLsRgRsmbRsRgbRibLcb
RcbRjbLcbRoRsRsRsmmmbReRsRsLsmmbRgbRebRebLcRsbRcRsRcmbLeLsLsLsLsLimmmb
LsLebLgbLebLebLoRhRsRjmbLoLgbLgbLhbLeLhbLebLebLeLebLebLibLgLsbLgbLsLsm
b

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 30; Drug: Control PTZ 2.5 mM
bLoRobRgLhbRcRsmbRcRebLebRoRiRsmbRoLsbRcRsmbLoLeLsLiRsbRsbRsbsbsbsbRsR
smbsbRsbLoLibLcbRgbRgbRgRiRgbRgRsmbReRsRsmmbRjRebRcRobRsRsRsRgRsRiRsmm
mmbRsRsRsmmbRsbRebLjbRiRebRgRsmbRsRgRsmbRcRsmbLsLsmbLgbReLsbLobRcbLcbR
sbLcbLiRgbsbLsbRsRsRsRsmmmbRgLsRsRsRsReRsRsRsmmmmmbRgbRsbRsRsmbRsRsRsR
sRgmmmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeLsLsRsmbLsLsLsLsLiLgLgmmmbLsLgLgLsLsLgRsmbLsLgLsbLsRhbRsRsmbRgRsmbL
eLebLgLeLsLsLiLeRsmbLsLsLhLsmbLeLgbLsbLgLiLsLsLsmmbLsLsLsLemmbRsLcbLsR
sRsmbRsRhRsRsRsmmmbLebReRsmbRsbRsRsRsRsReLsLgmmmbRsLsbReLsLobLeLebLeLe
LsLsmbLeRgRhbReRebReRsmbLsRiRsmbRsLsRgLsbRsLsLsRsRsmmbLebLeRsRgRsRimbR
sRsRgRgmbReLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsbLobLobRobRibLobRebRcbRobRobLgbRebLcbLobRebRcbRobLebRgbRebRobLcbRhb
LcbLebRobLobRebRebRsbRobLsbRhbRibRebRobLebLebRibRobRobRebLobLgbRobRebR
hbRebLebLgbLobLibRsbLobRebLebLibLobRcbRebRebLcbLobLobRsbLgbRcbRebLgbRe
bLobRibLhbLebLobRobLcbRcbRebRcbLebRibLebLobRebRcbLobLcbRebLibRobLcbLob
RibLobLobRebLibLcbRebRobRgbLgbLcbRobRgbRebRebLibRcbLcbRobRobLjbRebLebR
obLobLobLebRcbRebLebRobRgbRebLebRcbLobLebRebRobLobLobRebLhbLobRobLcbLe
bRobLobRobRcbLobLebLobRcbLibLobLibRobLebLsbLobRobRcbRibRobLobRebLobRob
LobLobRsbLobLobRebRebLibRcbLebLobLebLobRobLebRobLebRobLobRobRobRobRcbR
ebLcbRobRebLebRobLobLebLobRobLcbLsbRgbRebLobRcbRebLgbRibRobRebRsbLobLo
bLobLobRobRgbRgbRcbLobLibLebLobRobLsbLgbRobLebLobRobLgbLobLobLobLobLeb
LobRebLebLibRebLcbLobLebRibLobRebLobRibRsbLobLgbLobRobRobLgbRobRebRobR
jbRibRobRebLgbRebRsbRcbLebLhbRhbRibRobRobRobLebRobLebLsbLibRobLhbLobLe
bRobRobLebRobRebLobLsbLebLobRcbRsbLebRobLgbLobRebLebLebLobRebLobRgbRcb
RobRobLcbRgbLobRgbLobRsbRebLobRebRobLobLebRcbLebLcbRcbLebRobLobLobLcbR
obRebRobRobRibLebLobRibRobLobRcbRebRobLcbRobRgbRebRobLebLobRibRebLcbRc
bRcbLcbRobRebLcbLebLobLebLebLcbLebRgbLjbRobLobRibRebLobRcbRebLobLibLob
LobLobRobRcbRobRibRebRobRibRcbLebRobLebLebLobLgbRobRobRebLsbLebLgbLobR
obLgbRebRcbRobLobRobLebLobLobRobLibLobLcbLobLobRebLebRcbRobLebRebRobRi
bLobRgbLobRobRebLcbLobRobLibLibRobLhbLcbRibLobRhbLibLsbRobRhbLcbRibRib
LobLgbLcbLcbRebRobRcbLibLobRebLobLebRobLhbRobLobLobRsbLobLebRebRgbLobR
obRebRgbRobLebLgbLhbLgbRhbRebRibLebLobLgbRebRcbLebLibRgbLcbRgbLgbLobRc
bRebLibLobLhbRebRobRobRcbRebLibLebLobLobRebLobLobLsbRhbLebLebLobLebLeb
RebLebRobRobLobLgbLebRobLhbLgbLgbRcbLcbLebRobRgbLibRobLobRebLobLobLibL
ebLobRibRobLobRebLebRobLobRgbRsbLobRsbLobLobLcbLebLobRobRobRobRebLobRo
bLebLebRebLobLobRcbLebLibRobRobRobLobRobLibLgbRobLobLhbRobRobRebRobLob
LebRcbLebLcbLobLobRobLebRebRibRobLobRibLibLobRibLobRebRobLcbRsbLobLobL
sbLcbRcbLgbLebLobRebLcbRebLgbLobRebRobRsbRsbRcbLebLgbRcbLibRebLobRcbRo
bLobRgbRobRobLobLobLobRobLcbLhbRibLibRebRobRobLobRhbLobRibRobLobLebRcb
LsbLgbRebLobLobLcbRcbLobRhbLibRebLobLebLebRobLobRcbRgbRebLsbRgbLobLibR
ebLebRcbRobRobRsbRebLobLobRobLjbRobLobRebRebRobLcbRebLobLhbRcbRebLgbLo
bRgbRobLgbRgbLebRebLebLgbLobLcbLibRibLobLcbLebLobLcbLsbLobLobRcbLebRhb
RgbRebLobLgbLcbRcbLibRobLebRcbRcbLebRcbLobLobLebLebLobLibRebLibRobLibL
cbLibLsbRcbRobRobRobRcbRobLebRobRobRobLcbLibRcbRebRgbRobRobRebLebLcbLi
bRobLebLibRebLobRebLcbRhbLjbLibLebLobLebLebRgbLcbRobLobLebRebLgbRcbReb
LobLcbRcbLobLobRcbLcbLcbRobLobRobRobRhbRobRobRobLgbRebLebLobLcbLebLobR
obRgbLebRobLhbLsbRibLcbLcbRobRibLobLcbLebLcbRcbLobRobLebRobRebLebLcbRo
bRobRebLgbLobLebRsbRebRebLibRgbLobLgbLobRibRcbRebRsbLcbLibRcbRobRsbLcb
LibLebLcbLobRobLebRibRebRobRobLgbLcbLobRgbLebLcbRcbLebRobRobRebLcbRobR
obRgbLobLebRcbRgbLcbLobLcbLebRebRebRebLibLibLsbRebRibRobRibRsbRgbRibLh
bRebRobLobLcbRibRobLobRgbLebRebLcbLobRobRsbLebRibLcbRobRebRebRibRhbRob
Lgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bRiRsmbLgLsRsbRsRsmbReRsmbRsRsLsRsmbRsReRgRcRcLobRgRebLgRgbRjbRsLsbLiL
jbLjbReRebRsbRsRgReLcLsmbLsRsRsRsLsRsmmbRcLebLcLsRgmbReRsRsmmbRiLebReR
gLsbLhLsbLgbLobRibRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcLsLhmbLjbLgLsbRhbLcbLsLsmbLoLcLsLgmbLsLsmbLobLcbLcbLcbRjbLcRcbRobRi
bLoLsmbLcLsLeReLgLoRsmbRsRsLsmbLjbLebLeLgRoRsRsRsRsRsRgRsRsLsmmmmmmmbR
ebRsRsRsmmbRgRhReRgRsmbReRsmbRiRgRsmbRgRsmbRsRsRsRsmmmbRsbRsRsRsRgRsRi
mmmbRsRsmbRhbRebRcRsmbsbLsbRgRcLcRibLobLebRoRsLombLgLgbLjLebLgLsLebRsL
sLsLsmmbLsLsmbRobLcLsLsLsmmmbLsbRsRsRsRsLsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bLoRcbLsLeLsLobRgRsRsmmbRibLebLcbLsbLsRsbLebLoLsmbRgbLsbRcbLebLeLeLeLs
bLiReRoRsRsRsmmmbRsRsRsRsRsRsRsRgmmmmmmbRsRsRsRsRsRsmmmmmbLsRcbRsLoReb
RobRebLiLeLsLeLgbLsLsRsLsmbLsLsLsmmbLsLsLsLsmmmbsbRsbReRgLcLibLeReLeLi
bLsbLsLsLsLsRsmmmbLsbRcbRobLibLibLsbRsbRsbLiLobRebLhLsRoLjLeReRebRgRsR
sRsRhmmmbRsRsRsRsmmmbRsRsRsRsRsRsRsRgmmmmmmbLcLeRsbRebRoRsRcmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bRobLsLsLsLsmmmbLsLsLsLsLsmmmmbLsLsLsLsLsLsLsLsmmmmmmmbLsLsLsLsLsmmmmb
RsLsLsLsmmbsbRoRsmbLcRsbRcRgbLsbLcbLgLsbLiRoRsmbLcLsmbRiRsmbLibLsLsLsm
mb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bReLobLibLcbLebLebLebReLgbRgbRebRiRsmbRiRgbRibRsRsmbRsRsRsmmbRgbRsRgRg
LebLgbLibLgLsbLsbLsRsLsLsLsmmbRsbRsLsbRsRsLsmbRgLsLobLgbLsbLsbLgbLsLib
RibReRsLoLsLgmmbRgbLcLsLsmmbLebRsRebRsbRsRsRsLsmmbRgLsbRiLjbLsbRebRsLi
bLcLsmbLgLsbRsLgbLiRjLsLsmbRgbLhbRebLgLsLsmbLsRsbLsbRsRsRsmmbLoLibRoLs
bLeLsLsmbLsLsmbLobRgRiRgbRebRibRibRgbRsRgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bRebLcLsmbLcLoLsLsmmbLoLsmbRobLgbLgLgbLsbLoLsmbLoRgRsRsmmbRgRobRobLsLs
LsLgmmbLoLsmbLcLgbRgbLobLoLoRsRsRsmmbLcLsmbLobLcLsLoLsmmbLsLibLsRsRsLs
LimbRobReLsLsmbLsLiLsLgbLgLsbLsLgLsLcLsmbRsRgRhLiLib

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bLobLoRsbLjbRcLeLeLebLsLgbLobRgRsRsRsmmmbRsRsRsmmbRsRibRibLsLsRsRsmmbR
ebRgRsRsLgmmbLhbLebLebLibRoLsbLobLsLsLsmmbLgLsLsmbLsLgbLgbLsLsLsLsLsmm
mmbLjbLgbLcbRoRsRoLsLsLsLgLsmmmbLsLgLsbRsRsLsmbLeLsLsmbLeLgbRsRsRsRsmm
mbLoLoRsbRsRsmbRcRsmbLebLiLsLsmbLoRsRgbRsbLoLsmbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bLoLoLobRsRcRgbRgLsbRibLhLsbRoRsRembLobRebRebRebRcbRebRgLobLhLsLsLsLsL
smmmmbLiLeRiLobLgbRsbRgRsmbLhbLebLoLgRsLsbLibLoRsbLobLsbRjbRcbRibReLgb
LcbRgRsRsRimmbLcbRobLsLgLsbLibLcbRcRsmbReRsmbLibRjbRcRebRobRibRsbRiRsR
imbLcbRcbLcbRgRsRimbLobRsbLgLsbRebRiRsRiRcmbLgbLiLoLsmbRgbRiRsmbLcLsLg
mbLsReLsbRibRgbLsLsmbReRsmbRibLcRsbLiLsLsLsmmbRsbRiRsRgRsmmbRiRcbRiRsR
smmbLcbLibRebLiRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bRcLoRobLeRebRgRsmbRsLgbRsRsmbRsRsRsLeLommbLcbRsbLcbRibRsRsRsRsmmmbRsR
gRsmbRebLgbLebRebRjbLiRsbReRsmbReLsbLsbRebRebRiLcbLgbRiLsbRgRsRsmmbRsR
sRgmbRgbRsbLjbRhLobRebRgRsReRsLsmmbLeLcbLhReRsmbRibRgRcLebRsbLeRebRibR
ebRebLcLsLsmmbRsLhbLsLsmbLgRgbRgbRibRsRsLsmbRsRsRgRembLsbLebLebRcbRhRs
mbRebLgLsRebRibRsbLgbLcRobRebLgRsbLsbRjbLgbRcbLsbRjbRsbLoLoLobRgbRsbRe
RcLoLsLsmmbLiLoRsbRiRsmbRgRoRobRsbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsLsLsmbLsLsLsmmbLsLebLcLsLsRcmmbLcLsmbLsLsLsmmbLsbRsLsbLeRoLsbRsbLjb
LgbLebLoRsbLcLobLsbRhRsRcRoLembLsLsLiRgmbRsbRibLeLsLsLsmmbRcbRoLcbLeLi
bLhbLsLsmbLsLsLsRsmmbLsLsmbLiReRgLsbLsbLjbLgLeLsbLgRsbLgbLsLsLembRsbLe
bLoLgLsLjbRsRsmbLgbLhLobRobRgbLebLcbLsRsbRgRsLsmbRebLobRsbLsbLsLsmbsbL
eLsbLsLsmbLeLobLcLsLsLsLoLoLsmmmmbLsLsLsLsmmmbLsbRgLsbLgbRsbRcbRoLeLhb
RsbLgLeRsbLeLsLgbLsLgLsLcRsbReRsmbReRsmbRcbRcRsRcmbRiRcbLsLsmbLeRsbRcL
sbLeLsbLsRsbRsRgbLeLgbRsbRgbRiRsmbLcRsbRsRoRgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsRsRsRsmmmbLsbRiLoLsmbLsLsRombLsLsmbLsLiReReLsLsLsmmbLeRoLsbLsRsbLsL
iLsRsRcbRsRgRsmbLjbLobLibLgbRsbLsLsRsmbLgLgRsbRebLcbRoRebRoRoRibRebLeL
sLsmbRebLiRsbRcRsRsmmbLhbRgbLgbLsbRsbRsRsmbLcLgLsLoRoRsmbRobRsRobRoLsR
ebRsbRgbRsRsRsmmbLiLsRsbRgRsmbRsRsRsmmbRsbRcRsLgLsLoLoRsLgmbRgbRcbLsLs
mbsbRoReRobLeLoLoLsmbLsLgRsbLebRoRsRsRoRsRsmmmmbRsbLgbRibRebRiRoLoRsbL
jbLgbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbLobLoRsbLiLsbRsLsRsbLiRsbRsbRsLjbLoRsbRibRobRobLgLsLiLsRobLiLsLsmb
LobRiRsmbLsRsRsRsmmbRgbLgbRebLcbLeLsbLgLgbRsLibLsLgbRsLsLsLsLsLsLsLsmm
mmmmbLgRoRsmbLcbLeLsbRsRiRsRsRsmmmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsLsbLsbLsbLebsbLeLcbLiRobLoRcbRobLibRsbLsbRsbLcbLjbRobLiRoReRsRsRsmm
mbLjbRjRsRsRsmmmbReRsmbRcbLebRsRsmbRjbRsRsmbLoReRsRsLeLsmmbRhbLsbsbsbR
sRsLsmbRsbsbLsbLgLgbLsbRgRsmbRebRgbRjbLgbRebLcbLebRgRobRsLjbRiLsbRsLsb
LsbRsRebLebLebRobLgbLobLsRsbLsbRcbLcLobLsLsmbRibRhbLgbRcRsmbRcbRoLsbLo
bLsbLgbRebRobRgbRcRsRsmmbRjbRobLoLsLombRgRsmbLiLsbRjbRgbLhRsRebLsbRsbR
ibLobRoRsmbRsbLjbLsbLsbRcbLcbLsRsRsmbRsbRgbRsRsmbRsbRsRsmbLsLsmbLcbRob
LsbLsbLsLsLgmbLebRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bRebRiRsmbRgbLoLsmbLiLebLebRgbLcbLsbLgbLsbLebRsReLibLiLsLgLeLiLcRebRgb
RsbLsLsmbRiRsRsmmbRhbReRsmbRsReRgRgRsmbRsRebRsLsbRiRgbRiRsmbLgLebLibRc
RgReRsmbRgLsbRgLsLsLsLsRimmmbRsRgLsLcbLsLsLsLgmmbLebRcbReRsRsmmbRsRhRe
bRsbRebRsRgLcbLebRebRgLsLeLsRobLebRgRsmbRiRsRsRgRiRiRimmbRgbRgbLgbRgRs
mbReRsmbRibRsRsRsReRsRsRhRsRsmmmmmmbLebRiLsLsLsLhmmbRibRsbRgRsRsmmbRsR
smbLsRgRsmbLsLjbRhRsmbLgbRsRibRgRsmbRgRsRgmbRiReRhbRsbRsLgbLsbReRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145435; End: 145935;
Recording: 3-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bRcRsRsmmbLcRsbLcbLibReLsbLgRsbLjbLgbRcbsbReLcRsLcRgbRgbLcbRobRebRebLc
LebLgbRebRoRsmbRcbRsbsbRcLsLcbRsLgbLgbLcLsLimbLcbLcLsLsLiLsmmbLebLcbLc
bLoLiRsbRgRsmbRcbRcLsLoLsLcLsmmbLobLhLgbLcLiRgbRoRsmbRibRcbRcbLoLcLsmb
LeLsbLcLcRsbLibLgRsbLsbRhRgRsmbRcRsLoLsmmbLcbRebRcLjbLeRsRsLsmbLcbLcbL
ebRjLcbRhbLhLsRsbLeRsbRcbRcLcLoLobLcLsmbLhLiLsbRibReRgRsmbLcbLcLcLcLib
LcLsRcRcRsmmbReRcRcbLibLcLsRsmbRoLsbLcLsmbLhRsRcRsmbRiRsmbReRsRcRsLsLs
LsmmmmbLobRebRiRsmbRiRgbLcRsLobLcLsmbLcbLjbLeLsLcbRgRobLibRebRgLibLiRe
bReRsRsmmbRiRsmbRhbReLcbRcRsmbRsbLebLobRebRgRgRsmbRcbLobRsbRsbLgLhLsLj
bRcbLcbRgRsmbLebRiRsRsLemmbLsLiLsbLgbRsRsmbLgbRgbReRcLobRibRebRoLoLhbL
hbLcbLcbRcbLobRcLsLoLsLsLsmmmbLcLsLsLsLsmmmmbRcRsmbRoLoLsLsLsLsmmmmbLe
LsRsbLgbRcbRcRoRsLsLeLeLembLeLgbLgbLsbRgbRgbRgbLeLsbRibRibLcLsmbRjbRcR
sLsLoLsLsLsLsLsmmmmmmbRcbLcLsmbLiLsLsmbRjbLeLsbRcRgbRsbLcbRsLsbLcLoLcb
RgbRoLcbRiRsRsmmbRebRoRgRgbReRsRsmmbRcbRhbLhLsbRcbLeRsbLgLsbLsbRoRsRsm
mbLobRsLcLcLsmbLcLoLsmbRsRcRsmbRibRcbRcRsRcmbRgRsRsmmbRsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 1; Drug: Control PTZ 2.5 mM
bLgbLcLsmbLgLebRibLcbLgRsbRsRgRsRsmmbLsRsRsmbLsbRjbRebLcLsRsLembRsRsRs
mmbRgRsmbRsRsRsRsmmmbRebRsLcbLcLsmbLebLsLsLsmmbLsRsbLibRsReLeLsLsmbRgb
RgRsRcRhRsRsRsmmmmbRsLsRsbRsRsRgRsmmbRsRsRsRsmmmbRgRsRsmmbLsLsmbRgbRgb
RebLsLeLsbLoLsmbLgbLsbLsbRsLsbLsbRhRebRobRebRibLsbLeLgbLjbRgLsbLgLsReR
ebRsReRsmbLiLgbLhLsLsmbRgbRcbLsbRgbRgRsmbRsRsmbRhLsRsbReLsbLibRiRsRsmm
bRsRsRsmmbRiLsLsRsmbLsRsRsmbRgbRiLsbRiLsLsmbRgbRiRsRgmbRsLeLsRsbLeLgbL
gbLgLgbLsbRiRsRsRsRsmmmmbRebRebLsLsRsLsmbRgRgRsRcmbLsLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 2; Drug: Control PTZ 2.5 mM
bLsLsmbRsbLsLsmbLcLsLembRsRsLsLsLsLsmmmmbLiRsLsRsRsRsmmbRobLeRsbRgRsRi
RgRsRgRsmmmbRgbLobLiLiLsbLsLgbLsLsLsLsLsmmmmbLgRsLsbRjLcbLgLgLsLebLsLs
LsLsLgRsLgmmmbsbsbRobLeRebRhRebLcbLebRcRsReRsmmbRebRsRsRgmbRsRsRsRgRsR
ommmbRgRgbRgRiRsReRsmmbRibRgRsmbRebRsLsbLebLgbLsbRcRsmbRsRsmbLeLcbLsLs
LsLsLgLemmmbLsbRcLebLeLsLibLsLsLsmmbLgLsLsLsLsLgmmmbLsLsLsLsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 3; Drug: Control PTZ 2.5 mM
bLsbRcRsmbRsRoRsmbRebRsbRcRebLgLsLsLsLsLsmmmmbRiRsmbRcRsReRsRoLsmmbLsL
hbLoLcLsLcmbLobLsLsLsmmbLcLcbRoReLsbLsbRcRiRcLsbRcbLsbRoRobLsLsLsmmbLc
LcLsLsmmbRcRoLsLcbLoLsLcmbLcbRiRoLcbLcbLsLsmbLcbLcbRebRobRebLsLsLsmmbL
sLgLsbLebLobLoLgLcbRgRcbRcbRsRsRsmmbLjbLeRcbRcbRcbLebRobRcbRobLobReReb
LcbLsLcbLcbLsbRgbRsLhLcbLoRgbRoRsReRombLgLsbRcLcRgbReRsRgmbRebRebRebRe
bRebRgRsRgmbRsRebLcbLobLiLsLcbLibLeLgLsbRhRsmbRebRoRsmbRjbRebLsbRebLgL
sbLebLebLibLsbLcbLhbLcbLsbLcReb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 4; Drug: Control PTZ 2.5 mM
bLcLeLsRsbRsRsLgmbRobLebLhLcbLsLsLsLsLsmmmmbLsRsRsRsLsmmbLcLebLsbLgLcb
LcRhbLgLsbLobRebRibRcReRsRsmmbLcbLiLhbLsLsLsmmbLiRjbLcRsRsLcmbLjLcbRsL
oLcLsmbLsLebLgLgbsbLcRcbRsRgbRebRcbReRgbLobRhRsmbLeLsLgbLsRsRsLsLsmmbs
bRiLsLsRoRsmmbRgRsRsRgRgRgLsmmbLeLsRsbLgLsLsRsRsmmbLsLsmbRebLeRsRcRsRe
mbRgbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 5; Drug: Control PTZ 2.5 mM
bLjbLsRiRsmbRsbRcbLcRsbLeRsbRgRsRsLsmmbRsRsmbRsRsRsmmbRsbRibLgLsLcbLcL
sLimbLgbLgbLcbRebRsbRsbLsRsLsbLibsbLsLebRsbRcLgbLebRebRebRebRebRhRibRe
bRebsbRsbsbRsRsRsRsRsRemmmmbLebLobLebLsLebRgRsRsmmbRsLsbRsbLebLgbLsLeb
LgbLibLsbLebLgLsLsLsmmbRebLsLsmbLsLsLsLemmbRgbLgLsbLsLsLembLcLibLsbLsL
sLsLsLsLsLimmmmmbRcbLjbLibLsLgbLcbRsbRobRgbLcRgbRjbLcbLsbLibLsLiLsLsmb
LcbLgLsbRobRebRebRhbRsRsRsRsmmmbRsRsRgmbsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 6; Drug: Control PTZ 2.5 mM
bRcLsbRjbLcRgLsbLgLsbLcLsLembLsLsmbLsLsLsLsLemmmbRgRgbRsRgbRsReLsbLgLe
bLebLebLebLebLebLiLsLgLebLsbLiLebRobRebLiReRsReRsmmbRgRebRobLcbLcLobRe
bLgLsLsmbLgbLeLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsRsmbRsRsmbRoRhLsbLcLsRoLsmbRibLsRsRebLcbRsRsmbRsbRobLcLsmbLsRebRgRs
RembRiRibRsRgbRsRgRsmbRsLiLoLoRsLsbLsbRsbReRgRsRgRombRsbRsRsRsRsRsRimm
mmbLiLiLsbRsbRsRsLembLsRoRobLsbLoRsRsmbRsLeLsbReRsLsmbRsRoLsbRcRoRobRs
bLebRebLsLsRsRembRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcLcRsRsRoRsmmbLsbLeLsRebRhbRcbLobLobLiLgLsbRsbLgLsbLeRebLebLhLsbRsRs
mbLeRoRobRgRcbRgbRsRsRsLsLsmmmbRsLsbRsRsmbLsLsmbRhLobLiLgbLsbLsLgReLcR
jRoRsLimbRgbRcbLgLebLgbLsbRcbLcbLeRgbRebLsLcbLcbLgLsRsbRgbRebLcLsLsLsR
immmbRgbLgbLcLeLsbLcbLsLsmbLhRoRcLsRsRcRsRsmmbRsRibsbRsRsRsLsmmbLsbRsb
LeLoRoRgbRgRobRsLsbLsbLibRjbRcRebLebLiRsRsRsRsmmmbRebRsbLobRobRcLsbLcb
LoLgbLoRsbLcLsmbRcRobLcLsLsmmbLcLobLgLsbLsLsLsmmbRjbLeRsRcReLeLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bRhLsLebLsbLgbLcbLgLsbLsLsLsmmbRsbLgLsbRcbRobLgRsbRgbRebLjbLsbLibLsLsL
sLsmmmbRebLgbLebReLebRcbLsbRhLebRsbRibLobLcbRgLebLsLsmbLoRcbRiLebLcbLe
LsbLibLjRiRoRsmbRsRobRebLgLsbRsLsbLjLsLsmmbRcbRsLsbLgRebReb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsLeRoRoRobRiRsmbLhRjbRsRcRsmbRgRsmbLebRhbRobLcLeLeLeLsbLgLsLgLoRsbRs
LsbRcbRjbLcLsRsmbRobRhLibLgbRgbRiRgbRcRsLcmbRcbLobLebLobRjbLjbRibRsRsL
gmbLobRebLoLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsLoLiRsbLsbRgRsLsRgmbRebLsbRiRsRgLsLhmbRjbRsRsmbRsRgbRgbRgbLeRcRoLjb
LgbLebRebReRsmbLsbLsbRsbRobLiLeLgRcRsmbRibRsRsLeRsmbRsRsRsRsRsmmmmbRcR
sLsLcmbLsbLgRsbRgRsRoLsLsLgmmbLebLibLgbLgLsLsLsLsmmmbRsRsLgLcmbRsbLebR
ebRgRgbRjbLeLgbLiLebLhbRcbReLeLeLebRgRsLsLoRsmbRiRgbRsRsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bLobRsbLjbLibLsbRobLibLcLoRgRsmbRsRsRembLgLsLsRsRsmmbRjRsmbRiLeLeLsRjb
LsbRsbLsbRsLsbRgLoLcbRebLoLobRsRsLsmbLebLebLcbRsRcRsRsLgmmbRobLjbRcRsL
cLgLsmbLgLsbLeLcLcLsmbRsbLiLoLobRsRsmbRiReLcLsmbRjRsmbRebLsLcReLsbLcLs
mbLsbLeLobRobRgbRsRsRsRsRsRsRsRoRjmmmmmmbReRsmbLjbRebLsRsbRsReRsRsRsmm
mbRiRsLembRebRsRsRsmmbRgRsRsRcRsmmmbLebRgLsbRsLebsbRgRcRobRsRsmbLsbLsR
sbsbsbReLsbLcLsmbRsbLsbLsbRebRiRsmbLsRsbsbLcbReRhLsbLcbRjbLsRsReLhbLiL
sbLiLcRsReRsmbRgRsmbRgLgbLcbLiRebRiRsRgRsmmbRebRsRsmbLiRsbRsRsmbLiLsbL
gbRsbLeLgbRjLsLsmbRibLhRsbLcLcbRebRgRgRsLsRsLsmbRsbLcbLgbLsRsbReLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgRsRsReRemmbRoRibRsLsRiRsmbRsRoRsmbRgLsbLibRsLsbRsbLiLsbLibRsRsmbLsL
ibRsLsbLebRsbLeLibLibLsRsbLebRibLsbLibLgRsRsmbLebRiRsmbRcbReRsmbRgRgbR
sbLhbRsbsbsbLgLsbLsLibLibLgLsLsmbRcbRiRibRsRsmbRsRgbRibRgbRgRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bLiLsRsbLibLcRsRobRcbLcbLgLoRebRsRgLsbRcRsmbRsbRsRsmbRsbRsbLjRsbsbsbLj
bLgbLhbRcbLsRcLjbReRcRsLcmbLsLsmbLiLiLsRsbReRoRibLgbReLibRcLiRsbRebLsR
sbsbRebRsbRsbLsbLcbLhbRgbsbLsbRsbRsbsbLsbLsRebRoRsLgmbLcLsLsmmbLiLsRiR
sRimbRjbLcRsbRhRobRcbLgbLcRebRgbRiRcbRiRsmbLcbRsRsmbsbReRsmbRobLsbLgRs
RsmbLsbLiLsLsmbRjbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bReLobLsLoRsbLebLsLsLsmmbLsRcbRcRhbRgLsbLsbRebLsLiLebRebLjbRcRhbLebRib
LebLebLcLsmbRhRsRsmmbRiRsLoLsmmbRsLoLsmbRgbLebLgbLgLsLsmbRebLeLcbReLeb
LibLeRsbLibLgbLgbRsbLeLsLsLsmmbRsLsbRsRsRsmmbReLsbLobLgLgLsLsmbLebReLs
RsbRiRoLcLebLsLsmbRsLebRsRsmbRsRsRsRgRsRsRsmmmmmbRsRebLgbLsLcbLobLjbLc
LgLsbLsLsmbLsLcbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bRebRoRebLeLsLgbRcbLjbLsbRgbLsbLsbRsbRoLsLsLsmmbLcLsLsmmbLeLgRsbLsbRsb
LsRsLsbsbLsbLsbRcLsbRebLeLgLsRsbRgbLcRsLsbLeLsbRcbLjbLgbReRsRembRiRsmb
LjbLjbLsbRgRsmbRsRsmbRsRebsbsbRsbRobsbsbsbLjbRgbRebLjbLsbRgReRsmbLcbLs
bLebLsLgLsbLeLcbLsbsbRsbLsbRiReRsmbLcLsLiLsmbLeLcRsLsLsRsmbLiRsbLsLsmb
LgbLsbLebLhbRsbLhbLebLeRsbsbLgbRjbRebRgbLjbsbRsbLcbLobLgbLeLcbLsbRsbLs
LsmbLsbLsbsbLsLsmbLsbLsbLsbLsbRebRsbRgbsbRsLsLsRsmbLibRhRsReLsmbLeRsbL
gRsbLsLsLembLsbLcbLsLsmbLgbLsRsRcRcLsbReRsmbRgRsmbLibRsLsbRsbLsbLgbRgR
sRsRemmbLgbLebLhRsbRjbRebLeLsbLeRobRoRsmbRgRgRsRgRsRsRsRsRsReRsmmmmmmm
bLjbLsbRhRsmbRsRsLsmbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcbLibLgLsRsbRgbRobRcbLsLsmbLsLsmbLobRsRcbRibRobLeRobRsLsbLiRsbLcbLsb
LsLsLsRommbLcbLoLobRibLsbLibLibLgRsRsRsmmbLibRjbRobRobRgLsRsLoLsLombLc
bReLsbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsLsLiLsmbRsRsLeRcmbRcLobRibRgbLsLsRsRsmmbLsbLsLsRsmbLsbRcRobLgRgbRsb
LsbRsRsmbRobLsbLsbRoLcLsmbLcbRebRoRobLgRebRsbRgbLsLibLeRoLcLsmbRgbLsLs
LsmmbLebRibLoLsLsLgmmbLsLsLombLcbLeLsbRgLsLsmbLsbRsLsLsLsmmbLsRsbLsLgL
sbLsLsRsmbRcLobLobLobLgbLsLgLsbLsLgLsbLgbLsbRjbRoLsbRsLsbLgbLebLiRsbLs
bLsRobReLcRcReRebRebRsbRibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbLeLcbsbsbLsbLsbLsRsbLsLsmbRsbLsbRsbRsbLsRsRsmbLsbRibLibLsbLsLibLgb
RsbsbsbRcbLsbsbsbLsLebLsLgbLeRsRsRsmmbReRsmbRebLgbLebRcLiLsLsmbLsbsbRj
bLibLsLebRcbLjbLcbRgbLibLsLibRgbLiLsbRgbRcRsmbLeRsbLibLeLsbRcbRsbLgLsb
LibLsbLsbLibRsbLcRsbRobLcLsLsmmbRebLjbRibLgbRgbRjbLcbLsbLibLhbLeRsbRsR
ebLebRebLebLsLsRoRsmmbLjbRsbRgbLgLgRsbRcbRcLsbLebLgLsbLhbLgRsLgLsbLeRg
bLebRebRiRsLsmbRebLhLsbLsbsbLsbRebRgbLsbRiRsmbLhbRcbRgbLebRebRiRsmbLhb
LhbRjbRsLcLsmbsbRsbLhLobRcRebLibLibLibRgLsbLgLsbLcbLeLibReRsmbRgLeLcbR
sbLebRsbsbLiRsRsmbRhLeLcbRebLjbLiLsLsmbsbLsLeRsRsmbRsRsRgRimb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bRcLcbRobLgbLgbReLsLcbRsbLibLgbRcRsRsmmbLobRcLsbRsRgLobLgbRcRobLeLsbLc
RsRsmbLibLjbRebLsRsbLcbRgReRsmbLcbReRgRsmbLcLcLobLobRcbReRsmbRsbRcbRsL
cbLhbReLsLobRcRsmbRcRobLgLgLsRsbRsLsbLjbRhbRoLeLsbLgLoRoRsmbLobRsbLgRs
bReRsRsRsmmmbsbLjbRoRsmbLobLcbRsbLsbReRsRsRsRsLjmmmmbLgLjLsLsLsmmmbLgR
sbLjLsLsmmbReLobRebLsLsmbLgRhRsRcLombReRsRsmmbReLsLsmbRsLobReRsLcmbLeb
LoRsRsmbRgLgbLebRebLsLjbRibRsbsbLibRsbLgbReRsmbLjbRiRobLibLgbReLoLiLsL
sLcmbReLsbRgbReLobLgbLibLgRgbLhRsbLeLobRibRsRsRsmmbReLsbLsLobLsbLibLsb
RsbRgbsbsbLsLgbLsbReLobRoLsLcbRgbLibRcbLiRoRsmbRoLsLsmbRgRsmbLjbRjbLgb
RgbLiRsLobLsRsbLsRsbRsbLsbRsbLjLsLsRsmmbLjRsRsmbRgbReRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbLgRgbRsbRsbLibRsbLsbRsbRsbLsRsbsbsbsbLiLsbRsLeLgLgbsbLebsbsbLsLsLs
LsmmmbRsbRsbRsbLeLsbLebRiRsRhmbLebLsRibRgbLeLgbRgbsbLsbLgLsRsbLsbRsbLg
LsbLeLsbLcLsLsmmbLobRcbRsLsbRsbRiRsmbRsRsmbLcbLsbLsLsLgLsLsLsmmmbLsLsL
smmbLsbLeRsbRsRgbReLsLsmbRoRsLgmbLcLoRsbRhbRsRsmbRsLgbLgLibRobRsbLibLe
bLsbLsbLgLsLsLsmmbLjLgLsbLsbRsbRsbRsbRsbLsbRsbLsbRsRsmbLsRgbRsRsmbRsbL
sRsbLsbLsbLgbLgbRsLsLsmbLcbLiLsbLsLgRsbLgRsbRsLeLsLsmbLgLsbLiLhbLobRsb
LibLsbLobRcRebsbLgbLebLgLsRebLoLsLsmmbLgRsbRsRsmbRhbLebLgLsLsmbRgbLgLs
bRsbLsLsmbsbLsbsbLsLgbLebLoLsmbRoLobLibLgLsbRgbRsbRsbLsLsmbLgbLsbLsbRs
LsRsLsbLebLebRebLsbLebLsbRsbRjbRsbRobLsLsRsmbRsbLjbRsbLsbLsbRsbsbRsbLs
bLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbsbsbsbsbsbsbRsbLgbLgbLsRsRsmbRoLsbsbsbsbsbLsbsbsbRsbsbsbsbRsbsbsbs
bRsbLsLsmbsbLsbRsbLsbsbsbsbsbLsbLgbRoLsLsLsmmbLeLsRsbRsRsLgmbLeLsLobRi
RoReRsmbRcRsmbRsbsbLgbRoLgRcRoLgbLgbLebLeLsbLsbLibLgbRiRsmbLsbLebLiLsL
obLsbRsbRsbRsLsbsbLgLcbsbsbRsbRsLsbLsRsbRsbLsbRibLgLobLsbLsbLebRsbLsbs
bRibLobLoLebLsbLsLsLsmmbLgLcRobLsbLiLgRgbRgLsbLobLibLsRsLgLsRsbLcbRiLe
LsbLsbLibRebRcbRgbRsbLsLsmbRsbLsLsmbRsbLebLsbRjbLibRjLsbRsbLcLgbLsLiLs
bRjbLobRiRoRgbLsLcbsbsbsbsbLsLsmbLeLsbRsLsbLoRoRobRebLeLcbLgRsbLiRsbLg
b

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bLebRebRebLsbLiRgbRgbRibReRgRsmbReLsLsmbLsLsLsLsmmmbLgbLgLsLsLcmbLibLe
LsbLibLhbRsbLsRgbRhbRobRsbRsRsRsRsmmmbRsbRebLibRgbLgbRsbRcbLebLcbRoRsR
sRsRhmmmbRoRsmbLsRebRebLobLsbRgRsmbRgbRiLiLsLibLiLsbLibRsbLgbsbsbsbsbR
sbRgbLsbLibLsLsRiLsmbsbsbLsLsmbLsLsLsmmbsbLsbsbRgbRsbLiRcbRsbLjbLgLsRs
bsbRobLjLgbsbRsbsbRibRibLsbLsbLsLsLsRsmmbsbRjbRcRsmbRgReReRebLgbLsLeRs
bLsbRcLcbRobRoRsRoRgRsRsRsmmmmbLcRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bRiRsmbRsRsmbLsbRobRoLsRobRibRobLcLsLombLobsbLcRsbLsRebLcbLibLgRsRobLe
bReLsbRsRoLsRebLgLsLoRgbLgLsRhbReLsbRgRsLsmbLebLsLsLgmbLobRsbLeRsRhRoL
sbLebLgbLgbRsbLgRsbLiLsLsmbLgLsLobRsRebRoLsRobLeLsbLsRsbLcLsLombLgbRsb
LiLsLsmbLgLsLgLsbRebLibRsbLjbLsbLsbLsLsLsLsmmmbLsLgRsRgRsLsmbLsLsmbsbR
sbsbsbsbsbRsbLebsbsbRsbsbRjbRhRsRsRoLommbLgRsbLsRgLsbRgbLebRoRcRsmbLeb
LsRsbLeRsRoLsbLebRjbRsbLsbLsbLibLgLgLgbRoLgbLsLsmbLsbLsbRjbLgbLgbRibLg
bRobRsbsbLgbLsbLobLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 25; Drug: Control PTZ 2.5 mM
bReLsbRsRsRsmmbRibRsbRsRsRsRsmmmbRsRsRsReRsmmmbRgbLcRcbRsRsRsRsmmmbRsR
cbRsRsRgRsmmbRsRsmbRsbLebRibLobLebRebRcbLcbLebRhReRsmbLebLiLsbRsRsmbLs
bLebRebLebRgbRebLcbLcbLebLsLsmbRsLibLsLgbLsLsLsmmbRsbsbLgbLebRebRebRhR
smbLsRsbLsRsbRsRibLiLebLcbRebRebLgbLhLsbLebLsLsmbLcbLsbLsbLgbRebLhbLib
LsbLsLiLsbRcLebLcLsLembRjRsmbLcbRebRjbRiLsbRsRsmbRiRsRembLebLebRsbRibR
cbLsRsbRebReRebLsbLcRsbRsLebRhbLgbLebRhRcbRhbLgbLebLhLsbLgbLjbLgbLeReb
LgbRgbLebLebLeLsbReRsmbRcbRebLebRjbRsRcbRebRsbRcbRibRgbLeRsbRebRebRsRs
ReRsmmbLgbRgRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 26; Drug: Control PTZ 2.5 mM
bLsbRcbLiLsbLsLsmbRcbRoLsbLsLsmbRgRobLeLsbRsbRcbLsbRsbRibRsRsmbLeRsbLi
RcRsmbRsbRgRsRsmmbLsbLcbRsbLhbRebLeLsbLsbRcbLjLiLgLsbRebRgbRebRgRgbRgR
eRsmbRgbRsLsbsbRsRsRsmmbRcbRebRebRsRsmbRgbRgRsReRsRsmmmbRiRsmbReRsmbRs
bRibRgbRibLcRsbLebLebRcbRsRsRsmmbRebRibRsbRgbRsRsRsmmbLebLeLsbLgLgLsbR
ebRebRgRsmbReRsmbRgRsRsmmbRsbRebRebRibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 27; Drug: Control PTZ 2.5 mM
bRsRebRiLebRebLsbRsbRsLsbLsbRsRsRsReRsmmmbLsRsRebLobLeLsLsRsmbLsbLsLiL
sbsbLsbLsbLcRoReReRiRsmbRebRsRsRsmmbRcbLcLsmbReRebLgbLjLgRjbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 28; Drug: Control PTZ 2.5 mM
bLibRebLeLsLcbRsRsmbLsbsbRcbRsRsRsmmbRsRgbRsRsmbRcRsmbRgLebLgLsbLgbLjL
smbLcLsmbLebRhRsmbLsbLiLsLsLsLsmmmbLibLcRsRsmbRcbLsbRobLhbLsbLcLsmbLsL
smbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 29; Drug: Control PTZ 2.5 mM
bLcRcbReRsmbRgbRoLiLibRcReRsmbRsbRebRebLsbRsRsmbReRgRgbRcRsRiRjmbRebLe
LsbLsbLsbLebRsbLsRebLgbRsbRcRsRsmmbRibRsbRsbRsRsRsRsLeLsmmmbLeLgRsbLeL
sLebLiLsLsmbLsLsLsLgLimmbLsLibsbRsLeLsLsmbLsLsmbLsLcbRhbRiRebLeLobRsbR
eLeLcLsLsmmbLcbLjLcbLgbLsLsmbLeLsRcRebLobLgLcbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 30; Drug: Control PTZ 2.5 mM
bLebLgbLiLgbRgbLeLsbLiRsbRiLcLsLgLsLiLgmbRsbRoRcbRgRgbRsRebReRsmbReRgR
smbRsbReLebLcbLibRcbRjbRiRsmbRsRsRsRsRsRsRsRsmmmmmmmbRgbRsRgRibLibRcRs
mbRsbRsbRebRgReRsmbRsRsmbLebLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsLsLsmmbLsLsLcmbLeLsRcLsbRiRgRsmbRgbRebLsLsmbLsLgbLsLsLgmbLsLeLeLcLe
LsLgLebLgbLsRibReLsbLgbRcRgReRibLsRgbRsRhbRgReRgRgRibReRsmbRgReLsbRsbL
eLeLiLebLebLeLsLiLebRsLeRsbRoReRebRsRsRsRemmbLeLeLsbRsLsLsLsLsLsLsRsmm
mmmbRebRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bRebLsbRobLibRobRobRobLibRobRcbRebRobRcbLebLobLsbRobLebRebRcbRgbLobLeb
RsbLjbLebLebRcbRcbRcbRebRibLcbLcbLobLobRgbRobLobRsbLobLobLcbRobLobRibR
obLcbRcbRjbLobRobRcbRobRobLobRobLcbRgbRobRhbRcbRobRcbLobRobRobRgbRcbRe
bLcbRobRcbLobRobLobRebRobRebLgbRebRobLobRcbLebRobLebLobLobRebLobRhbRob
LobRobRsbRebLobRgbLobLsbLgbLsbLibRcbLcbRobRobLobLebRgbRobLcbRibLebLobR
ebLgbLsbRobLobLobRcbLebLibLibRgbRobLcbRobLobRobLobLebRcbLebRcbLobLcbLo
bLcbLibLobLobRebLobLgbRobRobRebRebLcbRibLebLgbLobLibRibRcbLebLcbRjbLcb
RobLobRobRobLobRgbRcbLibRgbLobLobLibLgbLebLcbRobRebLobRsbRcbLebRhbRebL
gbRebRobRcbLebLobLsbRibRobLebRgbLobLobLobLobRobRobLobLebLobLibRebRobLc
bLibLebLebLgbRobLcbLcbLobRobLebRgbRobLobLcbLsbLebLcbLebLobRebRobLcbLib
LebLebRgbRobRobRobRobLobRebRebRsbRobLebLgbRebRobRebRobRcbRebLibLobLobL
obLebLebRobRgbLibLobRobLebRobRebRobRebLcbLebLebRebLebLibRebRebRobLibLg
bLobRibLebLobLibRobRobLobLobLcbLcbRebLcbRobRobLhbLobLobLcbRjbRobRcbRob
LsbRobRebLobLobRcbRebRobRebLibRobLobRgbLibLobLobRsbRgbRobLobLsbLobLsbL
ebRobRobRobLhbRsbLebRobRebRibRebRobLebRobLebLobRgbLobLgbRebRobLobLobLh
bLobLobLobRobLsbRobLebRibLobRobRobLobRebRsbLobRebLebRcbLobRobRebLobRob
RcbRibLcbLobRebRobRobRobRgbLibRibLobRobRobRebRobLobLobRebRhbRgbRobLgbR
ebRebLobLobLobLobLobRobRebLebLobRebRcbLcbRgbRsbRgbLcbRebRobLebLebLebRo
bLobRobLibLobLobRgbLobLobRgbLobRebLebLcbLebLobRobRobRebRcbLobRobRobRob
RebRsbLobLobRobLebRgbLibRobLcbRobLobLgbLebLobLobLobRebRobRcbLhbLebRibR
cbRebLgbLobRgbLsbRebRcbRebRebRcbRebRibLobLobRebRsbLebLebLobRebRebLobRe
bRebLibRobLebRcbLebRobRobLobLebRcbRebRebLobLcbLcbLobRobLebRobLobRcbLob
LgbRobRcbLibLsbLsbRobLebRcbRcbLebRobLebRcbLgbRobLobLobRebRobRsbRobLobR
obRsbRebRebRobLebRobRgbRcbRcbLobRobRobRebLcbLibLebRibRgbRhbRcbRjbRcbRo
bLobRobRsbLcbLebLobRebLobRibLobRebRibLebLebRcbRobLobRebRsbRebLcbRobRgb
LcbRibLobLcbLgbLobLebRebRcbRobLibRcbRobRobRobLgbRobRobLibRebRcbRcbLebR
obRobRebLsbLsbLebLobLobLibRobLobLobRibLcbLebRobLobRebRobRobRebLcbLsbRi
bLobLobLcbRobRgbRobLebRobLgbRebRobRhbRcbRibLobLebRebRcbLobLobRebLibLcb
LcbLobRobRobLobRobLebLebRcbLgbRebRcbRobRobRobLebLobLobRsbLebLebRibLebL
obLgbRebLobLcbRgbLcbLobLsbRgbLgbLibLobRibRgbRobLobRobLobLgbLobRcbRobLo
bLobLebLebRobLebRobRebLobLobLobLsbLobLobLibRebLobRobRebLibRebLobRebReb
LobLcbRibRibLobRebRebRibRebRibLcbLebLebLcbRobLgbRobLcbRebRobLsbRobRobL
obRobRcbLgbRebRcbRobRebLobRcbRgbLgbRobLcbRobRsbLobLcbRcbRhbRobRgbLcbLc
bLobRebRgbLcbRobRebRcbLibLobLebRjbLcbLgbRcbRebRcbLobRobRobLobRgbLobLcb
LobLibLobRebLcbLcbRcbLibLibLobLebLcbLobRgbLobLsbRobRsbLcbRobRobLcbRobL
ebLibRcbRebLobLobLibRobRcbLibRibLcbLobLobLcbLobLobLobRebLibLibLcbRebLs
bLebRibLebLibRgbRobRcbLobLcbRibRcbRebLobLebLobLobLebRsbLcbRobLobRibReb
LibLebLcbLobRcbLebLgbLobLgbLobRobLobLhbRsbLobLcbRobRobRobRsbLobLebRobL
cbLcbRgbLcbRebLobLcbLobLebRobRibRobLibRebLibLebLebLobLgbLsbLobRcbLsbRg
bLhbLobLsbRobRobLsbLcbLobLobRobLebRobRobRsbLobRobLebRcbRgbLebRobLobLgb
RobLcbLcbRgbRebRcbRobRobRobRobRobLcbLgbLibLebRebLcbLsbRobLobRebRibLobR
obLobLcbRobLebLobRib

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsbLcLsRcRsmmbRcbsbRsRcbReRsmbRebLebRcLcLsmbLcbRebRobLibLibLsRsbLsbRc
bLcbRjbRjbLiRsbRibRsLsbRjbLgbLsLsLsmmbLgbLcbLsbRgbRsbRcbRebLcbLeRebRib
LebLibRsLsbRgbRiRsRsmmbRgRsRgRsmmbRsRsmbLcbRcRgLjbRgbRsbRebLsbRiRcLeLc
bRiRcLebRcbLeLoRsbRibLebLibLgRsbRcLjbRebLibLsLgLsLcLsReRhRiRsmmbRcbLsb
RebReLsLsmbLeRcbReLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bLebReRhRgbReRsmbRsRsRsRsLsRsReRsRsRgmmmmmbRsLsRsReRsRsReLsmmbRsRsRiRs
RgRsRiRgmmmbRsRgLibLebLsLsLcmbLsLsmbLsLsLsLsLiRsmmmbLsLsLsLsLsLsLsLsLg
mmmmmmmbLsLsRsLsmbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsbsbsbLsRsbLsbLsbsbRsbsbRsbsbRsRobLoLsLeLsLsLgLeLsmmbLhLsbLsLsLsLeLo
mmbLgLgLsbLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLsLsLsLsmmmbLsLsmbLgLsLoLsm
bLsbLgLsLsReRombLcLsmbLibRebLeLsLebLjLsReRsLsmmbRgLsbLebLebRcRsmbLeLeR
iRsRsReRsmmmbRsRsRsRsRsRgmmmmbRsRiRhRgRcLsLsmbLsLsmbLgLsbRcLebLiRsbLsL
sLsmmbRgbsbLeRsbRebRgRgbRsbRcLebsbLebLsLsmbRgbRjbRobLebLebLcbLsLsmbLib
LibRebRcbRobRobRebRhReRsmbLebLsLsLsLgLemmbLsLsLsLgRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsLjbRobLcRsbRcRcRsmbRsRsRsRsRsmmmmbRobRcLsRibLsbLcbLsLsLgmbLebLebRsb
RebLgRsRgRgRgLsLsmbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bRiRiRsmbLsRgbRsLsbRsLebLsbRobRgbReLoRibLgRebLsbLcLsRembRsbLibLebRobRi
bLobLcbRsLeRobRebLeLsbRebLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgRsRsRsLeLsLsmmmmbLsbLgbRsRsLembLcbsbRsRsLsLcLsLsmmmbLcbRgRsRsLeLsmm
bRgLcbRsRsRsRsmmmbRsbRsLgbsbRsbRobLjLsmbLobLeLeReLsRsbRoLsRcbLsbRgbLsb
LgLibLibRebLsLsLiLsLsmmbLcbLibRgbRsRsmbRsRsLsmbLgbsbsbRsLsbLsbLsbRsbsb
sbLsLsLsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsLsLsLsmmbLsLsLsLsLsLsmmmmmbLhbLobRgRsRsRsmmmbRoRsmbReRsRsmmbLsRsbRo
bRgbLobRsRsRsmmbRgRsRsRsmmmbLeRsLobRebRcbLcLgLsbRsLsbLoLsmbLebLsLsLgLs
mbRoRsmbLoRiRsmbLcLsLsmmbLiLsbLgLsLsmbLgLsLsRombLsRsRsLsRsmbLeRsRsRomb
RobLgLgbLebLibLgbLiLsbLeLsbRibLebLcLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bRiRsmbRiRsmbLcLgbReRgbRobLebRjbRhbRgbRiLsbRsbLsRebLsbLsbLeLebLibLeRob
RobLiLsbLeLsbLiLsLgbLibLgbLsbLeLsLsmbLsLsmbLcbRcbLhbLgbRsbRiRsRsmmbRhR
smbLcbRgbRcRgLoRibRsbRcLgLhLebLsbRcbReRobRobRiRoLsLgbLsLgbLcbLsLsRsmbR
cRgbRgRsLsmbReRcbRoRsRcmbLsbRebRgbRgRsRsmmbLobRebRibLcLibLsLibRgLsbReL
gLsLsmbLjbLeLsbLsbLcLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bsbLsbRebRsReRoRsmbLebLeRcRsmbRsRsLsRsmbLcRcbLoLsmbLsbRsbRsRsLsmbLsLsm
bRgbLcbLcbRebReRcbLobLsLsLsLeRcmmbRgbRsbReRoRsmbReLsbRsRsRsRsRsRommmmb
RebRoLobLsbLcRgbLcLeLjbLsbRgRsmbsbLgbRsbsbRsRsRsLsmmbLobRcbRiRgbRgRsRs
LommbRcRsmbRsbRebRcbRobLjbRebRsRsRsmmbRsRsLombsbLsbLebRgbRsbReRsmbLcbR
sbReRsmbRcRsmbLcLcRgbRgRsRsRsmmmbRsRsRsmmbRsbRiRcbLoLcRsbLsLsmbLsRgbLs
RsbsbsbLsLsRsmbLsbsbLebRobRcRebLgbRsRgbLcbLcRsbLsbLsbRsbLebRjbRgbRgbRc
bLebLsRcRsmbLcbRibRsRsmbRgLsbRiRsmbRsbLsLsmbLeRebRebRcLsbLsRsbRcbRoLob
LibRgbReLcbLiLsLsmbLcLsRsmbLibRsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bLeLsLsLcLoRsLsmbsbLiRsbRcbLjbLgRsbLhRcLcLeLsbLgbLsLsmbRjbLcbRiLgbRcbR
hRsRombLeLsLebLcLeLsbRcbRsRsLsmbLgLsLgbLcLsLsLommbsbsbRsbsbsbLsbRsbLsb
RgbsbRhRsRsmmbRoLeLsbLiLcbsbLsRsbsbRsRsLsmbLjbLjbRsbRsbLsbsbsbsbRsbLcL
sLsLsmmmbRibRoRobLgLsbLgbLsLsLgmbLsLsLgLsmbLgLcLsmbLebLsLsLsLsLsLimmmm
bLgLgLebLobLjLsLsLiLsLeLcmmbLebRcRsmbRcRsRsRoLsLsmmmbRsbRjbLcbRsbLoLsL
sLsRsmmmbsbsbLsLsmbRgLeLsbRsLsbLeLsbLsLsmbRebLcbRgRebRsbRebsbLeLgLsLsm
bRhbLeRsLsbRobLgbLeRsbLiLgLgLsbRsLsLsLsmmbLsLsLsLsLsLgLgmmmmbLsLiLeLsb
LgbRsbRcRsRgmbRsbLibLebRsRgbRhRsmbRcRobLgLgbLsLsLsLsLsmmmmbLebRibRgLgb
LhbLeRsbRsbRiLsbRibLebLoRsbRgRsRsmmbLsRsRsLsmbLjbLcRsRsRsmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgbLoReRiRoRgRoRibRsbLeLsRobReRobRcbLsbLhLsLsLsLgmmbRgbLiLsRsRsmbRcbL
jbRiReLoLobLcbRobLebRsLobLcLoRsbRsbRgRsRsRsmmmbRgbReRcRobRoRsRsmmbLjbR
ibRsRibRgLsbRsbLcLsRsmbLjLeLoRsRsmbLgLcLeLsbLebReRobLjLsmbRibLhRsbRjbR
ibLeLsLsLsLsLsmmmmbLgLsLsLsmmbRgbRgbLoRebRjRebReRobsbLiRoRsLsmbLsLsmbL
cLebLobRjRsRsmmbLebLoRibRebRoRsmbLebLebsbRgbRgbLebRobLebLobRcRebRobRob
LsbLiRsbRsbRsRibLjLsLeLoLombRobReLsbRiRsmbLsLsmbLobRsLsLsmbRhbLcbRoRcR
obLsLeLsLsRgmbRoLsbReLobLeLsLhLsbRgbRgbRsbRgRsLsLsmmbRsbLsLgbLeLsLgbLo
bRobLsRsRoRoRgbLgbReLgbLoLobRcRsRsmmbRsbLjRsbRhLibLobLsbRiLsbLcbRoLobR
cRsmbLsbLebRjbRgRsmbRsRgRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bRebLiLsRsRsmbLsbsbRoLoLsmbRsLsLsRsmbLsbLsRsbRsRsRsRsRsRsRsmmmmmmbLjRo
LsbLsRsbRsbLsLsLsLsLsmmmmbLsLsmbLsLsLsLsLsLsLsLsRsmmmmmmmbRsLeLcbLhbLc
bLoRsbRgbRsbsbRgRsRsRsRsRsLsLsmmmmmmbRcLsLsmbRsRebLcLcLoLobRoLsLcLsmbL
oLsLsmmbLgLsbLsLsLsLsLsRsmmmmbLhRebLebRcRsLoRimbLgbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bLobReRhbRhbLsbRiRgbRsbLjbRsbRebRebRcbRsRgbRiRgbReRsmbRibRoRsLsmbLibRs
bsbRebRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bRcbLeLsLhbRoRsRcRsmmbLsbRgbRgRsmbRsbRsRsmbRgRsmbLsbRhRsRombsbLgRsRjbR
iRgRsLoLembLoLsmbLsLsLsLeLiLsmmbRsbRgbRsbReLobLsLcbRiLsbLoLsmbLsLsLsLs
LsmmmmbRjbLcbRsRjRobReRsLombRsbsbLsbsbLgbLgbRsbLibLsbRjbRsbRsbRjbRsbsb
LeLsbRoRcRjbRsbsbLsbsbsbsbRjbRhRsmbLhLcLsmbLobRiRsmbLsRsRobRgbLhbLibLo
LibLsRsRsmbRsRjbLsbsbLsbRsbsbRgbRgLsLsLsmmbRibLsLobLobRsLsLgLibLobRcbR
cRsmbRsRgLcRsbLcLsmbRjbRcbRebLoLobLcLsLsmmbLsbLsbLgRobRebRsRsmbLcbLcRo
bLsRsLsLcbLgbRhbRobRiLjbLobLsbRsbLibRjbReRsmbLcLcLsmbLsRsbRibLcbLsbRsb
RsLsbLgbRsbRgbRcRsRsmmbLcbLcLiRsRsmbLsbLjbsbLsbLsbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bReRiRsmbRebRebRhRcbLeLsbLgLsbLsbLeLsbLebLebRjbRsbRebLgbLsRcRsmbRsbLeb
RebRgbRgbRibRiRsRsmmbRgbLcbLgLgbLeLgbRsbRsRgLsbRibLsLsmbsbRgbLsbLsbLsb
LeRsbLibLiLsRgbReRsmbRiRsmbRibRiLibLibRsbRsbRiRsRgRsRgmmbRibRgRgbRsRsm
bLibLjbLsbRsbLsLsmbLeLsLibLebRibLsRsbRsRgRgbRsRsRsRsRsRsRimmmmmbRgRsmb
RsRsRsRgRsmmmbRgRsReRsLsmmbRsbRiRsRsRsRsRsRsRsRiRsmmmmmmmmbRsbLibRebRs
RgRsLsRcmbLsRsLsbLcbRjRebLgbLgbRcRsmbLjbLsLgRgbReLsLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 145937; End: 150437;
Recording: 4-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgLsLeLsLsLoRsmbRcRsmbLobRoRsmbRcbRoRsRsmmbLjRsbRhLoLobLcLsmbLcLoRsRc
LcRsRsmbRoRgRsmbRibRhbRiLobRhbLeLsRsbLcRsbLoLsLsmmbRibsbsbRiLsLsmbReLo
LsLsLsmmmbLcLsmbLobRcRhbLcRsbLhRsbLoLsLcLsLcmmbRebLsbLeLsbLcRgRsRoRsmm
bRcRsRcmbLhLsLgbLeLeLhbLcbRoRsmbReRsmbLjbRhRsRsmmbLobRiRsRsRsmmmbLgRsb
LsRsRsmbsbsbLsRoLoLsLcLsmmbLoRsLsbLeLsLsLcLcmbLgRsRsmbRsRhbRiRsmbLhLsb
LebLjbRhRsRsmmbLsLsmbRiRsmbRgLcLgLcbLebLcbRiLsLsLcmbLebLeLsLebRgLcLsLs
LcLhmmbRibRcLsRsbLgbRgbRiLobRoRsRsmmbLjbLgLsbLsLsmbRcbRhLsLoLcLgbLcLeb
RhRsmbLsbReRsmbRhLsLoLsmbRcRsLsmbRsbLcRhbRoLsbReRsRsmmbRoLgLsbRobReLsb
RiRsmbRebLcLsLsRsRsRgmmmbRobLoLsLgLgLsmbRiRgRsmbRibLcbRcbRcbRobLcLebRe
bRebRsRgbRsbRebRibRgbLgbRsbLhbReRsmbRsbRiRsRsmmbRiRsmbLcbLgbRsRsmbReRs
RsmmbLsbLcLcLobRiLobRibRgRgbRgRsmbRhLoRsbLoLgLoLobLibRcbRiRsRsRsmmmbLc
bRcRsmbLcRsbLebRob

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 1; Drug: Control PTZ 2.5 mM
bLsbLgRsbLcLoLeLsbRiRsRsmmbRgbLiLgbRcbRebRsRebRjbRgRsmbRsRsRsmmbReRcbR
gRsmbRjbLibLibRsbLsRgbRsRgRsRsmmbRcbLsbLsLsmbLsbLgLsbLsLsLsmmbLhLsbLcL
sLsmmbLsbRoRsmbRiRsmbRiRsRsmmbRgLsbRiLsbLeLsbLjbRiLsbLsLgbLsLsRgmbLiRs
bRsRibLobRiRsmbLgbRebRoLsbLgbLiLgRsLhbRgLgbLoLsRsmbRebLgLsbRgLgLsbRebL
cLsmbLhbRsLgbLeLsLsLcmbReRsRsmmbRgRsmbReRebLeLsRsbLebLebLgbLibLjbRoReL
sLoLsmbReRsRsmmbRiRcRcbRgRibRgbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 2; Drug: Control PTZ 2.5 mM
bRcbLgbRcRsmbLgLsbLsLobLibLebLcLobLhLgLsbLsLgLsLsLsLsRsmmmbLibLcbLobLg
RsbLobRgRsmbLebLeRgLsbRobRgRsRimbRgRgRsmbRcRoLcLeLeRsbRebRsRsRsmmbRgbR
sRsRsRsRsmmmmbRsRsRsRsmmmbRsLsRsbRsLsbRgRsLsLsmmbRoRgRcbLgLsLhLsLcRoLs
bLgLebLibLgLsbLsbRsbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 3; Drug: Control PTZ 2.5 mM
bReRsLsmbRebLsbRcbLeLsRsRcbLgLsLsmbRoRsRembLobRgbRobLsLsLgmbRsRobRobRe
bRgbRcbLsbRcbRiRcbLobLsbLibLcbLjbLcbRhbLcbLsLibRsLibRsRebLebLsLgbLeRob
RebLcbLsLsLimbLibRoLsbLsLsLiLsLembLsLsLgLsRsmbLsRiRgbRoRcRsRimbRsbLcRc
RobReRsLsRsRsmmbLsRgRgRgRsRsRsLsmmmbLeLgbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 4; Drug: Control PTZ 2.5 mM
bLcbLcbReRcRoRsmbReReRobLsLsRsRsmmbRcbLcLeLsbLeLiLcbRcbLcLiLsbLcLiLsbR
ebLsbLebLeLebLeLsbLsRsbRgRobLeLeRsRsmbLcbRsbRcbRobLcLsmbReReRsRgRsmmbR
cLsbLeLebLsLsmbLgLcLsmbLiRsbLebLcLgLiLobLiLiLebLcbLsRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 5; Drug: Control PTZ 2.5 mM
bRsRiLeLsbLebRoRcRsmbLebLsLgbLsLsLsLsLsLsLsmmmmmmbLsLebRsLsRsbReLsbRcb
RsLcLcbLsRebLeLcbLgbLsLgLcbLsbLcbRcLeRebRsReRsmbLgLsbLsbRjRsmbLgbLebRs
bRsRsRsRsRimmmbLsLsRgRcLsmbLgbsbsbLsbLsLsLsmmbLsbLsbLsRsbReRsRsmmbRgLs
bLcLcbLsLebLoLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 6; Drug: Control PTZ 2.5 mM
bLcRiRsLoLsLsmmmbLcLcLeLjbRibRibLjbRebRcbRebRebLcbLgbLebLcbLebLebLebRs
RebLgbLcbLibLebRebLobRcbRcbLiReRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bLhbRsRsmbRsbRsRsmbLeLsbLgbRsRsLimbRebRcLsLsmbLsLsRsmbRsRcRobRsRsmbRsL
eLgbRgRsRsmmbReRsmbRgRsRembRsbLeLsLsLsLsLsReRhRsmmmmmbRsLsbLebRjbRiRsR
smmbRsRgRsLeLiLsmbLibLsLsLsLsmmmbLsLsLsLsRemmmbRibRsRgRoRobRebRsRibRoL
sbRcLcLsLsLsLgLommmbRgRsRsRsmmmbRsRsRsmmbRsRsRsRsLcLommmbLgLsLsmbLsLsL
smmbLsLsReRcmbRsLsRsbsbLsbRsbLiRebRgbLsLsmbRoRsmbRgRsLsmbLjLeRcbRoRsmb
LebLsbLsbRsRsLsmbLsLsLsRcRoLsRommbsbRsRsmbLebRsbRsbLebLeRoLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsbsbLsbLgLsLsLsRsmmbRcLobLibRsbLcRcbRsbRsbRsRsRsLsmmbLsbsbLebRhReLsb
RcbLcLsmbRcRsRombLsbLjLcRsbRcRsmbsbsbRgRsReRsRgmmbLcRhbRebRcLcbRsbRiRc
LiLsbLsLsLgmbLiRsbRoRsRgmbRsRsRsmmbRsRsLsmbLcbLcRcRebRgRcRcRsRsRsmmmbR
sbRsRgReRsmbRhRsLimbRsbLsLsmbRhRsmbLcLsLsmmbRcbLeRibLsbRebLobLeLgbReRi
RsRimbLeRsbRsRgLsbRoRsmbRcLoLsmbLcbLobLsLsmbLsLgLsbLobLsLsmbRcRoLcLobR
gRsRsmmbRsRsmbRsLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsbLjbLebRsbRsbReLsbLoLsmbLeLobLiLsbLgbLgRsbsbLsbLsLsLsmmbLsLsLsLsLsm
mmmbLsLsRsRsmmbLebLibLsbReLebLsbRjbLebLgLsbLgbLsLeRsRcbReRibLsLhLgbLsb
LhbLsRsRsmbRebLsRebLsbLgLsLsmbLsLebLcRsRsmbLebLjReRcRsmbRsLsbLeRsRsmbL
cLsmbLsLsLcmbRoRgRcbReLcbLgbLsbRgbsbLsLebLoRcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bRgbRsLcbRsbRebRsbRsLsbLsbLobLebLsRgbRcbLgLsbRibLcLeLeLsbLebRsbLiLebLs
LcLcbLebLibRebRsbRobLebReb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bRebLebLebLsLsLsLhmmbRsLsLibLsLsRsRsRsLsmmmbLgLebLeLsLebLsLsLgLgLsmbRs
LsLeLgbLgRebRebLsRsRsmbLeLsLcbLhLgbLsLsLsmmbLiLobRebLsbLsLsLsmmbLeLsLs
mbLeLgbLsbLsLsmbLcbRjbLsLiLsLebRebLsLsLsRsmmbLebRsLsbLsLsLsLsLsLsRsmmm
mmbLsLsmbRsbLsLsLsLsLsLsmmmmmbRjbRsbRebRebLgLjbRgbRcbLeLiLebLeRobRebRg
bLcbLoRgLebLsLsLiLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bLobRcbRsRsmbLgLsbRgbReRsRombRgRsmbRsLsRsRsmbRsRsRsRsmmmbRsRsmbRgRsmbR
cLcbLjbsbRjRsRcRoLoLembLeLcRsbLcbRgbRebsbLgRsbLibLsbRiLsLsLombLsbRhbLe
RsbLsRsbReRsLsLoLsmmbRgbRhLobRgbRcRobLsLsLsLsmmmbRjbRgbsbRsRsRsmmbRsbs
bRsbRebRsbLiLobRgRcbLjbLsLsmbLsbRibLeLsbLcbRcbReLjbLeRebRiRsmbRgRsRsRs
mmmbRobLebLjbLhLcbRiRsRsmmbRiRsRcLsmbRoLsbRsbLjbRiRsRgRgLsmbLebLiLsLsm
bLgRsbRjbRgbLebLoLcbRoRebLebRhbRsbRsLsbRsbLsRsbLsbLjbReRsRsmmbLibReReb
RobLcbLebRgbRhRebsbRgLsbLeRsbLcbLsbLeLsbLebRiRcbLjbRibRebLcRsRsRgmbLgb
RsbRsRsRsRsRsLsRoLsmmmmbRsbRiRsRsRsRsmmmmbRibLcRobRgRsRcmbRoLebRgbLsbL
ibRebLhbLjbsbLgbLsRsbRsLsbsbRsLsbLsbRebLcbRibRebRcbLoLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgbRsbRibLgLibLsbRgbLsbLjbLobLgLsbLgbLibRsbLsLsmbRsRgbRcbRsbRiLgRsbLs
bRsbRgRibRgbLebRjbRebRebLgReRsmbLebLsLsmbRsRsRsmmbReRgbRsRsRsmmbLgRsRg
bRsRsmbRsbRgRsRsmmbLsbRjbRibRjbLgbLjbRebRsbRebLebLeRsRgbRebLibLcbRjbRe
LobLjbRebLsLcbLgLgLsRobLsLsmbRgbRobLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcbRoRobRsRcLsbLgbRcRsRsmmbReRsRoLsmbsbsbRsbRsbRsbLsLsmbRsbLsbLsbRsbL
sbRsbRoRsRoRsmmbLebLoLoRsbRiRsLsmbRgRsRsmmbRsRsmbRcReLsLsRimbLsbRoRjbL
cbRsLsbRibRebRebsbLcbRsbRibLgLsbLgbLiLsLobLobRjbReRcbRobLcRsbLiLgbRebL
ibLiLsLoRsRsmbRiRobRobReLsbRobLcRsRsRsmmbLcbRcbLcRsLsbReRsLsmbLobRcbRe
bLoRsRcRsRombReRsLsmbRobRibLoRsbLibRobRhbLeRsbLsbLebRobRcLgbRcRgRsmbLs
bRsbRcLjbRsLsbLibRsRsmbLibRsLsLsmbsbLsbRsRsmbRjbRsRsRsmmbRsbRsbLsRsbsb
RcbLsbLeRsbsbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bLeLoRsbLobLsbRcRobLsbLoLsLeLsmbLgLsbRcbRgbRsReLjbLobLsbRsRsmbRsRsLsmb
RsReLsbRgbLcRcRsmbRebRgRsRsRsmmmbRsLsbLeLsbLebRgbLeLeLsbRgRgbRgbRsLeLs
bRsRsmbLgbLcLhLsbLsLsLiRsmbLgLsRsbLebRgRsmbRiRebLgRsbLebLgRcbLebRgRsRi
LsRsmbRhbRjbRsbLibRibRibLibRebRibLjLebLsbRebLebRebRobRiRgbRgbLgLsbLsLs
LsmmbLebRcRibRibRsRsRembLebReRgbRibLgbLeRiRebRsLsRsbRgLsLsmbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bLibRsbRiLebLeRsbRgRsRsmmbRhRgRsmbRebRgbLobLgbLibRebLgbLsLeRibRjbLibLe
bRobRsRsLsRsmbLeLobLsLsmbRobLeLcbLsbLebLobRibRebRebRebLgbRebRsLsbLjLcb
sbRobRebLebRgbRebRsRgRsRgmbRcRsmbReRsmbLsRsbsbRebLsbLjbLibLsRsbRebLibL
ebLebLsbLebLgbRgbLcbLobLsbLiLgbLebLebLebRcbLcbLebLebLebRsbRsRsLsmbRsRe
bRiLsbLsLjbRsbRcbLebLebRjbLobLiRsLsbLsbLiLebLsRsbRebRgbRebsbRsbRsRsmbR
iRsRsmmbRsRsRsLsRsRsRemmmbReRgbRsbLibLibLsbLsbRsbLgbLsbRebRgbLibLhbLgb
Lgb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsLsLsLsmmbLsLsmbRcbLjLsLeLcLsRsmmbRsRsmbRgbRsbRcLoLsmbRsRsRgmbRsbRgb
RebLsbRobLoLsmbLebRgLcRoRibRsbLcRsbRiRcbLsLsmbLobRobRcbLsbLobLiLsbLsbR
hbRcbLiLebLcbLiRsbLsbRcbLsLsLembRebLebRoLgLobLhbLhRsbLgRsbRebRobRcbsbL
hLebLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcbLgbRcRsLombLcbLgLsRsbLsbLsLsRsRsmmbLsLsLsmmbLiLsRsRsmbReRsLoRgmbRi
RsReLsmbReRsLjmbLiLibRoRsmbRjbLgLsbReLcbLobLibLsRsbLgLsLsLsmmbLeRhLsLs
mbReRsmbLgbLsbLgbRsbRobRoLobRebLsLsRoRombRcRiRsRsmmbRsLsbLsbLsbLsLiLsb
LcbRgRobLibLeLoLsmbLhLsbLgbLcLoRsbLsLibLibRsbLeLsLsmbLcbRebRsbsbRgbReb
RiRebRoLsRsLcbLsbRgbReRsRsmmbRgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsLhbLsLsmbLgbLcLsLimbLibLebLebLcRsRsmbRebLeRsRsmbRsRiRsmbRiRsRsmmbRs
RsRsRsRcmmmbLhbRsRsRsLsmmbLibLiLsRsbLcLsmbRsRsmbRsbLibLsbRgLjbRcRsLsmb
LebLsbLebReLiLsbLgbLsbLgbLgRsRsmbLsbLsLebLgbLsbRgRsmbRebLeLsbRibRibLjb
LcbRsbLebLibLebLibLebLgbRgbRsbRiRsmbRibRebLgbLcbLsLsLsmmbRsbRcbLgbLebL
gLsbRcbLcbLeRsRsRsRsmmmbLeLsbLhbLgbLsRsbRsbRebLoLsLsmmbLsbLhLsbRsbRsbL
gLsbLgLsbRgbLebRebLcbLebReRsmbLjLsmbLeRsbRgbLhbLcbLsbLebLgLsbLsLgLsLiL
iRsbRebRgLsLsmbLebLsbsbLgRsbLiLsbLgbLibRebLjbRoLsRibLoLsmbLhLsbReLgbLe
bLgLgbLgbLsbLsLsmbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgbRcbLoLsLsLcmmbLgbReRsRsmmbRhLcbRoRgRsmbRsbLsLsmbRsbsbLsbLsLsRsLsLs
RsLsmmbRsbLibReRsmbRcbReRsmbLibLsbsbLibLjbReRsmbRjbReLsbLobLeLsbLjLibR
gbRsbsbReLobRibLgLsLsmbLsRsbRgbRgRgRsmbLgLsLsmbRsbLiLsRsLsbRsbRibRgbRj
bLjbRcLsbLoLsLsmmbLhRcRgLcLsRsmbLiLsbLsRsbRsbLhLsbLgRsbLgRsbLsbLiLsbRj
bRcRsRsmmbLjbLeRgbReLoRcLsbRsbLjLeLsLsmbRgRsRsmmbRebLcLsLsLsmmmbLsLsRs
mbReLcLsRsRsmmbReRsLoLsRcmmbRsRsmbLsbLgRsbLsbLgLsbsbsbLgRsbRsbLsbRsRcR
gRsRsLsLsmmmbLgbRsbsbRhbLsbLeLsbReRsmbRiRoLgLsbRibLcRsLsbRebLhbRhRsRsR
sLsmmmbRgRobRsRsRsRsRsmmmmbLeRsLsLsmbRsLsbRcRsLsmbLcRsbLeRoRsRsRsRsmmm
mbLjLsmbsbLeLsLoLsLsmmbsbReRsmbRsbLgbRsbLsbLibRcLiRsbLibReLsbLobLeLebs
bsbRebLcLsmbsbsbReLsLjRsLcLsmbRsbLsLsRsmbLiRsbRebLoLsLsmmbLebLoLsmbLob
RsLsRsbLsRsRsmbLsbLebLsLgRsbLjbRjbRibLsRibRebsbLgbLsbRiRsmbRsRhRsmbRsL
sbsbRcLcLsmbLhLsbLebRgRsmbRsRebRobLsbRgbRiRsmbLjRsbRsbRsbRsRsmbLibRjRi
RsmbLibRsbReRsRsmmbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bsbsbsbLsLsLsRsLsmmbRsbRjbRsLgbLsbRgLsLsmbLsLsmbRsRsmbLgLsbRsLgbLgbRgb
LcbRoRsmbRsbLjbLebLebLebLebRsbRgLsbLsbRsRsmbLibLsLsmbRsbLibLgbRgbLsLsL
sLsmmmbLsLsmbRsbLsbRjbRsbsbsbsbLsbRsbLiLsLobLoLibLsbRgbRsbRsbsbLsLsmbL
gbLsbLsbLsRsbsbLsbLsbRsLsRsbRjbRsbRsbsbLgbLgbRsbLsbsbRsbsbRibLcLcbRcbL
gRsbRsbRgbRsbLsLsmbRsbLibRiLcRsbLsbLsbLsLsLgmbLsRgRjbLcbLibLobLebRgRob
LiLsbLsLsmbLibLiLsbRebLhRebLsbLsLgLsbRgbLibLsbLibLcbLcbRiLsbRiRsmbRiLs
bsbRjbRsbsbsbsbsbLsLsmbRsbsbsbRsRsmbLsbsbRsbRsbsbRsbRsbRsLsbsbsbLsRsbR
sbsbRsbsbLsLsmbLsbRgbRsbLsbLiLebLsbLgbLsbLgLsbRgbLsbRsbRsbLsRsbRsbLsLs
mbLsbRsbRebLsbLsLjbLgbLsLgbLsLsmbLeRibRjbLsLsmbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bRcLgbRsbRebRobRebLoRebRgbRgbLsbRsbsbLhRcRsLsmbRcLsbRcbLcLsmbRjLsbLhLs
bLjLsmbLiRoRsRsmmbRgLsbRgLsRsbsbLsRsbLcLsRoLeLsmbRobLobRsLsLsmbLeLsLsL
smmbLebLsbLibLiRsbLcbLeRibLsbRsRsmbLgbLoLobLebLibLebLebRgbRsRgLsbRgRsR
smmbLsbRiLsbRgRsmbRgbLsLsRsmbRsLsbRoLsRobLcLsLsmmbLgbLsLsmbLsLsLsRsmmb
RjbLgbRoRoRiLsbLebLebRgbLgbRsLsbRgbLsbLsbsbRsbLsLcLsRsLeLsLombLeLsLgbL
oRsbRiRsmbLsLsLsmmbRsbRiLsLsmbLcReRgLgbReLobRibRsLsbRsRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsLsmbLsRsbLsbLgRsbLsLgbRoRoLcLsmbLebLhbRsLsLibLibLhLsbLsbRsRsmbLhbRg
bRcRsmbRsRcRibReRsmbRobRsReLobRsbLibRebRiRsRcRoRembRcbRcbRebRebRsbLsbR
sbRsbLsbRsbRsLsbRsbRsRsLsLsmmbRsbLsbRsbLsLsmbRsLjbLibRsbRebRibRebLgRsb
LsbRiRsmbRebRjbRcbLgLgbRgRcbLgbLjbLiRsbLsLibLgRebRebRebRgRsmbRgRsmbsbs
bRsbsbsbsbsbLsbLsbRsbsbReRobRsLgbRoRobsbLgbLsLsRsmbLsLsmbRsbLgLgbsbsbL
jbLsbLebLibRgbRebLsbRobLhLiLebLgbLgLebLeLebLsLeLsbRsLiLgLsbLgLgRibRcRs
RimbReLsbLobLebLsLsLiLsmbLebRsbLgRoLibRebRsRsLsmbLeLibLiLgLsLgbRoRsRsm
mbRhRebLiLsRebLiLcbLgbLeLebLiLgLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbLeLhbLsbLsbLsbRobRgbLeLsLeLsLsLsRcmmbLgLsbLebLgLsbLcLjbRgRiLoLsmbR
cRgbLibLgbLgbRjbRgbLsbLiLiRsRoLsRebLebLsRsbRgbLebRobLsbLobRjbLsRsbLgbL
gbLsLgRoRgbLcbLcRgbLcbReLsLobRsbLebRgbLeLeRibRjbLgRsbRcbLibRebLobRibLo
bLsbsbRsbLsRsbsbLsLjbLgRsbLgLsbLebLsbLgLebLoRsLsRsbLsLsLsmmbLjbLsbLsbL
sRsbLeLcLsmbRoRebRsbLsLsLsLsLsLsLgmmmmmbLibLgbRgRsLembLsbLebLjbRsLcLsm
bRebLsRsbLsLsmbLjbsbsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 25; Drug: Control PTZ 2.5 mM
bLjRhbRebLeRsbRjLeLcRsbLeReRsmbLgLcLcbLcbLgbRhbReRsmbRsRsRsRsRcmmmbLsL
sLembLebLsLsLeLsmbLebLgRebRsLcbLsLsmbRsRibLobRcbLobLiRsbRjbLibReLsbLeb
LsRgRsmbRsLcbLsLebLgReRsmbRebRcLobLeRgbLebLgLsbLibLgLoLgbLebLsbLsbLsbR
obLcbLiLsbLsLgLsbLsRsbLgbLiLsbLsbLeRsRsmbLebLebLsLsLiRsmbLgLsbRcbRebRe
bRebRebLgLjbRcbRebLsRibRebRsbLebLcbLebLcLgbLeRsbRebRsRebRcbRsRsReLsmbR
jReRsmbLgRsLsRsbLebRcbRsRsRsRsmmmbLjbLjLebLeRsbLebRhbRgLsRibLgRsbLgLcb
LiLgbRebLsReRsmbLebRgLeLcbLebLeRsbLibLgRebRcbLsLsRsmbLjRiRsmbRebLebLeb
LgLiLsLsRsmbLeLsLsmbLeRsbLeLsbLeLsRsbLgRsbRebLsLebLebLeLsbLibLsLsLsmmb
ReRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 26; Drug: Control PTZ 2.5 mM
bRebsbReRebRgbRgbReRsmbRibRibRgRsRsmmbRebRebRibRebRgbRhbRsRsRsLsmmbRhb
RiRsmbRgRebLcLsLsLsmmmbReRsmbRebRibRibRebRiRsmbRcLgbLeLcbLcLibLeLsRcbR
iRsReRsmmbRebRebRgRsmbRebRgRebRebRebRgbRebRgbRebReRsmbRebRgbRgbLoLsmbL
ebLibRebRobReRsmbRebRgRsmbRebRebRsbRebRebLgbRebRgbRcbRoRsmbRebRibRgRsm
bRgRcbRiRsmbRgRsRsmmbRgbRibReRsmbLcRsRsmbRebRebRiRsRsmmbRgRsLsmbRgbRgb
RsRsmbRgRsRsRsRhmmmbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 27; Drug: Control PTZ 2.5 mM
bReRibLgbRsbReLobRebReLobReRsmbLeLhbLsLsmbRjRcRsmbLebRsbRobRsbLjLsmbRe
ReRsmbRgRsmbLsbLibLcRsRebLcLsLgLsmbLgLsbRoRibsbLsLsmbLeLgLsbRgLeLeLgLi
LeLsLsLgLsmbLsLsmbLgRcbLeLcLsLsmmbLsLsLsLsLsmmmmbLsRgbLsLeLsLsmbRjbRsb
RsRoRobLsRsRcbRoLsbLgLsLgbRebRgbRebLcbLebLeLgbLibLgRsRsRsmmbLcbLibRgbR
ebLeLsbRcbLebLcbRcRsmbRibLebLsLsLsLsLimmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 28; Drug: Control PTZ 2.5 mM
bLibRsLsLsmbLsLsRcmbRsRebRebRiRsmbLoRsbRoRsmbRobLsLsLsmmbRcbRgRcLsRsbL
sLsmbRcbRcbRebRiRsRgmbLhbLgbRebRsbRgRsmbRiRsmbRsbRgbRsRgRsmbLobLgRsbLs
LcbLgbLsLiLsbLoLsLsmmbLgbLeLsbLhbLsbLgbLiLsbLhLsbLhbLsRsLsLsmbLoLsLomb
RgRsmbRhbRsbRcbRebRibRebRibRgbRgbRgbRibRgbRgbRgbLsRgbRgbRgbRgbRgbRgbRs
bLjbLcbRsbRcRhbRibRgRsmbRgRsmbRgRsmbRgRibRsRgbRiRsRsmmbRsRsmbLsRibRgbR
sRsmbRsRsLsRsmbRsbRiRebRebRebRsbRgRsmbRcbLibLsRsbLsRsbLhbRiLsbRiRsmbRi
RsmbRsRsmbRiLsbRsbRsbRsRsRsmmbRsbRibRsRsmbRsRsmbRibRsRsRsRsmmmbRibLsLs
mbLhbLgbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 29; Drug: Control PTZ 2.5 mM
bRgLoLcbRcRsLcRcRcRsmmbRgbRsRhLgbRsbRobRcbLgbRgRsRsRsRsmmmmbRsbRsRsmbR
eLhLebLebLhLsbRibLsbReLsbRcbRsbReRobLsbRgRsRgmbLjbRcbLgbRebRebReRgbReb
RebRsbRsLebRcbRgbRsReLsbLeLebLeLsbLgLsbLgRsLsbLhbLsLibLebLiLhbReRsLoLe
RcmbRibRgbRsRsRsLsmmbReRgbLjLeLcbLhbLiLgbLibLgbLeRsRsmbRiRcRcbRsLcbLgb
LsLsLsLsLimmmbLhLsRsbLsLsLsLsmmmbReRoLsbLhLgbLeRsbReRsmbRebRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 30; Drug: Control PTZ 2.5 mM
bRobLcbRibRcLsbRsRhbRsbRsRsRsRsmmmbRsRsmbRsRsRsRsmmmbRsRsRembRcbRebRcb
RsRcbRebRebRiReRsmbRibRsRgRsRgRsmmbRsbRsRsmbRhReRsmbRsbLobRhRhRebRgbRe
bRebRgRgReLsRsbRgbRcbRcbLebRebRebRebRgRsRsRsRsRgmmmmbRgbRsRsRsRsmmmbRs
Rsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeLhLibLsLgLgbRsLsLsLsLsLsLsmmmmmbLgbLjbRgbRsbLsbRsbLsRsRsRsmmbRebLhR
sRsRgmbRsLcbRsbLebLsLcLsLsmmbLsbLebLsRsbLsRebLsbLebLeLibLgbRoRiReRsRsm
mbReRebLgRebLsbLgbLsLsLsmmbLsLsLsLgmmbLgLsLsmbLsLebLgLsbLgLsLsLsmmbLgL
sbLiLsbRsLsLgLsbLsLsmbReRsmbRsRsRsRsmmmbRgReLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bRebRebLobRobLebRebRcbRcbRobRebRebLebLebLcbRobLcbRgbLobLibLcbLcbLobRob
RcbRhbLobLgbLgbLebLobLcbRobRibRobLobRebLobRobLobLcbLsbRebRsbRcbLibRobR
obLebLobLobLobLibRgbRebLobLobRebRebRibRebRhbRobLcbLgbLsbLebRibRobLsbLh
bRgbLobLebLibLsbRobRcbRcbRibRgbRebLhbRobRibLobLobLobLibLobRobRobRcbRob
LobRobRebRobRibRobRebLcbRebRobRibRhbLobRobRobRgbLobRobRobRcbRibRobLebR
hbLebRobRobRebRgbLcbRebLebLibRebLgbLebRebRcbLobLebLebRobRcbRebRobLebRo
bLebLobLcbRobRcbRibRsbLobRobRebLobLcbRcbRobRebRobRhbLobLobRebRebLcbLob
LebLobRibLobLobLcbRebRcbRobLgbLebLsbRobRcbRobRibRgbLobLcbLobLebLobRobL
cbRibRebRebRebLhbLebLibLibRcbLobLcbRobRsbLebRebRcbRebRobLobLebLebRcbLg
bRcbRgbRcbLobRsbLcbLebLebRobRobRebRebLebRebRobRobLobLhbRobRobLhbRobReb
LcbRsbRobRobLibLebRcbRobRebRhbLobLobRebRebLobRobRibLobRcbRsbLcbRobLobR
ibLobLobLebRobLebLcbRobRobRobLobLcbLobLsbRobRobLobRobLgbRobRobRobLobLc
bLgbLebRcbRcbLobLebRcbRibRcbLgbRebLobRcbRcbLobRebLebLebLcbRibRhbLcbLeb
RebRobRebLebRebRobRibLsbLibRobLobRebRebLgbRebLcbRcbLebRobRgbRobLibRibL
obRebRebLcbLcbLsbLobRobRgbLgbLcbLgbLibRobRobRobLobLebRobLobLebRibLobLc
bRebRobRobLcbLobLobRobLhbRebRcbRobRibLebRobRobRobLgbRobRsbLgbLibLobReb
LebLcbRobRobLobRjbLgbRgbLhbRsbRebLcbLobRobLobLobRibRgbRcbRobRobLgbLobL
ebRobRsbLebRcbRebRcbRobLibLobLcbLebRebLobRebRebRebRebLgbLebRebRjbLcbRc
bRebLebRebRcbLobRobLibLhbRcbRcbLcbLibLebRobRsbRsbRebRobRebLhbLcbRobLob
LebLcbLebRsbLebLsbLobLobRobRhbLebLobLibRgbLobRibRcbLebLebRcbLebLcbLobR
cbRobRibRcbRobRebLobRebLobRcbRobLcbRebRobRobLobLcbRebRobLibRibRcbLgbLi
bLobLcbLibRgbRobLebLobLcbRobRebRcbRgbLebRobRcbLebRebRcbLibLgbLobRsbRob
LobRebRhbRgbRobLsbLobRobRcbRsbRhbRobRobRobRebRobRebLobLebLcbRebRcbRebL
ebLobLgbRgbRebRgbRebRhbLobLibRebRebLcbLibLcbRobLobRobRcbRobLcbRobRebRc
bLobRibRhbRobRobRobRebLebLebRibLhbRhbRobRgbRsbLobLgbRibLobRobRobRibLeb
RobRobLibLebLsbLebRobLebLgbLgbRebRobLobLobLebLebRobLebLobRobRebRebLebR
ebRebLobLebLibRobRobLsbLobLebRcbLobRebLobLobRobRsbLgbLebRobLgbRobRcbRe
bRobRhbLibRobLhbLgbRsbRobLcbLobLobRobRobLebLobRobRobRobRcbLgbLobLebLgb
LhbRhbRobLgbRcbLebLobRcbLgbRobLobRobRobLobRobLibLibLcbLsbRsbRgbLobRhbL
ebRibRibRsbRebLobLobLsbLcbRobLobRsbLobRobRsbLebRcbRcbLcbRobLobRsbLcbLc
bRebLhbRebLobLobRgbRobLebLcbRobRebLobRibLebLebLobRibRobLcbRcbRobRhbLeb
RobLcbLsbRcbLobRhbRebRobLobLcbLhbRobLgbLcbLcbRsbRobRebRobRgbLcbRcbRsbL
obRcbRsbLcbRobLobLcbLobLcbLgbRobLcbLobLebLcbRobRcbLebLcbLcbRcbLebLcbLi
bLobRobRcbRobLgbRcbLgbRebRcbRebRobLcbRcbRsbRobRobRibLobRobLebRcbLcbLcb
RobRibLobRebRobRobRebRebLobRobLhbLebLobRebLebLobLobLebLebLebRcbRobRobR
obLcbLobLibRebRgbLhbRobRebLobRobLebRobRsbLsbRibLebRebRobLcbRobLgbRgbRc
bRhbLebRobLobLibLcbLcbLobLgbLobLobRibRobRsbRebLcbRebLobLcbRobRgbRcbRob
LebLobLibRobLebLobLobLibLgbLebLsbLcbLobLgbRhbLobLibLgbRgbRcbLobRebLobR
obRebRgbRobRobLcbRebLebLebLobLcbRebLebLobRobRobLebRobLibLobRgbRebRgbLo
bRobLsbLebRcbRobLebRibRobLebRebLobLobLgbRobRobRebRibRibRobRebLgbRobLob
RebRcbLobLobLjbRibRobRobRobLobRobLobLcbLebLcbRebLsbRobLebLgbLhbLebLobR
obRobLebLibRhbRobLebRobRobRcbRebRcbRebLgbRobRebRcbRcbLobRcbRebLobRobLo
bLibLobRebRebRobLobRebRobLsbLibLobRebLebLobLhbLobLebRob

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bRoRebRcRgLebLsLcbLeLsLeLsLeLiLsbLeLeLiLsLsmbLgLsbRsbReReRoLsbLsRsbLgL
sLsmbLsLsLsmmbLsbLgLsRsbLgLsbRsLgLsbLsLsLsmmbRcRsmbRoLiLcbLebLeLibRgbL
gbRgbLsbRiRebRebLcbRebLgbRsbLibLeLsbLsLebRjbReRgbRsbRibRebLebRebLcLcbR
ibRiLsbRgLsbRiRsmbRgRgbLgbRhbLsbLsbLsLibRjbRibLcbLeReRibLgbLhbRsbRsbLo
LsmbLsbLgbReLgLsbRgbRsbLebLebLsRsLiLeLhLeLsLebLsbLgRsRsmbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcbLsbLgLsLsLgmbReReRsmbLgbLgbLsLsLsmmbRibRgbReRsRsmmbRgLgLsbRsbRobLc
bRsbRsLebLeRsbLeRebLsbLebLsLgbRsbLsLsLsmmbLsLsLsLsLsLsmmmmmbLsRebRiRsR
smmbRsRcbRhRsLeLeLsmbLebLsLsLembRsRsRiRsRgmmbRsRgLobLsbRoRsLcLsLsmmmbL
gLoLobReRsRsLsmmbRsRebRsRcRsmbRhbRcbLsbLsLsLsmmbLebLsbReRsmbRebLhLcbLi
bLobRsLgbRobRcbRebLibRebRoRsmbRiRsLsmbRebRsbRiRsRiRgLembLsbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcbRcRoLcbLeLebLsLgLsLgbLgLsLeRsRsReLgLsmbReRsRsRommbLgLiLsbLsbLgLgLo
ReReLeRebRoLcbRcbRiRsmbRsbRsRsRcmbRsbRobLebLcLsmbLibLeLsLsLgmbLebLsbRi
bLcbLcLebRcbRgRsmbRgRsRsRsRommmbLebRgbLsbRiRsRsmmbLcRebLhbRcbRcbRgRebR
sbRgbRiRsRsRsRsRsRsmmmmmmbRsRsRsRsRsmmmmbRiRsmbLsLsLsmmbRsbLoLobLeLiRs
bLsRsLsbLsbRcbLiLsRibReLsbRsbLeLsRobRsRebRibLcLsmbLibRsRsRsmmbRiRsLsmb
RsRsRsRsmmmbRsLsRsRsRsRsmmmbRiLoLobLsLsmbLiLsLsmbLobLsLcRcbRsReRobRgbR
oRsRsRsLeLemmmbLsLgLsbLsLsLsRsLsLsRsmmmbLeRcRcRsmbRgRsmbRsbLsRsbRsRsRs
mmbRsbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bLebLgbLoLeLgbLoLebRibRgRgbLsRsbRsRsRsRsmmmbRsbReRoLsLeRcReRsRsmmbReRs
mbRcbRiRsLsRsmbRsLsRsLsbRebLeLebLsbReRgRsRsmmbRiRsLembLiRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsRsRsRsRimmmbLsLsmbLsRsbLgLsLsLsmmbLsLsmbLsLsLsLsmmmbLiRsbRebLibLgLs
LsLsmmbLiLsbLsbLgbRebRgbRgbRgbRsLsRsbRgLsbLsbLsRsRsmbRgLsbLeRhbRsbRiRe
bRsRebRsRhLcbLibLsLsmbLebLsLgLjbRobRgbRobRsRhLsbLibRsbRoRsRsLsmmbLhLcL
sLgmbRebRebRgbLobLobRebRgbRhbRsbRobLeLcbLsLgLsLoLsLcLombRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bLgRhReLgbLcbRcLiRgRsRsRsRsRgRgmmmmbRcbLcLsLimbRobLobLobLsRsRsRsRsmmmb
RsRsRsLgmmbReLoLsLeLsRcRembRiRsRembRsRebRcLsbLgbRjbReRsRsmmbRgbLsbRsbL
sbLsLsmbRebLeRjbLsbLobLobRgbRcRsRombLeLsbLsbRsLsLsmbLsbLgLsbLsLsmbLebL
obReRsRcmbLgbRsLsbLsbRsRibLobReRcbRcbLebLgLsbLsLsLsmmbLebLibRgRcbRcRgb
RgbLsbLeLsLoRsbReLiRsbLeLsbRibRsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bRiLobRsbLsbsbLcRsbRsLgLsRsbsbLsLsLsLgLsmmbLgbLibRcRsmbRsRsmbRobLcLobR
gLsLsRsmbLgLsLsLsLsLemmmbRsRsRsRsRsmmmmbRsRsRsRommbLgLsbLobRiRsmbReReb
RibLgRsbRhbLsLoRsbRsRoRobRibRoRjbRoRcLsRsRsRsmmbRsRsmbRsbRsRgRsmbRsbLo
bLoLsLcRsLsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bLeRsRsmbLsLsLsmmbsbsbRgbRsLsbRcLsbRsbRebRcRcbRibRiLsLsmbLgbLcbReRsRsm
mbLjbLibReRsmbRhRsmbRiRsmbRebLiLsLsmbLcLobLcLcRibReRsmbLsbLhbLsbLeLsbR
sRsmbLiLsLsmbRsbReLebLiRsRsLsRsmbRebRibLebReRsmbLjbRcbLgbLibRebRjRibLo
bRiRoRsRgRsmmbRgRsmbRebRcbLsbRgRgbLcRsbRiRsmbRebRgbRibRiRsmbRibLeLsLob
LcRsbLcbLsbLiLsLsmbLgbLibLsbLgbReRsmbRebRcRsRombRiReRsRsRgRsmmmbRcRsmb
RhRoLsbRsbLcLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsbLeRoRsmbRebRcbLiRcbLjLsLsLsmmmbRsRsmbRsbLcRcbLsbLcbRcbRcbRsLsRsbRs
LsbLjbLebRgbLoLobRcbLobRgRsmbRebLgbRsbLjbLoRsRcbLcbRibRgRsRsmmbRebLcbR
sRsmbReRsLembLibRibLcLgRsbRiRcbRebRsLsbReLsLcLeLsbLgRsbsbLeLsLsLoRsLcR
smbRsbRsbRhbRsbRgRgRsmbRcbLibsbLebLeLsLsmbRobRebRiLebRibRgbRgbRsRgRsmb
LebRsbLcbRjbRgRsmbRsRsLsRembRebRgRsmbRcbRcbLebLeLsbLsbRiRsLsmbLeLgbRsb
RsbLsbRiRsRsmmbLobLgbLgLsLsmbRebLsbReRcbRibReRsmbLsbReLsbLoLsLcmbRibLe
bLgLsLsLoLgmbLcLoRebLsbLjbRsbsbRcRsmbLgbRsRsmbLcbLsRgRcbRsbRsbRibLcbLc
bReLsbRsRsmbRebRsbLiLsbRsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bRcRsLsRembLgbRsRsLsmbRcbLeRsbLsLsmbsbLebLsbLsLsLsmmbLsLgRcRsmbRsRgRsm
bLjLibLgRsbRcbLsbLebLgLsLebRebRsbRibRiRhbRcbReLgbLsLsLsLsmmmbLsLsLsLsL
sLsmmmmmbLeLsbRcbLgLgLsRebRobLcbLsLcbLgRjbLebRobRsbRsLsbLcbRibRgRsLsmb
RsRsLsmbRcbLiLebLebRsRsRsRsLsmmmbLcbLebLgbRsLsbLebLsLsLsLgmmbLiLiLcbRs
RsRsRsRsmmmmbLsbLsbLoLsmbRsLsLsRsRgLsmbsbRsRsmbsbRebRgLsRsRobLgbLsLiLe
bRobRsLsbLjbRiLsbRsRsRsRgmmbLsLcbLsLsmbLsRebRebLcLsLsmmbLebsbRsbLgLsbR
sLsbRoRsmbRsRsRsRsmmmbRsRsRsRsRsmmmmbsbRcLsRsbLgbLsLgLgbLsLsmbLibLeLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bLeLsbRobRjbReReRsRsmmbRoLsbLeRsbRiRibRsRsmbRgRsmbLjbLeRoRobRhRsmbRibR
eRebReRcRsmbLsRgLsbLeLsbLsLsRsmbLsbLsbLsLgLsLsmbRibRcRsmbLcRsRoLsRoRsm
bRsbRsbRsLsbLgLgbLobRoRoRsRsRsRsmmmmbRebRhLsbRgbLcRoRoRsRsRommbRhLsLsL
smmbLcLobLibRhbLiLoRsLsbRgbLibLoLsmbReRgbLgbLcbLcLsmbRoRsRsmmbRobReRsm
bRcbRsbRebRcRsLgRiRsmmbReRgRsmbRhLsbLoLsLombRebRiLjbLiRsRsmbLjbLsRsbLj
bRiRsmbLgLoLoLoRoLsRoLsbRcRsmbLsbLcbLiLsLsmbLsbRcbLebReRhRoLoLoRsRsmbR
oRsmbLeLsLsLsRsmmbLeLobRibLgbLeRcbRgbLsLsmbRsLsbLoLsLsRoRsmmmbRcRsRoRc
mbLsbRsbRsbRjRsRsRsmmmbLjbRibLebRoLobRhRsRsmmbRcRoRcRoRsmbRsbLiLsRcbRe
bReLobLeRsRsRsRsmmmbRsbRibLeLsRoRsmbRobRsbLeLsLibLiLobRgLobLsbLsRsbRcR
smbsbLsbRibLeRoLsLsmbRebRcbReLsRoLsbRebRsbRgLsbLcLoLob

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsRsLgLsLsmbLsLsmbLsLsLsLsLsLsLsmmmmmmbLsLsRsmbRsLsLsLsLsLsLsmmmmmbLs
RsRsRsRsRsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bReRobLobRgbLibLibRsbReLsbLibLibLsRsbLhbRebRgRsRgRiRimbRsbRebLsReRsmbR
eRsmbRcbRsRcbRgbRjbLsbRsRiRebRgbReRobLibLibLob

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bsbLsLgLsLsmbRgRobRobRcLsbLsbLobRoRgRsmbLgbRebLsRsbLsbRgRsmbRhbRsbRcbR
gbLsLsmbLcRsbLgRsRsmbLgRsRsRsmmbsbRsLsbLsbRsbsbLsLsmbsbsbsbsbsbRgbLsRs
RsLgmbRcbsbsbsbRsbsbsbsbLcbRsbLcLsmbLgbLsbLebRsbLsbRgbRgRsLsmbLsbLcLsm
bsbsbLsbsbsbLgbRibLibLeLsbRcRsmbRgRsmbRiRgRsmbRsLsbRibLcLsRsmbLcRoRiLc
LsmbLhRcRgLoLsmbRsbRsbRcbRsRgbLjbRebLcLeLsbLgLsLsmbsbLsLsmbsbRsLsRsLsR
eRgbRsRgbRgRgRsRsRsmmmbRhbRsbRiRsmbRsLsLsLsmmbLjbLibLjbRcRsmbLibLgbLjb
ReRsRsmmbRsRcRsmbLcbsbLebRebRobLiLebLhLsReb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bLebLgbLsbLsLsLsmmbLeLgLeRobRibRgLsRsbRebRsRibRsLibRjbLeLgLsLsRsmbLeLe
LsLsmbRsLeLsbRsbLsLsLsmmbLgbLgbRsRsmbRsLgbLgbLcRsbRiRsRsRsRsRsRgRgmmmm
mbRgRiRebRsLgbLsLgLsLsLsmmbLiRsbLibLgLebLsbRebRibRhbLcbRsLibRsbRgbRgbL
gLsRsbLsLgLebRsbRgRiRsmbLgbLsLsmbRibRcbRsRsRimbRgbRebRgbLgbRgbLgbRjRsR
smmbRsRhRsmbRsRsRsmmbRiRsmbRsRsRsRsRsmmmmbRibRsRsRsmmbRhbLgbRiRsmbRgbR
sLobReRsRgmbRgLobRjbLeRgbLiLsbLsbLeRsbLgLibLgRsbRgRsmbRibRgRsmbLcLsRsm
bLhLsLoRhbRsRsRgRsRsmmmbRsRgbRgbRgRsmbRsbRgRsRsRsmmmbReRebRgLsbLsLgbLe
RcbRgLsRsRsRsRsRiRjmmmbLoLsRsmbRjbLibLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 150439; End: 150939;
Recording: 5-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsLoRsbLoLsmbLiLobRoRsRsmmbLcLsLoLgRsLsmbLcLgbLgRsRsmbLhLsLcbRiRsmbRe
bLgLsLoLsLcLsLcLsLsLcRsRsmmmmmbRibRoLsLsLcLoRsLsmbLcRsbLibRhbLcLsLsmmb
RcRsmbLeRsbRoLsLsLombLcRsLoRsRsRsmmbReRsRsmmbRhRsmbRoLsLsmbLoLoLsLsmmb
LcLobsbLibLcLoLcLsmbLibLhLsLsmbRcbRsRiRsmbRgbRoLsRhRoRsmbRebRobLebLgLs
bRhRsRsmmbRobRgLsLoRsbLgRsbRibLcLsRsRsmmbRcRsmbReLoLsLsmmbLoLeLsbLeLgL
gLsLsLombRcRgbRcRsmbLebLsRsbRcbLeLobLcbLcbRcbRgbLcLsmbRhLsbRcbLoLsmbRg
LsLsmbRgbRcRsmbRgRsLsRsmbRiLcLgLsbRjbRgbRoLsLoLsmbLeLgLoRsRsmbRiRsRsRs
RsRsRsLsmmmmmmbRhLobLsRibLebLgLsbRcRsRsmmbRebLobRcRebLgLsbRebLgLsLsLsm
mbRjbLoLsmbLsLcbRiLsRsbLcLsLsmmbRjbLiLsbRgbLiLoRsRsmbRsRsmbLcbRiRsmbLe
LsbLsLgLsbRhbLgLobLiLiLsbLeLsbLcbLebLgLgLsbLhLsLoLoLsLsmmbLcbLgLsbRgbR
ibRhLsbRcRsLombLeLsbRcLsbLcRsbLeRsbRcbRhLhLoLobLeLoRsbRgLibRcRsmbRiLsL
oLiRsbReRsmbRgbLcRgbRsbRiLsbLoLsLsmmbLiLsLhRsbLebLcLgbRsbRebRcbRoLgLoL
oLgbLcLsLcmbLcRsbLebRiLsbRcRsmbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 1; Drug: Control PTZ 2.5 mM
bRhLebLsRoRsmbRiRgLsbLsbRsLcbLcLsLsmmbLhRebRsRibRgRhbRsRsmbRibRiRsmbRi
bRibRsRsRsRsRsmmmmbRgbRsRsmbRsRsRsmmbRiLsRsbRsRcLsbLgbLgLsLsmbLgLsLsLs
mmbLsbLsbLgLgLsbRebRsbLsRsbLsbRsRiLsbRsRgRsRsRsmmmbRebRsRsRsmmbRcbLibL
ibLsLebLsLjbLebRcRsmbLsbRjbLsbLhLsLsmbLgbLgbLgbLgbLgbLsLgbLebRsLsbRibR
iRsRimbLoRsbRiRsRsmmbRgRsmbRiRsmbLgRsRsRsRsmmmbLsRibRgbReRsmbLsRsbRebR
ebLebRcbRsbLhbLsLsLgmbLiLsbLgLgbRsbLgbReRsmbRebRibReLsbRsbLeLsLgLsbLgb
RgbRiRibRgRsRsmmbRsbRgbLsLsmbLsLsmbReLsbRsbLebLsLsmbRebRsRgbRgLsLgbRob
LgbLgLsLiRibRgRsmbRsRsRsRsLsmmmbRebRiRsLgmbRoRsmbRgbRsRsmbRhRsmbRsLsbR
sRsmbLgbRoRsmbRsRibLebLiLiLebLebRebRebRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 2; Drug: Control PTZ 2.5 mM
bRcLcbLebLeLsbLgbLsLsLsLsmmmbLsLsLsLiRgLiLemmbRgbReRsLeLcRsmbRsbRiRsLs
RsRsLsmmbRsRsRcLsLsLoLcmmbLgLsbLebLgLsbLsLsLgRsmbLebLebLebRiLsbLsbLgbL
gLsbLsLebLcbLgbLcbLobLebLebLebLebLebReRebLsLgbLgbRebRoLebLcbLobLcbRgRe
bRebRebRebRebRsbReRsRgRsRsmmmbRsbRgLsbLibLebLeLsbLeRsbLsbLebLgbLsLsLsm
mbLsLcRhbLobLiLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 3; Drug: Control PTZ 2.5 mM
bLiRcRhbLibLsLsLsReRsmmmbLsbLoRgRcbLcbLsLsLsLsmmmbRebRsRebRebRebLgLsbL
sLsLsLgLsLsLsLsmmmmmbLebRobRebReRsLsmbRsbRebRcbLcbLgbRebRebRcbLcbRebLo
bRsbLeLsbReLjbLgbLebRebRsbReRsmbRobRsRcbRsbLhLibReRsmbLcbLoRobRsRsRsmm
b

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 4; Drug: Control PTZ 2.5 mM
bReLcLcbLgLhRsRsRsLiRcmmbReLeLcLeLsLhLsLibLebLhLgLcLcbRebLeLsLeLsLeLeL
eLeLibLsLsLsLsmmmbRebLgbLcLiLcLhbLeLgbRobRebRoReRgbRgReLsbRsbRsRsRsRsm
mmbRcbLeLsLsmbLeRsbLgbReLsbRsbRsbRebLcLoLsmbRsLsbRebReRsmbRgRsRsRsmmmb
RsLebLebLsLsLsLsmmmbRhReLcLsLembLsLsLsmmbLsRsbLgRsbRcRebRsRgRsRsRiRoLo
mmbLsLeLsLsmbLsRebReRsmbRiLcRsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 5; Drug: Control PTZ 2.5 mM
bRoRcbLobRcRcbRcbReRsmbRsRsReRembRsbRsRgRebRsbRsRsLsmbRsRsRsRgmmbLsRsR
sRsRgmmbLsLsRsLsRsmbRsRhLsbRsbLsRebLeLiLobLcRsbLebRsRsRsLimmbLsRgbRsLc
LsmbLsbLsReRsmbRsLeRebLgLgbLhbRgRsRsRemmbRcbRgRsRiRsmmbRgRsRsmmbRebLcR
sLsLsmbLsLcbLsLsLsLsmmmbRebLcbLgbLsLsmbRsLsbLsRobRsLcbLsLobLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 6; Drug: Control PTZ 2.5 mM
bRebRebRsRsRsRemmbRsRsRsRsRsRsRsRimmmmmmbRiRsRgRsRcRsmmmbReRsmbLsbLgbL
obLsRcRoLsbRebRsRsmbRebRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bsbRoLcLsmbRgRobRcRoLsbLgbLoRsLsbRsRsRoLsLsLsmmmbRsRebRsLsbRoLsReReRhb
RsLsbRcLsRiRsmbRgRiRsLcLimbLiRsbRcLcRsbLsbLsbRebReLsbLebLsRsbRcbLebLeL
sbRsLsLsmbLsLcbRebRcRoRcLgRoLsbLsRoLsbRsLsbLebRsLsbLsLsRoRoRsmmbRsLgRe
LsRgRsLiLsLsmmbLsLsmbRiLebRsbRsRsmbLeLsRoRsRgRsmmbRebRoRcRhRoLsbLsLsmb
RsRsmbLeRcbRsRsmbRsLsbRobLeLsbLiLsbLsLsRsmbRsbRiRiLobRsbRsRcLsbLsLebLg
LsbLeLsbLgLsbLsLsmbLsLgRcRsmbRsRebLgLeLsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bRcbRcLsLoLobRsbRoLsRsbRsbRsRsmbRsRsRsmmbLoRsLobLeRcbRebRsRsmbReRebReR
ebRgbRebLcLoRsRsRombLiRebReRoRcbRsRsLsLsRsmmbLsRsbRsRsRgRembsbsbRsLsLs
mbLgLsLgLsbRebRsRgRsRsmmbRsbsbLcRhRsmbsbReRsmbRobsbRsRsmbLgbLsbsbLiLsR
eRsRsmmbRsRsRsRsmmmbLsbLcbLobRsRsmbLebRoRoLsLoLeRsLobRiRgbLgbReRcbRgbR
sbLjbRebRibLcbRoRsRsRoRsmmmbLgbsbRsRsRsRsmmmbLsbLcRsbRobRsbRsbRsbLebRe
RsRsRsmmmbLcLsLsRsmmbLeLcLsmbLebLsbReRsReRimbLsRsLsbsbRsRsRsmmbLsbRsbR
sLsbLsbRcRcRsmbLgbLeLsLsLsLsmmmbsbLeLhLcLsLsLsLsmmmmbLsLsLsmmbLeRcRsRc
mbRcRsRsmmbRgbRsbRiRsRcmbLeRsbRoRsmbRsRgReRcRsReRsmmbLsReReRsRembReb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bLebLgbLsbLsLsmbLsbRsbLsRsbRsLsLsLsmmbLsbRsRsRombLsLsmbLebReRjbLsbRcbL
eLsbLsbLebLgbLcbLebRebLsbLgbRcRsmbLsbsbLcbLeLsbLgbLeLsbLcRsbRebLsbLcbL
sbRobRgbLgLcbLebRsbRcbLebLcbLebRgbLsbRebRiRobLgbLiRsbRebLsbRcbReRsmbRg
bRobRsbRsRsLsmbReRsmbRebRgbsbsbRibRebRcbRgbRobRiRsLeRsmbLhLsLsmbLebRgb
LcbLebLsLsmbReLcbLhRsbLsLgbLeRcLeLsbRibRgbLeLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bLobRsbRsbLibReReRsmbRebLeLhbLgbRebRcbRgRsmbLsbLgLsbRebRebRoLsReRsmbRg
RsmbLeRcbRjbLhRjbLgbsbLsbRcbLebLebLebLsRsLsLsmbLibLoLsLgmbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bRibRsLsbLiReLibLsbLiLsLebRiRsRsRsLsmmmbRgRcRsmbRgRsmbRhbsbLjbRsLibLiL
eRjRcLsbRebLebLsLgLsbRiLsRiRsmbRsLsbReRsRsmmbReRgbLgbLjbRcbLsbLeLsLsmb
LgbLebRcbLiRibRcbRcbReRebLebRgRjbLebLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bRcRcbLoLsmbLibRsbRsbLebRibLgRsLsbLcbRiRsLsLsmmbRgbRiRsmbReRcRsRsmmbRg
bRgRoRebLeRsbLsRsbLsRsbRoLoRsbRiRsmbRsbReLeLsbLgLsRsbLiLsLsmbLgLsLsmbL
gbLsbRgRgRsmbRcbLcbLhbRcRebLcRsLsbLsLeLsbLgRsLsbRjbLcReRiRsmbReLsbLsLs
mbLsbRiRsmbLjbLcbRebRiLebRsbRgRsRcRcmbReLcbLgLsbLiLeRsRsRsmmbLebLcLeRg
bRibReRoRgbRsRsmbRgbLoLsLeLsmbLeLsLcbRibReRsmbRibLiLiLgbLsLsLhRsmbLgbR
jbRebReLsbRsbsbRcRsmbRhLsbRcbLjLoLcbLcLgLobRsRsmbRiRsRsmmbLebLebLhLsbL
cbReRcbRiRsRsmmbRhRcLsbLebRjbRgbRgLsLsmbRibRcLcRsRcbRgbRgRebRebRgbsbsb
ReRsmbRgRsRsmmbsbLeLsbLsbRgLsbsbLsbsbReRsRsmmbRcRsRoRsRsmmmbLjbLgbLgLc
bLcbLcRsLsLsRsmbReReRcbRjRsRimbLcbLiRsLeLsbLcRsLebLgRsbLeRsbRhRiRcLsbL
gRsbLgbRcbReRgbLcbRsbReRgbRsRsmbRgLebRjRcRsRsRsmmmbRsRgbRhRcRsLsLsmmbL
jbRiLsbRsRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
b

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bRcbRebLgRsbRcbLcbRobReRgRsmbLgbLgbRcLsbLgbRebLgbLibLiLgLcRobRebRiRobL
ebRsLobLeRsbLsbLebRgLsRsLobLeLibRoLgbReLsbLibRoRsmbRebRcbLibRsbLcbRgRs
mbRobRebRgRsmbRebRebRibLcbRoRebRcRjbLibRoRsmbLoRsRsmbRcbReRebRcbLcLcbR
sbRobRsRiRsmbRebReRebLibLhLsLsmbRebRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsbRsLeLcbRobRgRgRsmbLebLhLsbLeLiLsLgLsRsbRjbLgLgbLgLsbLsLsmbRjbRiLeL
sLebLebReRsmbRiRebLebLsRsbLebRebLeLcbLeLsbRsReRsRgRgRiReRembRebRebReRg
bLhbRgRgRibRiRibLsLcbRjbLeLcbRgRgbLeLsLsLsmmbLeLsbLgLsbRjRjbRcLeRebReb
RgbLsLsmbLsRgbLjbLhLsLibLebLcbRsRsmbLcbRebLgLeRsbRgRgbRcLebRgbRcbLgbRj
bReRsmbRoRgRgRsmbRsbLeRsbLsbLeRsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcbLcbLgLibLsLsRsmbLcbLsbLebLebLsbRsbsbRsbRebRcbRcbRobLsbLgbRjbRcRgRs
mbRgbsbRsbRsbRsLsbRsRsmbLsbRsbLsbReLsbRiRsmbLgbLjRsLsbLibRsRsmbLgLsLcb
LgRsbRgbRsbLebRsLcLsmbLeRsbLsbLiLsbLgbLsbsbLsbRsLsbLiLsRsbLsLsmbLeRsbL
hLsbLsLsmbLebReLsLsLeLsmbLcLsmbsbRsLsbRgbRcbLgbLsbLebRjbRcbRiRibLebRgb
sbLjbLebLgLsLsmbLiLsbLebRgRibLsbsbLsbLeLoLsRsmbRsLebLiRsbReRsmbLjbLgbR
ebRgLeLsLsRsmbLsLsmbLeLsLsmbLebLcbsbLcLsLsLsRsmmmbsbLgbRcRsmbLjRebReRs
RsmmbLgRsbsbRgRebRgRsRgRsRsmmmbRiRebRcbLobLiLgbLsRsbLsbRsRsmbLiLsLgbLi
RcRcbRsbLjbRsbLsbLsRsbRsbLeLsbLgbLsLsmbLibLibLcbRobLoLsmbLjbRcbRgLibLc
LeLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsbLobLebRsbLhLsRsRsRsRsRsmmmmbRobLcRhLobLoLobLsbRsbRsbRebRsRsmbLjbLc
RsRsRsmmbRsbRgRsmbLsLsRsmbLsbLsbLcLebLibLhLsRsbReRebLcRcRoRsRoRembRsRs
RsmmbLoRgRcRcRcbLeRsbRoRjbLcbLsbRgLcbLsLsLcmbRsbLsLsmbRsLsRsbReLibLoLo
bLsRsLcbRsbLgbLebLebLhbRgbLsbsbRobRjbLgLsLsLsmmbRcRiRsRoRsRsLsmmmbRsbL
oRsbLgRsbRgRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcRcbLcLsmbRsbRsRsLsmbLeLsLsLsmmbRsReLsLsLimbLcbLsLsmbRiLsbLsLsmbLsLs
mbRebRcbRhbRgbLiLcbRobLgbRobLgbLibLoLhbRsRsmbLgLsbLgbLsReRsLsRsmbRebRe
RsRsmmbRgbLsRsbRjRcRobLsRoLobLhbLsbRsbLsRsbRsbLsbLsRgLsbReRgbRgbLsLsmb
LsLsmbRebLgbRsRobRgRsRsmmbRobLoRjbRcbReRsRimbRhRgbReReRebReRhbReRsmbRs
RsRembLobRgbRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbRsRsRgRsRimmbRsRsRsLsmmbRgbReRsLsmbLeLeRsbLebReRsmbRsRgbLcbLebRjbR
sbLsRsbRsbLsbRsRsmbLsRsbLgbsbLsbLebRebLeRgRsmbReRsRsmmbRsRsmbLcbRgRsmb
ReLsbLeLsLebLebReRsRsmmbRhbRiRgbRcRebLebLeLiLsbRsLsLsLsmmbLsLsLsLimmbL
eLsLgRsbRoRiRsRsmmbLeLsbLebLiLebRiRsRgRsReLsmmbRsbLcbLsbRsLibLeLsbRebR
hLsRibRiLsbRsbRsRsRsRiRcmmbLsRebLeLsbRgbLhLibReRgbsbLsLsmbLebLeLsbRebR
sRsRsLgmmbLcLsmbLebRhRsRsRsmmmbRgLsLsmbRsLebRebRsRsRsRsmmmbRebRsLeLeRs
bRhbRsRsmbRsRgRsmbRiRsRsmmbRebRsRsLgLiLsmbLiLsLsLembRgbRsbRhRsmbLcLsmb
LcLcLhLsLibRcRsmbReLsbLeLsLsmbLcbLebRebReLsbLebLiLeLsbLebLgLgbLiLsbRsb
RebRgRobRoRsmbRibLobLebLsbLsLsmbLibLgLsLebRsRsRimbLibLsLgLsbLsbLsbLsbL
sbLsbLsLsmbLsbsbRgbRsbsbRjbRsbLgLsbLsRsbLsbLjLgLgbLsLsLgLeLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbReRsRsmmbReRsRsmmbRcbLgbLiRsbLebRcbRiRsRsmmbRsRsmbLjbRiReLoLsmbLsb
RebLcbLsRgbLsbRgbsbRsReRsmbLgbLgRobRebRjRgLsLobRsRsmbLiLsLsmbLsbLgLgLs
LsmbLsbRsbsbRiRsmbRsbLsLsRsRsmmbLsbLsbReRsRsRsmmmbLgRsRsRsRsmmmbLjbLsL
jRsbRsLsbLsbsbLsbsbLsbRsbLiRcRsRcLsmbReLobRsbRibRsbLgLsLgRsbRcRsLcLsmm
bRoRsLoLsLsmmmbLgRgbLibLsbReRsmbLsRsbLibLgLgRsbLgbRibRgLsbLgbLgbReLoLs
RsmbRsbReLsLsmbLgRsbRcbLgbLsLgRgbLjbReRsmbRebReLoLsmbLgLsLsLsLsmmmbLgL
sbRsReRsRsRsmmmbLgRgRgbsbRgLsbRebLoLgbRibLcLsLoLsmmbReRsmbRgRsmbLjbRsL
sbLibRgbLsLoRsLsbRsLoRsRsmbLibRhRsmbLgbRhLcbLgLsRsbLsbRgbLibRcbLjbLcLs
LsmmbRjbReLsbLibLjbReRcbLsLoLsLsmmbRsbLsRsLsbLjLgRsRsRsmmbLgRjbRiLsbLc
LsLsLsmmmbRsRgRcLcLsmbRsbLiLsbRgbRsbRcRsmbLhLsLsmbRibRcRsRgRsRsmmmbRgL
sbRcLobReRsRsRsRgmmmbReLsbLcbLeRebLibLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbRsLsbRsbLsbLsbRsLsbLsbRebRsRsmbRsbLsbLsbLgbLsRsLsbRsbRjbRjbLsbRsbR
sbLjbLsbRsbRgbLsbRsbLsbRoRgbLsbRgLoRjRobLgbLibLsbRjbLsbsbLibLgbLsRsbLg
LibLeReLsbLiLsbRgbRjRibRsbLsbLsbRsbsbsbRsbLsbRsbsbLcLsmbRjbLcbLeLsbLob
LobRjbRsbLgbRsRsmbLgbLsbLibLsbRjbLsRsbLsbRebLgbLebReLsbLgLcbLebLoRebRs
RsmbLsbLgbLebLcLobRibLebLsbRgbLgLsLsmbRsRgbLgLgbLgLsbLobLiRjbLsbRibLeb
RcbRibLgbLibLsLgbRebLcbRsbLsLsmbLsbRiRsmbLcLeRoLsLcbLgbRsLobsbsbRjbLgb
LebRcbRsbLsRsbRsLsbLebsbRjbLsbRjbsbRsbsbLsbLsbRgbRsbLsLsmbRsbRsbLsbLsL
smbRsbsbLgbRsbRsbLsLsmbRjRjbRjbLsbsbReLsLcLgbLobLoLsLsmmbRgLsbRjbRjbLj
bsbRsbLebRiLsbRsLobRebLsbRsbsbRsbRsbLsbLsLsRsmbRsRsLsmbsbRgbRibLgLsLsm
bLsLgbLcRcbRgRsLgmbsbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bsbsbsbLcRoReReLsbRibRsbRsbRsbsbLgbLgRsbRoLsRsbLsbsbLsbRsbLsLsmbRibRgb
LsbsbRsLsbRebRoLsLsRoRsRimmbLsLobRsLsbsbRcLsbRsLgLsLsLsmmbLoLobLhbLhLo
bLsbRgbLebLsRebLcLsLsLsLsLsmmmmmbLgbLoLsmbLeLsbLgbLgbRoRsRhmbRebLsbLcR
obLibRebLhbLgbRgLsbLobLcLobLibLibRsbRcRsRsLsmmbRgbRgLsbLsbsbRsbLsLsmbL
sRsbRsbRsLsbsbRobLcbLoLsmbLsLsLsmmbLiLgbRcbLcbLobRhRebRiRcbLsbLsRsRsmb
LsbLsbRsbsbLsbRgbLjbLiRebLcLsmbRebLeLoRsbLsbRsbLsbRjbLgbRgbRgLiRgbRibL
sbLiLsLobLcLsLoRcRsRhLgmmbRgbRjbLiLsbRiLsLsmbLibRjbLibLjbLebRoLibRoLgL
sbRjbLhbRoRsLsmbLjbLgbLebLsLsLoLsmmbRobLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bLeLsLibLsLsLsmmbsbsbsbLsbsbsbsbsbRgbsbRjbRsRjbRcbRhLhbRhLcLsmbLgLsbLi
bRgLsLgbLjbRcbRobRiRjbRebLsbRebRgRsmbRibRsbRsbLcbRgbsbLgbRoRibLibLcbLg
bRebLebRebRjbLiLibRgLobLgbLgbRobRgRsRgmbsbLsbRebLgbLibRgLebLsbLsLibRcR
iRgRhbRsLsbLhbLibRebRsbRebLcLsmbLebLgbRjRebLoLsmbLibRsLgbLsRsbRcbRebRs
LsbLsbRgRsRsLsmmbRsbReRebRebRcLsbRgbRsbRsLsRsbRsbLgbRebRcbRibLgbLgbLsL
sRgmbRcbRhRsmbRhbRoLibLiLgLsbLgLsbLgbRoLebReLsbLeRsbLcRebLiLsbLcLsmbLs
LgbRcRoRsReRsRemmbRsLsRsbLsReb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bRhbRibRgbRibRsbLoRsbLibLeLsbLsbLcRsbLsbLoLsmbRobRhLcbLeRsRgbLebRoLsRe
bLgbRjbLebLibLsLsmbLsRebRsLebLgRgbRsbLoLsmbLobsbsbRgbLeLsLsmbRibLebLeb
RcRsRimbLeRebLgbLgbLsbLcbRsLsbsbsbsbLjbLobsbLcbLcbRgbLsbLsbsbRibLcbRgb
sbsbsbLobLibLobRsLobRiLsbRsLsbsbLibLhbLeLsLsRoLsLsRsmmbLobRgbLcLgLobLe
RsbLiRsLibRsbLsbLsbRgbRebLeLsRgbLgLebRoRsRoLsmbRobRebLsbLjbLcbRsLsbRjb
RoLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 25; Drug: Control PTZ 2.5 mM
bsbsbRcbRebRebRsRcbRebReRsmbRebRebLcbRjRebLeLsLcbRgbRebLjbRgRgRsRsmmbR
gbRsbReRsmbLsLebLebRcbRgbRgbReRibRsRsmbLsRsbRgRsRsmmbRcRsRsmmbRebRiRsR
sRemmbLebLebLebLeLsbLeLsbLhLobLgRsbLebLebRibLebLsbLgbLebRibRjbLebRjbLi
bLsLebLeRsLsbRebRcbLibLcLsmbLebLebRebLcRsbLsRebRsRsRsmmbRgRcLsRsbRebRs
RsRsRsmmmbRsRebRsLsbRsbLebLjbLcLcRsLsbLsLebLebRebRsRebRsbReRcbLjbRebRe
RsmbLsbLebLebLhbRebLebLebRhbLsRsRsRsmmbRsRgRsmbRebRsRsRgmbRsbLsLebLebR
iRsmbLsbRjRebRgRsmbLsRsReRebRsRebLebLeLsbLcLsLcLsmmbLhLcbRsbRibReRsRsm
mbRebReRsmbRgRsRsmmbLgRsbLebLhbLebLebLhRsbLeRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 26; Drug: Control PTZ 2.5 mM
bLebRgRsmbRebRcbRebRgbRebReRsmbReRsmbRhRsmbRgbReLsLeLsbRsLibLeLsLsmbLe
LobRsbLcbLcLsRsmbLcbRgRsmbRebRgbRebRebRgRsmbReRibLsbLhLsRsbLibLgbLebLo
LsmbLgbLhbLhbLhLsLsLsmmbLgLsbLsbLgbLgbLgLsbLiLsLsmbLcbRcbRebRobRgbReRs
mbReRsRsmmbRebRgbLebRcbLcbRcLsbLebLsbLgLsLsmbRcLsbRcRsmbRebLobReRsmbRe
bLcLsmbLebLobLibLiLsLsLsmmbLebLebLiLsbLeLsbLcbReRsRcmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 27; Drug: Control PTZ 2.5 mM
bRebRhbLebLsRsbReRsmbRgRsRsReLeRsmmbLoLgLsLsRsmbRsLsbLsLsmbRsbRsRsmbRc
RsRsmmbRsRsLembLgLeLsLsLsLiLeLimmbReRgRsRsmmbLcLsmbLsbRhbLcbRebRiRsmbR
gRgLsbLeRsRsmbLsbLcbRgbRebLsLobRebLebLebLebLoRgbRsRsRsmmbReRiRsRsRsmmm
bLeRhbLcbRsbReLeLsLsLsLimmbLsbsbRsbRebLsRsbRoRsRsmmbLjbLsbsbRiRoRebRsR
gLsbRcRebRsLeRsLeLsbLgRsRsmbLsbLebLsLsLsLsmmmbRcLsbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 28; Drug: Control PTZ 2.5 mM
bLgbLsbRebLiLsbLgbLcLsmbLsLsLsmmbLiLsbLgLsbLgLsRsbLsLsmbRcRsmbRgbRcbLs
bLcRgRsmbLhbLsLsLsmmbLsbLsLsLsLsmmmbLsbRebRsbRgbRebRobRibRibRgbRgbLsbL
ibLgRsbLsLsLgmbLibRebRgbLsRsRsmbRibRsRgbRebLeLsbLibRsbLsLsLgmbLibLibLg
bLgbLgLsLsLsLsmmmbLibLiLsbLibLibLibLebRsbLsRoRebRobReRsmbRibRgbRebRcbR
sRebRebRsbRgRcRsmbReRsLsmbRsbLgbLsRoLsLib

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 29; Drug: Control PTZ 2.5 mM
bRiRsRsRcRsmmmbLcLsmbLiLgbLeLobRebLsLeLsbLsLsRsLsmbLgRcbLsbLcLibRebRjR
smbLsbLobLebLebReLcRcLeLebLebRsbLeLgbLsbLeLibRjLgRgbReRebLebLsReRsmbLs
bRsRiLcbLibRsRsmbLsRsLsbRgbRsRgLsLsmbLebRsLsLiLsbLsLsmbLgRcbRcReRebLeb
LeLsbLebLibLsbRsRsmbLibLgLebRsReRcReLsbLjbLeLsbLgLcRsLsbLgbLjLsLiLsmbL
sLsLsmmbLgLcbRsRsmbRebRcbLhLsLgLsbLsLsLsmmbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 30; Drug: Control PTZ 2.5 mM
bReLcbLebLebLobLgLibLgLsbReRcRsmbReRsmbLsbLsLeRebRgRcbRcRsLcmbLsRsbLcb
LobRcbRebRebReRsmbRgbRcbReRibRebRgRsmbRsRebLebLhbRsbLsbLsLsmbLsbRsbLgb
sbsbLsbRsbRsLsbRobRcbRebRgbRsRsRgmbRsRgbRsRsRsRsRsLsmmmmbsbRsRsRgRgLgm
bLsbRcbLebLebLsbRcRgbLsbLsLsmbsbLcLeLsbLsbLsbRsbsbRsbRsRsmbLsbLsLsmbLi
RobRsLsRsbRsRsLsmbLsbLsbLgLsbLebLeLsbLgbLsbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bReRsRsRsRsmmmmbLhLibLeLsbLgbLgbLgLsbRsLsLsLsmmbRsLsbRjRebLgbLgLsbLsLs
LsLsmmmbRjbLebLsbLebLeLeLsLsLembRoRgReRsmbRhbRgbLsLsLsmmbRoRsRsmmbRsbL
cLeLeLgLgLeLebLeLsLsmbRsReRsRiLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bRiRgRsRsmmbRgRsRgmbRsRsRsRsmmmbRiRgRsRsRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bRibLebRcbRebLsbLebLoLsRsRsmmbReLiLoRsbRibLsLsmbRiLeLsbLsLgbLgbLgLsLsL
smmbLsLsmbLgbLsLsLsRsmmbRsLsLsLgmbLsLgLsbRsbRebRcbLsbLiRsRsRsmmbLgLsbR
eLeLsLsLsLcmmbRibLebRgbRibLgbLjbLibReRgbRjbRebRsRsRsRsRsmmmmbRgbRgbRcL
ibLcLsmbLgbRjbLebLiLsRsRsmbLebLobLhLsRsbLiLsLsmbLiLsbLgLsbLiLibLgbLsRo
bRcbRgbRjRiLsLsLgLsmbRgRsmbRiRjbLgLjRgRibRebLebLeLsbLsLsLembRiLsbLsLsR
embRibRebLobLsbRiRcLsLsLgLsLcmbRsRgLebRsRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bLgLcLsmbRgbRhbLcLsLcLembLcbLcbRsRcbRgbLcRebLsLsLembRibRsRsLembLgLiLsb
LiLiLgbLgLgbLsLsLsLsmmmbLsLsLsLsmmmbLsLsLsLsLcmmmbLcLsmbRcbLiLsLsLhLoL
ombRibRsRgRsmbRgRgRgbRgbRgbRobRiLsbRcRsmbRgbRsRsRsmmbRsRsmbRebLhbLcbRc
bRcbRsbLebLcLsmbLgLgLibLebRsRsmbRobLebLobRiLebRebRsRebLgbLsLsLombLgLsL
smbLsLgLcbLcbRsbRcbLsbRcbRebRebRebRebRgbRgbRsRsReRsRsmmmbRsbLsLsmbLcLc
bRsLhLsLsmbRsLsRsbLsbRcbLobRcLcbLebLgLsRsbLsLsmbLgLgLsLsmbLsRsbLsLsLgL
sLsmmbLsLgLsLsmbRoRobLsRsbLsbLcLsLeLsmbLeLobRsRsRsRimmbLeLsRgRiRgRsRsm
mbRsRgbRsRsRsRgRommbLgLsbLsLsLgLgmbLsLsLsLsLsLsmmmmmbLsLsLsmmbLsLsLsLg
mmbLsLgLgbRobLoLibLsLsmbLsLsLsLcLsmmmbLgLebRebRgRcbReLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bRiLsRsRsRsmmbLcLsmbsbRsbRsLsbRjbRcLgRibLsLsLsmmbLsLsmbLsLsLsLgmmbRgRi
bRsLeLoRebRgbLebLebLeLsbLeRsbRsRsRsRsmmmbRcLeLsLsLsmmbRsbRoRsLeLsmbLeL
sbLsLiReLsbRsRcRsmbLsLsmbRoRsLembLeLsbLgLsLsLsLsmmmbLgLsLsLsLommbRsRsm
bLgbRcRhbLsRsbLcbLgbLgLgbLgLsbLsbRhbLeLsbRsRsRgmbRsRsRimbRhLsLibReRsmb
LjbLiLgbLsLgLsRcbLiLsRsLsLsmbRebRcRebRgbLgRsLeRobRibLcbLebRsbRobRjbLob
LgLsLsmbLsLsLsLsLsmmmmbReRsmbLebLiLebRsLsRsRsmbRoRsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsRsRsRsRsRoLemmmmbLjbLsbLsLsmbLsLsmbLsLsLgLsLsmmbLsbRsbRgLobRiRsmbLc
bRjbLoReLiLgLgLsLeLsLoLebLsLsLsLsLgLgLsmmmbRjbRsbRgbsbRsLsbsbLsLsmbLsL
smbLsbsbsbLsLsLsmmbsbsbsbRsbReLcLebLsLsRcRsRsmmmbLsRsRsmbRgLgLsbRsRsRs
RsRsRsRsRsmmmmmmmbRsbRsRsRgRsRsmmmbRsbRgRgRsLgmbLebRsbRcReRgbRsbRsbLeR
sbLsLsLsLsLsmmmmbLsLsLiRsmbLsLsLsLsmmmbRcbRjRobRobLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bLeRsbLobReLgbLeLsRoRgRsRgLgmbLhLobRiLsbLcbLhRgbLgLsLsmbLebRgbRgRsRsmm
bLobLsLsLsmmbReRibLhbLiRebLobLeLsbLgbRsbRebRiLsbRgbRsRsmbRgRsmbRsbLoRi
bLibRgRsLsmbLsbLebLsLebRibsbsbLebRoRebRiLobLeRobRgbRsbRsLsbRsbLoRebRib
LsLeRobRjbLebLcLiLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsLsmbRsbLsbRsbLsbRibRebRhReRsRimbRgLsbRgLsbRsbRgbLiLebRsbRcbLsReRsmb
ReRibRebRiLsRsbRsRsmbRibRhRsmbRsLsbRsRiRsLsmbsbsbLsbsbsbLsLsLsmmbLsbsb
LsLsmbRsbRiLsRsbRsLjbRsLsbRgbRsbLobRibRsbLoRsRoRcbRgbLsbLebRsRsmbsbRgb
RgbLhbLsLsmbRcbRhRoLeRsbLcLsmbLsLsLembRsLsLsmbLsLoLeLebRgLsbLsLsRsmbLc
bRsLsLsmbLoRoLgRoLobLibLebLiLsbLsRebRoRsmbRhRoRsLsmbLgbLoRsbRsRgRsmbRs
bRsLcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bRcbLsLsLcLsmmbLgRsRgRsRsmmbRgbRebRebLcLgbRsRsmbLiLsLsmbRsbLgLcbRcRsmb
RsRsmbRgRsmbLsLsRsmbRsRgLsLsRgRsRsRcRsLsmmmmbLsLgbLsLsLsmmbRsLcbLgbRoR
smbLgbLsLsLsmmbLsLgLsbRsbLeLsLjbRoLsLiLsLgbLgbRebRoRsRsRsmmmbRsRgRsRsm
mbLcbRoRsmbRcLsbRcRsmbLoLgLsbLobLgbLiLeLsLiLsbLgLsLebLebLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bLibRoRsmbRebLhLoLiRsbRcRsmbLebLhLebRiRsmbRibReLsRsbLsRsbReRsRsmmbRgRs
RsmmbLsRcbLcbRcRsmbRsRsLsmbRebLcLhLsbLgbRcRsLsmbRgRsmbLsLsmbLebLsRsRsL
smbRoLeLsbLebLgbLibLibLgbRhRsLgmbRsRhRgbLgLgbLsRsRiRsmbRsLsbRgbLhbLhLs
RsbLebRgRsmbLibLoRebRiRgbRiLsbRiRsmbRgLsbRgRsmbLcbReLsbRsRgbRiRsmbReLs
LsmbRibLcLsLsmmbLibLiRcbReLsbLhbLiLsbLiLsLsmbLebRgbRgLsbRhRsmbRhbRcbLi
bLebLgbLiLobLsbRsLsbLebRsLsbRiLsbRhRsRsmmbLibRcLeLsLgbRebRebRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bsbLeLsbLsbLgbLebLcLsmbLsLsRgmbRcbLeLsbRcbRcRsmbLcbRgbLjbsbLeRcbLjbRsb
sbRcLcLsmbLcLsmbLeLobRjbsbLeLsbLsLebRcbRcRsmbLsbReRobLhbLiRsbReRsmbRsR
smbRsLsbLcbRcbLcLsmbRiRgRcRoLcLsmbLeLcLcLsLsmmbLsbLsbsbRgbsbRsbLsbLsbs
bsbsbLsbsbRcReRebLcLoLsmbLcLgbLebLsRsbRebRebRsRsmbLeLcRebLcRobLsRsbRcb
RsbRebLiLsbLsbLeRcbRsbRibRsbRebLcbRebLcLsRcmbLebLsRgbRhbLjbLsbLhbReReL
oLsmbLebRebLsbRgbLeLsbLobRebLsbLibReLsLsmbLibLoRcbRsbLsbLjbRcLoLsmbReb
LcLsmbRgbLhbRcLoRsRgLsbRgRsLcLsmmbLeLsbLiRsbLsbReRcLsbLcbsbLeLcbRsbLsb
RcRebLibRsbReRsRsmmbLcLsmbLcLsmbLsLsmbLsbRhbLcbLcRsbsbsbLebRibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bLgLsbLhLsbLobLibLebLeRsbRgRsRsmmbLjLsLgLiRembReRsmbRsbRsRsLsmbLsLsLsm
mbLsLsLiLsLsmmbLjbRgbLcLebLsLeLsLebLeLsLgLsbLsLsLsmmbRjbRhbLcLsLsmmbLg
bRsbRcbLcbLsbLiRcLsbRiRsmbRsLsbLoLsmbLiLibLobsbRsbLsbsbsbLiRobLsRsRsLs
mbRebRibRoRsRgmbRsRsRsmmbReLibLcLibRsLsLiLsbLsRjbRiRcRsmbLsbRsLsbLebRs
RsmbRsLsLsLsmmbLgLsLsRsmbRoLsbRsRsRsmmbRsRsmbLgLsLsmbLsLobReLsbRsbLsRc
LsbRsRsmbLsRhbLcLsRsmbLeLsbLsLsRsmbRcbReRjbLobLsLsLsmmbRsbLoLsmbLhLsLs
mbLsLsLgmbLsLsmbLsLsLsmmbLgLcLebLjbRhbRsLsLsLsLsmmmbLeLsbRgbReLsRsbLsb
LeLsbRsRsRsRsmmmbLcLgbLsRsbRcRsmbRebRsRsmbRgRebRsRsRsmmbLhbRoLgRsbLebs
bRgbLsLeLgLsbRgbLgbRsbRobRsbRsRsmbRsbReRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bLibLiLsLsLoRsRsmmbRsRgLgbLjbLebRibRiRcRhbLoLsmbLiLsLcLobReRsRsRsRsmmm
mbRebRoRsRsRsRsLsmmmmbLjbLeLeRobLgbRgbRhbRiRsmbsbLgbLeLsbLgLsbRiReRoLs
bRgRsmbLjbLsLsmbRoLobLebRhbLcbLcLjbRhbRcbRiLsRsbReRsRsRemmbLobsbRjbLsb
LcRoLobRsRoRsRhmbLebLsLsmbLsLsLsLsRsLsRemmmbRgbRebLsbLeRsbRebsbLgbLeRe
bLgLsbLjRsbLsRsbLebLsLsmbRjbRsRsmbLebLgbLcLoRoLobRsLsbLcbLhLoRsbLsbRjb
ReRcbLoRsbRebsbRgRsLsRsRsmmbReRsmbLsbRgbRiRsRcRombLeLoRibRhRsRsRsRsRgR
sRsRsmmmmmmmbReRsmbRcbLhbLebLiLoLobLeRsbRsbRsRsmbLsbRsLcLsLoLoRsRsRsmm
mbRcReRsRcmbReRsRsRsmmmbRsbRjbLoLobRsbRgRjRsRsRiRsmmmbReRsRsmmbsbLsRib
RoRsRoRombRiRsRsRsmmmbLcLiRoLsbLgLebLebLebLebRjbRsbLhbRhRsmbRgbLoRgRsR
oRsmmbReRsmbLsbLgbRhbRgbRoLoLsmbLiLeLsRgLsRsbRsLsbLiRgRoRsmbLeLsbLiLsb
RgRsmbLhRoRsmbLeLsLobRebLiLgLsbRsRsmbRgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsLgRsbLsRjRsmbLsbRiRsRsmmbRoRcRcRibLoRsbLebLsRsLgLgLebLiLsRsbLgLeLob
RcbLgLsLsLsLsLsmmmmbLgLsLgbLsLsLsLeLgLsmmbRsRsmbLgLsLsmbLsLsLsLemmbRsR
oRcbLsbLsLsLsLsLsLsmmmmmbLsLsLsLsRommmbLsbLoRhbRiLgbRibLsRsRsLsmbRcLeL
sbsbLhLgLsLsmbLibLiLgbLsLsmbLsLsLsLsmmmbLgLsLobLcbRsRsLsLsLommbRcLsLsm
bRgLeLobLebLgbLsLeLsLobRobRcbRiLsbLeRsLoLoLsmbRsbRoLoRsbLcRobRcbLgLsLs
LsLsLgLsmmmbRsLsbLoLcbRgbLibLsLsLsmmbRgLeRgbRsRsRsRsRsRsRsmmmmmmbRsLsb
LsLsLsRsRsmmmbLsLsLimbRsLeLcLoRoLgLsbRjbRhRsRsRsmmmbLgbReLsbLoLcbRoLsb
RibLcLcbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsRebRibRcRebLeRsbRsRibRsbRsbRsbRibRcRsmbReRsRombLsLsLsmmbLiRsLgLsbLs
bLibLiLgbLgLsbLgbLgLsbLsbLebLsbRgbLgbLsbLgbLsLiLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsRsbLsbRsbLsbLgbLsbLcbRsbsbsbRgbLsbRsbLsbRhbRgLsbsbLsbsbRsbLsbReRhbR
ibLoLsRsmbLgLgbRibRsRgLsbLoLoLsmbsbsbLsbsbLsbLcRsRoLsRsbLsLsRsRsmmbRsb
RsbLjbRebLhLsbLcbLsbLsbRcbsbsbsbsbsbLsLsmbLsRsLsbRibRebLhbLhLgLgbLobRe
bLcRsRcbLsbLcbRsLcbLebLgbRcLobLcbReLsbLgbRjRsRsRsRsRsRsmmmmmmbRebLoRcL
sbRgLcLsmbRsbLgbLjbLeRjbLhbLsLsmbLsbsbRebLsbLsbsbRibLsRsbLsbRsbsbsbRcb
RcbRsRcbLcbRsbLsbRobLgbLsbLcLibRhRgRgRsmbLebLob

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsLgLsLsLgmbRsbLsLsLsLsRsmmmbRsbRcRsRgmbRsRsRgmbRjbRobRsRsRiReLsmbRib
RiRsmbReRgbRsbRsRsRsRsmmmbRsRgLebLeRsLsLibRibRgRgbRsRsmbRsRsRsmmbLobRh
bRibRsRgLsbRsbRsRsRgmbRgRsRsmmbRgRsRsmmbLhbLeLsbRgLsRsLsRsRibLsbRsRsmb
RsRgbRgRsmbRgRsmbRsRgRgRsRgRsmmbRgbRgRsRsmmbRibRebLibRsbRsLsbRsLsbLcLs
LsmmbLgbReLsRsRsLhmbLeLebRsLeRcRsmbRsRgRsmbLsbLgLcbLgLsLsLsmmbLeLebLeR
gbLsLiLsLgLsLsLsmmbLeLsRgRsmbRcbLjLsmbLsRsbLgLsbLebLgLjbLsbLsLsLgmbLgb
LebLsbLgbLsLsLsmmbRcbRgbRhbRgbRsbLsRsRsReLgmbLsRsbRiRsmbRiRgbRsRsRgmbR
sbRgRibRsRgLsRsbRsLsbRsRibRjRsmbRiLsbLiLsbRiLgLsbRgRsRsmmbRibRgRgbRiRg
RsRgmbRgbRgRsRsLsmmbRcbRibReRcbLibLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 150940; End: 151440;
Recording: 6-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bRjbLcLsLsRsmmbRjbRcLsLoLsLsLsLsmmmmbLeLsRoRsmbRiRiRsRsmmbRhbRsRsLsmbR
cLsRsbRiLsLsmbLobLcLeLsLsmbLobLcbLebLibLsLibLsLsLsmmbRjbLebRcLobLoLoLc
bLgLsbLcLsmbLgLsLsmbRsLsbRcLsLsLsmmbLeRsLgLsbLsbRhbRiRsLsmbRebLsLsmbLi
LsLsmbLobRsbRoLsLobLcLsLimbLeLsLebLsLgLeRsbLebLsRsbRebLcLsLoLoLsmmbLsL
sLsLsLcLsmmmmbLeRsLcLhbLeLsbLeLsbRjbsbsbsbRgbsbRsLsLsmbsbLsbRgbRiLoLsm
bLgRsbReLsbRoLoLsLoLsRimmbRiRsRsRsmmmbRsLsbLsRhRsmbRjbRsbLgLcLjbLcLebL
eLsbLgLgbRgbRsRsmbRgbRgRsmbRgLsLsmbsbRhbLgLsLgLsLsRsmbRjbLsRsbLoLobRgL
cbLgLebRsbLcbLobLsbRsbLgRsbLgbLhbRobRebLebLcbLcbLsbLsbLcRsRsRgmbLgbRgR
smbLeLsLsmbRcbLsbRebRcLsLsLsLoLsmmmbLcLoLeLebLsbReRsmbRsbRsbRiRsRgRsmm
bRoLgLsLsmbRobRhRsRsRsmmmbRoLgLcLsLcmbLgLsLsLeLsmbLcLoLsLsmmbLebLeLsLi
bLgbLeLoRebRsRsLsmbRgRsmbRgRsLsmbRgLsbRiLsbRjRjbRsLsLsmbRsRsRgRsmmbLeL
sLsmbRjbRcLoLsLsmmbLeLhLcLiLcbLgLebLeLgLgLsbRsbRjbLgLcbRjbLsLsmbLsRsbR
eRsmbRibLhbLibRcRsLsmbLiLsLsmbLeRsRsmbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 1; Drug: Control PTZ 2.5 mM
bLsRsLeLgbLebRsbLsbLebRjbRsRsmbRsRsmbRgRsmbRgRsmbRiRsRgmbRcbRebRcRebRi
bLobLebLgbLhLsLcbLsbRgRsRcmbRsRsLsRsmbRgLsLsmbLebRebLgRcLsbRgRsmbRsReR
smbRsLsRsbRsRgRsmbRsRsmbRsRsmbLsRsbRsRsRsRsmmmbRsRebRgbLibLebLebLcLsmb
LibLgbLsbRobLsRsbLgbLcLgbLsLsLsmmbLeLsLsmbLiLsbLibLsLgbLsLsLsLsmmmbLsL
sLsmmbLsLgLsLsLembLsLsmbLgLsbLgLsRsLsbLebRsRsmbRsRsmbRsbLgLgbLsLsLsmmb
LsbLsRsbsbRiRsRsmmbRjbRebRebRgRsRsRimmbLsRsbRgRobRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 2; Drug: Control PTZ 2.5 mM
bLeLcbLebRgRsmbRsRsRsLsmmbRiRsRsmmbRgbRsRsmbRcLsLeLibLsLsLsLsLsLsmmmmm
bRsLsbLsbLeLsbLebLiLsbRsbRgbRebLebLcLhLibLibLeLebLsLsmbLsLsLsLeLsmmbLs
LsRcLembLeRsbRgRsmbRebRebRebLeLsRsbLeLeRsLeLsLsLiLsmbLiLsbLeLsLsmbLgLi
bRsLsbLebLebLebLgLsbLsLsmbLcRsbLibLsLsmbLgLiLebLgbRsbLeLsbLgbLsLsLsLsL
sRimmmmbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 3; Drug: Control PTZ 2.5 mM
bLobRcRcRcRoRibRsRsRsRgmmbLcRcbRsRsRsRsRsRsRsmmmmmmbLcRsbRebRebRebRsbL
ebLgbLgbLsLgLsbLsLsLgmbRobRobRoRebLsbReReRsmbLsRsRsmbRsLsRsRsRsRsmmmbL
obRcbReRsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 4; Drug: Control PTZ 2.5 mM
bReLeLebLeLsLsmbLeRsbLgLeLcbRebLgRcbRsRsmbLebRebReRgLcbLeLsbLgbLsRsRgb
ReRsRsRsLsmmmbRsbRhRoLsbLgReRgRsmbRsRgRsRsRsmmmbRsRsReLsLsRcRsmmmbRgbR
eRsmbRgLsbLcLsmbLeLoLsLiLsmbLsLsmbLsRsbLcRsbLcLsmbRebLsRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 5; Drug: Control PTZ 2.5 mM
bRoRsRsRsRsmmmmbRsRsRsmmbLeLsLgLeLgbLebLsLsLgLsmbLebLiLiLsbLsLgLsbRsLs
LgbLhbLsLsmbLsLsmbLsLsLsLsmmmbLsLhbLgbLiLsRsLiLsbLgRgRsRsmmbRsRsRsRsmm
mbLcLsmbLebLsbLibLgLebRcbReReRsReReReRsReRgmmbReReRebRsbRhbRgbRsRgbRgR
sRsmmbRsRgbRsLebLhLcbRsbRebLeLgbLsLsLsmmbLhbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 6; Drug: Control PTZ 2.5 mM
bLhbLebLsLgbRgLsbRsRsRgRsRsRsLsmmmmbRsLiLoLsLcmbLeRsbRoRebLcLcLcbRebRs
RgRsRimbRgbLsLgbLeLsbLgLeLsbLgLsLsLsLsLsLsLsLgLsmmmmmmbLgRiRebRsRsLoRc
RcReReReRsRsReReRemmmbLgLsbLeLiLgbLsLsReRcRsRsLsLemmmbRebRgLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcRebRgRgRobLsbRoRobRoRsmbRsRsmbRsRsRsmmbsbReLsLsLsmmbRgbRcRsmbRgLebR
sLcRcRsRsmmbReLsbLsLsmbLsReRsmbRsRsReLsmbLsLcRebLhbLsbRiRibLcLsRsmbRcb
RobRsRebLsLcbRsLebRsRcbRcbRsLsRsRsmbRsLsbLeLhbRjbRhLeLibLsLsLgmbLsLsRe
RsRsRsmmmmbRsRgbRoLsbLsLsLsmmbLsLgLeLsbLsLsmbLsLsLsLsRiRoLsmmmbRsbRoRo
bLsbLsbRoRhRsmbRsRsLeLcmbLsbRcbLoRsRoRsLsmbLsbLiLiLsbRgbLcLoRsbRiRsLeL
iLombRoRobReLsLcLcRsRsmbRsbRcRsRsLsRsmmbRhbLsbLjReRhRsRombRgbLcLsmbLeR
sb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bRcLoLcbLsLcbLeLsbLgLgLebLsRsRsmbLeLsLsmbLgLsLsLsmmbRcRoRgbLjbLhLsLoRs
bRsRsRsRsRgRsReRsmmmmmbRsRsRgRgLsmbRiRsmbRcRsmbLeRsbLcRsLcLsmbLsbLsLgL
sLsLgRcLombLhLibLgbLcbRsRcReRsmbRebLjbsbLgLsLsLsLsLsLsLeRcmmmmmbRgbRgb
RsRsRsRsRsRsRemmmmmbLsLsmbLsbRcbRoLsRsRsRsRsmmmbRcRsmbLsLsLsLsLsLsmmmm
mbLeLoLcbRcRsLsmbRcRebRcRsmbRobRsbLsLcbLoRsRsRcRsmmbLsbLjbLsLhLsLsLsLs
RsmmmbRcLhbLcLcLgLsLiLsbRsRsLsmbLobLobsbsbsbsbRcLsbRcLsRsbLeLsLsLsmmbL
sRsbLeLcLobLgLgbLsLgLsLsmbLcLeRsbReRsRombRsRebLcLgLsLsLsLsmmmbLsRsRsRs
LsmmbLsLsmbLsLsmbLiRgLsLsmbLeLeRsbLobReRcRsRgmbLsbRgRebRsbLsRsRsLeRsmb
ReRobRsRsLsmbLoLiLobLhLsbReRsRsRhLcmmbReReRcRcbRsRgRsmbRsRsRsLsLsmmmbL
iRsbRsRebRsRcRsmbRsRsmbLjbLsLeRcRsRsRsRsRsmmmmmbRgRsRcmbLsbLjbRcReRsmb
Lcb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeRcbRebLsbLebReRsmbReRsmbLsRsbLebLeLsbLebLgbLeRsbLeRsbRibLebLebLhbLi
bRebLebLcbLebLcbReRsmbLcbRsbRsbRcbRsbsbLcbRjbsbLsbLjbRjbRcbLebRcbLebLe
bLsbRobLgbLjbRebRcbRsbLgbLebLsbLsbLcRsbLebLebRibRebLiRsbRsbsbRebLsRcbL
ebRsLgbRgbLebLebLebLgbRibLgbRebRobRebRcbRebRsbRcRsmbLsbLeLoRsbLebRobLs
ReRobLgRsbLebLibRebLibsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bRgLjbsbLeRsbRhRsmbRjRgRsmbRebRgRsmbRgLobLebLgRsbRobRgbLjbRsRsmbsbLcbR
ibLgbLgbRgbRcbRebLiRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bRibRcRgbRgRsRsRsRsmmmmbLsbLsbRsbsbLsRgRjbRibReRiRsRsmmbRsLsbLsLsLgmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeLeRhbRgbLsRgbRsLsRsRsRgmbLsRebLoLibReRcbRgbLsbLiLcbLsLsmbLsRsbRebLo
RcbRcbRgbRebRgbLjbRsbRjbRebLcbRsRjbRebRsRsRsRcmmbLhLsbLhLcbReReRsmbReb
LcbRgbRgbLoRsbLeLhbRsbLoRoRsRsmmbRsLsbReRsLombLeLsbLjbRebRsRoRsmbRjbRh
RebLibLcbLgRsbRobRgbRhRsRgRsmmbLsbLoLebRcRsmbRibLsLsmbRebLcbRcbLcRcbRo
RcbLebLsbLgbLebLibRebRjbLoRgRgRsmbLjbLjbReRsRsRsmmmbRiRoRobRsbLeLsLsmb
LcRsbLoLsLgLsLsmmbLgLsLsLsRommbRebRcbLibLgbLobRsLobRcbRcbRebLsbsbsbRjR
sRsRgRsRsmmmmbRibReLebLcbLeLsbLcLsmbLebLcLcbRjbRiRgRcbRgbLebLebLeLiLsb
RjbLibLeRebRgRsRsRsRsmmmmbRebRebLeReRsmbRgRsmbLeLebRsRsmbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsLobRsRsRsRsRsRsRsmmmmmmbRsRsRsmmbRsRgRgbRsRgbRgRsRsRsmmmbRsRgRsRsRs
mmmbRsRgRgRsRsmmbRgRsRsRsRsRsRsmmmmmmbRsRsRsRsRsmmmmbRsRsRsRsmmmbRsbRs
RsmbRsRsRsRgmmbRsRsRsmmbRsRsmbRgRsmbRgRsRsRsRsmmmmbRgRsLsmbRsbRsRsRsmm
bRsRsRsRsmmmbRsbRsbRsRsRsRsRgmmmbRsRsmbRgbRsRgRsmbRgRsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcLgbLgbLebLiRsbLsRcLjbLcbRsbLibsbRiRsRgRsmmbLoRsbsbLsbLsbLsbRcbRibRc
LsbLsbLoLsLoRsmbRsbRebLcLsmbRgbLiLsbRsLsbRsLsbLsbReRsRsRsRsmmmmbRebLeb
LcRsbLibLgbRebRiRcbLibRcbLsLsmbLsbLibRebLsLgRsbRebLgbRsLsbRjbLsbLoLcbR
sRiRgRsLsmbReRsmbRcbRsbRsbRsbLsbRsLsbRobLjbRsRsmbLobRgLsbRibLcRsRsmbRe
bLoLsRsmbRsbReRoRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsRsmbsbRsRebRiRsmbLebReRcRsmbRiRebRcbRebLebLgLsbLeRsbRsbRsRiLebRjLeb
LsbRebRcLcbLgLgLgLsbLebLeLebRebRobLeLeRsRsmbRjLiLsbLibRcRsmbLgbLiLjbLe
bRgbLebRgbRgbLsReRsRsmmbLgbRcbRebRiRsmbRiRsLcLsmmbLcbLibLsLeLsbRsRiRhR
iRsmbReRibLgbLgLgLgRsbRibReRsmbsbRsRsmbRsLsbRsbRebsbRgLsbLgRoLsLsmbLiL
sRgbRhRibRsbLibReLsRhbLgbLsLgLsbLeRsRsmbRgbsbRsbLebLsLsmbRgbsbRsbLsLsm
bRhbRebLhLgLsLgbRibRgRebRgReLsRsbRibRsRsRsRimmbLsRebRhRsRsmmbRgbRebLgb
ReLcRsbLsLsLeRsRsmmbRgRsRsRgmmbsbLeLibRsRibLebRcbRsRebLsbRjRsmbLebReRs
mbLcRsbLiLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bReRgbRcbLibRebRsRsmbLgbRebReLsbRebLcRsLsbLibRebLibLebLgRsLsbLhLcLsmbL
sLsRsmbsbsbLsbLcLsLsmmbLeLsLsmbLsbLcLcRsbLhLsbLcRsbLcbLjbLibLobRebRsbs
bRsbLibLcLeLebLebLiLebLgRebLgRsbRsbRebRebLgRcbLcbLiLsLsmbLgLsbLeRobReL
sbLsLcbLgbRcRsmbLsbRsbLibReRsRsmmbRsbRiLebLgbRcbLjbRsbLibReRsRsmmbReRs
mbReLeLibLgbLebLcLsLcmbsbLebLhLeLsbLgLsbLgLsLsLsmmbLsRsLsbRsLibLhbRsbL
sbRsLsbLebLeLsLsmbLcbLibRoRgRcbRgbLcbLhLsbLcbLebLsLebLibLgLsRcbRgRcRsm
bRiRsmbRsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgbLeLsLsmbRcbLiLcRsLobLiLibLcbLgRsbLsbLgRsLsbRobRsbLebRobLebLoRsbRgb
LebLcRsbRjRsmbRebRiRobRoLsbLjbLsLsLsLsmmmbRgbRoRoRsLsLoLsLeRcmmbRibRoL
oRobLcbRobLsRsLsLeLsbLsLsLsLsLgLhLgLgLiLgLsLgLsLsLsmmmmmbLiRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsbLsLsmbLsLeRsLobLcRjRcRsmbRsbRsbRgbLcRsbRcbRsRsRsRsRsmmmmbRebLoLiRs
bLeRsbLibLsRsLsbRsRsLsLgmbLsLsmbLebLsbLsLsmbRsLsLsmbsbReLsbLcRsRsmbLsb
LcbLsLiLsLsmbLibLibLsLsmbsbLsLsmbLibRibRhRsmbRsLsbLhbRcRobLebRsLobLcLs
mbLgbLsbLobRsRsmbRiRsmbRgRcRobRsbReRsmbLcLsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgLsLsmbLsLsLembRhRsRembRsbLsLsmbRsbRsbRsbLsRsLsbsbRgRsLsmbLsbRsLsbsb
LsbLibRgbLsLsmbLsbLsLsLsmmbLeLsLsmbRsRiRsRsRgRsReLsmmmbLibLebLsLsLembR
jbLsbRjbLsbRsRsmbRsRsmbRgRsmbLsbRsRsRsRsLsmmmbLsRsbRebReRgRsRsRsmmmbLi
LgLibLcRsLsbRsRibRsRgRgRsRsRsRsmmmmbRsLsLsLembRsRsRsRgRsRsLcmmmmbsbLsL
smbRsLsbRjbRcbRsbRsbsbLsbsbRiRsRsmmbLsRsRsLsmbReRsRsmmbRsRsLsLsmmbReRc
LsbLeLcRgbLsLcLsLsmmbLsLebRiRgbRgbRebLsLsLsmmbRhbReRsRsmmbLgbRgbRgbLsb
RcbsbLgLeLebRsRsRsRsRsRsRsmmmmmmbRsbLjbRebRsReRsmbLeLsbRsLsRsbLsLgLsLs
mbLsLsmbLgLgbRsbRhbLeLsLjbRjRibLjLibRsRgLsbLsLsmbLsLsLiLsLsmmbRcRsmbRi
RsmbLsLgbLsRsRsmbLebRsLiLgbReRhbRgRsRsRsRsmmmmbRsRsmbRgLsbRsRiLsbRsRsR
iLcLsmmbRjbRsRoLsbsbLsRsLsbRgbRsRsRcLsRcRsmmbLsLsLsmmbLeLebRsRgLsbRcRs
mbRsbLsLebLsbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bsbRebLibReRsRsRsmmmbRgReLsLsmbLibLibRhLsbLiLsLsLsmmbLeRsLcbRcRsLsmbLe
LsbLgRgbLgbRcReLcLcbRcLsRsRsmbRgLsRsLgbLeLsbLgReRsRsRsRsmmmmbRsbsbRsRs
mbsbRsbRhRsmbLgbRsRsRsmmbRibLsbLjbLhLsbReRsRgRsmmbReLoLhRsbLsLsmbsbsbL
cRsbRgbLeLsbLcbRjRsmbReRsmbLobLsbReRsRsRsRsmmmmbRsbReRsLsmbReRsmbLcLsL
smmbLsbLibReRiRsmbRsRsRsmmbsbRsLsbRsbsbsbRgbRcbRcRsLoLsLsmmmbLiLsLsmbR
ibLeLsbRgRsmbRebLsLsmbRsLsbRebLcbLsbReRsmbLiLsLsLsRsLsmmbRcRsLcLsmmbRs
RgbRcLcLoLsmbRcRebRsbRsRiRsRsmmbRgbRgLsReRsmbRsbRsbRebLiRsLsbLgLsRsbLs
bLsLsRsmbLgRsbLsRsRsmbRhRgbLjRsbLsbLgbRsbReLsbLcLgbLebRjbRgRsmbRsRsmbL
jbRsLsbLsbRiLsbLibsbRsbsbLsbRsbLiLsbReRgRsmbLjbLhRsbRsbReRsmbLibLeLsbs
bRcRsRsRcRiLoRoRsRsmmmmbRgRsRsmmbRgLsRsbLgbRcbLcbRhRsmbRsbLeRsbRgbRobL
cLsmbLsRsLsLsRsmbRsbLgLsbRsbLsbRibRebRiRsmbLjbLhLsLsmbLgLsLsLsmmbsbLsb
LgRsLsLsmbRibRjbRiRsRsmmbRgRsRsRsmmmbLgbLsbsbRsbLeRsRsmbLsbsbRjbRcLsbL
cbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbLibLebRibRobRibRgRsmbRsbReRoLoReRcbRiRsmbRgRiLibLsLobRsbLibLgbLobL
sbRgbRsLsRsbLibLcLiRjbLeLsbLebLsbRobLsbLsLgbLsLcbRcbLeLsbLgbLobLebRebL
gLsLsmbLcRcbLeLhbRibLoLgLgbRebRgbLcbRebLoLsLsmmbRsbRsbLsbRsbRsbRebLebs
bsbsbLsLsmbRjbRsbRcbLsRsbLobLibRcbLebRgbRebLobLsbRoRsmbLsbLsRsbRhbLgbL
sbLeLsRsbsbRebLcbRebRgbLsRebLgLoLsmbRsLgRsbLgbLobsbsbRibRcbLsbLsbRsbLg
bRcLgbLebLsLsmbLebLgLsbRsLsbRsbsbRsbRsbLebRgRsRsmmbLsbLeLsbRsbLsbReLsb
LsbLcRoRsmbLsbLhbLcLoRcbRgRgRsmbLsLsmbLebLeRobLcLgbLebRsbRjbLgbRsbLsRe
bRsbLebLsbLsRobLsLsmbLgbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bsbLsRsbRsRsmbRsbLgLsbLsbLgLsbsbLibRsbRsbLsbLsRsLsbLjbLsbLjLgRjLsLsmbL
jbLibLobLeLsbLgbLgbLjLcbLcbLgbLibLcbLibLgbLsbLobLiLsbLeLgLsLsLsmmbLsLs
mbLgbLeRebRoRsRsmmbLsbRsbRjbLsbLgbLeLjbLobLobRsbRsbLsbLoLsRsmbRsbLgbRe
bLoLsLsmmbLsbLsbRebRiLoRoLsRobLsRsRsmbRsbRebLjbLebRcbRebLebLjbLgRobLcb
LcLsmbLgbLgbLobRsRsmbLcbLebLgbLeRoRoLsLsmbLeLsbLeLiLsLsmbRoLsbLebLgLgL
oLgbLcbRsbRsbLgLsLebLobLebRcbLgbRsbLcLsmbRibLgLsbLgLsLsmbLobRibRgRgbLe
bLgbLebLgbRoRcbRibLjbLsbLobLgbRsRsmbRobLebLeLsRoRsmbRsbLgbLsbRgLsLsmbR
ibLsbsbsbRsbRcRsmbsbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bLebRsbRjbRoRsRsRgRsmmmbsbLsLiRsbLsLsLsmmbLiLsbRsbLsbsbsbRsbLgRobRcRiR
gReRsmbReRsRiRcRsmmbRebRsRgbRobRgbLebLibRebLgbRsRebLgbRobLeLibLobLebLo
bLeLsLsmbLibLgRhbRcbsbRebLeRgbRsbReLebLsLibRsLobRebLibLeRsbRsbRsbLsbRs
bRoLcLsmbLsRebLsbLsLibRsLsLgbsbsbReLcbLsLgbLsbLebRcbLgbRebLgLiLiLsbLgR
sbRsbRsbRgbLsRcbLsRsReLsbRcbLibLsbLeLsLsLombRgRsRcmbRcbLiLgLebLgRgbRgb
RsRebRiRsmbLeLsbLiLeLeLeLgLsbLsbRgRgRgbReLsbLsbRsLsbRsRsRembLiLibLiLsL
smbLsLsLsmmbLsLsmbLgbRsbLgLsLsRjmbLsRebLhbLgbRcbRcRsmbLibLsbRobLgLeLcb
LeLibLiRgRsRsmmbReRcbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bLeLsbLsbLibLcRcbLebLcLgLgbLsLsmbLibLebLsbLgbRsbLsRsbLgbLsRsbRsRsmbLsb
RsLsbLgbRsRsmbLebRebRcbLgLsbRsLsbLgLsLsLsLsLsRsmmmmbRebLobLobLsbLsbRsb
RebLsLsRsmbsbsbLsLobLsbLgRsLsbLobLcbsbRsLsbLsbRcRgLsbLsLsRsmbLsLsLsmmb
LjbRobLebRgbLsbLsLsLsmmbLsLsLsLsLsmmmmbLgLeRsbLobReReLsbLsLgbLoRsbRsRs
mbLgLsbRsbLjbsbsbRsbRjbRcLsbLsLsmbLjbRibsbRsRsmbLsLsmbRobLcbRobLcbRgLs
bReb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 25; Drug: Control PTZ 2.5 mM
bRebLebRsbLobLebLcbLebLgbLibLebLeLsbReRsmbRcbRebLsbReRsRsmmbRebRebRebR
cbRsRebLebLebLebLibLibLcbRhbRgRsmbRsRiRsRsmmbRsRebRsRsRsmmbLeReLsbRsbR
eLeRgbLhLsbLebReRsmbRhbRebRsbRsRsmbRsRsmbLsbRsbRsRsRsmmbRcbLebLebLebLg
bLeLsbReRsmbRibRsLgbLcLsmbLiLsbLsLibRgbLsbRjbReRsmbLebRebRebRebRebRebR
ebRibRibLsRiLsbLsRsRgbLebRgbLcLsmbLibRjRsmbRebReRsRhmbRebLebLgLsLsmbLe
bRiRebRsbRjbLebLcReReRsmbRgbRsRsmbLsRsRsRsRsmmmbRebLsbRcbLsRsbLsLsRcRs
mmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 26; Drug: Control PTZ 2.5 mM
bRebRebReRsRsmmbRiRsmbRsbLcbLgLsbLobLobRcbRibRibReRsmbReRsmbReRsmbRebR
eRsmbRebRibRhbRiRsmbRhLsbLebRebLcbRiRsmbRgbRcLsbLcbLobLsbRcbLebLibLsbL
gbLhbLjbLhLsbLeLsbRcbRcbRgbLiLhLsbLgbLsbLcbLcbLgbLiLsbLhLsRsbLeRgbRebR
eRsmbRgRsmbRsRgRebRoRsRsmmbLsLsmbRcbRibRiRgbRebRoLsbRgbReLsbLeLsbLhbRs
bRsRiRsRhRsmmbRgReRsmbRsRgRsmbReRsmbReRcbLgbRoLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 27; Drug: Control PTZ 2.5 mM
bReRsmbRsRsRsRgRsRsRoRsLjmmmmmbRebRsbLiRobLcRcLsbLeLebLebRgbRcbRsLsbRg
RsRsRcLcLsmmmbLgbRgRebRibLoLgLebRoRsRsLsmmbRsbRebRibLobRcRsRsRsRsRsRgm
mmmmbReLiLebRsbReLsbRoLsbLsRsRsmbRcLobLgReLsRsbRsLsbLoRoRgbRsbRiRcLsLs
LombLgLsRsbRcLeLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 28; Drug: Control PTZ 2.5 mM
bLgbLsLsLsLsmmmbLsLsmbLgbLsbLsLsmbLgRsbLgbLsLsmbLsLsmbLsLsmbLsLsLsmmbL
sLsLsLsmmmbLsLgLsbLsbLgLsLsmbLsLgbLsLsmbRsLsLgbRsLsLgbsbLgbRsLsbLgLsLh
bLgbLsbLsRoLsbReRsmbRgbRgbRgRsmbRiLsbRgRsmbRhbRgbRhLsbRsRsmbLobRgRsmbR
gbRsRsmbReLsbLsbLiLsLsmbRgbRjbRcbLebRebRsRcLsbRebRebRsbRsbRgbReRsmbRib
RsRsmbRcbRiLsbLsRjbLobLsbLobRiRgbRgRgbRiLsbRibRibRibRiRsmbRgbRebRsRsmb
RgbRebLibRsbRebReRebReRsRhmbRsRsRembRebRgLsRsRsmbRsRsmbRsRsRsmmbRsRsmb
RsRsRsmmbRibRgRsmbRsRgRsRsmmbRgRsRsRsRsRsmmmmmbRsRsmbRsRsRsRsRsRsRsmmm
mmmbRiRsmbRsRsRiRimbRgRsmbRsRsRgmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 29; Drug: Control PTZ 2.5 mM
bRgRsmbLeLgLsLsmbLsLsmbRobRsbRcRsmbRsbLiLsbLsLsLiLsRcmbLsbLebLebRebReb
RgRibRiRsmbReLsbLeLhRsRcRcbLeLebLiLgbRcbLeLeRsRcbsbRgbRsbRgbRsReRgRsmb
RsReRgReLsLsmbReLsbRgbRsbRibRgRsRsRsmmmbRsbRgRsmbLsbLebRebRebReRsReRem
bRiRsRsRgmmbRsbLsbRebRebRebRebRebRgRsRgmbLsRsRsRsmmbRgRsRsmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 30; Drug: Control PTZ 2.5 mM
bRsRsRsmmbRgRsRsmmbRebReLgLsbLsLcRsbRgbRsRobLsRsbLsLsmbLsLebLsLsmbLsRs
bRebRebLebLebsbLsbLsLgLsLiRsbLsRsbLsLsLsLgLsmmbLsLsmbLeLsbRcbRiRebRibL
ebLebLcbLebRsbRjbLsbRgbLsbsbRsbLsLsmbsbLsRsbLsLsmbRsRsmbRsLsRsbsbRobLe
bLcbReRsRsRcmmbRebLcbLgLsLsLsLsmmmbRsbLsbLsbRebRgRibRsLsRsRsmbRsbRsbLe
LoLsmbRsbsbLsLgLsRebLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bRgRsRoLcRsRimbLeLgLeLsLsmbLiLgbLgbLsLibLibLoLiLsLeLebLebLgLgbLeLgLgbR
sbLeLsbRebLeLsLgRsLsbLsLsLiLsmbLsLsLsLsLsLcmmmmbLibRcLsLgbLibLebLsLsLs
LeLimmbLibLsLgbLgLcRsLsLebLsLsLsLiLgmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bRhRgLsbRiRsRsmmbRgRsRsRsmmmbRsRsRsRsmmmbRsRgRgbRsRsRsRsRsRsRsmmmmmmbR
eRsRsmmbRgRsRsRgmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsbReRcRibRjRcLcRebRcRsmbRiRsmbRebReRjbRjRsRsRsRsmmmmbLeLsLobLebLeReb
RiRhLsbLsbRiLsbLeLsLibReRebLsbLebRebReRsmbRsRgReRsRsRiRsLsmmmbRsRsmbRg
RgRsmbLeLsLgbLiLsLsLeRhmbRebReRsmbRebRiRgbRsLsbsbReRibLcReRcRsReRsReRs
mmmbRibReRgbRiRsmbRsRsmbRsbRsRsRsRgmmbRsRsRsmmbRibRjRibRsRsRsmmbRsRgLs
bRsRsmbRsLcLsmbRgbLsbRsRsmbRhbLebLsLsmbLebRcbRsbRibReLebLsbLsbReRgbLeL
sbRiRsRimbRgRsRsRsmmmbReLsbRgRebLcbLsReb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bReRsRgmbRsRsRsmmbRsLsLsmbRcLeLcbLsLsRcmbLgLsbLgbLcbLiLsLsmbLgLgbLsLsL
sLsLsmmmmbLgLsbLsLgLsLsmbLsReRsmbRsRsmbRebRhbLgRsbLgLsLgLsbLebLgLsLsmb
LeReRcbLebLoReReRsmbRibLjbLcLeReRsmbLibLeRsbRsbLeLhLgLcLsmbLeLcbLgLsLs
LsLemmbLgLsLibLebLhLsbLsLsLsLsmmmbLsLsLsLsmmmbLsLsmbLsLsLgmbLgbLgLsLsL
smmbLsbLsLgbLsLsLgLsLsLsmmmbLsLsLgmbLebLgRsbLsLsLsLiLsmmbLgLsLcLsmbLsL
sLsLgLsmmbRebLebRcbLeLsLsRoRcRembLebLebLgLgLsbLgLgLgbLcbRgRsmbRsLeLsbL
ebLebLsbLcLsmbLsLiLsbLgLsLsLcLcmbLgLibLsLsLgLcmbLgLebLsLsLsLsLsmmmmbLg
LcbRjbRgbLeLsbLsLcLob

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bLgLobLebLgLsLsmbLibLebRoLsLsmbLsRiRsmbRiRsmbRsRgRsRsRsmmmbRsRsmbRgLiR
cLsbLiLsLsmbLsLsLsLsmmmbRoRoRsLembLsbLeLsLebRsbLebRebLobLhbRgbLhRsbRcL
sbRsRsRcmbLgbRiRsmbLsbRiRsRsmmbLoLsLcmbLcbLsLsLsmmbLsLsLsLsLsmmmmbLsLs
mbsbRsbsbRhbRgbLsLsRsmbRjbLcRcbRebRiRgRsmbRgRgRsRiRsRsmmmbRcbLsLsmbLib
LgRsbLcbRcLsRsLsbRcLsbRoRcLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeLebLsbRsbLsbRsRsRsmmbsbLsRsRsLeRsLsmbsbLsLsLsLsRsRsmmmmbsbsbRsLsbRs
bLsbsbRsLsbLsReLcLcLeRgbLsbRiRgRsRsRgRsRgRsmmmmbRgRsRgRoLembLgRsbRhRgb
RsRsmbRsRgRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsbRsbReLebRibRgbRgbRsbRsRsRsmmbRgRgRsmbLeLsbLsLsmbLgbLgbLgLsbLsbRgbL
eLoLsmbRgbRsbLgbRiLsbRgLoLibRgbRsbLcbRgbLsbLcbLgLsbRgbLebLgLoRebRjbLeL
gb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bReRsmbRsRebRsbLoRebRgbLgbLeLeRjbLiLgbRjbRcbLobLobLcbLsRgbLgLsLsmbLgLg
LsbLebLibLsLgLsRsbRibLebRjbRobRoLgRoLsbRibRcbReRcbRsRiRgbLsRsLsbRsbLsb
RsbLeLsRsLgLoLoLsmbLgReRsmbRgRsLsmbRiLhbLsRcRibReRebLsLsmbRobReRsmbRsR
gRsRsmmbRgLsLsmbLoLeLgLgbLeRcbRsRsLsRsRsmmbRiRsRsmmbLsRibLibLibLsRobLg
bRgRhbLgbLgbLcbRobLcReRsLgmbLsLsLgmbLhRebRobReRibRiLsbLsLiLsLsLhRoRcRg
RsRsmmmbRsRgRcbRiRsRoRsmmbRgLsbRgRiRsmbRsbLhRcLoLeLobRjbLcLoRsbRhbRiLg
b

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bLiLsLsmbRsLiLsbLiLsbRgbLiLoRsLsbRhRsmbLeRsbLcLsmbLeLsbLebRcbLeLsLsLsm
mbLcLgbRoLsRobRcbRsRsmbRgRoLsbLsbRsRcRibLsLgLsLsmbRsLsLsLsmmbLeRsbLebR
ibRoLsLsLsLcRsRsLoLsmmmmbLeLsLiLeRsbRsLsRsLsbLgLsbLsRsLsLsLoRsmbRsRsRc
mb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bLibLcbReRsmbRsbLcbLeRsRsRsRsmmmbRcRsRoRsmmbRhRsmbRsLsbRibRgRsRsRsmmmb
RcRsmbLibLebRgbLhLsbLeLsLsLoLsLommbLcLobLibLiRsbLcbReRsmbRhRgbLsbLjbLi
LsbLeRsbLeLiLsbRsbRsbLibLgLsbLgbLcbLgbReRsRsRsmmmbLgbReRsmbLibRiRsRsmm
b

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bLebLsbLsbRsbLibLgbLsLsRsRgmbRebRobRebLebRoRsmbLebLgbRsbLjbLgbRebLsRsb
LcLsmbRcbRjbRebsbLsbRsbLsbsbRibLhbRsbRsbRjRsmbRsbLgbLibLeRsRsRsmmbRsbL
sbLeLcRsbRebLeLsbRsbLjbLeRcRcbReRebLhbRebLeLsbLgbLeLcLsmbLsbLeLsRsbRcb
LeLcRsLsRsbLgbRcRsRsRoRcmmbRsbRsbLsLsmbLsbRcReRsmbRcbLeLsLsmbLcLsmbLcL
sLcLgLsLsmmbLsLsmbRobRsRsmbLsbRsLsbRsbsbRsLsLsmbRebRebLiLsbLebLsbRsbLi
bsbsbsbLsbLsbReLcbLsbRsLsRsbsbRebRsbRsLibsbLeRsRsmbLcLcRsbsbLsbLsRsbRe
RsRsmmbRcbLcLsmbReLsbLeLsLsmbLcLoLsmbReLcbLiLsLgbLeRsLsLcLsmbRgbLebLsb
LcbLsbReLsbLgbRsbReLibReLoLsmbRsRsmbLebRebRcRhbLsRsbLcbRsbLcLobLsbRcRs
mbLcbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsRibLjbRjbLobLsbLiLebRsLsbRjbRgRsmbRcRgbLsbLhLsRsbLsbRgRiLeLsbLgLsLs
mbsbRsLsLsLsmmbRsRsmbLsLebLcbLsbRibLhbLibLebLsLsLsLsLsLsLsmmmmmmbLeRsb
RsLsbRsbLsLsLsmmbRsRebLsbLibLgbLsLsRgmbLgLsbLsbsbLcRiRsLsmbRhLsLgbLebL
sLebLeLsbLobRsLsLsmbRgbLeLsRhRsmbLgLebLsbLgRsbLibRsbRjbRjbRcLsLibLsLsL
smmbRiRsmbRgbRiLsbLhLgbRgLsRsbLgbLhbRjbRobLsLgbRsRsRsmmbRhbLhbLgbLiLcR
oLgbLhLsbLsLibLsLsLsLsmmmbLsbRsbRsRebRsRsmbRgbLgbLebLsbLsbLeRsLjbRebLs
bLibLebLeLsbLsRsbRebRobLsLsmbLibLibLgbRiRsReRimbRsRsRsmmbLjbRebRsbLgLs
bRgRgbRhLebLeLcLsmbLibLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbLeLsLsmbLeLsLsLombLcbRiRsRiRjRsRiRommbLsLgLgLsLsmbRebRsbLcLsmbRcRs
mbRsbsbLeLsbRjbRsbRsbRsLoRobLobLsLsLsLgLsmmbLeRsbRcRsLsmbRsbRgRsmbLhLe
LcLsLsRommbReRsLsmbRibReLoLsLoLembLebLgLsbLeRcbLebLeRcLsbRcRcRcbRibReb
LgbRiLsRsbRibLibLoLgLoLoRobRgLsbReRsRsRsRsmmmmbLjbLsbRgbRgbLsbLeRobLgb
RgbRiReLsbLebLoRsRoRsRsmmbReRsRsmmbLsRsbReRoLsbLcLcbLsbRebRcRoLsRsRobL
eLoLoRgRoRsmbRiRsmbLhbRibRhReRsRcRgRsRhmmbRcbsbLhbLcLoRoLoLsRsRcRsmmbR
sRsLsmbRgRsmbRsbRiRsmbRgLsLsmbLibRhbRgbsbsbLjLsmbRcRebLoRcRgRsmbRcRoRo
LsbsbLcbsbRibsbLeRoLobRcbRiRsmbLcLsLsLsLsLsLsLsmmmmmmmbLibRoRsLsmbLjbR
jbLjbRibsbRsbLebRibLjbLcLobRcbRsLeLoRsRsRsmmbRiRsmbLsbRgLsbLjLjbLiLsbR
jbLcRsbRjbRobRsbLeLsRsbRcbRgRsmbLcRcbRoLsbRsbReRsmbLoLsLoRsmbLhLsLsLsm
mbLebRsbLeRoRsmbLjbLobRcRsmbRhRoRsRombLeLgbRjbLgbLgRsbRsRsRsmmbRiRsmbL
cRsRsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbReLsLoLeLgbRsLoLiLcbReRsmbRiLsbLeLsLsmbRsLsbLgbLsLsmbLjLsmbLcLobRc
RsmbRsbLgbRcbRsRsmbLcRsbRcbLoLsmbLsRiLsbLeLsRoLsLsmbLeLcLebRgLsbLcbRcb
ReRsmbLcLsRsmbLsbRibRsRiRsLsLsmmbLiLjLcLsLsmmbLeLsbRcbRiRsRsLsmmbLgLgR
sbRobRcRsRsLsRsmmbLobLgbRoLsbRoLsbRsbLoLeLsLgLsbRsRsmbLobRoRsRsmmbLgbL
oLsLsLsLgLcmmmbLgRsbLsLoLsmbReLsbLsbRsLsLsLsmmbReRsLcmbLgLsbLgRsLsRsbR
ebRhRsLcLimbRoLsbLcLsmbLsLgbLibRcbRcRsmbLsRsbLeLsLsLoLsLsmmmbLeRgRsRom
bRsLeLobRebRebRsLoLsLembRibRcbLcLoLgLibLeLoLgbLsLebRcRsmbRiLsLsmbLsRsb
RiLsRsLsbLcbRibRcLsLsmbLsLobLjLeLsLsmbLgbRoRsRsRsmmmbRsbRsLsRsbLcLsmbR
cRsRsRsmmmbRsLsbRsbLeLoLsmbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgbLgbLiLsbLibRgbLsbLsbLibLgLsLgbLiLsbLeRsbRgLoLgbRibRsRibRebRgbLgbRe
bRgbRebLsReRsmbRgbRsRebLgbRgbLsbRgRobRibRibLsRsLsbRsbRiLobRebRibRobLhL
sRsbLgRsbReLeRobLebLeLgLebLobRoRibRsbRobRsbLibLsbLsbLebRgbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bRebRcRsmbLsRsRibLsRsRsRsRgLjmmbLcRsbLcLsLcmbsbRgRsRsLsLcmmbLsLsmbLgRg
bRibLgLsbLgLsbReLcLhLsLobLiLsbRjbRibRoRsLsmbsbLiLsbLeRcReRcRsmbLsbRsbs
bRsLsbsbRsRgbRsbLsbLsbLsbRsbRsbsbRibRiLcRebLsbReRsmbRibsbLsRsbRsbLsRsR
sLsmbLsbRgbRsRebRsRsRsmmbLsRgRsmbRsRgbLcbRebLgbLebLibRsbRjRsRsmmbRsRsR
sLgmmbLcbRcbRgbLibLebLcbRcbLoReLeLsbLsRsRjbRgRsLsmbRiRsmbLebRjbRiLgbRc
bLsLsmbRiRsRsmmbRsRsRsRsRsRsRgRsmmmmmmbLjbReLcLcLsmbRsRsmbLsLsmbLcLcbR
eRsmbRgLgbLeRibRgbReRsmbRsLsRgbRibLibLcReLsbRsbRsLsbRgRsmbLsbRgbRgbLcb
RcbsbLhbRibLobRgbsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bLiLgbLgbLibLsbLgLsLgbLsLsLsLemmbRibRcRsRgRsmmbRiLsbRsRgRsmbRsRsRsmmbR
sRsRsmmbRgbRsRgRsRsRsmmmbRgRoLgbLsbRsRiRsRsmmbRgRgbRhbLoLsLsLsmmmbLsbR
ibLcbLobLgbLgLjRsbLjLsmbLjbLhbRsLsbRibsbLebLsLsLsLemmbLsLgbLsbLsLibReR
smbRsbRgbRsRsmbRiRgRsRgmbRgRsRsRsmmmbRsRgbRsRsmbRsbRsbRsRsmbRsRsmbsbLs
bRsRsmbLsLsRsRsRsmmmbRiLgbRsRsRsmmbLjbRgRsRsmmbRsRsRsRsRimmmbRsbsbLeLs
bLsbLsbRjRsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151442; End: 151942;
Recording: 7-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgLsbLcLoRebRoReReRsmbRgbRgRsmbRsLsbRjRgRsmbRgbRiRsRgRiRsmmbLibRiRsmb
LgbRiRsRsmmbRiRcbLeLcLsRsRsmmbRebRsLsLsLsmmbLibRsRebReLoLsmbLebRjbRiRs
mbRiRsRsmmbLoLcLsLcmbRcbRibLgLsbRcLsLobRiRsLsmbLsRsbLeLsLsmbLeLgbRsbLe
LgLsLsmbRcRgbLsRsRsmbRiRsRsmmbRiRsRiRombLsbLcLsLsLcmmbLsLsmbLeLsbLgbLe
RcbRcbRibRsbLebRoRsRsmmbRgRsmbLsRsbReRsLoLoLcLoRsmbLiLsLsmbRjbRhbRsRsm
bRoLoLsmbLeLcLgbRsRcLsbLjbLsLhLsbRcRgRgLgbLcRsbRoRcLsRsbRhRsmbRcRsmbLs
bRcRsLoLsmmbRcbLeRoRsRombRiLsbRcbRibLeRsLsbRcRsRsmmbRiLsbRcRiLsRobRcLs
bLgbLoLsmbLgLsLgLeLsbLhLebLjbLjLsmbLgLsbRsbRibRiRsRsmmbLcLgbRebLgbLoLg
bLgLsLsLsLgLgmmbRjbRsRobLcLsRoLsRombReRoRgbRgbRsRiRsRsRsmmmbLgbLcbRcLs
LoRsLcLoLeRsbRobLcLgbReRsmbsbRibRsbLcLsRsLsmbRibLcLsLombRsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 1; Drug: Control PTZ 2.5 mM
bLgbLsLeLsbLibLsLgLsbLsLsLsmmbRcbLcLsmbLsLsLgLsRcmbRiRsmbRsbRgRsmbRibL
sRsRsRsmmbLeLgbRsbRoRsmbRebLcLebRsLebLcbLebRgbRsLeLgbRsRiRsRsRgmmbRsRg
RsRsmmbRsRsRsLsmmbRgRgbRebRgLsRsbRgRsmbRsRsRsmmbLeLsbLebLcbLiLcLsmbReb
LiLsbReLsLsmbReRsLsLsmmbRgbRsRgbRgRsRsmmbRgRsRsmmbRebRhRebRsRgRsmbRiLs
bLsbRebRsRsmbRebRgRsRsmmbRsRsmbLebLcbLobLeLsbLeLsbLgLsbLgLsbLsLsLsLgmm
bLgbLebLebLhLsbLebLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 2; Drug: Control PTZ 2.5 mM
bRebLcLsmbLsLsLsmmbsbLsbLeRsbLgbLgLeLsLsmbLebLgLsLsRsmbsbRebLebLgLsLsm
bLsRsbLgLeRsbLjRjbLcbLebLgbLebLcbLhbLeLebLebLeLsbLeLsbLgbLebLsbLsLgLsL
smbLsLsmbLiLcbLgbLsLsLsLemmbLgLgbRcLsLcbLebLeLsbLsbLeLcbLeLsbRsLsLsmbR
cbLebLcbsbRcLobLobLcbLsbRsbLeLcLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 3; Drug: Control PTZ 2.5 mM
bRgRcbLibRcRoLsbLsLsLeLsmbLsLsmbRgbLsLcbRcbLoRebRcbLibRsbRebRcbLebRobR
ebRsLsLsLsmmbLcbLibRcbRcRibRebRebRebRebRebRebRebRebRebRsRsRgRsRgRgRiRs
mmmbRcLcbLcbRebRcbRjLsbLsLibLeLsLsLsmmbLsLibLcbLsLgbRcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 4; Drug: Control PTZ 2.5 mM
bLcbRhLebLgLsRebLiReRsRsmmbRibRsRsRsRsmmmbLsLcLsmbLeRsbRcReRsRsmmbRcbL
cRsbLcLsLsmmbLeLsbLsbLgLsRebRsRsmbReRoReRebReRsRsLemmbRcRgbRebReLcLobL
gLsbRsLsRsbLebRebLebLebLeLsbLebLcbLcbRgbReRibRcbRhbRhRiRsRgRsmmbRjbReR
smbRcbLjbLebRcLsbRsRsmbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 5; Drug: Control PTZ 2.5 mM
bLcbRcLsLsmbLiLobLsLsmbLcbReLsLgLsbLebRobRgRgbLsRsRsRsmmbRsbRsRsRsRsRc
mmmbLgbLsLsLsmmbLsLsLsLoRsmmbRgbLebLebRsRgbRsRcbLcbLoRcRsRsRsRiRsmmmmb
LcLsLsLeLeLgmmbLeLsLeLebLsbRiRsmbRiRsmbRibRsRibRcbRsRcLsbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 6; Drug: Control PTZ 2.5 mM
bLobLcbLeRgbReRsLsRsRsmmbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsReRsmbLeLcbLsLsmbReLsLcLoRobRgRoRobRsLhbLeLcLcLsmbLeLgLsRsRobLgbRoR
cbRsLsbRsLsRsLeRcbLsbLgRsbRobRgbRsLcLsmbLebRsbLiRsRibRebRsRsmbLsRebLob
LiLobLcbLcRebRgReRobRsLeLibLgRhbRsRiRsmbLebLsLsmbLsLsmbLsLoRcLsLsLsLsm
mmbLsReRcbRiRsLsmbRjRsLsmbRsRgLeLsLgRebLsbRebLebLsbLgRsLsLsLsLgLsLsLsL
sLgRsmmmmmbRsLsLsLsLsmmmbLebRebRsRgRebReRsmbLsbRcbRoRsmbRsRsRsmmbRsRgL
hLobRsbRsRcLoLgRcRsmbRsRsRsRsmmmbLeLsRsbLsLgLsLsLsLsLsRsLsRsmmmmbLeLsL
cbRcbRobLobLib

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bReRebRsLsRsbReRiRsRsmmbRsbLeLcRsbRibRoRcRsmbLoLsLsmmbLeLiLcbLsbLiLgLc
RsLgLsLsmbLgLebRsbLoLobLobRsRsRsmmbRgbRebRsRsRgmbsbLgRebRsLsbReRsRembR
sRsmbRebRgRgbRebRsRsRsmmbLoLsLsLcLcLemmbLsLsmbLsbRcRsmbLcbRcRiRsRcmbRo
bRgbRsbReReRsRgmbLsRsLsRsRsmbLiLsbLsbRobRsLcbRsbRcRsmbRsRibReRsLsmbRgR
eRsmbLgRsbLebLoRsbLsLiLcRcLsbRjbLibLeLsbRebRsRsLcmbRobRsRgRgRgLsLsmbRs
bRsRsmbLsbLjbRcbReRsmbReRsmbRgLgbRgLcbRsRebRsLsRsbLcbRcRoLsRsbLoReRebR
sRgRsmbRsRsRsRemmbRgbRhbRsRsmbLoRsRsRsmmbRcbReRcbRsRsmbLcLgbLcLcLcLsmb
LsLsLsLsmmmbLsbReLcRebRgbRsbRgRgbLsLjReRsmbRsRsmbRgbRsRsmbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsReReReRsRsmmbRcbReLobLgLgbLeRsbLiLibLhLsbRsbLsRsbLebLsLsmbLobLebLeR
iRsLeLsmbLebRebRebRgbLgbRsRsmbReRsmbRsRiRsLembLebLeRebLgLsLsmbLebLebLc
bLgbRcbLcbLibLebLebRcbRgbLsLsLsmmbLsLsmbRebLhbLsRibLebRcbLgbLgbRebLebL
ebLiLebLeLsLsRsmbRebLebRgbRsbLsbLiLgbLsbLsbRibRcLsbLsbRsbLsbRsRsLsRsmb
RsRsmbLibRgbRebLeReLsLcbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bRcLeLsbLsRsbLeLiLsLsmbLibRibRebRebRcRsRcmbLobLobRgRsRsmmbLsbLsLobRoRs
mbRsRgLsbLobRhbLobReRcbReLobsbLiRsbLsLsmbLibLeLsbRibLobLebLcLsLombRcRe
bRebLebLebRebRiRcbRebRibRibRgReLsbReReLibLoLsmbLcLsLsmmbLgLgbLiLcLsLcm
bRjbRiReLebLeRsbRebLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsLsLsLsLsLsRsmmmmmbLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLsLsLsLsLsLsLsmm
mmmmbLsLsLsLsLsLgLsmmmmbRsLsLsLhmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bReRsLombRsbLsbRgbRsRebLiRsbLsbRsbRebRiRsmbLeLcbLcbRibRebRsRsRombRgbRj
bRebLeLsbRibRjbRibRiRsmbRebRebRebRebLeLsLsLembLsbLebRcbLeRoLebRgbLsbRc
bRgRobRiLsbRsRebRgbRebLgbLgbRibRjbLjbRiRcbLibLebRiRsLjmbLebReRsmbRibRe
bLcbRcbLeLcbRgRsmbLoLsmbLeLoRsRsmbRsLgLcbLibRebLhLsbLgLsbRjbRebLgRibRe
bRebRcbRcbLcbLcbRgbRsbRcbLebLsbsbRsLsbRsRsRsmmbRibRebLcbLiLsbLcbRsRiRs
mbRsLsbLsLsRsmbRsLcRcLoRsbReLsbReRsRsRsRsmmmmbsbLsbRiRcRebRgbLeLsbRebL
oRsbLibRibsbLeRebLgbRhRsmbLeRsbLsbRibLcbLeLcRsbLgbLsLebRjbRcRsRsmmbLcb
LgLsLsmbRhRsRsmmbRcLsbRgbReRcLsbLcLcbLgbRiLsLsmbLeLsLhLsbLiLcRebRsRsmb
RgbLcbRjbRcLcbRiRobReRibLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgRgbLsRsRgbRsRsmbLsRsRsmbRgRsRsRsmmmbRsRsmbRgRsRsRsRsRsmmmmmbsbRsRsR
sLsmmbRsbRsRsRsRsRsmmmmbRsbRsRsRsmmbRsRsmbRsbRsRsRsmmbRsbRgbRsbRgbRsRs
mbRsRsRsRsRsmmmmbRsRsmbRsRsRsmmbRsRgRsmbRsRsmbRsRiRsRsmmbRsRgRsRsmmbRs
bRsbRsbRsbRgbLsbRsRsRembRebLcbLsLgLsbRebRoLsbLiRgLgbLgbLsLsLsLsLsRsmmm
mbRsRsRsmmbRsbRgRsRsmmbLsLgLsRsLgbLibRsbLgLsbLeRibRebRobRhRsmbRsbLsbRg
RsRsmmbRsLsbRgRgbRgbRsRgbLsRgRsRsRsRsRsRsRsRsmmmmmmmmbRsRsRsRgLsmmbLsR
sRgRsRsRsRsRsRsRsRsmmmmmmmmbRsRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bRibRsbRebLcLsmbRoRsLsmbLsbRobRjbRhRsmbLsbsbsbLsbRsbRsLsRsbRsbRsLsRsLs
LsmbLsbRsLsLsRsmbLsLsLombLcbReLgbLibLjbRgbRsbLsbRiRibLcbRibRcbRgbRsbRs
LsbLjbRcbRoRsRsRemmbRebLebLcRsLsRsLsbLsbLobLhLsLobLsbRibRebRebRebRebRs
RsmbLoRsbLiRsRsmbRebRhbRobLoLgLsbLebLcLsmbLgbRebRgRobRsRsRsRsRsLcmmmmb
LgRebReLebLgRebRebLgbLsbLeRsLsLsRsRsmmbsbReReLsbLibLibRsbRsbRsbLcbRjbR
cbRgRcbRebRebRsbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bRebLcbRiRgbRsRsmbRgbRebReRsRgRsLsmmbLgbLibLeRiRiRsmbRsRsmbRgRgRgbReLe
bRgbRsLsLsmbLeLebRiRsRsmmbRibRhbLgbsbReLsbRsbsbLgbLiRsRsmbRsbRiRsReRcR
smmbLsbsbLsbLsbRgbReLsbRcbRsRcbLibLgbLiLsbLeLsbRebRibRebLebRibLibLebRg
bLebLsbRhbRhRsmbLebLsbLgbRebRebRebRebLeLsRsRebRebRgbReRsmbReRsRsmmbRiR
sRsRsmmmbRgRsRsRsmmmbRsRsRsRgRsmmmbReLsbRsRsmbRibRsRsRiRsmmbReRsmbReRs
RsRsRcRsmmmmbRsRsRsRsmmmbRsRsRsRsRsmmmmbLsLsmbRgRgRsmbRsLsbRsRsRsRsmmm
bLsLsmbRiRebLebReRiRsRsRsmmmbRsRiRsmbRiRsRsRsmmmbRsRcbLgRsLsLsmbLsLebL
obRgRsRsRsRsmmmmbLsLsmbReLsbLgLsbLgLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bLeLsbLiRiRgRebRebRebRcbLibLebLsbLsLiLsbLeLebLsLebLeLsbLibLebLgLsbLibL
sLsRsmbLsbLsbRgbLsbsbLebLgLsRcRhRgbRsbLsbLeLsRcbRsRgLsbLobLgLsbLgLsbLs
LsmbsbLcLsLcmbLibLeLoLsLsmmbLcbLebLebRsLsRsbLcLgbLiLsbLiLebLhLsbLeLsbR
ibLiLsLsLsRsmmbsbRiRsmbRhbRebRcRcbRsbRibLoLebRgbRebLjbRsbRsbsbsbLsbLib
ReLsbRjRebRebRibLebLibLebLebLgbLibRebRcbLgRsbRcbLebLsbLsbLgbRcRsRsmmbR
cRibLgbLeLsbLibRgRsmbRcLsbLsLsmbRibRebRhLsbLebRsbReLeLsLsmbLgbRebLeLsR
cRsmbRebLjbLebRsbReLgLsRobReb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsLgLsLgLgbLsLsLsLsLgLsLgLsmmmbLsLsLsLsLsLsLsRemmmmmmbRjbRgRgRsRgRsRs
RsRsRsmmmmmmbRsbRsRsRsmmbReLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bLgLsLsmbLsLsLsmmbLebRiLgbRsRibRiRsRsmmbRebRebLcLoLsmbLsbLibRcRhRsmbRg
RsmbLsLsmbRsbLcRsbRsbRsbLsbLibLiLoRsLsbRgRsmbRiRsRsmmbRgRsmbLjLjbLcbRi
bLcbLgLebRgbRsRgbRibRiRsLsmbLoRsLsRhRoRoRsRsRoRsRsmmmmbRgbRiRobRgbLebL
sLsmbLgLsLsmbsbRsbLsbRibLibLebLsLsLgmbRsbLsLsRimbRgLsbLcLsmbReRsLjmbRo
RsRcLsmbRsbRgbRebRibLcRsLoLsLsmmbLgLsRsbLsbLsLsLsmmbsbRsLsRsLsbRsLsRcb
RgbRcLsLeLsbLcLoLebLgRsbRsRsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bLeRiRsmbLsLsLsRsReRcmmbLsLsLsLsmmmbLiLsbReRsmbRgRsRsRsmmmbLgRsLsbRcbL
sLebRsLsLsRsmbLsLgbLhbRjRsmbLcbRebRhRsRimbLsRsRsmbRiRsmbLsRsbRsRsRsmmb
RiRsmbLgbLeLebRiRsRsRsmmmbRsLsbRsbRgbLsRsbLsLsmbRgRibRibRsRsmbRgRsRsRg
RsRsmmmmbLgRsbRgRgRsmbsbsbRgLsbRgbRibLiLjRsLsbLeLsbRsRibReRsRsRsmmmbRs
bLsbsbLsbLsRsbRsRibRsbRgRsRsmmbRibLsbLeLsbRsLsRsLsbLsbLsRsbLibLgbRebsb
LsLsmbRsbLsbRsbLgbRcbsbLebRsbsbLibRsRgRibRgRgbLsbRsRsRsmmbLsbRsLsLsmbR
sRsmbLsbLsbLjbLsbRgbRhbRsRsmbRsbsbsbLsRcLsRsbLsLgbLgbLebRsReRhRcbRsbLj
bRsbsbLgLsbLsLeLsbLsLsLgLeRiRsmmbLsRsRgRibRsLebLsbLsbLgLsLsLsLsLhLsmmm
bLsLgLsbLsRsbLsbLsRsbRsbRsRsmbRsbLsRsbLsLsmbLsLsLsmmbRjLsbLsLsmbLsLsLs
mmbLgRsbLeLcRsbRsRsRgRsRsLsRsmmmbLiLsLsmbLsbLsRsLsbLsbLgRsLsLiLsLsRsmb
LsRebRoLcLgLsbLsLeLsbLsLsmbLgLsbRgLsbRsbRsbLgRsRsmbLgbLcLsLsRsmmbLsbRs
bLgbLsLsLsmmbLiLgbLsLsLsRsLsmmbLsLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbRebLgLibRebsbLoRsLsLsmbLibLsbRhRsmbReLsbLcLsLsLsLsmmmmbLiLsbLoLsmb
LsLsmbRcRsRsmmbRsbLeLsLsLsmmbLgbLgbLeLsbLiLsLsmbLgbLgLsReLsbRjbLsbReRs
RsmmbLjbLeLsbsbsbLgLsLsmbLsbLsLsmbRgbRebLgbLsbReRsRsRsmmmbLjbLcLsmbLsR
eRsRsmmbLibLsbRcLsLcLsRombRsbRibLcbLeRgLsbReRsmbLeRoRsmbRgRsmbRsRsRsRs
mmmbRsLsbRgRcLcbRgLsbRsbReRsmbLibReLcLcRsLcbsbLgRcRsRimbRiLsRsbRiRgbRe
RiRsmbRhRsmbRiRsmbLsRsLsbRsbRhRibLgbRsbLjbLjbRhRsRsRsmmmbLgRsbRsRsLsmb
LjLsmbRsRsRsLsLsmmmbLibRcRcbRsLsbLgbLjbRcbsbRsbReRsRsmmbLiLsbLsRsRsmbs
bsbLjbRcbRsRsmbRgbLobLsLsmbLsbLibReRcLsbLcbLebRebRgbLgbsbReReRsRsmmbLj
bLsLsmbsbReLsbRsbLjRsbsbLiRsbLsRsbRsRsmbLeLsbRjbRcRgRsmbLsbRsbLgbReLgL
gLsLcbReRsmbLjbRibRhReLcLsmbReRsRsmmbRsbRjRgbLgbReRsRsmmbRsbLgbRcbRgbR
sLsbRgRgbLgbRhbRsReRsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bLebRsbLsbRgbLsbLsRsLsRsbLsbRsLsRsbsbLcbLsbLsbLebRcbLsbLgbRebRebLobLsL
smbLibLsbRebRsbLeLsbLebLebLgLgLsLeRsbLibLgbLsbLgbLiLsbLgbRsbLeRcbRgRsm
bRsbLibLgbLgbRsbRcbRsbLebRjbRibRsbRgbLsbLsbsbRsLsRsLsbLsbRsLsbLsbRebLe
bLgLgbsbLsLsmbRobRjbRcbLoLobLgLsLsmbRsLgLgbRebLebRobRcbLhRsRsLsmbRcbLo
bLcLjbRobRobReLsLsmbReRsmbsbRibsbsbsbLebLgRiRsRiRsRsmmmbRgRsmbLibLsbRe
LsbLsbRhLebsbLcLsmbRgRsmbLebLcRsRoLsbRhLgbLsbRsLgbLsbLsLsmbsbLhbLgbLsb
RsLsRsbRibLgLhLsLsmbLsbRsLibRebLsbRsbLeLhbRsbLgLsLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbRjbLebLgbLsRgLgbLiLsbLobLeLsbLgLsLoRsbLsbLgbLcbLebRsLsLcbLsLsmbLib
LebLeRsbRsbRsbLiLgRsbLgbLobLebLebRobRobLsbRebLobLiLsLjbLoRsbLgbLhLsbRc
bRjbLibLcLsLsmmbLgbLjbRsbLobLsbRiLobRgLgbLsLsmbLgLsbLgbLcbLebLgLoRiRsm
bRiLcbLgbLsbsbRgbRjLebLobRobLebRobRebRebLjbLoLsLsmmbLjbRibLgbLgRobRibL
eRsbRjbLibLsbRcLgbLsRgbRoLsLsReRembLobRgLoRhRsmbLibLsRebRsbLiLcbLiRsLe
RsLibLsLebLcbRgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bLeLsbRsRobRsRibLebLiLsLsmbLibRjbLgRsbRobReRsmbRgReLhbLebRibLeLhbLiLeb
ReRsRsLgmmbLsLeLgLsLsmbRsLsbRebRsRebRsbRiRsmbRjbLobLibLibLebLibRibLsRs
bLsbLsRsbLsbLsbRsRebLsbRsRjbLebLsLsmbLsbRsbRsbsbsbLsRoRgRobRebLebLgLsb
sbsbsbsbsbsbsbsbsbsbsbsbsbLsRsbLgbLsbReLgbLsbLgLsbLgbLgbLibsbsbsbsbsbs
bLsbLgRobReLsLebLsbRebLebRibRoRsmbRcRsRsLhmmbLebLeLsbRgbRobRgbLeLsLsmb
LgbLsRsbRobLjbRobLeLsbLsLsLgmbRjbRsRcbRebLibRcRsRsmmbLobLgLibLhLibLiLe
bLiLibLeLsbLgLsbRsbRcRoLsRjbLiLibLgbRiRgbReRebRebLcRsbRebReRsmbRcReRgR
eLsbLebLoLebLoRsbRebLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bLebLobLsbsbsbLsbRsbRsLsbLsLgbRibLsbRsbLcRgRoLoLsmbRobRsbRsbsbsbsbsbRs
RsmbRsbLsbLgbsbRsbsbLsbRsbsbLsbLcbLgLsbLsbLsLebRibRebLhbLobsbLibLeRcbL
sbsbsbsbLebLsbRibLoRsbRebRobLgbLiLcbLsbRobRhbReLobLibLoRgbLobLebLoRsbR
cbLgLsLsLsmmbRhbLjbLibLebLsRsbsbsbsbRibLhbRsbLebLeLebRibRgbLjbLsbLhRsb
RebRibLobLgbLgbLsbLeRsbLhbLcbLsRsLsbsbLsbRsbLsbsbRsbLobRcbLobRgbRhbReR
ebLibLgbRibLebRgbLoRcbRebLobRibRobRibLobLobRoLsbRobRgbRsbRobLeRsbLsReR
sRsmmbLcbReLgbRgbLgbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 25; Drug: Control PTZ 2.5 mM
bLeRsRhRibLjbLebLgLsRsbLebLebLebLeRsbLgbReRiRsmbLebLsLeLsRsbRsRgbLobLi
bRebLsLeRsbReRsRsmmbRgReRebLsLsmbRsRsRcmbReRsRembLsLebLebLebLsRebRgbLi
bRsLgRsbReRsRembLeRsbRebRebRhbLeLcbRcRgbRsRgbRsRsmbRsRsRsmmbRsbsbsbRsb
RsRsLsmbRsLsbLsbRsLeLgRsbLeRsbRgbReRsmbLeLcLsLsmmbLcbLeLcbLsLeRsRsmbLe
RsReReRsmbRsReLcLebLebLebLsbLsRsbLgbLsLsLsLsLsmmmmbLsbLiLsbLebRsbLgbLs
LsRsmbLhbRsbRsRiRsmbRsLeLebLsLiLeLebLebLsbLoLsmbLeLsLeLsLcbRsLiRsLsbLs
RsbRgRsRsmmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 26; Drug: Control PTZ 2.5 mM
bRiRsmbReLsbLeLsLsLsmmbLiLsbLiLsbLeLsbLsbRhLsbReRcbLebLebLgbLibLeLsLhL
sLebLebLgRsLhbRebRebRiRsRsmmbRibRibRebLeLgbLeLcbLebRebLsbLebLibLebRcbR
ebReRsmbRiRsRsmmbLebRibLeLsbLebReRsmbRhbRhbRebRiRsmbRibRgbRcbLibRgRsRs
mmbRiRsmbRsRsmbRebRobRibReRsmbRgRsmbRgLsbRcLsLsLsmmbLobLhbLibLeLcLgbLe
LsbLgbLsLebLhbLibLhbLiLsbLebLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 27; Drug: Control PTZ 2.5 mM
bLoRiRcbRebRsRsLsmbLeLsbLgLsLgReRsmbLeLsbLsRsbLebLsLgbRsbLiLeLgLsLgLib
RebLebLsbLsbLoRcRsRsmmbLsLcbRsbRibReRsRgReRgmbLgbRsRgbRsbLebLsbLsLcbLc
LsLcRimbRsRsLsRsRiRsmmbRebLgRsbsbsbRsbLebRcRsmbLebLobLeRsRebRgRsRombLs
bsbsbRsbRebLebLebLsbRsbRibLgbRsRsRoLombLeLgbLsLsLsmmbsbRsbRsbsbLcbLcbR
cRsRoRsRsmmmbRsbRsRjbLsbRsLsbsbsbsbLgRcLeLeLcbLeRsbLeLibLgbRgRcRcbRgRe
bRebLobLobLhbRcLeLeLgRjbReRibLsbReRcRsRiLeLeLsLeLeLsLsLsmmmbLsbRebRhbR
sRsmbLebLcRsLsbLgbReRsRsLsmmbRebLsbsbLsbLeLsbLsLsRsmbLsbLsbRcRsmbLcbLs
LsmbRjbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 28; Drug: Control PTZ 2.5 mM
bRibRibRgbRhbRsRsRsRsmmmbLsbRibLsRsRsRsmmbRcbRsRsRsRsRgmmmbLsbLibLebRs
RsRgmbRebRgbRebRhbRcbLjbLgLsbRsbLibRsLsLsLsmmbLsLgLsLgLebRibRgRsRsmmbR
gbRgbRgbRgRsRsRsRsmmmmbRsRsRsmmbRgbRiRsRsmmbRcbRsbReRsRsRsmmmbRsRgRsRs
mmbRsRsRsRsRsRgRsmmmmmbRsRsRsRsmmmbRgRiRsRembLsbRcLsbRgbRiRebRsbRcbReR
smbRsRgRiRsmbRibRgLsbRgbRibRgRsRsRsmmmbRsRgRsmbRgRsmbRgRsRsmmbRgRsRsmm
bRgRsmbRibLobRsRsRgmbRsbReRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 29; Drug: Control PTZ 2.5 mM
bRebRgbLeLiLebLsLsmbRhRgbRsbReRhRsmbLsRsbRsbLeRsRsmbRebLcLibRiLsLebLeR
sbLgbLsbLsLsLcRsmbLsbLcbLgLiLcbRcbReRsmbRgbRgRsmbRgbLgLsbRgRsRsmmbRiLs
bLcRsRsRembRebRhbLsLeLsbLgLsbLibLsLgLsLeLsbLgLsLsmbLgbRiLeLeLjbRsbRebR
sbRebRgRebRebRebRibReRsmbRcRsmbRobRhbRsbRcbRebReRgbRebRibLeLsbLeLsLsLg
LsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 30; Drug: Control PTZ 2.5 mM
bRgRcbRgRsRimbRsRgReLsbLsbsbLeRebRgLeLsbLgbRcbLiLsbLsLgbRebRcRebRgLsbL
eLcLsmbLgLsbLsLsLsmmbsbRsLsbRsLsbLsLsLembRcbLibLebRebRiRebRgRsmbRsRsRs
RemmbRebRsLebLeLsbLebRcbRsbRobRgbLsbRebLebLebRcRjRsmbRebLsbRoLgLsLsmbL
gLebRibLiLsbLsLcLsmbLsbLsRsbRcLebLgLebLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bRhbRsRsmbRiRgbRsbRgRgRsmbRgRsmbRsRgRsRsmmbRgbRsRsRsRsmmmbLsLsRembRebR
eRgbRhRgRsRgRiReRsmmbRsRsmbRsbRgbRgRsmbRgRsmbRsRgRsRsmmbRgRgRgRgRgRsRs
RsRsRsRsRsRsmmmmmmmmbRsRsRsRgmmbRgbRgRsRsRsRsRsmmmmmbRibRsRsRsRsRsRsRs
mmmmmmbRsRsRsmmbRsRsmbRsRsRimbRgRgRsRsmmbRsRsRsRsmmmbRgbRgRsLsRsmbRgRs
mbRgbRsRsmbRgRsRsRsmmmbRgbLgbLcbLebLeLgbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsRgbRsRgRsRgmbRgRgRgbRsRsRsmmbRsRgRsRsmmbLsRsRsRsRsRsmmmmbRgRsmbRsRg
Rgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bReLsRgRcRebLoLhLcLeRoRiReReRhRgbRsbRiRsLsLsmmbLjbLsbsbRsbLsRsbReRsRsL
smmbLeLebRgbLhbLeRebLgRsbLeLeLsbLgLsbLibLgRsbLsLeLgbRibRgRsRsRsRsRsRsm
mmmmmbRsRsRsRgmmbLsRsbRibRsRsRsRsLsLsmmmmbRsRsmbRgRsmbRsbReRibRsLeRebR
sRgRgbRjLsbLhbRebRebRsRsRcLeLeRsRsmmbRsbLiLsRebRiRsRsRhRimmbRibRgbRebR
gbRibRebLebRiRsRhmbLibRobRgbLsRsRsmbRebRgbLsbRhRsRsRsRsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bRcbLobLebLebLebRsRibRsRsRsmmbRsbRsRgReRsmbRsRsRsRsRsmmmmbRsRsmbRebLsL
gbLsRjbRhbRsRsLjmbLebLibLebLoLsmbLsLsLsLsLsmmmmbRcbLgbLsLsLsLgLimmbLsL
sLiLgLeLcmbLsLeRsbLsLeLcLcbLsLsLsLgmmbLgLgbLsLsLgLsmbLsLebLiLsbLgLgbRi
LgRsReRgbRebLeLsbLsLcbLsLsLsLsLsLsLemmmmmbLsLiLcbLebLibLibLsLsLsLsRsLs
mmmbLsbsbLsLsmbLeLsbLebLebLeLjbLsLsLsLsmmmbRsbLeLsLcbRgRsRcmbLsbLcLsmb
LsbLebLoLsLsLsmmmbLsLsLsLgLsLemmbLeLsLcLebLibLebLebLeLsbLebLeLsLebLhbR
cLgbLsLsLsLsLsLsmmmmmbLsLsLsLgLiLgmmbLsLsLsLcmmbLgLsLsmbLsLsLsLsmmmbLs
LsLiRsLcmbLsLsLhmbLsLgLcbRsbRcbLeLcbLebLgLsLcLsmbLiRsLsbLebLiLsbLebLsL
ebRcbLsLsLsLcLsmmmbLsbLsbLsLsLsmmbsbRobLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsbLgLsbsbsbRibRoLsbLcbRsRhRsLeLsmbLebLsLsLsmmbLsLsmbLsLsRsmbLsbLiLsL
gLcRcbLobLsbRjLsbLsRgLsRsbLsLsmbRoLsbLgbLsbLobRcRcRsmbRgRsmbRsRsReRsmm
bRsRsmbLgbLebRoRcbRgbRsLsbsbLsbsbsbLgbLsLsRsmbRsLsLsmbRsLsbLsbRcRsmbLe
bLgbLiLsLebLibLhLsbLsbRcLsbLcLsLombRgRsmbRhRsmbLsLsmbLsRsbRiRcRoRsLsmb
RiRsmbRgRgRsRsmmbRsRsRgRembLibsbsbsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bReLsLobLsLebLsLsLsmmbLsLgRgbRsRsmbRoLebRobRsbRgRsRgRgRiRhmbsbsbRsRsmb
RoRsmbLibRebLcbLebLebReRsRsmmbRgRsRiRgmbLsLsmbRsLcbLobRgRcbLsbLhLsLsLg
RembRibLeRobLjbRebLgbLsLsLsLsmmmbLhRoRgLsRcLgbLsLsRsmbLeLsLebRsbRsRsmb
RcLcbLgbLsLsLsLsmmmbLsLsLsLoRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bRebRjLibLobLebRebLcRibRibRcbLibRebLsbRcbLiLsbLebRobLcbRebRibRsRsRimbR
gLobLgRsbLgbRcbLgbLobLobLibLebLiLsLsLsmmbRebLiLsLhbLjbRsbLiRsbRobLoLsm
bLebLgLebLibRcbLoLebLebRebLgbRiLcbRcRsmbLsbLobLebLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcbRcbRgRibLsbRcRsmbRgRsmbRgLsbRiLsbLiLcRgLcRcRcbRiRsmbLcLsLsLemmbRsb
RibRibLcLcRoRsRoRcRcRimbRgLsLsRsmbLsbLsbLsbLsbLsbLsLsmbRcbReRsRimbRsLs
bRebLcLsmbLebLsRsLsLsLsLsLsLemmmmbLgLsbLsLebsbRsRsmbRsbRjbRgLsbLgbRhRc
RsRoRsLsLsmmmbLsLgLebLsLgLoLsLsRcmmbRsbLgLeRsRoRsRsReRsmmmbRgRsLsRsmbR
sLsbRgLsLsmbRibLcRcRebRgbRsRsmbRsbRiLgbLiLsbRoLsbLsbsbLsbRhLsbLiLoRiRs
ReReReRembRebRsRgRibRsbLcbRcLsbRgRsmbRiLsLsmbLcLsLsLsLsRcRgmmmmbRebRiR
sLombLeRsbRsRsmbRjRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgRiLsbRhbRibLeLsLobLsLeLsbLsLiLgbLeLsLsmbLeLsbLcLsmbRcRobLcbLiLsbRcL
sLsLsmmbLsLsmbRoRsRsRsmmmbLoLgbLiLsbLeLsLsmbRoLcbLsbRsRsRsRsRsRsRsRsmm
mmmmmbRsRsRsRsmmmbRoLsLcLsLgmbLgLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bRebLeLsbReRsRsmmbRgRsmbRcbLeRsbLiLsbLeLsbRgbReRsRsmmbReRsmbLsbReRsRsm
mbRcLsLsmbLibLsbRsbLeLoLcLsLsmmbLiLsbLeLobLibRibLeLgLsbRgLgbLsLsmbLgbL
ebLhLsRsbLhbLsbLsbRsbLiLsLsmbRsbsbLiLsbLhLsbRgLsbLebRgbReRsRsRoLsLsmmm
bLhbLiRsRsLsmbLsLsmbLsbRsbsbsbRsbLebReRsRsmmbRgRsmbRsLsbReLsLsmbLiLsbR
gRsmbRsbRgRcbRsLsbLsbRsLsbRhRsmbRibRgbLsLsmbLebLobRsbsbsbsbsbsbsbsbsbs
bsbsbsbsbLsbLsLcLib

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcLsLsLsLsLoRsmmmmbRcbLoRsbReRsRsmmbRsRsmbRsRgLsbRsbRsRsRsmmbRcRsRcmb
LhbLgLsbRhbLsRsbLgbRsbLsbLibRjbRhbRgLsLcbLhbLebLibRebRibRsRsLsmbLsLjbL
cbRibLcbRobLcbLsLsLsRsmmbLcbRgbRhbLsbLjbRoRebLeLsbLgbLcRsRsmbLcbRcRgLc
RsLcbsbLgbLgbRebLeRsLcLsmbRebLgbLsbLgRsbLjbLoRobRcbRiRcbLebRsbLobRgbLg
LsbLgLsLsLsLgLsmmbLibLgbLsLgLsLgLsLsmbRsRsRsmmbRhRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bRjbRjbRsbLjbLcLsmbLeRcbRiLsbLebLsRgbLeLsRsbRsLsRsbLhbLsRebRgRsRsmmbLj
bRibRsLobLeLcbRsbLsLsmbsbLsbLsLsLsmmbLsLsmbRsbLibLsLsmbLgLsLsLsmmbLibR
cbLebRebRgLsbLobLgbLjbLoRsbLsbsbsbsbsbsbsbsbsbLebRsLsbLgLsbReLibLebLeL
gbLebLhbLgLgbRsRsmbLjLsmbLjbRhbLjbLebsbRoLsbRsRsRsRsmmmbRjbLhbLgbRibRi
RobLiLsLsmbLsLgbLsbRsRsmbLhbRcRsRsRsmmmbLjbLebLgLebRsRsmbRibRgLsLjbLiL
hbLgRgbLgbLsRsbLiRobRcLsbLjbRgRsLembLsLsLsmmbLhbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bRoRsmbLoLgRsLsRsbLsbsbsbsbRjbsbRibLsLcRoLoRobLeLsbRoLsReRsmbLsLsmbLcL
sLgmbLiLsLsLeRsRsmmbRsRoRsmbLebRsbRgbLoLoRsbRsbRgRsRimbRsRsLsLsmmbLhLs
bRcRsRsRsmmmbRgRsRsmmbRgLsbRgRsmbRibLoRobRoRoRoLsbRcRsmbRoRobLcRsRobLs
bRsbRebLebRhRsmbRjRjRsLcmbRjbLeRsbLgReRsmbsbLjbRebLoRoRsRsmmbLcLsLsmmb
LsbRibLgbLcbRjbRibLeRsbRoRsmbReRoLcbLcbLgLsbLgLsLsmbRsLsbLcLobLcLsLsmm
bRjbRgReLsbLgbRhRsRsmmbsbRsbRgLsbLeRoRoRsLsRsRsmmbLibLobRebRoRsmbsbLjb
LjbRcRsRsRsmmmbRsLsRsRgLsRsbRsbLoRsReRgReRebRgLsbRsLsbRsLjbRiRgRsRsRsm
mmbRgbLeLsbLsLsLsLsLsmmmmbRsRsRsRsRsmmmmbRsRsmbRcRgRsRgRsmmbLsbRsRgRsL
smbLsRcLsLsLoRsRsRsmmmbLobLiRsbRcbLcRobLebRcLsRsbRsbRgbLjbLsRcRsmbRiLs
bRcRoRoLoRsbRobRgRsmbsbLcRsRsmbRebLsLsLgmbRibLcLoLibRhbRgbRiRsLsmbLsLs
mbRibRobReLsLcbRebRiRsmbLcbRcRsRsmmbRibLsLoLsLoLoRgmbRhbLsRsbReRcLsbRe
RsRsLsmmbLsLsmbLobRsbLgbLoRsRibRsRsmbLsbsbsbLsbsbsbRiRsmbRoRoRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgRiRiRibRcRsReRsmmbLsbLobLebLiLsbRiLgbRcbRcLsbsbRebRsbReRgRsmbLeLcLs
LsLsmmmbRebRcbLsbLeLcLsLsLsLsmmmmbLsRsbLsbLeLsLoLsmbLoLsmbLsLsmbRhRibR
hRsLsmbLcLhbRibRibRebLeLsLsLgLsmbLebRibRgRsmbLcLsLsLsLsLsmmmmmbLebLgbR
cbRcbLeLgbLsRsLiLsRsbRcRsRimbLsbRsbLeLgbLibRcLsbRgbLeLgLsRsbRcLsRsbRgb
RibLeLhLsRoReRebsbRsRsRhLsmbRebRsRsRgmbRsRebLcbRcRsRcLsmbRsbRibRsbLgbL
cLsLiLsLsLsmmmbRcbLsLsmbLobRcbRibLhRobLcbLcRebRebLebRsbLjbRsRsmbRsRsmb
RcbRebRibLcbLibLjbRhbRebLiLsLsLsLsLsLiLsLimmmmbLsLsLsLsmmmbLsLsLsLsLsL
sLsLsLgLsLsLsLsLsmmmmmmmmmmmbLsLsLsLsLsLsLsLsLsLgmmmmmmmmbLsLsLsLsmmmb
LsRsRsmbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsLsbLgLibLsLgLsLhbLsRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bLobRebLsLsmbRjbsbsbsbsbRsbsbLgbRibLjRsbReLgbLcbLoRebRsbLsbsbRjbLiLsbR
cRsmbRhLebRsbRibLcbLgLsbRcLcbRjbLjbRibLcRebLgLcRsbLcbRcbLcRsbLobRobRiR
sRsmmbRsRsRsmmbRsbLcbLsRsbRjbLhRjbRhbRgbRiRsLjmbLcbRcbLsbLobRjbRjbRjbR
gRsmbsbsbsbLibLiLsbRibLgbLoLsmbLoLsmbLcRsRcbRhbLsbRgbLgbRsbRiRsmbLgbRg
RsRsRsRsmmmmbLgbRgbRsRibRcbsbLcbRcLoLsmbRjbLsbReLsLcLsLcmbLebRcRsmbRsb
LjbRcLcLebRhbRgLsbRsbRiRiLjbReLebLoLsLsRsmmbRgLsRsbRsbLsLsmbRjbLgbLgLs
LsmbLcLobLsLsLsLsmmmbRsLsbLcLgLsLhRsbLsRsRgbLsRgRsmbLgbRebsbsbRiLsbRgb
LoRsbRsLcLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbLsbLsLsLsLsLsLsmmmmmbRsLsLsmbLsLsLsLimmbRsRsLimbLsbRhRsmbRsRsmbRsR
sRsmmbRiRsLsmbRgbRsbLsLsmbRgLsRsbRsRgRsmbRgRsmbRsRsRgmbRsRsRsRgRsRsRem
mmmbLgLgLsbRsRsLsRsmbRjbRiLsbLsbLgbRobRgLgbRgRsmbRsRgbRsRsmbRgRsmbRsRs
RsRgLsLsmmmbRsRiRsRsRsRsRsRsmmmmmmbRebRsRsRsRhRgRgmmbsbLgbReRsmbRgRsRs
LgmmbRgRsmbRgRsRsLsmmbRsRsRsmmbRsRsRsRhmmbRsLsbRsRgRgRsRsRsmmmbLsRsbRs
RsRgRsRsmmmbRgbRsRsRsRsRsmmmmbRsLsbRsRsRsmmbRgRsLsmbRgLgbRgRgRsmbLsbRg
bRgLsbRgRsmbRsRgLsLsmbRsRsRsRsRsRsRsRsmmmmmmmbRsRgRsRsRsmmmbRsRsRsRsLs
mmmbRgbLsbRgRgbRsRsRsRsRsRsRsRgmmmmmmbRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmm
mmmbRsRsmbRgRsRsmmbRiRsRsmmbRsRsRsRsRsRsRimmmmmbRsRsReRgRgRgRsRsRsmmmm
bRsRsRsRsLsRhRimmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 151944; End: 152444;
Recording: 8-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bRibRibReRgLsLoLeLsLcbLebLeLsLobLebLibLgbRobRcLsLoLsLsLoLeLsmmbLeLsbLe
LsbLebLiLsbLiLsLsmbLgLsLsLsLsmmmbRoLsbLcLsmbRebLibRiLoLgLobLgLsLeLobRc
RsmbLsRsRiRsmbRiRsLsLcLsmmbRcRsmbRsRsLoLeLgmbLeLeRsRgbLgLebRebRiRsLsmb
RjbLgLobLsRsbLsbRcRsRembsbRgbRiRsLsLsmmbRiRebLgbRjbLoLsLsmmbLsRsRcbRjL
sbLsLgLoLcbLebLebLoLobLiRsbRjbRebLcLhbLoLgbLibLgbLoLsLsLimmbLsLibLgLgb
LsbLcbLsbLcbLiLsLibLcbRiRoLsbLsLsmbRhbRgbLiLsLsRcmbReLoLgbLgbRsLgLsbRj
bLeLoRibLsbRebRgLsbRgLgbLebLsbLgLsLsLsLemmbLeLibLeLsbLeLeRsbLcLgLsbLhL
sLcLsmbLiLsLeLcRsRsmbLsbReRsRsRsmmmbRgLoLgLsbLeLgLsbLgLgbLeLsbLsLibLeb
LsbLsLsLsLsmmmbRjbRiRobLiLsLsmbLebLgLsbLgRsbLsRsbRebLebLeLsLebLiRebRjR
smbRsRsLoLsLsLgmmmbLgLsbRiRsmbLgbLeLsbLsLiLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 1; Drug: Control PTZ 2.5 mM
bLsRobRgLsbLiLebLsLsLimbLsLsLsLsLgmmmbLsLsmbLgLsbLsLsLsLsmmmbLsLsmbLeL
sRsbRsbRgbLibLgbLgRsbLgbLsLsLimbRgbLgLsbRcLsbRsRiRebLgbLgbLsRsbRgRsmbR
sRsmbRgbRsbRgbRebLeLsbLebLebLsbLebRebLebLsLsLembLcbLgLsbLsbRsLsbLsLsmb
LsbLsLsmbRsbLsLsmbLsbRsLsLsmbLsLsLsLsmmmbLgbLcbLsLsmbLsLsmbsbLsbLsbLsL
sLsLsmmmbLsLsmbLsLsLsmmbLsLsLsmmbLsLsLsLsmmmbLsLsLsmmbLsbLsLsLgmbLcLsm
bLgbLcRsbRsRgbRsLsbLjRcRsmbRiLsbRgRsmbRsRsRsmmbRsRsmbRgbRgRsmbsbsbRsRs
mbLsRsbRibRsRsReRsmmbRiLsbRsRsmbRgbRhbRibRsbRobRcRsRsRsLsLsRsmmmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 2; Drug: Control PTZ 2.5 mM
bRsRsRsmmbLebLiLobLebLiLsLsmbRcLsbLcbLebLeRsbRibRsbRsRsRsRsmmmbRsRsmbR
ibLcbLebLsbLsbRiRgbReRsmbReRsmbRsbLeLgLebLsLeLsbLiLsbRsLsRsbRebLebLebR
ibRibRsRsRoLcmbReRsRsmmbLebRgbLebLcbLibLsLeLsLjbRcRebLcbLgLsbRsbRiRsmb
RsbRebLebLobLiLsbLebLsbLeLsbLgbLebLebLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 3; Drug: Control PTZ 2.5 mM
bRsLsRebLsLgbLsLeLsLsmbLsLsLeLombRgRsmbRsLsbLcbRsLcLsmbLsLcRoRcLsLsmbL
sLiLgLibLeLsbRsLsLiLsbLcLsLsmmbLsbLhbLhbLcbLibRebRgbRobRsbRgRsRsRsRiRs
mmmmbLsRsRsLsmbLcbLcRebLcbLgLgLsbLiLobLsLsLembLebRcbRebLebRcbRebRcbLeb
LhLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 4; Drug: Control PTZ 2.5 mM
bLeLsLebRhbRsLsbRgLebLgLgbLiLgLcbLebReReRsRsmmbRibLgLeLsbRsLobLgLsLsmb
LcRsRsRembRsRcbRebReRsRsRhRcRsRsmmmmbRibRebLeLsbLeLsbLcRsbLeLcLcLcLsmb
LebLibLsLsLsLsLsmmmmbLgLebLcLsmbLcbRjRgRebRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 5; Drug: Control PTZ 2.5 mM
bLjRgRobRgRobRcbLcLeRebLjbRiLebLeLsbLebRgbLobRgRhbRiRsmbLebLsLsmbLsLsL
smmbLebRebLebRcbRgRebRgRsRgRembRebRsRibRgRibRsRgRsmbRsbLeLsbLebReLeLsb
LebLeLgLebReRsmbRebRiRgbRiRsmbRsRgRebRiRsmbRsRsmbReRsmbRgRsRembRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 6; Drug: Control PTZ 2.5 mM
bRsbLsbRsLsbLsbsbLsbLsbLsRsbLsbRsbLsbLsbRsbLsbLsbRsbLsbLsRsbRsbLsLsLsm
mbLsLsmbRsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bRebLebRebLsbLcLcbRsbLcLsmbLsLebRhbRsRcbRsRgRsRsRsmmmbRsRgRcbRsbRsReLs
LsmbLcLcLsmbRsbRoLhbLsbLiRcbRsbRsRgRsRsLimmbLcLobRsReLsRsbRsRoRsRcmbRg
RsmbLibLeLobReRoLcbLibLibLsbLjbRcLsLgbLsLgLsLsmbLgRebRebLsbLeRhbRsRsRs
RimmbLeLgLcLobRsRsmbLebRsLobLsRsbRsRibLcLsmbLhbLsLgLsRsbRoRcbRsRebRsRo
bReLsbRsRsmbRsRibRcLcRcbRsRsmbLeLsbLgRoRsmbRiLobLsLsLsLsmmmbLsLsmbLsbL
sRgRsmbReLsbLsLsLeLoLsmmbLsRcbRsRsRhRsRommbRgRoRsmbRsbRsLcLsmbLgLsLsmb
sb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsbLhRebRgRebRsbRhRgRsRcmbRsbRebLjbRcbRcRsmbRcRsmbRsLsbLhbLiLobReRcbL
eRsbRcRsRsRsRsmmmmbLebReRsRsmmbLeLsLeLsbLsLibRobLjLsLsmmbLoLsRsmbRhbLc
LsmbLcLcbLebLsbRsRsRimbRsRsmbRsRsLsmbLgRsbLibReRsRsLiRgmmbLoLgbsbLsbLs
RsbRcReRoRsmbRsbLsLibRcRsRembRsbRsRsmbRobRobRebRsbRibRgbLcLsLsmmbLsLsm
bLcbRebRebLsLobLcbLobLsbRebRibLcRoRebRiRcbRgRsRsmmbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bRibLcRsbLsbRsbRibLsbRhbLebLgbsbLgRsbRsLsbRjbLjbLgbLebRebLsbRsbRgbRsbL
hLsbLeLsbLsLsmbLsbLgRsbLebReLgbLgLgbLgbRsbLebLsLsmbLoRebLsbRebRibLibLj
bRsbRsbsbRsLsbRjbRebLebLebRsbLsbRsLsbsbRsbLsbRibRgbLjbLcLibLsbLebLebLc
bLoLsmbLeRsbLebLebLeLsbRgbRebRebRsRsmbReRsmbLsbLcbRsbLcRcRhbRebReRcRsL
smbRsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bLiLsbRsLsbLgRsLsbRcRoRoRsRcRimbRcbRsLsbLeLebLsbLibRgbLsLobLiLiLsLcbLe
bLsbLsbRcRcbRobLgbRsbRhRjbLebLibLebLebRgRiRebLebRebRibLebLsbLeLobRsRgR
smbReRcbLsLsmbRsRsRsmmbLobReb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsbLsLgLgLsLsLgmbRsLeLsLsmbLsLsLsLsLsLsLgLsmmmmmbLsLgLsLsLsLsLsLsLsLs
mmmmmmmbLsLgLsLgLsbLsLgLsLgLsLsLsmmbRsLsLsLeLcmbLsLiLsLsmbLsLgbRgbLsLs
LgLsLcLsmmbLsLsLiLgmbLsLgLsLeLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bReRsmbLeRsbLsbLebLebLeLsbRiRsRsmmbRebRsRsRsRsLsmmmbRebRsbLcRcbRebLjbL
cLsRsLsmbLsRsRsmbRsbsbRebRcbLcbRgLoLsmbLsLobLgRiRsmbLeLeReRsmbRsLsbRsR
sRgRsRsLgmmmbLebReRcRsRgmbRiRsmbLsRebLebLgbLcbRsRsRsmmbLgbRiLcbLebLsbR
ebReRsRsmmbRsRsRsRsmmmbLebRebLebRebRoRsRsLoLgLemmbRgbRjbRgRcbLebRobLcb
RsRiRsRcmbLgLebLsbRebLebRebLcbRebRjbLobLsRsbRebLgbLeLsLsmbLiLgbLcbLsbL
ebRcbRebRebLibRgbLibRebRebLebLcbRgbRgbLjbRgbRcbLsbRhbLebLsLibRsReRsmbR
hRsRsmmbRhRsmbLsLsmbLcbRebReLsbLsLsmbRgbRcbRgRcbLebLsRsbReLebLeLcRsbLs
bRcbRebLebRebLcbLsbLsbsbRibLibLoRsbLgRsbRjbRcbReReRsRembRsLsRsbLjbRgbs
bRgbLeLsLsmbLiLsLcbLcRsbsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsbRgbLsRgRsmbRsRsRsRsRsmmmmbLsRgbRsRsRsRsRgmmmbRgRsRgmbRgRsRsRsmmmbL
sRsbRgRsRgRsmmbRgbRgRsRgRgRsmmbRgbRsRsRimbRgbRsRgRsRsRsmmmbRgRsmbRibRg
RgbRgRsmbRgRsmbRibRgbRibRgbRsRgRsRhmbRsRgbRgRsRiLsmbRgbRiRsmbRgbLsRibR
gLsbRsbRsRgRgRgRsmbRgRsmbRsRgRsmbRsRgbRsRgRsRsRsRgmmmbRgRsRsmmbRgRsmbR
sRiLsbRgRgRsmbRiLsRsbRgbRiRsmbRgRsmbRgLsbRgbRgRsRiRsRsRsmmmmbRgRgbRgLs
bRsRsLsRgRsmmbRgRsmbRgRgRsmbRsRibRgRsRsRsRsRsmmmmmbRsbRsRsRsRsmmmbsbRg
bRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsLjbLsLcLsReRhLcmbRhRgLsLsRsmbRoRsmbRcRobRiRgbLhbRcRobRgbLiLsLsmbRsR
smbLiRcRsRsRsRsRsRsLsmmmmmmbLsLcRsbRobRsbLsLiLsbRibRoLjbRjbLsbLibLebRs
LibRgbRjbRebLcLsmbLgRsbsbLsbLsbReRsLcmbRebRebLgLibRsLsRsbLeRsbLiLsRsbR
ebRibLsbLibsbLjbRsbLibLhLcbRcRhbRgRobRsbLjbLebRsRobRcRsRombLjbRiRgRsRs
RsmmmbRcRobLjbReRsRsmmbLsbLobRgbLjbRsbLebRsbRoRsmbRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bRcbRsRsRsmmbRjLsbRcRobLgbLeRsbRsRsRoRsmmbRgRgRsmbsbRsbRsbLiLsbRgRsmbR
sbLebRsRsRgRgLsmbReLsLsmbRgRsmbLsbRsbLsbReRgLgbLebRebRcbRibLsRsLsRsLsb
LsLsmbReRsmbRsbRjbLsRsRebLoLiLsbRsbRgRsmbRebLjbLjLsLsLgmmbLebRibRiRoLe
bLebLebLiLsbsbsbRjbRsbLeLsbLgbLebLibLsbRsbReRsmbRgRsmbRgbLjbLcRcRsReLs
mbRiRsRgmbRebRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bRebLgbRebReRhRsmbLebReRsRsmmbRebLebRebLgbLeRcbLgbsbLibLgRsRsmbLeLsbLe
LsLsLgmbLsbRebRebRiRsmbLeRcbRgbRsLibLibLeLsbLsbRcRsmbRsbRebRcbLebReRsR
smmbRgRsmbLjbRgbLsRsbLibLhLgLsRebRebLibLgbLsbLgbRcbLcRebLebRsReLsbRebR
eRsmbLibLebLebLsbRgbRcbLgbRebLsLsmbsbLsbsbRebLjbRjbReRsmbRibRsbRsRiRsR
sRcReRsRsmmmmbsbLsbRiRhbRibLiLgLsbsbRsbRsbRsbLsRsbRgbRibRiLsbLjbReRsmb
RiLgLsbRsRsmbRsRsRsRsmmmbLibRgbRebLsbRebRsRsmbRiRcbLsLib

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bRobRsLcLsmbLebLgLsLsLembLsRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsbRsbLsbsbLsbLsLsmbRsRsRsmmbLsRsLsbLsbLgRsbRjbRibRsLoLsLombRcbRgbLsb
LgbLsbLsbLeLsbReRsmbRgLsbRiRsmbLgbLeRgRjbLgbRcbRebRsbRgbReLcLobRsbLiRs
bRoRcbRiLsbRsbLgLsLsmbLhbLcLobRoRsmbRiRsmbRsbRsRgRsRsRsRsmmmmbRsbRebLc
LsmbLebRjbRgLsbRsLgbsbRiRsmbRgbReLsLsmbReLsbLsbsbLsRsLsRjbRebRgbRebLsb
RobLgLsbLhLibRebRibRgRsRsRsRsRsmmmmmbRgLsbLsbLibLsLgbReRhbRgbLebRcRgbR
gbReRsRombLcLiLsbLsbLeRsRcbRsbRsbLcbRgLsbRsLcLsmbRsLsRsRsmbLgbLeLoRcRo
bRgbRsLsbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgLsLsLsLsLgmmmbReRiRgbLjLsmbRiRsRgRsmmbRibRibLhLsbLgbLiLsLsmbLsLsLem
bLgbLgbRhRsLsLgmbLebRgbRsLhbLgbLhLsbLsRsLcbLibLgLsLsmbLeLsbRsbLhLsRsbL
sRsRsRsmmbLiLsLsLsLsmmmbLsbRsbLgLsbRsLiLsLeLsbRsLsbRiRgLebLgLcRcRsLoRs
mbsbRsLsRsbLsRsLsbLsLsmbLsbLsRsLsbLsbLsLsmbLsbLsbLsbLsbReLsbLobRsLsLgL
sbLgLgLgLgbLsLsRsmbLsRsLsLsLiRsmbLsLsLsLsLsLiRsLsmmmmbLsLsLsmmbsbLsLgb
RoLsRsbRsRsRgRsmmbRsRsRiRsRsRsmmmmbRsRsRgmbRgRsmbRiRsmbLsLgRiRhRsmbRsR
sRsRsmmmbRsRsRgRsmmbRsRibLgRsbsbRsRsRsRgRsmmmbRgRgbRsRgRsmbLsLsmbRsbRs
bRsRsmbRgRsmbRsRsRsLsLsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bLibLgbRhRsmbRiLsRsRsRsmmbLgbRgRsRsLsRsmmbRebRgRsRsmmbLjbLjbRsbLgLsLsm
bLsLsmbLsRsRsmbRsRsmbRsbsbReRsRsRsRsmmmmbLcLeLsbLibRsbRsbReRsmbsbRsbLg
ReRebRiLsbRsbReLsbRgRsmbsbRsbRsbsbRsbLjRsbRsbLhRsbRcbRsbRebLjLgLsbLsRs
bRcLsLsmbLgRibLebLsbsbLgRcbLsLsmbRiRsRsmmbRiRsmbRiRcbLsbReLoLsmbRsRgbL
sbLjbLsLgLsLsmbRsbReRsRsRsmmmbRgRsmbLsLsRcmbLcbRsRsmbLsRsbLiLsbLsbLibR
gRsmbReRsmbLgbLiLsLsmbLgLgLsbRgbRjRgRsRsRsmmmbLibsbsbLhLsLsLsmmbLsLsmb
RcbLcLsLsLsmmmbLgLsRsbReRsmbRgbRjRgRebReLsLsmbLibsbRebLebRsbsbLsbLibLs
LsLsmmbLibLsRsbRgbReRsmbLcbLsbReLsLsLoLgmbReLsLobLebLgLgLsbLgLgbRgbRgR
sRsRsRsRsmmmmmbRgRsRsmmbRgRsLsLsmmbRsbLsbRsRsmbLjbRhRsRcLsReLsmbsbRsRs
mbRsbLgbLhLsLsmbRcbRsRsmbLgLsbLjLsLsmmbLsbReRsmbLiRsbRsRsmbRsRsmbRsLsb
RoRsRsRgmmbLgbRsbLsbLhbRgRsmbRcLoLsLsLsmmmbLgLsbLsbRsbRsRsmbLsbLeLsLcR
cRsmbLsLsmbRibsbRgRsmbRgRsRsmmbRcRsRsmmbRsbLgRsbLcLsmbRjbLiLsbRjbRcRsm
bRsbRebsbLhRebLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bRhbLebLgbLsLsmbsbLsLsmbLsbRsLsbLhbLgLsbRcbLgbLcbLcLsmbsbRsbRsbLsbReRs
LsmbRebRhLoLobsbRebLsRsbRibLsbLsbRebRsRsRsmmbLeLsLsReRsRsmmmbLobLebLsb
RsRsRsmmbRsLsbRgLsbLobRiLobLsbRiLsRsbRsRsmbRsbLebRcLcLhLsbLsbLsbLgbLcR
sbRgLsbLobRsRsmbLebLiLoRsbRibsbRsbRsRsmbLjbLcRsbRebLsbRjbLsbRebLsbsbsb
RsRsRsRsmmmbLsbLjbLeRcbsbLsbsbLgLsbLcbLibLibRibLebLebRiLibRhRoLsbLjbRs
LsbRjbLhbLebLgbRhbLibLsbLsbsbLebLsLcbLgRsbLgRsRsmbsbLsbLiLiRsRgLsbRcbL
sbLgbLebLsRebRgbLsbLcbRgbLgbRcbLeLsbRebRsbLebRjbRhRsmbRsbRsbRebLsRiLsb
LebRcbLsRsbReLsbLebRebLsbLebRgbRibLjbRobRgbRoRoRsmbRsbRibRibLgLebRobLs
bRebRebsbsbLeRcbLcLiLsRobLjbRebRsbLcLgRcLsbsbRoLsbLcbLebsbsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbLobLebLebRibLgbLeRobLebRibLiRoRsmbRoRsmbRsRsmbLebReLgbLoLcLsmbLobR
sbRcRsLsmbRcLcbLiRsRsmbLebLebRcLsLgLsbsbLcRsbLoLsLgRoLsmbRjbLcbRebLebR
gbLebLeRsbRgRobLibLsbLebLobLsRobLsbLebLjbLobLebLgLibLsLgbLsbLoLsmbRgbL
sLjbLoLsmbLebLibRoLsbRgLgbRiLsbRebLebRsbRibRibRebRcbLsLgbLsbLjbRiLcLcb
RgbRobLeLsLsmbLibLcbLsRibRsbRsbLjbLcbLgbRgbsbLsbLsLsmbsbLsbLjbRoLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bRebRebRebRiRsRgmbRcRsRsmmbRhbLsRsbLcLsmbLebRgLgbLgbReLgbRgbRgLibReReb
RhbLsLgbRobRebRebRgRsmbRcbRebLobLiLsbRsRjbLebLsRsbLebLiLsbRgbLcLeLsbLs
LcbLibRibLiLsbRibLobRgbLhbRebLcbLiLsbRebRgbRibLsbLsRsbRsLobLcbLsbLgbRi
bLgbLebLibLebLeLsRsbLsbLsbLsRsLsRsLsLsmbsbsbsbLiLsbLhLsbRsbsbRsbsbLsLs
mbRibLsbRgLsbRcbRoRsmbRebRsbRgRsRsmmbRsRebLsbRsbsbLsbRoRsmbRcbRgbRebsb
RebRgbRebLsRsbRsbLsbLsLsmbsbLebLsbRibRiRsRombLeLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bLeRsbRobLsbLeLobLhbRobsbRsbRsRsmbsbLobLjbLjbLhRgLsbLsRsbRebLeLobLsLsm
bLcbLebRobRhbLcbLobLsbLsbLgbsbRebRibLebLcbLcbLiRsbLebLoRcLsLobRebLebRe
RjbsbRsLsbRsbsbsbRsbLsbsbLsLsRsmbRsbsbLsbRsbLcbLebLsLgbLsbLsbRjbRgbLib
RcbLcbLgbRiLsbRgLsbLgLsbRgbLgLsbsbRsbLiLsLobLgbLibsbLobRibRsLsbLjbLeLs
bLiRsLgbLobRgbRgbLebsbLsbsbLebRhLsbLobLeRibRobLsLsmbRgbLibLebRhbLiRebR
ibsbsbsbsbLsRsLsLsRsRsRsmmmbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 25; Drug: Control PTZ 2.5 mM
bReLgLsbRsRebRebLcLsmbLeLsRsbLsLebRibRsRgRibRsRsRcRiRimbLcbRhLsRcRsmbR
cRsmbRebLjbLebLebRcbLsLgbLsLeLsbLeLsLsmbLsLsLhLsmbLebLebLjLebLsbReRsmb
RsbRsRsmbRsRsRsRsRsmmmmbRsbRsRsRsmmbRsRsReRsmmbsbReRsmbLsReRsmbLebLhRs
RsmbLeLibLebLsLibLebLsbLeRsRsmbLebLgbRsbLcbLsLcbLsLebLeLsbRebLeLsbLeLs
bLebLsbRebRcRsmbRcRsmbReRsRsmmbLsLebLebLebLebLcbReRsRsmmbRcbLcbLgbLsbR
gbRiRsmbRsRiRsmbLsRsRsmbRsReRsmbRebReRsRsmmbLebLsLebLeLsbLgLsbLebLsbLe
bLsLsmbLebLsLibLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 26; Drug: Control PTZ 2.5 mM
bRebRcLsbLebLiLsRsbLhLcbLgbLgLsbRcRsmbRhbRibRiRsmbRebReLsbRebRibRebRgb
RgRebRebReRsRsRsmmmbRebRebLgLibLibLgLsLgLsbLgRsbLgLsbLcbRobRebRebLobLc
bLebLsbLcLsmbRcbReRsmbReRsLsmbRebRgRsmbLeLsbLeLsbLgbLeLsbLiLsbRcbReRsm
bRgbReRsmbRsbReLsbLebLiLsbLiLsbLibLhLsRoRsmbRibRibRibRsRsRsmmbReLsbLhL
sLsRsmbLibLiLsbLebLeLsbLiLsbLiLsbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 27; Drug: Control PTZ 2.5 mM
bLcbRcRgRgRsmbRebLebLeLsbLsRsbRhbRgRhLeLsRebLcRcRsRiRsLsmmbReRsmbRsbRs
RsLeLsLgLgRoRgmbLibRsLsbReRebRebLgRsRgRsmbLjbLcbRsRcbRebLobLebLebLiLsR
hbLgbLebLsbLgRebRgbRgbLsRsbLsLcbRsbRebRobLebLebRcbRgbRhRebLsbRsbLebLsb
RsbLobRebRebLebLsbRgbLcRsRsLsmbRebRsRsmbRcLebLebLgRsbLcbRsbRebRcbRibRe
LsbRgbLjbLoRobLeRsbLgbRobLsbRsbLcRsLsbLebLgbLcbLsbLsLsLsRsmmbRebLeRebL
cLsLsmmbRsbRjbLgbLcLsLombRcbLcbLebLgbRsLsbRcbLiLsbLgLgLcbRcbRoRsRsRsRs
RimmmmbLiRsLebLgLsLsLsLsLsLsLsLeLsmmmmmmbRhbRibRsRsmbLeLsLcLsLeLsmbLib
LsLsmbsbsbsbLsbLgbLgbRebLebLsLiLsbLsLsLsLsLsLsLgLimmmmmbLsbLeRsbRoRcbR
sRsmbLsRsRsRsRsRcmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 28; Drug: Control PTZ 2.5 mM
bRebLsbRebReLsbRhbRsRgbRsRgRsmbRcRgRsmbRsRsRsRgRgmmbRobLgbLgLebLebLebL
eLsbLsLsmbLsbLgLsLsLsLgLsmmbLsRsbLgLsLsmbLgLsLgbLgLsLebLsLsLsmmbRcRsRs
RsmmmbRsRiRsmbRgRgRsmbRsRgRsRsmmbRebRiRsmbReRsmbRgbRsbLsLgbRhLsbRibRgb
RgbRebRsRgbRcbRebReRsmbRgbRebRebRgbLiLoRsRsmbRsRsRgRsRgmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 29; Drug: Control PTZ 2.5 mM
bRibLcLgLsLsmbLibRebRebLiLiLsLgLsbReRebRgbRsRsRgmbRsRsmbLsLibLsbRsLsLc
bRebRebRsLsbRsbRgbLsRsRsRsRsLemmmbLsLsLsLcmmbRsRgbRcbRsRsmbRcbLiLsLcbL
sbLebLibLgLgbLsLgLsLeRsLsRsbLebLsLsLsLsLsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 30; Drug: Control PTZ 2.5 mM
bLeLsLsmbLgLsbLsLsRsLsLembRebLgbLibLobRcLeLebRebRgbRebRibRiRsmbRsRgRgR
smbLgbLeLsbRhbLebRebRsRsmbRgbRsRsRcmbRibRebRsReRsmbRgRgbRsbLibLebLebLs
RsbRsRcbLebLebRcbLebRgbRsRsRembLsbLsbRgbLgbLebLcbRsbReRsmbRgbRgbReRsmb
RsbRsbRgbReLcbLebRsRsReRsmmbRsReReLsbRgbRgRsmbRebRcRsmbRgbRiRsRhmbLcbL
sLsmbRsLsbsbsbRcbRebRebRgbRsRsmbRebRsbRsbRgbRgbRsRibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeLgbLsLsLsLeLiLgLsmmbLibLebLobLebLebRsLsLsmbLsLsmbLsLsLhmbLsLgLsLsLs
mmbLsLgbLsLsLsLsLeLgmmmbLiLsbLsLgLsbLsLsmbLcbRgbLebRiLsbReRsmbLebLebLs
LsLiLsLiLiLembLsRcRsLsmbLjbLebLobRsRgReReRib

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsRgRsmbRgRgRsRsmmbRsRsRgRgmbRgbRsRgRsRsRsLsmmmbRiRsmbRsRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bReLcbLiLsRsbLeRcbRcbLsLsmbLgLiLsLsmbLjbRgRiRsmbLsLsmbRsRcbRsRsmbRjbRi
bRcLcbLhbRsLsbLeLgLsbLiLsbLsLsLeLgmbLsLiLsbLibLsLsLsLsLsLsmmmmmbLgLsLs
mbLgLsbLibLsLibRsLsLgLibLsLibLgbLsbLgbLsLgbLsLiLsbLibLsLsmbRsLgLsLsmbR
sLsbLgLsLsLsmmbLsLgLsbRsLsLsLsmmbLsLeLsLsmbRsRsmbsbLsLjbLeRcbLeRebRcRg
bLhbRebRib

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcbRgRgbLebLgLgLsLsLsmmbLsLsLsLsLsmmmmbLsLsLsmmbLsLsRsLsmbRsLsbRiLsbL
sLiLgLsLibLebLgLsbLibLibLgLcbRsbLibLebRgbLobRcbLebLebLcbLsLsLsLsmmmbLs
bLsLsmbRgbLebLgLsLiLgbLibLebLhbRsRsRsRsRsRgmmmmbLobLobLgLgbLcbRgbRebRe
bRebLebReRiRebRebRebLebRiLcLsLembRgbLsLsLsmmbLebReRsmbReRiRsReRimbRsRs
RgmbRsRsRgmbRsRsRiRsmmbRsRgRsmbRiRsRimbRiRiRsmbLeLsRsLcLsLsLemmbRsbLcL
sLcmbRibRsRgLsLsmbLebLebLeLcbRsLeLeLebLgLsbRsLsLsLsmmbLsRsLsRsbRsbRcLg
bRsRsmbLeLebLeLsbLgLgbLgLsLsmbLsLhbLgbLsLsLsLsLsRsLsLgmmmmbLibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsLeLsbLebLsbLibLeLsbLsbLebLiLsRebRgbsbRiLsRsbLsbLcLsRsRsmmbRiLsbsbLs
bRsbLeRcLsbRsRsRsmmbLiLsLsmbsbLsbLsLsLsRsmmbLsbLcLsLsmmbRoRcRsmbLobLsL
sRsmbLsLsRsmbRsbRhRsmbRgbLsLcLsLgLsmbLsbRsRhRebLsbLsLsmbLebRoRsmbRgRsm
bRsRgbRsRsRsRsRsRemmmmbLhbLsLsmbRsLgRebRsbLcbLsLsmbLgbRibLobLgLhbRsbLe
bRcRebRsRebLgLsbLsLsLsmmbRsLsbLsbRebLebRoRiRsmbRsRsRsRimmbRsbRgRsRsmmb
RgRsmbRsbRebRcRsmbRsRgbLhbRjbLeLiLsLebLcbLgbRebRcbRebRcbLgLsLobLebLsLg
bRgLsbRcLsbRgLsbLeRsbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bLgbRobRsRoRsLcLcLsRommbReRsRoLgmbLsLcRiLsbRsRsmbLsbLcRcRsmbLsLsLsLsLs
LemmmmbLsLsLsLgmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsRsmbRebRgbReRoLsLsLsmmbRcRibLsLsLcmbLebLebRiRsRsmmbRgbRgLsbLeLibLob
RsbRgbLsbLebLiLsbLebRebRgbRsRsmbRibRibLeLobLiRcRsmbRibRibReRcRsmbLgRhb
RgbLebRgbReRsmbLsbLsbRgbRgRgbRibRgRsmbLoLeRsbLgbLebRsbsbRebLibRgbLcbRs
bLgbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bRcRsmbLsbRiRjbRsbLebReLobReRsRsmmbRsRsRgRimbRgRsRsRsRgRsRsRsRsRemmmmm
mmbsbsbLsRsRsmbsbRgbRgLsbLsbLgbRibLgbsbRiLsRsRiLoLoLcLobRgbRsbRgbRjbLi
LebLiLsLsmbLcLcRibRebRgRibRgLsbReLsbRsRsmbLgbRsbRiLgbLobLcLiLsbRjbLjLg
LsbRsLsLsLgLsLsmmbLsbsbsbLeRcRobRcbRgbRgLsLsLsmmbLsbRgRsRsLsLsmmmbLsbR
sbRiLsRsLsbLsRsbRibLsbLjLcLsLsmmbRgLsbReRsLjLeReRimbRgLsLsRsRsmmbRsRsm
bRgRsmbsbRgRsmbRgbsbLsbsbsbsbsbsbsbsbRsbsbsbsbsbRgRsLgLsmbRjbRcbLjLoRo
RibLcbLeLsbLiLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bLsLsLsLsmmmbLoLsLsmmbLeLsbRjRoLsLsmbRsRsLsLsLsRoLsLsmmmmbLhbLgbReRsmb
LgbLeRsRsRoLombRgLsbLiLsLsmbLebLeLsRoLsbLsRsbRcbRsRsRsRsmmmbRsRgbRsRsR
sRsRcLsmmmbLsReLsRsRobRoRsmbRcbLsRgRsmbRsRgbLsbLsLoRsRsRsLiLsmmbRsLsbL
gLsbLebLsLsLsmmbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bRcLebLobRsLgLsbsbLeLsLsmbLeRsbLgbLobRcRsRsmmbLsRhRsmbReRsmbRgRsmbRhRs
LsmbRibRcbLsbRebLgbLcLsLsmmbRebRgbRibReRsRsmmbRsRiRsmbLhLgbLgLsbLebLsb
LsbsbRsLsbsbsbLcLsLsmmbLiLsLsLsmmbLgbLsRsLsbLiLsLsmbLebLebRebRsRsLsmbL
sbRiLsbRsbsbRebLiLsbLebLeRsRsmbReRsmbRibRgbRgLsbReRsmbReRsRsRoLsmmbRob
LibLeLsbLhbLsbLeLsLsLsLsmmmbRgLsbLiLsLsLsmmbLeLsbRebRhRobRsLsbLeLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bLgLsLsmbRcRiRsmbLsLsLsmmbLibLeLsbReRsmbLgbLebLeLsLsLgmbLsLgLsLebLsbRs
bRibRsbRsbReRsmbLebLiLsLsmbLeRsbRebLsbLsRsbLsLsmbLsLiLsLsLsLsmmmbRcbRc
LsbRsbsbLeLebRsRsmbRibReRgbRcRsRsRsmmmbRcRsRsmmbRebReRsmbRsRsRsmmbsbRs
bsbRsLsbLsbsbRsbRsLsbsbsbRsLsbRsLsbRsRsLsmbLsLsmbRsbRsLsbRsbRsRsLsRsRs
LsRsmmbLsRsRsReRembLcLsLsmmbLgLsLcLsmbLebLsLebLhLiLsLsLsmmbReRgRsRsRsm
mmbReRsRsRsmmmbLcbLebLcLebLsbRobRhbRsbReRsRsmmbLcLcbRcLsLsmbLsRsbReRsR
gRsmmbRcRcRsmbRsRsRsmmbReRsRsRsmmmbLeLgLsbLsbReRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bRiReRgbLsbRsbLsbRgbRsLcLgbLibLgLsLsLsLsmmmbRcbRiLobRsLsLsRsmbRibLcLsL
smmbRcLsbLcLeLobLhLsbLiLsbLcRsbRcbLebRsbRgbLibRiRsmbRgRgRibRcRgRsmbLhL
sbLiRsRjbLhRsbLjbLgLebRebLiLgLgLeLsbLebsbLsRibRcLsbLiLsbRjbLgbLebLsLsR
smbLgRjbLsbRsbRebLsLgbLebRebRsbLcbLsbRebRobLsbLjbRgbRibRebLcLsLsRemmbR
sReRsLsmbLhRsbReLsbLoLgLgbLgLebRibLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bRibLoLoRsbRebsbLjbLsRsbRsbLsbRoRsRsmmbRsReRoRibRgLsRsLsLsmbLsbLsLhbLo
bRhbRcRgRsmbLgbRjbRibLcLgRsbRobLcLsmbLgLsbRebLeLsLsLsmmbRcRsmbLsRsRsmb
LoLsLsRsmmbLeRsbLeLoRcLsbReRsRsmmbRiRsRsLoLsmmmbLoLsmbReRgLsbLsbLsLebR
oRsmbLsbRibLcRsbRoRgbRcLoLsLsRoLsmmbRsbRsbsbRebLeRsbRibLibRjRiRsmbRiRe
RsRoRsmmbLcbLoRoRsRoRhmbLeLsbLsbRebRhbLebLeLsbRgRsRimbRsbRobLebRjbLcRe
bRgRsmbRebRibLsLjRsbLjLiLsRsbLoRsRgbLeRsbLsbLoRobRgRsmbReRcLoLoRsbReRs
RsRsmmmbLeLsbRjbRebRsLsLsmbRiRsmbRhLsbRgLoLhLiRsRsLombLsLsLsLsLsLsLsLs
mmmmmmmbsbRcRsmbRsRsRgRsmmbReRoRsmbLiLgbLeRcRsRsRsmmmbRibLcbRcRiRsmbLs
bLobRcbRsRhRsmbRsRsLsmbRsRsmbRibRsLoLsLsmmbRebLgbRsbRjbRiRsRsRsRsRsLcL
oRsmmmmmbRgbLsbRcRiRobLsbLjbLsRjbRibRsbRsbRhLsLsLoLoRombRsRcbRiRsmbRhb
LjLibRibLoLsRcmbLibRcRsmbLeLsRsbLeLsbRoRhRsRsRsRsmmmmbRgRsRsRsmmmbRgbL
sbsbLsbsbRsLsbRsbLsbRsbRebLcLoLoRobRebLsbLeRsbRcRsRembRgRsmbRibRiRiLsR
sRoLsLoLsmbRjbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsLsLsLsLsLsLsLgLsLsLsLsmmmmmmmmmbLsLsLsLsLgLsLsLsLsLgmmmmmmbsbLsLsmb
LsLsmbsbLsLsLsmmbLsLsLgLsLgLsLgLgLsmbLsLsLsLsLiLsLsLsLsmmmmmmbRsRsRsRs
RgmmmbLhLiReRsmbRgbLsbRgbLsLsLsRsLsmmbLsbLsLsLsLsLsLsLsLsmmmmmmmbLsbLs
bLsLsmbLsLsLsmmbLsLsLsLsLsLsLsLsLsLgLsmmmmmmmmbLsLsLsRiRsmmmbRsRsLsmbL
sLsLsLgLsLgLgLsLsLsLsRsRsLsLsLsmmmmmmmmbLsLibLsLsLsLsLsLgLgmmmmbLiLgLs
LsLgLsmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLiLgLsLsLsLsLsLsLsLsmmmmmmmm
mmmmmmmmmmmmmmmbLsLsLsLsLsLsLsLgLgLgLsRsmmmmmmbLsbLsLsLsLsLsmmmmbLsLsL
sLsLsLsLgLsLsLsLgLsLsLsLsLsLsLsLsRsLsmmmmmmmmmmmmmmbLsLsRsmbRsbLsLsLgL
sLsLsmmmbLsLsLsLsLsLsLsLsLsLsLgLsLsmmmmmmmmmmbLsRsLsbLsLsLsLsLsLsLsLgm
mmmmmbLsLsLiLsLsmmbLsLsLsLsLsLsLsLsLsLsLsRgmmmmmmmmmmbLsbLiLsLsmbLsLsL
sLsLsLsLsLsLsLsLgLsLsmmmmmmmmmmbLsLsLsLsLsLsmmmmmbLsLsLsLsLsLsLsLsLsLs
LsLsLsLsmmmmmmmmmmmmmbLsbLsbLsLsmbLsLsLsLsLsmmmmbLsLsLsLgLsLsLsLiLimmm
mbLsLsLgLsmbLsLgLgLgLsLsmbLsLsLsLsLsLsLsLgLsLsLsLsLgLgLiLgLsLgLsLsLsLs
LsLsmmmmmmmmmmmmmmbLsLsLsLgLsLgmmbLsLsLsLsLsLsLiLsLsLsLsLgRsmmmmmmmmbL
gLsLibLsLsLsLsLsLsLsmmmmmmbLsLsLsLsLsLiLsmmmmbLsLsLsLsLsLsLsLsLsLsLgLs
LsLsLgLsmmmmmmmmmmmbLsLgLsLgLsLsLgLeLsLsmmbLsLeLsbLsLsmbLgLgLsbLsLsLsL
sLsLsLsLiLgLiLsmmmmmmbLsLsLsLiLgLsLsLsLsLsLsLsLiLsLsmmmmmmmmmbLsLgLsLs
LsLsLgLsLsLsLgLsLsLsLsLiLsmmmmmmmmbLsLgbLiLsbRsRgbLiLsLgLsLsLsLsLsLsLs
LsLsLsmmmmmmmmmbsbLsLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bRhbRhbRebRibRebRgbReLsbRsbRsRebRgbLibRgRsRsmmbRibRibRsRsRgmbRibRgbRib
RiLsbRgRsmbRibRiLsbRsRsmbRsRgbRibRgRgbRsRgbRibRsRgRsRsRsRsmmmmbRgRsRsm
mbRsbRsRibRgbRsRsRgmbRibRibRsRsRsLsmmbRgbRiRsmbRiRsmbRgbRsRgbRgbRsRsRs
mmbRsRsRsRsRsRsmmmmmbRsRsmbRsRsRsmmbRsRsRgmbRgRsRgmbLsRgbRsRsRgmbRsRsR
gmbRgbRsRsmbLsRgRsmbRsRsRsmmbRsRgRsmbRibRsRsRgmbRsRsRgmbRsRgRsRgmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bLibRibRebLhbLcLgbLeLsbRcbRsbLsbsbRgbLeReRiLoLsmbRibRjRsmbLjbLebLobLsL
smbsbLsRsbRsbLsbRjbRgbLcLcRsRjbRcbRsbRgRsmbRgbLcbRcRsmbRsReLcRsRsmbLgb
RjbLgbLebRjbRibsbsbLibRjRibsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLibLsbRjb
ReRgReLsbLsbLsLsmbsbLhLsRsLsbRjbLhbLgLeRcRsRsmmbRsbLsbRgbsbRsbRiRsmbRs
LsbRsLsbRsbLsRsLcbLsbReLebLcLsLcmbLcbLgbRiRsRsmmbLjbRsRgRsRsmmbLsLsmbL
ebRgbRgLibRcLsbLsRsbsbRjbRsbLeRsRoRsmbRsLsbRiLcbRjbRebLsLcRsbLgbRgbRgb
sbsbsbsbsbLsLsmbLsbRsbLsLsmbRsbLsLsmbsbsbsbLgbLjbLeReRcbLhbLsRsbLsbsbR
ibsbsbsbLsbsbLsbRsbLjRibRiLsLsmbRcRsLcRsmbLjLsmbsbRjbRcRsmbLsbLjbRebLo
LeRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsRgRsRsRgRgRgRsmmmbReRsRsmmbRsRsRsRsRsRsRsmmmmmmbRsRgRsRiRsmmbRgReRs
RsmmbRsRgRgRsmbRhbRsRhbRgbRsbRgRgbReRgbLibLeLsLsLsmmbRebLobLgbLsLsmbRs
RsmbRsRsmbRsRsmbLsRsRsRsRsmmmbRgRgRsmbRsRsmbRiRsmbRgRgRgbRgbRsRgRsRsRs
RsmmmmbRgbRiRsRsRhRemmbLsRsbRcbRgbLsbRobRibRgRsmbRebRgbLhbRsRsReRsRsRs
RsRgmmmmmbRsRgbRebRgRsRsmmbRgRsmbRgRsmbLsRiRsRsRsRsmmmmbRsRsmbRiRgRsmb
RibLgbRcLsbRgRsRsmmbRsRgbRhbRoLsbLiLsLebLsbRebRiRsmbRgbRebRcLjbRgbLebR
ebLgbRibLgRgbRgbLibRoRobRoLobRebLsbLgLiLsbRibRhbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152445; End: 152945;
Recording: 9-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bReLsRsbRgRsmbRibRgbLoLebLeLeLcLsmbLsLgbLeLsLsmbLeLsbLiLibLgLcRebRibLo
LgbRcbRsRsRgmbLsbRhbRiRsLsmbRgRsRsmmbRibRgRsmbLsLsmbLebLiLgLsbLeLgLeLe
LsbLebRiRsmbLsRsRsmbRcLsbRiRsRsmmbRgLsLsLombLsLgLsLsLsLsLsLsmmmmmbLsLs
LsLsLsLgLiLgLsLsmmmmmbLiLsLgLobRgLsbRiRsmbLcLgRsbLsRcLsbRgRsLoLsLcLeLh
LsmmbRsLsLgLsbLeLiLsLgLgLsbLebLeRobLobRsRsLsmbRsRsLsmbLeLsbLsbRcbLsbLi
LsLsLsLsLsLsmmmmmbLeRgbRcbLsbLgLsbRsRoRsRsmmbLoLebRcLgbRsbLsbLjLgbLsLs
RcRsmmbRhbLcRsbRebRiRhReLoRjbRgbReRiLsbRsLcbLeLsbLcLebLsLsLsmmbLgLsLsL
sLsmmmbRebLgLsbLobLebLebLebLibLebLcbRgLsbRgLgLsLsmbRgLsLsmbRsLsbLoLsmb
LiLsRcRsRgmbRgbLeLgRcbLsbLiLeLsbLgLsbLebLeLibLeLsbLsLhLeRsbLsRiRsmbRiR
smbRiRsmbLsRgbRgbRiRsLsmbRgLsLoLsLsLsLsmmmmbRsbLgRsbReLsbRsLsbRhRsLsLj
mbRgbRsbLgbRhRgbRiRsRsRsmmmbRgRsRgmbRsRsRsmmbRiLeLiLiLsbLeLebLsLebLeRs
bRibLgbRsbRcLsbRgRsRsmmbReRhLsbLeLsRsbRhRsLsmbRiLsLsmbRiRsRsRsmmmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 1; Drug: Control PTZ 2.5 mM
bRebRsRebLhbRgRsRsRgmmbReRsmbRsRcbRgRsmbRgRsmbRsRcbReLsbLibLibRgbRibRs
RsRsmmbRsbLgRgRsmbRsLsRsRsmbRsRsmbRsbRebRjbRsbRgbRebRsRgRsmbRsRsRsRsRs
mmmmbRgbRebLiLgRiRebLgLjbLebLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 2; Drug: Control PTZ 2.5 mM
bRhbRibLcLcbLgLsLsLsmmbLebRibLebLeLsLeLgbLgLsbLsLsLsmmbLsbLebRobRsRgRs
RembLoLsLsLemmbLsLibLcbLebLgLsLsLimbLgLoRsRsLcLsLsmmmbLcbLebRsbRcbLebL
cbLcLebLsLeLebLibLibLcLsmbLibLebLebLiLsLeLsbLibLsLsmbLebLsLcbRebLsbLeR
sbLeLsbLebLiLsbLeLebRcRgbRgLsbLsLsLsLimmbLibLsLcbRjbRcbLebLoLebLiLsbRs
bLeLsbLiLebRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 3; Drug: Control PTZ 2.5 mM
bReRcbRebRsbLibLsLebRobLsbRhLsbRsRsmbLcbLsLsLgLsLsLcRoRsmmmbLeRcbLebRo
bRebRobLgbLhbLsLiLgRsbLsLebRcbRcbRcbRgbLsRobLsLsLsLsLsRsmmmmbLeRcbRebR
gbRsbLebLcbLcbRebRobLgbLgLebLeLsbLebRcbRcbRsRgRsRsmmbLsbLeLsRobRcbRcbL
hLgbRobRebLebLebLebRebLeLsLsLeLgLsLsmmbRsLeLeLgLsLiLgbLibLsLgbLsLsLsLs
LsRsmmmmbLsLsLsLsLsLsLgLsmmmmmbRiReb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 4; Drug: Control PTZ 2.5 mM
bLeLebLebRjRsmbLiLcLebLebLeLebLsLiRiLcLsLembLgbLsLsLsmmbLsLsLsmmbLgLsb
LebLeLcbLebLiRsLsbRcRsRhRsRsRgRsmmmmbRsbLeLsLsmbLebLeLsbLiRsbRcRsRcLsm
bLeLeLeLsLsLeLgLgmbLeRcRsmbLebRjReRsRsRsReRsRemmmmbReRebRebRebRgbLcbLg
LeLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 5; Drug: Control PTZ 2.5 mM
bRiLgbLsbLiLhbRgLgbLhbLebLsbLebLeLgLsLebLsbLebLiRsbLsLsmbLibLsbLsLgLiL
sLsmbLibLgLsbLebLebLebLebRgRsmbRsbRgbLebLebLcbLgLcbLiLgbLsLsLsmmbLebRs
LsbLgLgbLsLsLembRsRsRsLcLsLsmmmmbRsLsLsLsLsmmmbRsLsbLsRsLcbRebRebRiRsR
smmbRsRsRsRgmmbLsLsLcmbLgLeLib

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 6; Drug: Control PTZ 2.5 mM
bRsRgRsRsRsmmmbLjbLebRgRebRsLsLsLsLsLemmmbRiLcLsLeRgmbLgLeLgbLebLiLsbR
gRebLeLibLsbLobRobLebLcbRebReLcbLobLebRgLsbLsRsbLsLsLsLcmmbReRcbRsRsmb
RsRsRembLeLiLsbLsbRcbLebRebRcbRibRebRgbLhLsbLibLsLgLiLsbLsRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bRhRgbRsRiRsRombLsLsLgRsmbRiRoLsbLsbLgbLsRobRsLcRobRsRsRhRimbLeRsRobRs
RiLebLsLsLsLsmmmbRsbRcLsLcbRsbRhbRsRsRsLcmmbRibRsRsRsRsmmmbRsRsRsRsmmm
bRgbRsbLsLgbLsRsLgbLcbLsLsLgmbLsLsmbLebLobLebLcLebLobRsReRebRobLeRsbRh
RebLgbLsLsmbLsLgLsbLgLgbRgRgbRsbLebReLsbLgRebReRsLjmbRcRsmbLcbLsLebReb
LebLibRebRsbLgbRsbRobLsLsLombRoLsbRiRsRembRoRcbRcbRsRgRsmbRibLebLgbRgR
cbRgRebLibLsLebRgRobLiLcbLebRgRgbRebLoLsmbLgLobLcbRsLebRebReLsbRebLibR
eLobLsbLiLcLsmbLeLeLsbLibLebLebLebRcLeLcbLcLsmbLiLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeLibLcRsbLsLoRsbRsRebReRsmbLjbLiRsbReRsRembReRiRsRembReRsmbLjRibLgRe
RibRhLjbLebRoRsmbLsbLeLsbRcLsLcLhLsLsLsmmbRjbReLcRsbLeRsRsLcLsLsLsmmmm
bLsLsRsmbLsLgbRcbRcRsmbLsbLcbLibRgbRsbReRsRsmmbRgLebReLcLibLcLoLsmbLsb
LiLgRebRcbRsRsLombRobRsRsRsmmbRsRsLsmbReLsRcLsbRsRsRsmmbRcLibLeLsbLsRs
LiRebRobLsbLsLsReRcRgRembLsbReRsmbLcLcLhbLcbRcRsmbLobLhbRibLobRsRsRsmm
bRsRsmbRsRsmbRsRcRcRsmbLhbLgRsRsmbLsbRoRcbRsbLibRsbLgbLiRsbRcReLsbLsLs
LsRsmmbRgRgRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcbLeLsLsmbLiLebLeLsbLjRsbLsbLgbRebLebLebRebLebRebLobLebLebLgbLebLebL
ibsbLgLsbLebRebRibRsbLebRgbLcbLsbRsbLgLsRsbRgbLobLcbRebLebReRiRiRibReb
ReRsmbRebLcbLebRcbLebLebLeRsbLebRebRebRsbLebRebRebRgbLebLgbLeLsbRsbLsb
LeRsRsRsmmbLsRsLsbLgbRsRebLeLsbLgLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcLgLgLoLsmbRsbLsLeLsbRsbRiRsRsRcmmbLibLgLsLobRsRsRsmmbRsRgbRoLobRiLs
bLsLsmbRsLgLsbLiLoLoRcbRsbReRcbRsRsRcLoLsmmbRgbRcbLcbLebRobRoRsmbRebRg
bReRoLsbReRsmbLoLsRjmbRobLsbsbLgRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcLcbRsLiLebLsLsLiLsLsLsmmmbLsRsbLsRsbRsRsRsLsmmbRsRsRsRsRsRgmmmmbRsR
sLsRsRsmmbLsLsmbRsLsLsLembLsbRgbLsRsRsRsRsReRsmmmmbLsLgRebLgLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bLhbLsRcbRiLsRcRsmbRsRsRsRsRsRsRsRsRsRsRcLsmmmmmmmmmbReRsmbLcRebReReRs
mbLgbRobRgRsRsRcRemmbLeLcLsmbsbLibRcRoLobLibRibRebLcLsLsmmbLsRsbLebRsR
ibLebRhRsmbLjbLcRcRsRembReRsmbLsRsLsbRcRebLjbRoRsLsmbRsRsRsRsRgRiRsRsR
smmmmmmbRebLcbRsbReLsLcbRebLgLsbLsbRgbLcbLgbLjbLcbLebReRsRsmmbRsRsmbsb
RsbRsLsbRebLcbRgRsmbLcbLsbRsRsLsmbLibReRsmbLebRgRsLsmbLibLebLebLgLsbLe
bRebRsRsmbReRoRcRcbLcRcbRgRsmbRgbReRsRsRsRcmmmbRcbLcRsbRcbRsbLeLsbLsLs
RsmbRhRsRsmmbLhbLcbLebLcbRsbLgRsbsbRibRoRsmbReRcRsRgRsRsRgLsRsmmmbLsRs
bRsRgRebReRsmbRsRsRsRsmmmbRcLeLoLsmbRgRhbLsLsmbRsbLibLobRsbRebRcbLeRsb
RcbRsbLsLsmbRsLsRsRsmbRebLcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsRgRsmbRsRsRgmbRgRsmbRibRibRibRibRgRsmbRiRsmbRgbRgRsmbLsbRhRsmbRibRg
RsRsRsmmmbRiRsmbRsRsRsRsRsmmmmbRgRsmbRgbRsRgbRsbRiRgbLsRibRgRsmbRgRsmb
RgRsRsRgRsLsmmmbRgRsmbLsRebRsRsRsRiRsRsmmmmbRiRsmbRsRsRsmmbRgRsRsRgmmb
RgbRiRsRsmmbRsbRsRsmbRhbRsRsmbRgbRsRgRsmbLsRgbRsRsRsmmbRgbRsRgbRgbRiRs
RhmbRibRgRsRsmmbRibRgRgbLsRsRiRsRgRsmmbRgbRsRsRsmmbRgRsRsRsmmmbRsRgbRg
bLsRsRsRsRsRsRsmmmmmbRgRsmbRiRsRsmmbRibRgRsRsRsmmmbRgRsRsmmbRibRsRsmbR
iRsRsmmbRiRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsbLgbLibRobLsRobRiLsbLoRsbRebLsLsmbLgLsLcbRebRebRebRsRobRsbRoRebRcbL
oRsbsbRebRebLibLgbRebRebLcLsmbLibLobRobRsbRcRsRsRsmmmbRsbLcRsbLeLsLsLs
mmbLebLsbRgbRebRcbRiRsmbLcbLebRsbRiRgRibRebLoRsbRibRebReRjbRcbLibLsRsb
LgbRobLibRsRjbRsbLsbLibRjbRiRsLgmbRsbRiRgRiRsRsRsmmmbsbRsRsmbRsbRsbRsb
RsbRgRsRsmmbLsbRsRsmbRsLsbsbsbLcbLsbLsbLebRebReReb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bLgbLsbLsLeLsbLoLsLsLsmmmbLsRsbRiRsRsmmbRsRsmbRebLsbLsRsbRebLiLsbRjbsb
LebLsbRsRsLeLsLsRsmmbLgbRsbLsbRsbLibLsbLeLobRgbsbLiRgbReRibRsLsbLgbLgb
LgRiLsbRsRebLebReLcLsmbRjbRcRsmbRcbLjbLsbRgbRgbRibRgbRibRsbRgbRcLsRsbL
sRgRsmbRiReLgLsbLgLsLsmbLebLgbLsbRsLsbsbLibLiLsbLhbRgbsbRsRsLsmbRjbLgb
LebLibRebRcRsRgmbLebLsLsmbLcbLebLebRcbRobLsbLebRgLsLgbRibRgbRiLcbsbRib
RebRgbLeLgbLebLibLibLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bRobLibRgRebLcLsLgmbsbLsbLcRsLobLiLsLsLsmmbLeLsbRgbLcbLgbLsRsLsbsbLcLs
LsLcmmbLgRsbLgRsbsbLcLsmbLsbRsbRsbLebRsbRsbLcLsLsmmbLiLsbRjbLcbLsbLhbL
sLsLsmmbRsLsbLsbLcbRobRhbRgRgRsmbRibsbsbsbLsbLcbLgbReRsRsmmbLsRsbLsbLe
bLjbLsbLcbLhLcRsLcLsmbLhbLgbLiLsbRcbRcLsbLeRsRsRsmmbLcLsLsRsmmbLeLsbRc
bReRsmbRsbReRsmbReRsRsmmbRibRsRsRgRsmmbRebLgbReRjbRgbRcbRebLgbLcbLiLsb
LiLgbLsLsRsmbLjbLcbLsbLibReRsmbRebLibLcbRsbLsbRiRsmbRiRgRsmbLeLsLgbLsL
smbLjbLiLcLsmbRcbsbLibRjbRiRcbRebLebLeLsLcbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsbRsbLeLsRsbLoLgRsLiLsbLeLebRjbRsRsmbLcbLibLsbLcbLsLsLeLcmbLjbRobLeb
LiRjbLobRoRgRsRsLemmbRcbLebLcbLcbRiRsLsmbLsLsmbRgRsRgLjmbLeLeRsbRsbRsb
RgbRjbLsbLgbLgbRoRoReRsmbRsbLcbLsbRsbRsbLsbRsLsbRsbLsbLsLsmbRsbRsLsLsm
bLsbRsLsbRsLsbLsbRsbRsbsbsbsbsbsbsbRjbLeLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgLobLebRsbLsLsmbLsLsLsLsLsmmmmbLebRcRobLobRgbRgbRsLgbRsbLebRiRsRsmmb
RsbsbRsRsmbLsLsmbRsbLebRsbRsbLgbsbsbLsRoLsLobRiRgRsmbRsRibRsbRsRgbRcRo
bRsbRebRobLgbLcLiLebReRsLombLoRsbLiLsLsmbReLsRsRsLsmbsbRsReLsbRhbLsLcb
LsLebLsLsmbLsLhRsbLgRsbLgbLsbLsbRsbRgbLsbLhbLsbRjbLsbLsbLhRsRcbLgbLsbL
gbLgLsRsbLsLsLsLsmmmbRcbLgbLeLsRcRibRob

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bRjbRsRsLsmbRsRsLsmbLsRgRsRsmmbRsRsReRsmmbRsRsRsmmbLsRgbLsRsRgbRsbRsRs
RsmmbRsbLsbRgRgbRsRgRsRsRsmmmbRiRgRsRsRsmmmbLsbRgbLgLgLsLsLgLgmbRiLsbL
sbLhbLsRsLsbLsRsRsLsLgLsLsLiLgRsRsRsmmmmbLsLsLsLsLgmmmbLgLgbRsbLiLsLsL
sLsmmmbLsRgbLiLhLsLsmbLsLsLsLsmmmbLgLsbLsbLsbLsLsmbLsLsmbRsLsLsmbRjbRg
bRsbRsbLsbLsbLhLsLsRsmbsbLsLsmbLsLsmbRsbLjbLgRsLsLgLgbRsLobLsRsbLgRjbL
gbLhLgLsbLiLgbLgbLobRibLsLsLiLimbRsLsbLgLgLsLgbLsLsLiLgLsmbLgLsbLiLsLs
mbRebLgLsLsRsRsmmbRgRsmbLsLsLsmmbRsbLsLsmbRgbRsRgbLsbLsLsmbRsRsRgmbRsb
RsbRibLsbRgRsRsmmbRsbRsRsmbRsLsRsbRsbRgRsRsRsRsRsRsmmmmmmbLsLobRsbRsbL
obRgRsRsLsLjmmbRebRsLsRsRsmbRsRsRsmmbRsRsmbRsLsLsmbRgRsmbRiLsLsLiLjmbL
ibLsLsmbLsLsRsmbLsLsLsmmbRiRsmbRsRgbRsRsRiRgRgRgRgLsmbRgRsRsRgRsmmmbsb
RsbLgLsRsRsRsmmbRsRsLgmbRsRsRiRsRsmmmbLsLsRsRsRsRsmmmmbRgbRgRgRsmbRibL
sRsbRsRsmbRsLsbsbRgRsRsmmbLsRsRsRimbLjbRsbRsbsbRsbRsbRsRgLsRsbRsRgRsRg
mbRsbRsbRgRsRsRsmmmbsbLcRsbLsLsRgRsRsRsmmmmbRgRsRsmmbsbRsbRsRsmbRsbRsR
smbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bLeLsbLeLsLsLsLsLsmmmmbLgLsLsLsRgmmbReRiLsbRebLiLsLsLsRsmmbLsbsbRhRsRs
LsRsmmbRsbLebLsRsbLgbRjRsmbLgRgLsLsmbsbLhLsbReRsRsRsmmmbLjbLjbLeLsbLsR
sRsmbLsbRsbReLsRsRsRsmmbLjbLsbRsbLiLgLsbRgRsmbLsbRsRsmbRebLsRsLsbRsRcR
smbLsbLebRsbLsbRjbRsbsbLgbReLsLcLsmbLeLcbLibReRsRsRsmmmbRgRsRsmmbRgRsm
bsbLjbReLcLsLsLsmmmbLsbLsbsbLsbLsbLgbRiRsRsLsmmbLebRsRsRsRsmmmbsbRjbRs
LsbLhRcbLjbLsLsRsmbLgbRgRebLcLsmbLsbLiLsLsmbLsRsbsbRebLgbRsbsbLgRsbRjb
RsRsRgmbLibsbLhRsRjbRcLeLsbLebReRebLsbRsReLebLcLsRsmbsbsbLsbLsbLsLsLsm
mbLsbLiRcbsbLgbsbRebRsRsmbReLsbRsRsmbLsbLibsbRgbReRsRsRsmmmbLhbLiLsbLs
LsmbLiRsLsbRsbLsLgLsLsmbLsLsRsmbReRsRsmmbRsRsmbLibRsLsbLsbRcRsRsmmbLjb
LsbLiLsLsLgmbRsbRgbRebLsRsbLibLebRcbLjbLibRcRsRsRsmmmbLjbRcRsmbLoLgbRg
LsLsmbReRsRsmmbsbLiLsbRibReRsmbLjbLiLsLgRgbRgLsLsLsmmbLiLsbLsRgbRgbReb
LsbLiRsRsmbLsbLsRsbRjbReRsRsmmbRgbsbRsRsmbReLsRsbLcbLiLsbRebRhRsRsmmbL
jRsbLsbLgRsRsRgmbRjRsRcRsmmbLobLgbLsbLsRsbRgbReRsmbsbLjbLsbLsLsmbReLgL
sbLsLcLsmbLjRgRsRsmmbRjbLgbRebLgbLiLgbLsbLsLsmbLsRsbsbsbRsRsRsRsmmmbLs
RsLsbLgbRcRsRhmbLgbLebLgbLsbRjbRsbLgbRsReb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbLcbLibLoLsmbLcbLgbLsbRebRibLcbLibsbsbRsRsmbRsbLsbRcbRjbLibRgbLeLsb
RjbRibLcbLgbRgRebLebLgLsRsbLsbLgRjbRibRgbLsbLsbLsbsbLsbsbRsbRsbLsRsbLi
bRobLiLebRibRsbRgbLgbRjbLcLsmbRsbLebRsRcbLjbRibLsLsmbRibLgLsbLsLebsbLj
bLsbLjbLsbLgLsbRebRgRsmbLjbLiLoReRebLsLsRsmbRgbLsbLebsbRsbReRhRgbRsbLg
bLcbRsbLebLeRsbLgRobsbLjbLebRjbRgbsbRsbLebRibRobLgbRsbRibLsLcbLgbLsbRs
bRgbLsbRoLsbLibLsbRsbLsbRibRgbLgbReLsbRhbRjRibLcbLgbLgbLsbLiLeRsRsRsLs
mmbRhbLebRjbRjbRsbLhbLeLsbLgbRcbRibLebLebLcRobRcRsmbRgbRibLebRsLsRsRsm
bLsRsbRsbLsRsbLsbRsbLsbsbLsLsRsLsRsRsmmbRsbRsLsLsmbLsRsRsmbRsLsbRsbLsb
RsbRhbRiLgbRsbLcRsbReRiLsRobLgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbLobRcbLebRgbLgLsbRhLsbLgLsbLgLsLsLsmmbLsRsLiRgbRsbLibRibLcbLebRibL
oRsbLjbLcbLcLsmbLibLcRsRhbLjbLobLobLgLsLsLsLsmmmbLgLsbLsbLgLsLsmbLjbLo
LsRgmbRiRsmbLebRibRgRoLsbRobLebLibRobLebRjbLsbLobRoLsbLcRsbRsbLsLobRiL
eRsRsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bRebRebLebLibLibLgLsbLsbLsbRsbsbRsbLiRcbLsbRgRiRsmbsbRsbLsLsmbLsLsmbLs
bsbsbRcbRjbRgRebReRsLeLembLeLsbLeLsbLebLsLsmbLsLsLsmmbLgbRcRobRcbLhbRg
bLgbLebLiLsbsbsbsbRgLsLsmbLgbRobLgbRebRebRsbRgRhbLcbReRsmbRobRebRebReb
RgRhRsmbLgbLiRsbRcbLoLgbRsbLgbRibLobLibRebLebLgbRoRsmbRebLebRebLsRgRsm
bRsbLgbRcbRhbLeRsRsRsmmbRcRibLiLsbRoRsRgRimbLibLsLgRjbRoRsmbReRjbLgbLe
LeLsbRsLeLibLeLcbLiLsbLebLhbLhLsbLebLgRsbLebLgRoRsRoLgmbLoRsbRiReReb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbRibLsbRsbsbLsbLobLoLsLsmmbLebRcbRsRsmbsbRsLcRsLsbRibLobRsbLsbLgbRi
bLsRsbsbLcLsRoRjmbRhRcbRsbRebLebRcRgbLgbLebLebRsbRgbLebRjbLgRhbLeLobLs
LsmbLeLcbRhbLobLiLgLsbLcLsLimbLebRsRsLsmbsbsbsbRsLsRsbsbsbLsbLsbLsRsbL
sbsbLsbsbsbRsbsbRsRsmbsbsbsbRsbRsbRsbsbsbLgLgbLeRsbLcbRhbLibLebLebLsLs
mbLebRsRsmbLjbRgbsbLcbLebRsbLcbLhbLhbRsbRsbLgbLcbLoLsmbRgbRjbLsLsLsmmb
LebLgbLibRsbRebLebRibLibLsbRobLebRcbLebLsbsbLcbLoLsmbLeRsbLebRsLsLoRsR
oLsbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 25; Drug: Control PTZ 2.5 mM
bLsLsLhmbRebLibRebRsRcbLsRsReRsRembLeLsRjbRebRebRgbRebLeRsLsLsLsmmbRgb
LebLobLsLsLembLebLcbLeRsbLebLebLsRgbRebRebReRsmbLgbRebRsRsRembRebLeLob
LcRibLebLsLsmbLsbLiLsbLsbRsRebRiRcRsmbRsRsmbLebLeLsbLibRebRjbRhLgbLebR
obRebLgbLeLebLebLgLsbLgbLgbLsLsmbLeLsbLebLebLibLsLsLgmbRsRibsbReRsmbLg
bLebLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 26; Drug: Control PTZ 2.5 mM
bLeLsLsmbLeLsbLibLiLsbRebLeLsbLoRibRiRsRsRsRsmmmmbLcbLebLgbLibLhbLiLsb
LibLibLibLsLsmbRibRebRebRebRibRiRsLsmbRiRebRgbRebRebReRsmbRgbReRsmbRib
RgRgbRibReRsmbRebRgbRibReRsmbLebLebLebLebLgbLiLsLsRombReRsmbReRsmbRebR
ebRhbRhbRcbLeLobLcbLibLebLeLsbRgLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 27; Drug: Control PTZ 2.5 mM
bRcbLebReRsmbRgRsmbRsRibLgLsLsmbLsLcbRsRebReRsRsRgmmbLebLiRjbRcRsmbRsL
sbLsbLsbRebLebLsRebRcLeLsLsRimbReReRgReLsRsRgReRsReRsRsRsRsLsmmmmmbRiR
smbReRsmbRiRsmbReRsRsRsRsRsRsRsRsmmmmmmmmbRsRibRsRibRsRsmbLeLsbLeReRiL
sLeLgbLgLsLsReRembReRsRsmmbRsReLsLgbLsLsRsmbRsRsmbRcLcLsmbLsLibLsLsmbL
ebLeRsRsmbRsRiReRsmbLebLhbRsLsRsbLcbRoRsmbRibRiLsbLsRcbRgbRsbRebReLsLs
mbLsbLiLcLoLsLsmmbRsLeRsbLcbLgLsLsmbLsLeRebLsRgRsmbLjbReRsmbLsRsRsLsRs
mbRsRsmbReRsRsmmbRebRsbRsRsRgmbRsRsLembLcbLsRsbRcRsmbRsReRsmbRhLcLsmbL
sLebLoLsLsmmbLeLsLsmbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 28; Drug: Control PTZ 2.5 mM
bLebRgbLeLsbReRgRsReRgRsRemmbRgbRsbRsRsRimbRsRsRsmmbRsbRcbLgLsLsLsmmbL
gbRcRobLgLgLsbLsLibLiRsLsbLibLoRgbRgbRgbRsRsRsmmbRsRsmbLsbLsRoLsbLeLsL
smbLsLgLsbLiLsLsmbLgLsbLebLsbLeLsbLiRjbLoRib

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 29; Drug: Control PTZ 2.5 mM
bRebLsbLcbLsLgLsLsLsLiLgmmbLgLsbRsLsLsLsmmbRsLcbRgReRebRibRgRsRsmmbLeb
RcLsLcbReLcLeLgbLibRhbRoRcbLhLsLsmbLhbLsRsbLsbLebRobLgbLibLibLsbLgLsbL
gbLsLsLsLsLsmmmmbLjbRcbRiRsRhRsmmbRgLsbRsRsmbRcbRibRebRebRoRsmbRiRsRgR
sLsLsLsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 30; Drug: Control PTZ 2.5 mM
bRebLeLsbLeRsbLsbRcbLiLebLsbLsLibLeLsbRebRebRoRsmbRibRgbRsRsRsmmbRsRgR
gRsmbRsRsmbLeLsbLeLsbLgLsbLgLeLsbRgbLebLsbRcbRibLsbLsbRcRibRebRebRgRgb
RebRebRsbRebRsLsbRibLeLsbLsbLebLsLsmbLibLsbsbsbsbRsbLjbLebRibRebRsRebR
cbLebLebLobLgbLgbLsLsLsmmbLsbLsLsRsmbLsRsLsbLgLsbLgbRebRebRiLsbLsbRgLe
RsbRebRgbRsRsmbRgRgbRsRgRsRgmbRgbLsbLsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bReLgbRsRoRebRebRiRebLsRsRsRsRsmmmbRsRsRsRsmmmbRsRsRsmmbRsRsRsRsRsRsmm
mmmbRsLsRsLebLgRobRcbRgReRgbLsReLsbRebRsbRiRsRsRsmmmbRsRebRebRebReRiRs
mb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bLgbRsbRsRgRsRsRsmmmbRsRgRsRsmmbRsRsRgRsRsRiLsmmmbRgbRsRsRsRsRsRsmmmmm
bRgRsRsRsRsmmmmbRgRsRsRgmmbRgbRsRsmbLgLsbLhRsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsRsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bLebLsLcbReRoRsReRsmmbRebRibRebRibRebLsLsLsLeLgLgmmbRsLcRoRsmbRibRebLs
bRebRgbLebLcbLgLsLsmbLsLsLsLcmmbLsbRsRsmbLsRsbRcbLcbLgLsbLsLsLsmmbLsLc
bLeLebRcbRhbRgRsmbLibLeRsbRebRebLgLsLsLembLibLcLibLebLcLjbLcbLsLsLsLsm
mmbLsLsLsmmbRcbRebLhbRhRcbLobLebLsLsLsLsLsLgLgmmmmbLsLsLsLsLsmmmmbLsLs
mbLiLsLcbLsbLsLsRsRsLsmmbRjbLebLibRjbRiRsmbRsRsRgRsmmbRgRgbRsRhbRhRsmb
RebRebLsbLibLsLgLsbLsLsLsmmbRsLsbLsLsLsRsLsmmbRibRobLebLcbLibLobLcbRsb
RgbRsRsRsRsRsRsRemmmmmbRcbLgbLibLgLobRebLebLgbLibRebRcbLibRobLebLebLeb
LebLeLsLsmbLgLsbLgLsLsmbLeLebLhLsLsmbLsReRsLgmbLsbLsbReRsRgRsmmbRiRsRs
mmbRebRsLsLsLsRgRcRsmmmbLjbLeLebLiLcbLhLsRgbLoRsRsmbReRsmbRgRiRsmbRebR
eRsRsRsRgRsRiReRsmmmmmbRgbRsbRsRsRembRsReb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bLcLgRebLsRsRsmbRgRsLcLgmbLsLcLgLsbRsLsbLsLsLsLsmmmbRcRcbRsRibRgbReRsR
smmbRsRsRsRimmbRsRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsbRgRsRsRsmmmbLobRebRsRg
bRsRsRsRsRsmmmmbRsRsmbRsRsRsRhRcmmbRsRcLgbLibLsLsLsmmbRsRgbRebLebLebLc
bLhRebLcbRhbRcbRobsbLsbLhLsRsRsmbLsLsmbRjRebLgRsbRsbLebLsRsLsbRgbRgRgR
sRsRsRsRsRsRsLemmmmmmmbLebLcRsbLebLgLgRsbRgbsbRsLsLsRgmbRsbRcRcRsmbRsR
sRsRgRsRsRsmmmmmbRiLibLgLsLsmbLgLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsLsmbLsRgRsmbRcLsLsLcmbRebRsRsRsRgRimmbRiRsReReLsRsRgmbsbsbRsRsRsmmb
RsLeRobRsRsRsReRsRsRsmmmmmbRsRiRsRsRimmbLcLhLhbRebLsbRcbRgbLeLebLgbRsb
LsbLsLsmbLgbLsLsRsmbLgLobRebLgbLobReRsLsRsmbRsRsRsRsRsLeLsmmmmbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bRiLcLeRoLebRobRebRebLebLibLiLsLsLsLsmmmbLsLsLsmmbLsbLsLsLsLsmmmbRebLg
bLeLsbRsRsRsmmbReRibRibLsLobLsRsbLobRsRsmbRgRebRiRgbLhbRsbLeLobRgbRebL
sbLgbLgbLebLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsLsLiLiRcRebRsbRgbRsbLsRsLsbRgRsmbLcRsRsLsmbRcLebLibLeLsLoLoLiLibLeb
RgbLsbRsRsRsmmbLsLcLoLeLhbRcbRsbRgbLhbRcRsRsmmbRsbRgRcbRgLsbRsLsbRgLsR
sbRiLsbRsLsbLgLibRoLebRgLebLhReRsmbLeLsRgbLibLeLhbRgLsLsLsLsLsRsRsLsmm
mmmbLsbLsbLeLsRgbRibRibRcbLibsbsbsbRgbRsbLjbLgLgLcbLcLsLsmmbRjbRsRgbLi
bLiLsLiLsLsmbRiRsRcRsmmbsbRiRsmbLsLsmbRiRibsbsbRgRsLsRsRsLsLsmmmbsbsbL
sLsLsmmbRsRiLsLsmbRebLebRibLeLoLcLcbLsLgLsbRsRsmbLcbLsLsmbRibLgLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bLebRcbLcLsmbLibLgbLgLgbLeLsbLgLsLsLsLgmmbLeLsbRsRgRsmbReLsRsLsbRebRob
LeRsbRsLgLsLsLombLcbLeRsRsmbLebLcLsLsmmbLsLiLsLsmbLibLobLjbRobLiLsRcbL
gbRebRgLsbRibReLsRebRgRsmbRiRsmbLobLcbRcbRsRsmbRibLsLsRsRsRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bRebsbsbRibRgRsRsmmbRgbRgRsRsRsmmmbLsRsbLoLsmbRsbLhLsbRsbLsbLibLebLcbR
iRsmbLcLsmbRsbLeRsLsbRoRsmbRebLgbRiRsmbRiRsRsmmbLgbLcbLoLsLombLgbRebRj
bRoRsmbRgbLiLsbRcRsmbRsbRiLsbRebRsRsRsmmbRgbRsbRibRsRsmbLoLsmbLgbLcLob
LhbRjbRcbRgRsmbRibLebRsbRhRsmbReRsLsmbLebLgLsLsmbLgLsLsmbLsLsmbLsRsbsb
LebRgbRibRhbLgbRiLsbRsbRebRgbRibRiRsmbReRsmbRebRsRiRsmbRibLsbRsbsbRsbs
b

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsRsLembLcLsLsLcmmbRsbsbRcRgRsRsmmbLcbLcLsLsmmbReRcRebLibLcLsmbLobsbL
sLsRsmbLiLsbLcLgbLebLcbLsbLsbRsbRcLsbRcRcRsRsmmbRsRsmbRcRsmbReRsmbRcbL
sbRebLjbLgbLeLgbLsRsbRcRgbReRcLsbLsRsLsbRsbReRhbRcRiLsLsmbLebLeLcbLsbs
bRibReRsmbLcbLeLsbReRsRsRsmmmbLebLeRsbRgLgbLeLsbRgbLhLsLsLsmmbLeLsLeLs
bLeLsLsmbLeLgLsLsmbLsbReRsmbRcbRcRgRgRsRsmmbLcbLeRsbLsbsbRhbReRgRsRsmm
bRcReRsmbRsRsmbRsbRcRgbRsRsmbReRsmbLjbLeLsbsbsbLsbLeLsRsRsmbLgbRsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bsbRiRsmbRsbLebLgbLsbRjbRgbLebLebRebLebRibRjbLiLebRibRibRjbReRsLsmbRsb
RiRsmbLsRsbRcbLhLsLebRcbLgbRhRsRsmmbRcbLebLobRibRhbRiReRsmbRebRibRibRg
LsbReLiLsbRebRgbLsbRebRgRibRsbRsbRsbLebRcbRibRgbLsLsLeLsRsmbLsLsmbLgLs
bLiLsbRsRsmbRebRgbRgRsRsmmbLoRsbRjbLeLsRebRebLsLgbRgRsmbLeRebRebLsbReb
RiRsLsRgmbLebRcRsmbLebRcbLiLgbLeLcbLsLsLgmbLsRsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgRsmbLobRcRgRsmbLsRsbsbRiRiRsRiLsmbRhbLsbLoLsmbRoRgbRsRgbLjbLsLoLsRc
RombRebLgbRgRsRsRsmmmbLeRiLiLobReRsRsmmbLoLgLsLsmbLsbLsbRebLiRsbLcRsRo
bLebLcbRsbReRsRsRsmmmbLsbLsbLjbRsbRcRgLsbLsbRsLsbLoLiRobLeRsbReRcRsmbR
cbLcbRhRsmbLsbRgRsRgmbRgRsmbLcbRhbReLoRhLibRiRsmbLeLsLsRombRebLgbLcbLg
RsbRoRsmbReRsReLoRcRsmmbRcRsRoRsmmbLsbLcLsmbLobLeRibRsbRibLebRoRsmbLeL
obRgbRhRsRsLsmmbRgbLsbLoRobLjbRibRsRsRsmmbLjbLhbRsbRoRsmbLsbRgRsRsLcmm
bLsRjbRhRcLobRobLcLgLsbRsRgbLgLgbRjbLeLsLsmbRjbLoRoRiRhbLebRcRsRsRsRsm
mmmbLeRsLsbRcbRcLsReLoLsRoRiRsRsmmmbLcLsLsmmbRsbLsbRcbLeRsRcRsmbLjbRsb
RiRsRsLsLsLommmbRjbLsLsmbRcRsRsRsLsLsmmmmbLeRsbRgLsbLoRsbRhLgRoLsRcbLc
RoLoRsbReRsmbRgRsLgmbRebRsbLobLsRobRgLoLgLsRibLobLsbLgLsbLeLgLsRsbRsbR
cRgRsRsRsLsRsmmmbLoLsRsmbLsbsbRsbRcLsRcLsbRgbLjbRiRsRsmmbRiLsbLoRsRsRo
mbLcbRcRsRsRsRsmmmmbRsLsbRsbLgLcRcRsRsmmbLsbRgLsbRsbRsLsbLsbRsLcLoRcRe
Lsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbLeLebLebReRsmbLsbLgLsLsLeLsmbLsLhbLsLgRcbLiLeLsLsLsmmbRsRgbRibLiLs
LsLsmmbLsLsLsmmbLsLsmbLcLgbRcbRcRsmbRsRsRsRgLcmmbRsLeLsbLeLgbRsbRsLsRs
bLsbRgbRsbLiLebLcbLcbLsLebLeLsbLcbRebLcRsbLsLsmbRjbRsbRhbLgbLsbLeRiRsm
bRgRibLcLsmbLcbLeLsLsmbsbRebLgLcbLiLsbLsLibLgRsbLeLsbRcLgbLcbRsRibLibR
iLsbLcLgbLsbRcLsbLgbLcbLcbRibRibRiLsbLebLcbRibLebLebRebLcLgbLsLsLsLsLs
LsLsLsLgLsLsmmmmmmmmbReRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsRsLsRsRgRsRgRsmmmbRsRsRsRsmmmbRgRsRiRsmmbRibRibRsRsRimbRgbRsRsRsRsm
mmbRgbRsRgRsRsmmbRsRsmbRsRsRgmbRgRgbRsRsRiRsmmbRibRibRsRsRimbRsRsRsRgm
mbRibRsLsLsmbRibRgbRiRgbRgRsmbRiRsmbLsRibRsRibRiRsmbRjRsRsRsReRsmmmmbR
ibRiRsmbRsbRgbRsRibRgRgbRibRsRsRsLsmmbRgRsmbRsRgLsbRgRgRsmbRhReLsbLsbL
sLsmbLsLsLsLsLsLsmmmmmbLsLsmbLsbRsLsLsmbLeRebLibLebLsbLsbLsLsmbLebLeLs
bLiLsbLebLebLsLeLsbLgLsLgLsbLsLebLsLsmbLhbLiLibLsbLibLeLsbLsLibLsLsLsL
sLsLsmmmmmbLgLsbLibLsRsbLgbLebLsLgLgbLobLibRibReRcbRibRebLiLsbLebRjbLo
bLsbLgbRgbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bRebLeLibLsbLgLsLsLsmmbLgLebRgRgbLgbsbRsbRsbsbRgRsRsLsmmbLcLsLsLsRiRsm
mmmbRsRsRsLsLjmmbRsbRgbRgRiLsbRiLsRsLsbLjbLsbRhRsRsmmbsbRsLsRiRsmbRsRs
LcmbReLcbRcRsRsLsmmbsbLebRjLsbLiLcRsbRiRgbLsRsRsRsRgmmbLcbRiLsRsbRiRsR
sRsmmmbLsRebLsRsbLsRsRgbsbRsbLsLjbRsRsRsRsmmmbLsbLebRcRgLsRcLsbRiRgbLs
LsmbRsbRiRsRgRsmmbLsLcbLibRobLcLsmbReRsRhLsLcLsLcLsmmmbLgRsRgbLsbsbRsb
LhbLsbRsbRiLsbRiLgbLgbReRsRsmmbsbRsLcbRcRsRsmmbLcbRjbReRsRsRsmmmbLjbRi
bRsRsmbLcLsmbRsbLjbsbsbsbsbsbLsbsbLcRsRoRoRsRsmmbsbsbLjbRibRsRsRsLsLsR
smmmbLsbRgbLsbLibLjbRjbReRsRsRsLjmmmbLcbsbRsRsmbRcbRgbLsbLjbRjbRsRsLcR
smbLeRcRgbLjbRiRsRsRsmmmbLsRiRsmbLoLibLsbRjbReLebLeLibRoRsmbLgLsbLsRsL
sbRibLgbRsRsmbLibRcLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsRsRgRsRsmmmbRsRsRsRgmmbRsRgRgRsmbRgRsRgRsRsLsmmmbRsRsRsRsmmmbRsRsRg
RsRsmmmbRsRsRsmmbRsRibRsbRsRgbRsRsRsRsLsmmmbRsRsmbRsRsRsRsRsmmmmbRgRsm
bRgbRgbRgbRsRsmbRsRsRsmmbRsbRsRsRsRsmmmbRsbRsRsmbRsbRgbRsRsmbRsbRsbRsL
sRsbRsbRsLsbRsbLsbRsbRsRsmbRgLsbsbRsRsmbsbRsbRgLsbLsRsLobRsRsmbRsbRsbR
sbRsbRsRsLsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 152947; End: 153447;
Recording: 10-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bLcbLeLsLeLibLgLgLsbLsLsmbReRsLsmbRsRsRsRsmmmbLsRsRgbRsLsbLeLsbRcLsbLo
LgLsbLeLsLibLeLsLebLgbLsLebLgbLgbLgbLeLsRsLgbRibRiRsmbLeRsbRgRsRsLsmmb
RgbRgbRcbRsbLcLsLsLsLsLsLsLsLsmmmmmmmmbRjbReRgbRsbRsRsmbLibRcRjLsbLobL
hLsLeLhLibLiLsLsmbLebLoLgLsLsLsmmbLsLgLsbLsLsLsmmbLsLsmbRcbRiRsmbRiLcL
ebLebLeRsbRsLsbLgLsLsmbLiLcLcRsbLoLsmbLgbLsLhLgbLoLhRgRsmbRiRsmbLebRsb
RsRsmbRgLsbLobLebLobLsbLsbLiRsbLsRsbRgLobRsbLsbLgbLgLsRsLsLsmbLsRsbLgb
RcRsRsRsmmmbLcLsmbLiRsLsRsLiLsbLsLsmbLiLsbLcLgbReLsbRgRsmbLsRsRsmbLobR
cbRiLsLobLobLobRgRsmbRgRsmbLoLobLgLsbLiLsLgbLgLgbRcLgLcRsLjbLiRsbLsbLs
RebLsRjbRsbLoRibLsLsLiRcmbLoLibLiLsbLebLcLsLsmmbRhbRsbLgbRsbRcbRsbRgbR
gLebLhRsRsmbLsLsmbLcbLcRsbRibLibRsbLiLobRcbRebLibLgbLcbLebLhbLcbLeLsbL
sLgbReLsbRibsbLgLgbLhLgRsRgRsmbRsLsRgLsbLoLgLsLsLimbLgRsRjbRsbRgbRibLe
RsbRgbRibRsRsRsmmbRsbRsRsLeRsLsLsLsmmmbRgbLsLsmbRsRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 1; Drug: Control PTZ 2.5 mM
bLjbLcbLgbLsRsbRebLsbRgRsRsmmbRsRsmbLebRibLcbLebLsbLgbLebLebLebLeRsbLe
LhbLgbLebLgbLibRsbLgbLsRsbLiLsbLsLgLgbRcRsmbRgRebRebRsbRhbRiRsRsmmbRib
RebLsbLcbRgbLebLjLebRcbLcbLcbLebLeLsLsmbLgLibRsLsLsLsmmbLibReRhRsmbLeL
ebLebLsLgbRsRsRsmmbRiRiRsRsmmbLsLsmbRsbRjbRcLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 2; Drug: Control PTZ 2.5 mM
bLcbLebLhLsbLgbLgLsbLebRgbLeLcLsmbLeLgbLeLsbLgbLsbRcbLoRsbRsRsmbLebLeb
LgbRebLcbLebLebLobRcbLoLsmbLebLebLhbLsLgLgLsbRsLsLsLsmmbLgbLibLebLcLsL
smmbLcbRcbLebLebLebLgbLcbLcLsmbLibLebLebLibLebLcbLjbLebLsLsmbLcLsmbLsL
sLembLcbLsLsmbRsbRsLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 3; Drug: Control PTZ 2.5 mM
bRsLsbReRcbLiLsRebLsLsmbRsRsmbRsbLsLgbLsLgbRobRsReRsmbRsRsmbLsLcbRebRe
bRebRebRcbRoRsmbRibRsRsRsLsmmbLebRoRsmbRsRgRsRsRhLsmmbLhbRjbRoRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 4; Drug: Control PTZ 2.5 mM
bRsbReLcLsmbLgLsLsLgLeLsmbLebRebRsRebRobRibRsRsRsRsmmmbReLcbLcLsLeLemb
LeLsbLgRebLcLsmbRgbLeLsLeLebLeLsbLgRsbLeLsbLebLebLebLcRsbRsRcbRsRsLsRs
RsRsReRsmmmmbRoLsbRcbRsRebRiRgbLeLsbRibRebRcLsLsmbRsLebLsLsLgLsLsLgmmb
LiLsLsLgmbLsLib

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 5; Drug: Control PTZ 2.5 mM
bLgbReRsmbLebLcLgLhbLgLeLsbLgLsbLsLsLsRsmmbLsLsmbLsLebRsbRebLeLhbRibRs
RgbRgLeLsbLiLgLsbLsLsLsLsLsLimmmmbLgbLeLeLsbLebLiLsbLibLgbLgbLgbLebLcb
LsLgLgLsbLsLsLeLsmbLsLgLsbLgLebLsbRgRgbLcRsbRsbLcRsRcRebRsRsRgRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 6; Drug: Control PTZ 2.5 mM
bRibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bLebLobRibRhRsRsmmbRjLeLobLsLsLcLcmbRgRcbLsbRcLsLobRebRiRhLsbRebRobRsR
sRiRsRoRoRsmmmbRsRsRimbLsbReRcLoLobReRcRcRcRcLsbRsRcRsmbReRoRsmbRoRsRc
RsmmbRgRibRsRsLgLsLcmbLsRsbLsLsmbReLoLsmbLsRsRsmbRcLsLgLcRsbRsLeLsbLsb
LgRsLcReRebReRsmbRebRsRsRsRsmmmbRsRsRsLsLsmmmbRsbLcRsbReRhbRsRgRsmbLeL
sRsRcbRsLiLsLsLsmmbLsLeLiLobLsbRgbRcRsmbLgbLebLsLgbRsReRsRsmmbRsRiRcLs
bRebRiLsbRcRsRsLsmmbLsLsLsmmbRebRgLsLobRibRhLcbLebRgRsmbRcbRobRsRsRimb
RsLcbRobLobRsLcbLhLcbRebRsbRgbRsRgRiLsbRiRebRebRcbReRgRsmbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsLsbRsbRsLsbRsRsmbRsRsRsRsLsRsLsLsmmmmbLjbRsRsRiLgLembLsLsmbsbRsRsmb
sbLsbRsbsbLcbLebLcLcRibLsbLsbLsLsmbRsRcRebReRcbRcRebLhbRjbLcLsLgRsmbLc
bRibLcRsbLsbLcbRcbRsRsmbRgRsLsmbRsRsmbRcRebRobRsbLgbLjbRsbLcbLiLsLsLsm
mbLsLsRsmbLcLjbLcRsbLjbLjbRcbRcbLcbRsRsmbRsbsbRsLsbLcRcbRgRebRsbRsbRsb
RebLsLhbLeLsRsbLiLsLsRcLcLoLombLsRsLsLsmbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bRiRgbLebRsbLibRsLebLsLsRsmbLsbRebLjbLibLeRsbLeRsbRebLeRsbLeLhLsbLcbRe
LcbRebLibRibLgbRgRsmbLsbRjLcRsbLsbLeRcbLsbRsbRgbLibLjLebReRiLsRsbLsbLe
LsbRgbLsLsmbRebLebLsLcbLeRcbReRsmbRibLcbsbLeRsbLsbLjbLsLsmbLsbRiRibRsL
gbLebRobLebLsLsmbRgbRsbRgbRsbLebLebLiRsbLeLsbLeRiRsmbRiRsmbRiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeRoRsmbRsRsRsmmbRgRcRobReRsmbRgbRsLsbRsbRiRsLsmbLeLcbRhRcbLsbRsbRebR
cbLcLsmbLcbLgbLsbLebLobLoLsmbLsbLebRcRebRebReLeLsbReLsbRcbRgRsRcRoLgmb
LsbLsbLeLsbLcLebRsLsRsbRsLsbRsRsmbLebLgLsLeRgbRebRebRsbRiLgbReLobRsbRj
RibLgbRebRebRebRsRiRsmbReRsmbLsLsmbRsbLebLsLeRsLcbRcRsmbLobLebRgbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsRsReRgmbLibLgbRiRebRebRgbRcbLcLsmbLgbLsbLsbLcLsmbRoRsLsmbRgLsbLebRe
bLebLcLgbRgRsRgmbRsLsRsRsmbLjbLcbRcbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bLebLebLeLcLsLsmmbRsLsbLsRebLsLsmbRoLeLsRebRiRsRsRsmmmbRibLebRsbReRsmb
LsbLjbLeRsRcLsbRgLsbRsbRebLoLsmbRcRgbRebRgRsRembLcbLeRcbRhbLebRsbLjbLh
bRsLsbRebRiRgbRsRsRsmmbRebLcLsmbLgbRgbReRsLcLsLsmmmbRebLoLebLeLsLsLsmm
bLsLsLsRsRsLsmmmbRjbLsbsbRsbRsbLcLsmbLeLsbLeLsLoLsLsmmbLebLeLsbLgbRsbR
eRoRsmbLeRobRibRcbLjbLebLsbRjbRcbRsRgRgbRsRebReRsRsmmbRiRgRsmbRcbLsbLj
bLgbLcLsmbLsRsbRgbLsbLeLsbRsbLeLcbRebRjbRcbRcbLcLsmbLcRsbRebLibReRoRsR
cRsmmbRsRsmbReRsLsmbLcbRcLsRsbLjbRgRgRsRcRsRsmmmbLjLsmbLsbLgbLsbReRcbL
sbsbLeLsbRhbLsbLebLcLcLcRsbRjbLeLsbLsbLebRcRsmbLeRsRobRcbLsLsmbRebRsLs
bLsbLeRsbLcRsbRsRsmbsbReRgLsLobsbRiRsRsmmbRcbLjbLiRsbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsRsRgRsRsmmmbRibRsRgRsRsmmbRgRsmbRgRsmbRgbRiRsRsmmbRgRsLsmbRgRsRsRsR
smmmmbRgbRgRsmbRiLsbRgbRibRsbRiRsRsRsRsmmmmbRgRsmbRgRsmbRibRsRgRsRsmmb
RgbRibRsRsRsRsRgmmmbLsRgbRiRsmbRgRsmbRsbRsRgbLsRsRgbRgRsLsmbRgRsmbRibL
sRiRsmbLsRsRgRgbLsRgbRsRgRsmbRgbRgRsRsmmbLsbLsbRibLsbRgbRgbRsbRsRgRsmb
RsRibRsRgRgRsmbLsRiRsmbRgRsmbRgbRsRgLsbLsRsRsmbRsRsRsmmbRiRsmbRsRibRsb
RsbRsRsRgRgmbLsRsRhbLsLsmbRsbRsRgLsbRsRgbRsbRsRsmbRsbLibRobRgLsbRiRsmb
RibLsRcbLibRgRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bRibRobRobRiRgbLoLsRgmbRsbReRsmbLeRsRgbRjRsRsRsmmmbRebLeLsbLsbReRobRcR
smbRcReLsbLgbLhRsLsbLcLcbReRoLsbRebLjbLgbRobRebLiRsLebRebRgRgLgbLoLobR
sbRiRgbsbLsbLsbsbRsbRsLsbLsRsLsRsLsRsbRsbRgbRhLgLsbLoLcbLhbReRsmbRebLs
LsmbRcRebLoLsmbRiReRsmbLgRcRsRsmmbRsLsbLiLiRsbRsbRcLsbRgRsmbRobLsRsRsR
smmbRiRcbLeRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgbRgbRebRgbLeLgLsLsmbLibLgLebLsLcLsRsmbLsLeRcRiRobLeRgRsRsmmbRgRgRsR
sRsRsRsmmmmmbRiRcbLeLsLgbLgRsbRebRibRgbRcbRgbRebRsRsmbReLgLeLsLeLiLsLs
mbLebRibLcbLjbLiLgbRhbRebReRcRebRgbRhRgRsRgRgmbRiRsmbRgbRhRsmbLibLeRsb
RcLeLgRsbLibLibReLsbReRibRgRsmbLeLsbRsbLgLgLsRsbsbsbsbLsRsbRsRsmbLsbRs
bLsRsbRsbLeLsRcbRsbReLsbLsbRsLsbLebRsRsmbLgbsbLsbRsbLebsbLgbLiLhLsbRsb
LibLebLsbLebReRcRsmbRibLsLsRsmbLsbRiRsRsLsmmbRsRgRsmbLeLsLsmbReRcbLsbL
sbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bLgbLibRsLgbLsbLgbLeRsbLsbRsbRgbReRsmbRebRcbRibsbLjbRgbLsbRgbRsbRibReR
gbRibRebLsbLeLsbsbsbRsbLiLsbLsbLsbLsbLeLsbLsLsRsmbRsbRsLsLsmbLsLsRsLsm
bsbLsLsmbRsLsbRsbLsbLgbRcRsRsRsmmmbLebLcLsLsLsmmmbLgRsReRsmbRsLebLsLsm
bLsbLiLgLsbRebLebRcRsRsmmbReRsLoRsLsmbLeRsRcbLjbLgbLcbLiLibLibLgbRebsb
sbRcbReLgbRhbRgbRiRsmbLeRsLsbRgLgRcRibRobLoRebLebLebLebLeLsLebRobLebLe
LebRebRebRebRgRebRebRebRsRgRcbReRsmbRgbLgLebRob

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgbRcbLeLsLsmbRcbLsbLgbLebRobRebRebLoRsbRsLobLebLiRsbRobRcbRebLebLgbR
sbLjbRibLobLebLhLgLibRsRobRibLebLgRsbLgbRcbLeLcbLsbLsbLsLsRsmbLgLsbRgb
RcLsbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bRiRsmbsbRsbRsLsbRsbsbLcbRcReRcRobsbRsbLgLoLoRgLobLsbLsRsbLgLgbLcReReb
RibRgbRsbRsbsbLiLsLsmbRgLsbLsbRsLsbsbLsLgLsbLiLsbLibRgbLcLobRcbRgRiRsL
cmbLebLibLebLiLebLgbLgbLsLsLsmmbRjbLsbLiLgbRgRsmbLgbLsRsbLcRsbRgbsbReb
RiRsmbRibLsbRebRhbRibRsbRibRjbLobLgbLeLsbLebRebLoRsRcRsRsmmbRebRiRsmbR
sRsmbRebRgRsRsmmbLgRsbReLsRobRhbReLcLebLebLobLgLsbsbLibLcRebReRsRsmmbR
ebReRgbRibRgRebReRsmbRgRsRgRsmmbLibRsbLibLibLebLibLcLsmbLgLiLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsRsRsLsRsRsmmmbLsRgRsRsRsmmmbRgbRiRsRsRsmmmbRsRsmbRgRsmbLgbLgRsbRsbR
sbRsbRsRiRsLsLsLsmmmbLgbLebLsbRsbLsRgRsmbLsRsRsRsRgmmbRsRgRsmbRsRsRsLs
RsRsmmmbRsRsRsRsRsRsmmmmmbRsbRsbRgbRoRsmbRjbRgRsRsmmbLsLsLsmmbLsLsLsRs
mmbLsbsbLsLsLsLsmmmbLsLsRsLsRsLsLsmmbLsbsbsbLsLsLsmmbLsRsLsLsmbLsLsLsL
gLgLsLiRsmmbLsLsLsLgmmbLsLsmbLgLgLsLsLsLsmmmbLgbLgbLsbLsLsRsLsRsmbLsLs
RsmbLsbLsLsmbLgbLsLsLsmmbLsbLsbLsbLsLsLsLsLsmmmmbLgLgLsLgLiLgLsLiRsLsb
LsLsLsLgLsLsmmmbLgbLsLsLsRsmmbLsLsLsLsLsLsmmmmmbsbLsbLsLsLsLsLsLsLsLsR
sLsmmmmmmmbLgLiRsLsLsLsLsLsRsLsmmmmbLgLsLsLsmmbLsLsLgLgRsLsLsmmbLgLsbL
sRsLsbLsLsLsmmbLgLsbLgbLsLsmbLsbLgLsLsLsRsLsmmbLsLsmbLsLsmbLsRsLsRsRsm
bLsLsmbLsLsLsmmbsbLsLsmbLsLsLsRsRsLsmmmbLsbLsLsmbLsLsmbLgLsLsmbLsLsmbL
gLsLsLgLsLsLsLsmmmmbsbsbLsRsbLsLsmbLsRjbLsbLsbLsRsbLsbsbLgbLsbLsLsmbLs
LsLiLgmbLiLsRsLsRsbLgbLgLgbLsLsLsLsLsmmmmbLsLgbLgbLsLsLsLsmmmbLsLsLgLs
LsmmbRsbLsLsLsLsRsLsmmmbLsLsRsmbLsLsLsmmbLsLsmbRsLgbLiRsbLsLsLgLsLsLsm
mmbLgLsLgRsbRsbLgLgLsLsLsmmbLsbLsbLsRsLsbLsLsLsLsLsLsLsmmmmmmbLgbLsLsm
bLsLsLsmmbLsLsLsmmbRgbRgLibLgLsRsLsbLsLibRsLsLsLgLsLgmbLsLsmbLsbsbRibL
gbLsLsLsmmbLgLsLsLsLsLsLgLsLsLsRsmmmmmmbLsbLsLsLgLsLsLsmmmbLsLsmbLsLsL
sLsmmmbLiLsLgLsRsbLsLsLsRsRsmmmbLsLsmbLsbLgLsLsmbRsLsLsmbLsLsLgLsLsRsR
smmmbLsLsLsmmbLsbLgLgbRibRsRcReLcbLsLsmbLgbLgLsLsLsmmbLsRsLsbLiRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsLsRsbRjbLeRsbRcRsmbLeLsRsbRgbReReLsLsmbLeLsbLeLsLsmbLsbRjbLgbReRsRi
RsmmbRgRsmbRgbReLgbLsbLebRebLiLcRsbReRsmbRgbRsRsLsLsmmbLeLsLsmbLsbRebL
cLsmbRgbLeLsbRibLiRjbLsbRsRebsbRibLsbLibReRgLsLcbLgbReLeLobLgbLhbLiLcL
sRcRgRsmmbLgbRiRsmbRibRiRsmbRgRsmbRhLcLsLimbLsLsmbLsbLgRsRsmbLsbRcRsRs
RsLjmmmbLsbLiLoLsmbReRgRsRsmmbRsLsbReRsRsmmbLgLsRsLsRsRsmbLjbLibLgbRsR
sRgLsmbReLsLsmbsbLcLsmbRgbRcRsRsmmbReLcRcRsRsmmbLcbLiLgLsbRgRsRsRemmbL
jbLsLsmbLsLiRsLsbsbLsLsLsLsLsLgmmmmbLiLsLsmbLeLsbLsLsmbsbsbLsRsbsbRsRj
bRsbRgRsRsmmbLsbRhReRcLsbLeLsLgbRgLgLsbLgbLsbRsRsmbLsbLsRsbRsbRsLsRsLs
bRsRsRsmmbsbsbRsbLsLgRsbRjbLjbRcRsRsmmbLcLsLsmmbLsRsLsbRebLgbRjbLebLsR
ibRsbReRsLsmbRsLsbsbLjbRgbRcRsRsRsmmmbRjLcbLebRsLsbLibLgLsbRgbReRsmbLs
LsmbLeLsbRebLsbRgbLjbReRsRsmmbRcRsRsmmbLsbRsbLibRcbRsbRsLsbRibLcLsLsLs
LsmmmmbRsbRcRsRiRsRsmmmbLjbLjLsmbRsLiLsLsLsLgmmbRgbRsbLeLsbLoLsLsLsmmm
bRsbRiRsmbLgbLeLsLsmbLeLsLcRsRsmbRsbRcRsLsRsmbsbRcRsLjmbLcRsLsLsmbRsbL
sbRibReRsRsmmbLjbLjbLebLsLsRimbReRsRsRsmmmbLgbsbLeLsLsLsmmbsbsbRsRsRsm
mbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bLeLsLsmbsbLsLsLsmmbLsbLgbLgbLgbReLsbLsbRsbRsbsbLsRsbLcbsbRsbsbsbRsbRs
LsLebRgbLgbRebsbsbRsbLsLcbRgbReRibRibLsLsmbLsLsmbLgbRcbsbLgbLobRcbsbsb
sbLcbReRsmbRgbRcbLjbLcbRcbRibLcbLsbLgbLgLgLsbLsRsbRiLsRsRobLoLgbLebReb
RibRgbRsbLebRsLcLsRsmbLebRcRsmbLsbsbLjbLgbRobRebRgbLsbLsbLebReRsmbRsRs
mbsbsbRsRsLsmbLjbLibLsbLibLiLsLcLsmbLeLsbRebRibRcRgRsmbRiLsbRsbLsbRsbL
gbLjbRiLobLebLiLsLsLgmbRgbRibLgbLgbLsLsmbLsLcbLsbLsbLebRibRgbLcbRsbLgb
RsbLcLsmbLibRcbLhbLebRoRsmbRhbRsbRibLsbRcbLjbLjbLsbLgbRibRsLsbRjbLsbLo
LibLebLgbLgbLebRgbLebLsbLsbRcbLgLsbLibRebLebRsRcbsbRsbRsbRsbLsbRibLebR
oRsmbLebRebRgbLebLgbLgbsbLsbLsbLsbLebLsLsmbRjLcbRebLiLiLsbLibLgRsbRsbL
sbRebRsbLsbRsLebLgbRhRsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbsbRebLsLoLsLsLgLsLsmmmbLoLsLgLsmbLeRsbLibLiLjbRsbLibRoLsbLebLiRoLs
LcLsmbLeLsbLebRobRoLsbLgRsbLcLgbLiRsbLoRsRsLombLgLsbLibRgLsbRcRsRembLc
LsmbLsLsmbLoLsmbsbLsbLibLsbLsLhLgbLoRsbRcRsmbLsLebLsLebLobLiLsbRobLibL
eRgbLibLoLsmbLhLsbLiLoRsRsmbLjbLoRebRsbLsbRhbLsLsmbRobLebLibLeLsRsbLsb
LsbRgRoLsRebRibLcbLibLgLiLsLibLebLobRebLcLjbRiLiLsReLsbLgbRebLoRsLgbRc
RgbLgbLjbRsbLcbLgbRgLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bRhLgbLibRcRsmbRibRsRsmbRcbRsbReRsmbReRebRebRiRsmbRibReRsmbReRsmbRiRsm
bRsbRcbRgRsmbReRebRebReRgRsRsRsmmmbRebRebRsRibReRsmbLsbRcRsmbRsReRsmbR
ebRebRebRebRsbRsRsmbReRsRsmmbReRsmbReRsRsmmbReRsRsmmbRsReRebReReReRsmb
RebRsbRsbRhbRebRiReRsmbLgbRebRgbRebLebLiLsbLsLsmbRsLsLsRsmbLibRebLibRe
bReRsmbRibRsbRebLebsbLgbLsbsbsbsbRjbRcbLsbLgbLhbRsbLiRsbLibLsbRsbRcLsb
RiLsLcbLcLgbLgbLhRcbRgbRsbRgbRsRibRcRsRembRebRebLebLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbLsRsbLibLebRibLsbLeRsRebLiLsbLsbLhbRhbLebLebLeLsbLsbsbRebLgLsbLsbL
sLsRsmbsbsbLsbLsLsmbsbLsLsRsRsmmbsbsbLsLsmbRsRsmbLsRsbLsLsmbLsbLsLebRe
bRsLsbLiLsbRcbReLsbLhbLcRsLgbLsLsmbRsbRgLsRoLsLobLgbRobRiLsLoRsbLjbLgb
RcbLhbLobLgbLiLsbsbsbRoLsRgbLcLsLsmmbRjbRgRsmbLsLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 25; Drug: Control PTZ 2.5 mM
bRebRsReReRsRsmmbRebRgRebRebRibRsRebRsRsmbRsRsRcLsmbRebRsRgbRsRebLibLe
bLebLebLebLsLgbLsLsmbLhbLebLeRsbLsRsbRebLsRebRebLsbRsLsbRiRcbLsLebLeLc
bRebRiLsbLsLcLebLgLebLgLebLsLsLsmmbReRsmbLeLsbLebLeReRsRsmmbRebLeLsLsL
smmbLeLsbLsLebLsLeLsLsmbLsLebLsLsRsLsmbLsLebLeLebRoRsmbRsbRibRgbRsRgbR
sbRsRsRsLsmmbRsRibLsbRsRsRsmmbRcbRsLeLcbRgLebLoLsmbLebLhbLibRsbReRgbRs
RsRsLsmmbRsRsRsmmbRsRsRsRsmmmbRsRsRsmmbRsRsmbRsRgRsmbRgbRsRsRsmmbLsRgR
sRsRsmmmbRsRsRsmmbLsRsReRgbLsLeLsbLebLebLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 26; Drug: Control PTZ 2.5 mM
bRebLgRebRibRiRsmbRebReRsmbRobLhbReRsmbRebRebRebRcbRebRiRsmbReRsmbLebL
ebLebLeLsbLibLgRsbRjbRobRebRsbRebRebRgLjbLgbLobRcRsRsmmbLhLsLsmbLiLsbL
ebRebRebRiRsmbRebLgbLebLsLsLsmmbLsbLsbLsbRobRcLsbRsbRhRobRcbReRsmbRiRs
mbReRsmbRiRsmbLsLebLeLsbLibLiLsbLiLsbLeLsbLiLhLsbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 27; Drug: Control PTZ 2.5 mM
bLeLsRebReLoLsmbLebLsbLoRjLeLsbLsReRsmbRebRsbLgRsbLgLeLsbLsLsmbRibRebR
ibsbRsbRiReRsmbReRsmbReRsmbRgbRsRsRsmmbLeRcbRsReRsRsmmbRsRsmbRsbLsbRsL
sbRsbLsbLeLsbRcLsbLsLsLsLsLeLsmmmbLsLsLeLsmbLgLsLibLsRiRsmbLsbRsLeReRs
mbReRgbRsReRiRoLgLsLgLsLeLsbLcbLgLgbRcRsRsRsmmmbRibRcbRiRoRcbRhbRsRgbR
iLebLsbLcRsRcbRsReRhbLebLobRgbRsbRcRcRcLsbRibReRsRsRimmbRebRebLsbLgbRc
bRgRibRebLsbRiRsRsmmbRgbRsRibRsRsmbsbRsbRsbsbsbsbRibLeLiRsbLeRcRsmbReR
smbRsRsRsRsmmmbReLsLsLsmmbLeRebRoRgLsbRsRsRsmmbLjbLeLsLeRebRgbLsRsLsbL
cLsLsmmbLsbLsbsbRjbLsbRcbsbRebRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 28; Drug: Control PTZ 2.5 mM
bLhLsbLgbRgbRsbRobRsbLiLsbLsLsLgLsLsLsmmmbLsLgLsLsmbLsLsmbRsbsbLgRsbRe
LsbRsbRsRsRsRgmmbRgRgbReRsmbLsRsbRsRsRsmmbLhLgLsLsmbLiLgbLiLsbLiLsbLgL
sbLibLeLsLebLibLsbsbLsRcbRebRjbRgbRgRsmbRsbRebRgbLsbRsbRsRsmbRsRibRgbR
ebRebRebLeRsbLsLgbLoLsmbRsLsLsmbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 29; Drug: Control PTZ 2.5 mM
bRsbLcbReRebLgRsbLgbRhbRebRebRsbRcbLobLebRoRsRembRcbLsRsLsbRgRsRsRsmmm
bRsRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 30; Drug: Control PTZ 2.5 mM
bRebRgbRsRsmbLcLebRibRebRsReRebRebRebLsbRsLsbLcbLgLsRsbLsLcbLgReReRebR
sbRibRsRsRsmmbRsRsmbLeLsbLeLcLebLeLsLsmbRcbRgRsmbRhbRsRebRebRebRibRgRs
mbRsRsRsRsRsRemmmmbReLsbRsRibRgRsRsmmbRsRebLgLsbLsLsmbLsRsbRebLsbRebRs
bLibRebReRhbRebRebRebRiRsmbRibRgRgbsbRsRsmbRebReLsbLeLsbLgLsbLebLgbLsb
LsbRsbLsRgbReRsmbRgbRebLebLcbReRsmbsbLiLsbRsLcbRsbLobLhbLsRsLsbLgbLcbR
gRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeLeLgLibLsLhLgLsLsLsLsLsmmmmbLebLeLgLsLibLsRsRobRiRgRebRhRsRgmbRgRsm
bRsRsRsRgRhLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsLsLgLsLsLsmmmbLgbLsLsmbLsLsLsLsmmmbLgLsLgLsbLsRibRcbRsRsRsRsRsRsRsm
mmmmmbLhbLebLcbLcLsmbLsLsLiLsmbLebLgLsLsmbRobRebRgbLeLgbLebLiLgbLeLeRs
bRsLsLsmbLsLsRombLsLsLsLsLsmmmmbLsLgLsbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bRcbRhLsbLsLebLeLsRsbLgbRcLsbRsbRsRgbLgLsLsLsLsLsmmmmbRgRgbLsbRsbsbReb
LhLcbRjbLsLsRsLsLsLsLgmmmbLebRsLsbLoLsLsmmbLgbRebRsRgRsmbReLcLsRsmbLcb
LebReRsRcmbLgRsbLgbLsbLcLsmbLsLsLgmbLeLebLgLsbLsLgLsbLsLgbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bRiRgReLcbLgLsbLgbLgLcbLcbLgbLiRsbRsRebRgRsRsRcmmbRsLsbReRsmbRcbLebLsL
sLsLiLgmmbLsLhbLsLsLimbLsLsLsLsLiLsmmmbLsLeLsbLsLsLgLsmbLsLeRcRebLebLg
bLebLebLibLebLebLeLsbLiLsbLhLgbLibLsLsLgLsmbRcbLcbLcLsLsmmbLgLsbLibLcR
sbRebRsbRebRebLebLsLgLsLsmbLsLgbLcbLsRebLsbRebRjRsmbRsRsRgRiRsmmbRgRsR
smmbRebRcbReRiRjbRebLcbLebLebLsLsmbRebRcbLsLebLibLiLebLsLsLgLsLiLsmbLg
LsbLiLsbLgLsLsLimbLgbLsLsLsLsmmmbLsLsLsLiRsmmbRcbLcbLsLebLibLebLobRebL
sbRebRebRebLgbRjbLcLsRsmbLsLsLsLsLemmmbRsRsmbRcbLebLgbLsLsLsLemmbRiLsb
ReRsmbRebRsLsLgRsbLsbLhLsLgRcRsmbReRsmbReRcbReRsReRgRsRgmmbRsReRsRiRem
bsbsbLsRgReRsmbReRsmbReLsbRiRsmbLhbLhbRsRcRgbReRgRiRsRsRsmmmbRsRib

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsLsbsbsbLgRsbRjbRsbRgLebRcbRiRsmbReRobLsLsLsLsmmmbLsLsLsLsmmmbRsLsRs
bRcbLiLcbLsLsmbLsLsmbLsbLsLsLcRsmbRsRcbRsRsRsmmbRebRgRsRsRemmbRsRgbsbs
bRsRsRsRiRcmmbRsbRiLsbLsLsmbReLsRcRsmbRsRsmbRsRsRsRhmmbRibRsRsLsLsmmbs
bLebsbRcbRiLsbRsRsRsmmbsbLsbLsRsLsbLsbsbRgLeLsbLgbRjbLcbRsbRobLoLcbRgR
sRsRsRsRsmmmmmbRsRgRsmbRcLsRoRobRiRsmbRsRsRsmmbRibLjbLgRgbLsbLsLsLsmmb
LebLsbLgbRjbLsLgbLebRebLgLsbRsRsmbRgbLeLgRsbLgLgRsRsmbLgRsLsbRiLsRsRsm
bsbRoRsRsRsmmmbRoLgbLsRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsLcbLibReLsLoLcbLeRoRsmbRsRoLsbLcLsRcmbReRsRsRsmmmbRsRsRsLjRemmbRgLo
bLiRsbLgbLjbLobLgLsRsbRsbLobLebRoLsbRsbLcLsmbLgbLsbsbLibRoLcbLsbRebLgb
RibRsLobRcbLsbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsLgbRsRsmbLjbLhbLgbLiLsbLebReRsmbRibRcRsmbLeLcbLibLgLsbRgRsRsLsmmbRg
LsbLgbLcbLibLgbLhbRibRgLsbReLsbLebRgbReRcbLsLebLiLsbLebRobLsLsRsmbLibL
gbRgbRjbRiRsmbLjbLcLsmbRibRjbLcbLsbLsbLsbLgbLebLgbLeLcbReRsmbRebLgbRiR
sRsmmbReRsmbLeLsbLgRgRsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bsbLiLsRsRoRoLsRoRsRsRsRsmmmmbRcLsbLoLsLcmbLcbRjbLsLsLsLgmmbLcLoRcbRib
RsRgRsRgRsmmbRsbRiLsbRsbRgRgRsRsmmbLsbRebLgLgLsbRobLsLsmbLcLgLsbRsbLsb
LiLcbLiLiRsbRhLsbLsRcbsbLgLsLsmbLsLsRsmbsbsbsbsbRcbLjLhLhRsLoLsLcmbRjb
LsLsLgLsLsLsmmmbRgbRebRsLsbLsRsRcLcLsmbLsLsLgmbLsLsmbLgLsLsmbRgLoLsLsm
mbRgbRobRcbRsbLsRsbsbsbRjbLibRsRobLebLebRgbRcRgRsRsmmbReLsbLjbLeLsbRsL
gLeRcbLeLiLsLsLsmmbRjbLsLsmbLsbLgLsbLiLgbLeLsbRiReLgbRgbLgbLeRcRsRgmbR
gRsLsmbRgLsLgbLsbLsbsbRgLsLsmbsbRibRob

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcRsRobRgbRsbLcLgLsbLgbLsLgbLgLsbLiLsbRsLsLsLsLsLsmmmmbLsLoRsRsLgLgLc
LsLsmmmbLibLgLgbLobLoRibLgRsRebRhbRobRsRsRsRsmmmbRibRebLsLsLsmmbRoLsRg
bLsRgLebLgRsLebRsLsLsLsmmbLsLeLgLsLsmbLjbRsLsbLgLsLsmbLgLgbRgbRebLcRcR
sRsmmbRibRsRibRgRsRsmmbRiRoLgRgbRgbReRgRsRgmbRhbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bRhRsRsmmbLsbRgRsRsmmbRsbsbLsbRsLsbLsLsLsmmbsbsbsbsbsbRiLeRsbLeLsbLgLs
RsbLibLgLsLsmbLgbLgLsLsmbLeLsbRsRsRcRsmmbRgbReRgRsRgmbRgbRiRsmbRgbRjbL
iLcLebRgReRsmbRgbLsbLsLsLgRsmbsbsbsbsbsbsbsbsbLsbLhLsbRjbRsRcbRcRsmbLe
bLjbLcLobRsRcbRjbRiRsmbRiRgbRobLgbLgLgbRebLibLcbLgbRibLeRsbLsbsbLsbLiL
sbLsLsmbLgLobLobLsbReRgbRiRgRsmbRibRiLsbRgRgbRgbRiRsmbRiRsRsmmbRgRsRsm
mbRhLoRsbRebRibRgRibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bLjbLeLoLsmbLsbLcbLgbRibRsbRcRiRsmbLoLeRsbReRsmbReRsRsLsmmbRgbReRcbReR
sRsmmbRcbLsRsbReRsRsmmbReRsRsmmbRebLgbLibLsLsLsRsRsmmmbsbRcbRgLsbRebLc
LsmbLebLgLsbLeLsbLeLsbLcLeLsbLebRsbRcbRgRsRsLgmmbRsbRebRibLeLsbLcbRebR
eRsmbReRgRsmbRcRsRsmmbRcRsmbLgbLsbLhRsRsmbLebsbRsbLsbLeRsRsmbRsLsLsLsm
mbLeLsLcLsmbLgbLsbLebLeRsbLsRsbRsbRsbsbsbReRsmbLiLgLgLsLsmbRjbReLsbLeb
ReRsmbReRgbLebLiRsRgbRibRiRgRsRsmmbLcbRjbRsLsRsbRebReLsLsmbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bLgbLsbLgRsbRcRsmbLsbLsbRsLsbRsbLebLibRjbRcRsmbRiRsmbLcbLsLgbLgLsbReRs
mbLsbLjbRebLsRiRsmbRgLcLoLsLsmmbRebRgbLcLgbLgLsbRjRjbRebRsRsRsRsmmmbRs
RiRsmbRsRsRsmmbRibLgbRgbRcLsbRibRhRsRsLcmmbLsRsbLiLsRsbLeLebLgRobRsRob
LeReRsmbRibLjbRiRsmbRsbRjbRgbLibRjbLobLsbLsLsRsLsmbRcbRsbLiLibLibLeLcL
smbRsbRcRsmbRsLsbLjbLjbLsLgLgLsbLsLsRembRsbRsbRsbRsbRjbRsRsRsmmbRgbLgb
LebLsLsmbLgbRoRsRgmbRibRhRsRsRemmbRiRgRsLsmbRgbLeLebRgbRhbRsRsRsmmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bRiRsLsmbRsbLgLcLoRsRoLsbRcRibLobRebRebRebReReRsmbRiRsmbRiRgRsRsmmbRiR
smbRsLsbReLsLsmbRiLsbRsbRsbRcRsmbRsbLoLsmbRebReLsRsbReLsLsmbsbsbLsbsbs
bRiRsmbLsRsRsmbLsbLcLsLsLsmmmbRjbRhRsRsmmbRgbLobRsReRsmbLsbLebRcbRsbRs
bRsbReRobRhbRoRcLoRcbRsbLsbLsbRcLobLsLobsbReRgRsmbLsLsmbLoLobRobRsbLgb
RsbLgbLcLsRombRsbRsbRsbLsbRsRsRsRsRgRgmmmbReRsRimbLeLsLsmbRsbRgbRcRsRo
LgLoRombLjbLebsbLsLsmbRsbLoLgRiRhLsbLsLeLsLsmbLsLsRsRsLsLeRsRsmmmbRsRs
LgmbRgbLgLsbRsbRcbLoLebRcbLsRsRsRsmmbLsbRiRsmbReRsRsmmbRiLsLsmbLcbLiLi
LsLobRcbReRoRoRcRiRsmbLibLcLoRsRsmbRiRsmbRsbRebLebRjbRcRsRgRsLsmmbRsbL
cbRsbLsbRjbLcLoRoLsbLcbLeRsLsbLiRsbRibRgRsmbRgLsLsmbLjLhbLsLsmbRjbLcLs
RsmbRcbsbsbsbReRoRoRsmbsbRsLsLsmbLsLjbLgbRjbLiLsbRsbRcRgLsbLcLcRobsbsb
LsbLsbLhLsbRjbsbRgRsLcLoRcRsRsRsmmmmbRsbLeLsbLoLsmbRgbLcRsbRcRsmbRiLsb
LeLgLsLoLoRcRsmbRiRsRsmmbLgLsbLebLeRcbRgbLsbRgLsRsLsbRgLsbRgRsmbLcRsbR
cLsbsbsbsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bLeLsLsRcmbsbLgLcRsbLsLcLsLsLemmbLcLeLsRsbRsLeLsbLiLsLhbLgbLsRsLsLsLsL
sLsmmmmbLgLgReLgLeLsbLiLsLsLgLsLsLsmmmbLsLeLsLsLsmmbRibRebLsLsLsmmbLcR
sbLeLeLsbRgRsRsmmbReRsmbRiLoLcLsReRsRsRcmmmbLgLeLsbLsRsLeLsbRsLibLoLsm
bRibRsbLeReLsbsbLiRsbRebLeLsLgLsbLcbLsLsRsmbRebRsLsbRcRsLsmbLeLebReLgL
sbLsLebLsbRcRsRsmmbLeLcbRebLsRsbReRsRsmmbLoLsLsRommbRcRcbLgRhRcLsbRcbL
cLgLsLsRembRebLoRoRsRembLebRcLgLeRiLsbLgbLeRsLsbLsbLeRgReLsbLsLsLeRsmb
LsRsLsLsmbRsbRiLsbRsbLsLebLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bsbLsLsLsLgmmbLgLgbLsLsmbLsLsmbLsLsLsLsmmmbLgbLsbLsLsLgmbLgLsLsmbLsLsm
bLsLsLsLgLsLsRsmmmbLsLsmbLsLsLsmmbLgbLsbLgbLgLsbLgbRsLsLsmbLgbLsLsmbLs
LsLsLsmmmbRsLsLsLsmmbLsLsLsLgLsmmbLgbLsRsbLgbLgLsbLsLsmbLgbLgbLsLsmbLs
bLgLsbLibLsLsmbLsLsmbLsRsbLsLgLsLsmbLgLsbLsLsmbLsLsmbLsLgbLgbLgbLgbLgL
sLsLsLsmmmbLsLsmbLsLibLgLsbRsLsLgbLsLsmbLsLgLsLsmbLsLgLsLsmbLgbLgbLsbL
gbLsLsmbLgbLgbLsLsLsmmbRsLsLsLsLsRsmmmbLebLgRsbLsLgbLsLsLgmbLgbLibLsbL
sLsmbLgLsbLsLsLsmmbLgbLsLsLsmmbLhbLgbLgbLiLgbLiLsbLebLibLsLiLsbLebLgbL
ibLgbLsLsLembLeLsbLsbLhbLibLibLgLsbLsLsLgmbLgLsbLsbLgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bLeLcRsRibRiRsRsmmbRsbsbRsbsbsbRsbLsLsRsmbRsLsbLsRsbRsLsRsLsRsbLsRsLsb
LsbLsRsbRgbRsbRhbsbRsbsbsbLjbRsbLjbRebLjbLsLcbRibRcLcbLiLobLsLsmbReRsm
bLsRsRsRsmmbLsLgRgRsRsmmbLobRcbRsLsRsRsRsLgRsmmbLsbLhbRjRgbRibLjbRgLjb
LcbLgbLobsbRibRiRsLcLsLcmmbLcLebLgRsbLsLsLsmmbsbsbsbsbRiRsmbRebRsLsRiL
cLcbRsLcbLsLsRsRjmbRsbsbsbRsbRsbRsbRsbRsRgLibRgbLsRsbsbReRsmbLsbLgbLjb
ReLeLoLeLeRgReRsmbRsbLjbsbLsbRiRsmbLhRsbReRsmbsbRsbLsbsbLjbRsbRsbRsRgR
sRsRsmmmbLeLsRgbLsbRsbRsbRsbRsbRiRsRsmmbLsbRgbsbLsbLsbRgRsLeLhLcmbLibR
ibRgbLsbRiRsmbRsLsRsbLjbRsRsmbRsLcRhRsmbRgLsLsmbLcbsbRgRhbLjbRiRsmbLjb
RhbLsLcbRgbRcRsRsmmbLjbRgbRiLsbRobLjbLsRgRsmbLcbRgbRsbLsbRobRebRsRsRsR
sLoLsmmmmbRcbLjbRsRgbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsRsRsRsRsRhmmmmbLsLsLsRsmmbRsRsLsmbRsRsRgRsRsRsmmmmbLsRsRsmbRsRsmbRs
RsRsmmbRsbRgbRsbRsRsRsmmbRsbRsRsRsmmbLsbRsRgRsRsmmbRgbRsbRsRsmbRsRsmbR
sRsmbRsRsRsmmbRsbRsRsRsmmbRsbRsbRgbRsRsmbRsbRsRsLsmbRsRgbRsbRsbRsRsRsR
smmmbRgbRgbRsRsLsmbRsRgbRsRibLhbLobLobRsRsRiLsmbLsLsRsRsRsRsRimmmmbRsb
RgRsmbRsRsmbRgbRsRgbRsRsmbRsbRsRsRgmbRsRsRsRsmmmbRsRgbRsRsRsRsRsRiLsRs
mmmmbRiLhbLgLebLsLsLsLsLsLsLsLsLgmmmmmmmbLsLsmbLsbRsbLsLsLhmbLsLsLsLsL
sLgLimmmmbRsLsLsLsLsLsmmmmbLsLiLsbLsLsLsLsLiLsmmmbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153449; End: 153949;
Recording: 11-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bRgbRgRsmbRsbRhbRiRhLiLcRgbLibLiLibLcbLsLiLsLsRsmbLsLsLsLsmmmbLsLsLsLs
LsRjmmmmbReLsbRsRsRsmmbRsLcLsRoLsLsmmbRibLjbRsbRsbRsRiRsmbRsRsmbLsbLeR
cbRsLibLgbLiLgLsbLiLoLsmbLobLsRsRsmbLcbRiRsmbLsLsmbRgLsbLcbLgbRibRgLsb
RiRsRsRgRsRsmmmmbRgRsmbRsRcLjLcbLsbLsRibRgRsmbRgbRgRsRsRcmmbLgLsRebRsL
sRsbLsRsRsRsRoRsRjLsmmmbRebRgRgbRgLoLcLobLeLsLeLgbLeLsRcbLsbRgbLsbLiLs
bRjbRiRsRsRsmmmbRibRsbRgRsRsmmbRsRsRsRsmmmbRhLgbLsbLeRcRsLsmbRsLoLsmbL
gRsRsLsmbRcRsmbLjbRhLsbLobLgLgbRsLsRgbLebRcLcbLebRebLgbLjbLgRsbRsRsRsm
mbRsbRsbLsLsLsmmbRjbLiLgRsLsbRsbLjbLeLsLsmbLcLibLibLeRsbLjbRiLsbRgbRcb
RiLgbLoLsLgLgmbLsLgbRcLgbLiLeRsbRhRsLsLsmmbRcLgRcLsbRcbRcbRsbRsbLeLoLi
bLebLibLsLiRebRsLgbLeLeLgbLgLgLgbLsbLgbLsbRibLgLsLgLsbLgLebLhLsbRsbLiR
sRsmbLsLsmbLeLgbRhbLcLsLcLsmmbLgLsLsmbLiLsLsmbLsRsLsbLeLiLcLsLsLemmbLi
LeRgRiRsmbRibLsRiLgLsbRgbRsLeLsRgbLsbLeLgbLsbRsRsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 1; Drug: Control PTZ 2.5 mM
bLhReReRebRgRgbLsRsbLsRsbRsRsLsmbRsbRhRsLcRsRsmmbRgRsRsmmbLsRgRsRsRsRs
mmmmbRgRsmbRhRsmbRsLsLsLsmmbRiRsLsRsmbLeLgLcLsmbLebReRsReRsmmbRgRsRsRs
RsRsRsRsmmmmmmmbRsRsRsmmbRsRsmbRsbRsRsRsRsRsmmmmbRsRsRsRsmmmbRsRsmbRsL
sRsbRgRsmbRgRsLsmbRgRsmbRgRsRsRsmmmbRsRsmbRsRsRsmmbRgRsRsRsRgmmmbRgbRs
RsRsmmbRsbRsRsRsRsmmmbsbRgRsRsmmbRgRsmbRsbRsbLibRsbReRhReReRsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 2; Drug: Control PTZ 2.5 mM
bLebLeLsbLgLsbLsLsmbLsLebLcbRgbRgbRgbLebLibLsLsRsmbLgLebLibLeLibLebLeR
sbLgbLebLebRcLcRsbLsbLebLiLsbLebLgLibLsbRsbLsLeRcbRiLcbLgLsbLebLcbLgbR
eLsbLcbLibLsbsbLeLsLsmbLiLsbRsRsmbRjbRcbLobLeLsbRcbRgbRgRsRsRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 3; Drug: Control PTZ 2.5 mM
bRsbRcRebLebLhRebRhRgbLcbRcbRcbRhbRgbLhbRcbRcbReLgbLsbLsLgLsbLebRsLsbR
gbRebLsLiLsLgLgbLibLgbLsbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLcbRebReLjbRsRi
RebRebRebRebLsLgLebRebLsbRebReRsmbRobRsbRcbRobLebLcbRsLsbLgbRcbLebLibL
sLgLsLsLembLsLsLeRcRsmmbRebLhRebRsReRibLsReRsRsRsRimmmbRsRsRiRgmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 4; Drug: Control PTZ 2.5 mM
bLebLjbLeLsLsmbLebLeLebLebLhbLgLsLsmbReRsmbRsbRebRhRsRsRgmmbLeLhLeLsbL
eLsbLeLebLhLibRebLcbLebLsLebReRibRjRebRiRsmbRsbRebRiRcbReRebRsbRgRsmbR
gRsRsmmbRebLebLgbLebLibLcbLoLsmbLebLcbRcRsmbLeLeLsbLeLsbLebLebLgLcLcRs
bRiRgRsRsmmbRgbRebRgReRsmbRebRsRsRsRsmmmbRiLebLebLib

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 5; Drug: Control PTZ 2.5 mM
bRsRsmbRsRsRgmbRsReRgLsbRgRsRsLsmmbRsRsmbLsbRebLsLebLsLgLgbLgLcLibLebL
gLsbLsLsRsmbLsLsLcmbLsLsLgLsmbLsLiLsbLgLsbLsLsmbLsLgRsbRgbRjRiLobLsbLs
LsLembRsbLebLeLgLsLsmbLsRhbRgRsRhLsmbLcbRgRcbRsRsmbRcLeLcbLeRcRsmbRibR
sRebLhLsRsbLgRsbLsLsLembLcbLgLsbLgbLiLebLgbLgLebRcbLebLgLgbLgbLsLebLsL
sLsLsLsmmmmbLebRibRgRsmbRsbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 6; Drug: Control PTZ 2.5 mM
bLebRebLsbRsRobLcLcLeLeLsLsLgmbLsRjbRebRcRsmbRebRebRsRsReRhmbReRsmbRsb
RsRsRsRgRsRsRemmmmbRgbRjbRebRebRcbLcLobRebRgbRibLebRjLeLsbLgbRsbLgLcbR
ebLobRiRcRoRibRebLeLsRgRsmbRebLgbLebLebLcbLcbRhbRobRebRebLebReReLsbLgb
RsbLiRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bRoReReRiRsmbReRsmbReRsmbLeLsbLhLsbLeLgbLsLsmbRjbLcbRiLsbLeLsbRgbReLcL
gbLeLcbLobRsRoRsmbRsRgRsRoLsLsRoRsRsRsmmmmmbRiRcbLsLsmbRhRiRsRsmmbLcLc
bRsbReRsRgRsmmbLsbLobRcRsmbLebLcLcLsmbLsLsmbLcLobLhbLebLsLsLsmmbRsRgLc
LsLeRsRsRsmmmbRsRiLoLgLebRcbRebLgbRobRsRsRsmmbRgbLeRsRgbLeLobRsRsRsRsR
cRgmmmbRobLsLsLeLsLsmmbLsLeLsLsmbRsRgLiLob

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeLcRsbRcRsRsRcRsRoRsRsmmmmmbRsRsmbRsbLeLsbsbRsRjbLgbLiRsbRcLcLoLcbLs
RsRsmbRsLsbsbsbRsRsmbLsRsbsbLsbLsbsbLeLcRsRobRsRsmbRgRsRsRsmmmbLsbLeLs
RsRsRsmmbLeLobLobLgRsRcRoRsmbLsbRgbRsbLhbRoRcLoRsLsLsLsLsLsLsLsmmmmmmb
RgbRebLcbRsbsbLsbsbLjbLcRsbRjbRsRsReRsmmbRoLcbLebRsbRsbRsbLsbLsRsbLebR
jbRebLsbLsbLeLsRsbRjbLgbsbLsbRhRsLembLeLgLsbLsRebLeLsLsmbRsRsmbLsbLiRs
bRoLcLcLgLsLsLgmbLsRsRsRsLsmmbLsLsLgmbRgLobLebsbRsbLsbRcRsLsmbRebRgLsR
sRsmbRsRsmbLsbRsbRsLsRsRsmbRebRcbLjbLiLsbRgbReRsmbLebsbRibRgRsmbLcLsmb
RsRebReRsmbLeRsbLgLeLsbLcbRsbLsbReRsLgmbLeLiLcLsmbRsbLeLebLoRsbRsRsLsm
bLsbLsbRgbLjbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeLcbLeLsbRsRgLgRibLhLhRsbLeLsbLsLiRhbRibRsRgRgRcbRjbRibRebLeLebLsbLe
RcRsmbLebLgbReRgbRsbRgbsbLebRibLcbLebLebRebRebRebReRibRgbRebRibLebLgbL
hLsbLgbLebLeRsbLebReRsmbLibRibRgbLsbReReRhRsRsRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bReLgbRobRhLsbRgLobLgRobReRsmbLebLgbLobLobLeLsLcRsbRcRoRobLcbLgbLeLgbL
gbRibLsLsmbRsbLibRebRhbLsbRcbLebLibLobRcbReRibLebLebRgbRsRsRsRcmmbRiLs
bLebRcRsmbReRcbRebLeRobReRgRsRcmbReLebLgbRebRgbReRsRsRcmmbReRsmbRgbRsR
iRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsRsReRembRsbRgRsRsRsmmmbRsRsmbRsbLsRsbReLsbLeLsbLebRibLebLebLobRgbRc
RebRebRebLgLsbLsLsmbLsRsbRsbRsRsmbLiLsLcbLeRsRsmbRibLsLsLsRcmmbLoLgbLe
LsLgLsbLgbLgLgLob

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bLgbRhRsRsRommbRgRsRsmmbLcbLebRsbLebLebRsbRebReRsmbsbLsbLsbReLsbRobRsR
gbRebLsbRsbLiRsbsbLsbRsbLsbLcbLjLcbRcbsbRoRsmbLcbRcbLcLsmbLsLsmbReRgbL
cReRsmbRiRsRsmmbRsbsbRebLcRsbsbRhRsmbRcRsRcmbRcbLjbRebLcLsmbRsRoRsmbRg
RsmbReRsRsRsReRsRsRsmmmmmmbLsbsbRebLobRebRiRsmbLsbRsLsbReRsRoRsLsmmbLi
RsRsmbRsbLcLobLcRsbRibLsLsmbRjbRsRsmbLsRsRsLsmbRcRsmbReReRgRgbLsRsLsbR
eRcbLebsbRsbRjbRibLebReLcbLebLgbLsLsmbRsLcbRcReRsRcmbRibRsRsmbLgRsRsRg
mbRsbRcbLhLsbsbRcLjRsbLiLoRsRsmbReRsmbLgbLhbLcbRsbsbLiRsbsbRcLsbLobLiR
sbRsbLeRhbLsRsbRoRsmbRebLsbReRsRsmmbRiRibLcbLiLsbLoLoLhbsbsbRsbRjbRcbR
cbRcbRcRsmbRiRsRsmmbRcbRgRsmbRiLcLsmbLibRibReRsRsRsRsRsmmmmmbLsbLeLsbL
sbLeLobRsRsmbLgRgRsRsmmbRcbLeLsLsmbRcRsmbLebLcLsLsmmbRsbsbRiRsmbLcRgRe
bRsRsLsmbsbLsbsbRsbLjbRsbLsbRibRiLcbRsRsmbRsRsmbRcLcbLgRsbRsbRcbReRsmb
LjbLibRebRsRsRsRgmmbRsbLcbLeRsbLjbRcLebLgLsbRgRgLsbRsbLebRebRhbRebRebR
gReb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgRgRiRsmbRgRsmbLsbLebRgbLsRsLsbLsbLgLgbLsLsLsmmbLebRgRsRsRsmmmbRgbLs
bRsRgRsmbRgbRsRsRsRsRgRsRsmmmmmbRgbRsRsRgRsLsmmbLsRgbRgRsRsRsmmmbRsRsm
bRsRsRsRsLsRsmmmbRsRsmbLsRsRsRgmbRgbRsRsRsRsmmmbRsRsmbReRsmbLsRebRgRsm
bRgRsRsmmbRsLsbLeRcbRobRebRcbRibRobRcbLebRiLsbLcbLsbRjbRebLsbLsbRsbRsb
RgbRsbRgRsmbRebRgbRgbRsRsmbRhRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bLibLsbLsbLsbLsLsmbRsbsbLsbLsLsmbLsbLsbsbLsbRjbRsRsmbLeRsLoLsmbLgbLcRs
RsRoRgRsRommbLgbRiRsRgRiRsLgLsmmbRsbLibRebRcbLsLsLsmmbLiLsRgRsmbReRsRs
RsmmmbRiRsmbReRsmbLsbRsbLjbRiReRibRsLsRsRsmbRsbRhLsbRsRsRsmmbRsbReRsRc
RsRsmmmbsbLibRsbRsRsmbRsRsmbLsbLsRsbRsRsmbsbRgRsRsmmbRiRsmbLoRsRsRsmmb
ReLcbLcbRsRsmbLjbRcRcRobLsbLcbLobLcRsbRsbRsRcRsmbRcRsmbsbLsRhRsmbLsLsR
smbRsbRsRsmbsbRsbRsbRgbRsLsbRibRebRebRsbLgbRebRebRsbLjbRsbRgReRobReRgb
RcRsRsmmbLhRsLsbRsbLhLcLobRhbRsbLoRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bLeRsReLcLsLsmmbLsbLoRsRgbRsbRebRebLgbLeLgbRsLgbRcRsmbRsRsRsmmbRsbLebL
iLsLsmbLsRcRsRgmbRgbReLsbRsLebLeLgbRgbLeLsLsLembLsbRgRgbLeLsbLgbLibLcb
LebRsbLsbsbLsbLsbLgRsRsmbRhbLibLgbRcbRjRsmbLhbRsRsmbRgbRsbLibLebReLsbL
sbsbRsLsbRibRebRsbRsRsLsmbRgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgRsRsRsRsRsRsmmmmmmbRiRjbLsbLgbLcLebRibLsbRcbLsbRebRebLebLsLgbRgbRsL
cbLeRsbLibLgbLiRcbLjbRgbLgbRebRsbRgbLcLeLebRibRiRsLsmbLsLsmbReRsLsmbLs
RsLgbRsbsbLcbRcbRibRsbReLeRibLgbRiRsmbRcRsRsmmbRiRsRembRgbLcbLcbLibLcb
ReRsRsmmbRebLcbRebReRgbRgRhbRsRcbLsLsmbLiLgbLsbLsbLeLsLsRsmbLibReRsRsm
mbRiRsmbRebsbRsbsbRsbLcLgLsLsmbLobLebsbLgRsLsLsmbLsLsRsLsmbRjbRcLsbLeL
sbLebLebLcRsbRsbsbsbLcLsLsLgLemmbLcLsLsLsmmmbRjbLgbLsbLiLsbLhbLcLsRsmb
RgbLgRsbLgLgLsbLibLebLeRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bRgbRcbRgLsbLsbRebRebLgbLoLobReLsRsRebRsLgbLoRsbRcRsmbLcbRobRcbLcbLiLc
bReRgLsbRgReRsmbRebLsLsRsmbLsbLcbLiRsbRebRoLsRcRsmbLcLoRsbLcRsRsmbRebL
gbLebRgLsLsmbLsbLsLsmbLsLsLembRsbLsLsRsLsmbRsbRoRobLeLsLgbsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bLhbRsRebRsRjbLgbLcbLiLsbRsLsbLsbLsbLibLhLobLcRsLsbLgbRsbRgbRsRcRsmbRg
RsmbLobLsLsLsmmbLiLsRsLsbRjbRhbReRsRoRsRommbRcRsRsRiLommbLeLgRsbLgbLeb
sbLgbLsbLsbLsLgLsLsmbReRiRcRcbRcRsmbLibsbsbRiRsRsmmbRgRsRsRsmmmbRgReRo
bLeLsbRsLsbLgLsbLiRcbRsbRcRsmbLjbLeRsRsmbLhLsbReRsmbReLsLsmbRebRgbsbLe
bRsLsbLsLsmbsbLsLsmbLsbRsLsRsbLeRoRsmbRiRsLsmbRiRgRibLobLgbLiReRebRcbR
sbRsbRgRsmbRiRsRsRsmmmbLgbRibLgLebLobRsbRgbLcbReLobRobLibsbRsLsbLcLoRe
RcbRhRsRsRsmmmbRebRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsRsLsmbRsRsRsRsmmmbRsLsbRsRsRsRsmmmbRgLsbRsbRsRgbRsRsmbLsbRsRsmbRsRs
mbRsbRsRgbRsRsRgRsmmbRsbRsLsRsbRsLsbLsLsLsmmbLsRsRsmbRsRsRsRsRsmmmmbRs
RsRsRsmmmbLsbRsbRsRsRsRsmmmbRsRsmbLgRgbLsbLsbRsbLobRsbLhbRgRgbRsRsRsmm
bLsLsRgRsmmbLsRsLsbRsRgRsRsmmbRsRsRsRsRsLsmmmmbRsRsRgmbRsRsmbRsbRsbRhL
sLsmbLsLsLsLsLsRsmmmmbLsLsmbLsbRsbLsbRgLjbLsbRiRsmbRgbLsbRsRsmbsbRsRsm
bRsRsRgmbRsRsRsRsRsmmmmbRgLsbRsRsmbsbRgRsRsmmbRsLsbLebLgReLjRgbLsLsLgm
bLgLsLsLsmmbLgLsbRsLsLsLsmmbLsbLsLsmbLsbLsbLsLsmbLsbLsLsRsmbRsLsbRgbLs
bLsLsLsmmbLsbRsLsRsbLgbLsLsLsLsmmmbLsbLsLsmbLsbLsLsmbLsLsmbLsRsbRsLsLs
mbRsbLsLsLsmmbLsRsRsmbLsLsmbLibLsRsbsbLsLsLsmmbLsLsLsLsmmmbLsLsmbLsbLs
LsLsLsmmmbLsbLsLsLsmmbLsLsLsLsmmmbLsbsbLsLsRsmbLsLsmbLsbRsbLsLsLsLsLsm
mmmbLsLsmbLsLsLsLgLsmmbLsLsmbLsbLsLsmbLsLsRsLsRsmbLsLsmbLgRsbLsRsLsLsm
bLsLsmbLsLsLsmmbLgbLsbLsLsmbRcbLsbRsRjbRsRsmbRsbsbRgbRgbLsbLgRsRsRsmmb
RsRsRgRsmmbRgRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbLjbsbRebLgbRsLsbRsbsbsbLsLsmbLsRsbsbLjbRjbRiRsmbLibLjbLhLgLsLsmbRj
RsmbReRsRsmmbLgbLjbLsbRebLsRiRsLsmbRsRsmbReLebReLsbReRsRsmmbRsbRsbRiRs
mbRgRsRsmmbRgbLebRsbLhLsbLgLsLsRsmbReRsmbLgbRcRsmbRgbRgRsRsmmbRsbLeLsb
ReRsmbLsRsbRiRsRsmmbRgRsRsRsmmmbLjbLsbLsbRsbReLeLcLsmbRgbsbRhRsRsmmbLj
bRgLsbRsRsmbRhRsmbRgbLgbRebLcbRcLjbLibLgbLsbLcLsLeLsLsmmbReLsRsbsbRiLs
LsmbLebRsRebLsbLsbLjbLsbRgRcLgLsLsLsmmbLgbRgbLgLsLsLsmmbReRsRsmmbLjbRe
RsRsRsRsmmmmbLgLsLsmbLsLjbLsLsmbsbLhbLsbRjbReRsmbRgLjbLcbReRsRsmmbRebR
iRsmbRsLsbLhRsLsbRebRiRsRsmmbsbsbRgRsRsmmbRsbRsRsLsmbRsbLgbRsRsRsRgRcm
mbRiRsmbRiLsbRiRgRsReRsLsRsmmbLebRsLsLsLsLsmmmbsbsbRsbRsLsbRcbLjbLeLsb
LsLsLsLsRsmmmbLgbLsRsRsmbReRebRgbRiRsmbLsLcLsLsLsLsLsmmmmmbRsLsbLsbRsb
RgbRsbRebRgRsRsRsmmmbRsbLsbsbRiLcLsLsmmbRibRjbReRsRsmmbRsbLcLsLgLsLsLs
mmmbRsbRsbRebRgbRiLgbLhbLhLsbRgbReRsRsRsRsRsRsRgLgmmmmmmbRiRsRsmmbRibR
sbLsbRsRsRsmmbRiRsLsLsLjmmbLiLiLsLsLsLsmmmbLsbRjbsbRsbReRsRsLsLemmbRsb
ReRsRsRsmmmbRgLsbsbLeLsbRgbLsRsbRsbLiLgLgLsLsmbLgLsLsLsRsLsmmbLgLsLsRs
mbRsbRebLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbLjbLeLsbRjbRjbRibRcLibLgLoLsmbLebLebRhbRsbLgbRoLibRsbLgLsLsmbRibRe
bLebRebLgRebLoLsmbLebRebReLsbLsbLsLsmbRsbLeLsbLhbLsLsLsmmbRgbLsbLsbRgb
RsRsmbRgbRibLebRsRsmbReRsLsmbRiRgRsmbLobRebLjbLgbLgbLsbLgbRcbLeLgbRebL
sRsLsbLsbLsbsbLcbLgbRsbRobRsbsbLsbLsRsbRsbRsbLsbLsRsbRsRsRsmmbLsbLsbRs
bLcLiLebLgbRjbLsbLsbLgbLgLsLebRgbRebLgLsbLcbLsbLibLgRobLeLsbRjbLebLcLh
bLcbRsbLgbRiRsmbRebLebLsbRhbRsbLebLsbRsbRsRsmbsbRgLjbRsbRjbRibLebRibLe
bRibRibLjbLsbRiLsbLebLhbRcbReRsmbLebRjbRsbLibsbsbRsRsmbLsbLebRebsbLebL
iLsbRjbLebLcbRebLibLebRsbLsbLsbRsbLsRsbRsbRsLsbLgbLeLsbRibRsbLebRebLeL
sLgbRcbLcbRcbLsbLjbRjbRsRsRoRsmmbLhbLsbLeLsLsmbLsLsmbRsLsLsmbLjbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbLsLsmbLcbRgLgbLeLsRsbLebRgbsbLsRsLsLsmbLsLsmbLsbLgLiLsbLsbLeLsLsLo
LsmmbLsbLeLsbLcLsmbLgbRebRiLsLsLsmmbLsbLcLsmbLobLjbLgbLibLcLsmbLebLgbL
oLsRsmbLcLgLsLsLjmbLcLsmbLsLgbLgLgLsbLsLsLsmmbLebLoLsmbLgLsLsLsmmbLsbL
hLsRsbRgLsbRibLcbRebRebRgbLcRsbLebLibLgRsbLebRgRsmbLjbLgbLobLeRhbLobRs
RebLgbRibLsbLgbLeLhbRibRebsbLsbLsRsbsbsbRsbRsbsbRiLoRcbRebLoRsRiRsmbRg
bLcbLsLsmbLiLsbLeLob

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgbLsbRsbLsLgbRobRsRsRsmmbRhbRsRsmbLsbRsLsbLobLgbRoRsmbRebRgbRiRsRsRs
RsmmmmbLhbRsRsmbLgbRhRsmbRibRgbRebRibRgbsbRsbRsbRsbLgRsRsmbRebRgbRgLjb
RsbLsRcbRebRgbRsbRhRsRsmmbsbsbRsbLebLsbsbRjbRcRibRiRsRsmmbRjbLiRcRsmbR
sbRibLhLibLhbLsbRsbRjbRibRebRiLsRsbRibRgbRsRsRembReRgbLgbRcbRebRsRebRi
RsmbRgbRsRsmbRibRgbsbLsbLsbLsbRsbRsbRsbRsbRgbRgRgRgbRibRsbRgRebRgRsLsm
bLsLsRsmbRsLgbLsbRcRhbRgbRiRgRsRsmmbsbLsRebRsbRsbLgReRsmbLsLibRibLhbRe
bRgbRiRsmbRiRsmbRsbRibRgbRebRcRsmbRibRiRibRibRgRsmbRhRsRsmmbRsLsbRibRe
bLgbRgRsmbRgbReLsbRcbRebRgbRebRgbRiRsmbRgRgbReRsmbRgbRsbRgRsRgRsmmbRjb
RjbRebRsRsmbRgRsRsLsmmbLcRsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bLebRsRsmbLsbRgbLsbLibLobRsbRjRsmbRgbLsbsbLeRsbLcbLobLsbLgLsRsRsRsmmbR
gbRgRoRibRsbLobLsbRsbLsbLsbLcLsmbRoLsbLibLjbLgbLsbLsbLsbLsbLsbLibLsbRs
bRgbLcRebsbLsbRsLsRsbRsbLsbLebsbRjbRobLjbLhbLobRoLsLsRembLibLgRsbRebRh
LsLobLibRsbLgbLeRsRsmbRsRhLsLebLeRoRcRsmbRgbLcRibLcRsbRgbLsbLcRsbLsbRs
bLsbRgbLhbLgbLebLsbLcbRjbLgbLsLobsbRsbLebLiLebsbLobLsLsLsLsmmmbLsbLgbL
oRsRobRibRsRsmbLsbRsbLebsbLsLsmbsbsbsbLgbLjbLibRoLeReb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 25; Drug: Control PTZ 2.5 mM
bLeLsRsbLebLebLebLsLsLgmbRobRsRebRsRebLsRgRsmbRsRebRebRsRsRsRsmmmbRcbR
ebLgRcRsmbRsRsmbRsRsRsRsRsmmmmbsbRsbRsRsmbRsRebLebLeRsbLeLsRsbLeLsRsbL
eLsbLebLsRgRgRsmbRsRsRsRcRoRemmbRhRibLibRhbRsRgRsRsmmbRsRsRsRsRsmmmmbR
sbRsRsmbRsRsRsmmbRebRebRebRsbLcbRibRsLibLcLsmbLcLsmbLsbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 26; Drug: Control PTZ 2.5 mM
bLhbRcbRsbRcbRhbRibRebRibLcbLsbRebRebRibReRsmbRcRsmbRgbRcbRibRebRebReR
smbRebRebReRsmbRebRcbReRsmbRebReLsbRcbRiLsbLobLebLsLoLsmbLebLhRsbRsbRi
bRibReRsmbRgbLcLsRsLsmbRjbRsbRebRcbRebRhbLsRebRsbRebLeLcLsmbLebLhLsbLi
bLebLeLsbLiLsbLcbRcbRebRebRibRiRsmbReRsmbRebLeRsbLebLibLiLsbLebLebLeRs
bRobReRsmbRoRsmbRibRiLsLsmbRsRcbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 27; Drug: Control PTZ 2.5 mM
bLobRebRsRsRsmmbLeRoRebRsRsLsmbLjbRsbsbLsbRsbRsRsmbRsRsRsRsRsRsRcLsmmm
mmbLsLsLsmmbsbRsLsbRjbLsbRsbLcbLgLcbRsRebReRgbLiLsbRsRsmbLcbLcRcbReRgR
ebReRsmbReRsmbLsRsRsmbReRsRhmbRcbRcLsbRgbRiRsmbRebLoLgLsbRjbLsLsmbLsbL
sLsmbLsbRcbLsbsbLhbRebRgbRcbRgbReRsRsRgRsmmmbLeLeLsLiRjbLeLsReRsmbRsbR
eRsmbRsRsLsmbReRhRsmbLebLgLgRgbLeLeLsLsmbLsRsbsbsbLsRcbLebLcbLsbLebLiL
sRcbsbLgbReRsmbRsRcRsmbReRsRembRcRsmbRsReLgLgbLsLsmbLsLsRgmbReRgbRiRsm
bRgLebReLsbRebReRsmbRhRhbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 28; Drug: Control PTZ 2.5 mM
bLiLgbLgLgLgLgLsbLgLgLsbLsLsLsmmbLsLsRsRsmmbRjbLsbLsLsmbLsLsLsLsLsmmmm
bLsLsmbLsLsLsmmbLsLsLsmmbLsLsLsLsmmmbLgLgbLsLsLgmbLiLsLgLsbLsLgLsLsLgL
smbRibLebLeLsbLsRsRgRsmbLsRsbRsRsRsmmbRsRgRsRsRsmmmbRsRsmbLsRsRsRsmmbR
sRsmbRiLsbRsLsLsRsmbLeLsbLsLsLsLsmmmbLiLsLsLsmmbLebLebLebLsbRebLebLgRs
bLibLsLsmbLsLsLsmmbRcbLsLsLgmbRcbRcbRgbRcbReRsRsmmbRibRsReRsmbLgbRcbRi
LsbRgRsRsmmbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 29; Drug: Control PTZ 2.5 mM
bRsLobLebLcbLibLgLsLsLsLsLsLsmmmmmbLsLsLsmmbRgbLcLiLsLsmbLcLsmbLiLsLoR
sbRsRsRsmmbLibLhbLsLsmbLeLsbLeRgLcbRgbRgbLibLcbLiRcbRibRiRsmbRsRgReLsb
RgLsbRgRsRgmbRsRsRsRsmmmbRsRsRsRsRsmmmmbRgbRcbRibRgRsmbRsRsRsRsmmmbLgb
LiLcbLgbRcbRebRsbRebRebRebReRgRiRsRgmbRebLeRsLebsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 30; Drug: Control PTZ 2.5 mM
bLeLsbLgLsbLebLeLebLgbLgbLebRcbRgRsLsmbRgRiRsmbRgRiLsbLibLsbRcbReRcbRi
bRgRsRsmmbRsbRgbRebRsbRsRiRcbRgbRibLgLcLsLsLsLsLeLcmmmmbLgLgbLsLsLgmbL
sLgLsbRgbLsbRhbRgbRsRsmbRsRsRsRgRsmmmbLgLibLibLsbLoRsbRibRsbRsRgRgRcbL
sLsmbLsbRebLebRebRsbRcReLsbLibLiLsbRsRoRgbRgbReRibLsbLsRcbRebRsRsmbRsR
smbRsRsmbLcbRebRibLoRsbLsRsbRcRsmbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bRgLeLeLsLibLeLeLeRsbLsLgbLgLsLsLsLsLsmmmmbRsRcRgRiRsmbLgbLebLsbReRibL
gbReReRebRebRgRgRhbLeLsLiLeRsbLiLgbLsLeLebLsLgLsbLsLsLsLgLsLsLemmmbLiL
sbLebLsLeLeLsbLsLsLsLsLsLgLsmmmmbLsLgRsLsLeLsbLgLsLsLsmmbLsLsLsLsLsLsL
smmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsLsLsLsLsLsLsmmmmmmbLsLsLsLsRsLsmmmbLsLsLsLsmmmbLsLeRgbRcRoRgLobLebR
sRsRsmmbRsRsRsRsRsRsmmmmmbRsRsRgRsRcmmbLebRgRsRsmmbRebRebLsLiLgbLebLsL
sRjmbRobRcbRebRoLsbLebLeLsLsLsmmbRoRgRsmbRsRebLiLgLsLeRsbLsLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bRgbLeLsLsLeRsmbLeRsLgbLhLsLsLsmmbLiLebLsLsmbReLsbReLeLgbLeLgbRibRsRsm
bRgRgRobRgbRjbRebLhLgbRsRsRsmmbRebReRsRsmmbRsRsRsRcmmbLebLebLeRebRiLgL
sLsLombLcbRebLobRhbLcbRobRsRsRsRsLjmmmbRsbLsLsmbLsLsLsmmbRgRibLhRgRcbL
eLgbLsLgLeLsLsLeLembsbRiRsRsmmbRsRsmbRsRsRgRsRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsbRsLsRgbLgRsRsmbRebReRcRebReRsRgRembLsRgbReLsbRsbRoRsLsmbReRsmbReLs
bLgLsbReRsmbRsLsbRcRsmbReRhbRcLcLcLsLimbLcbLsLgLebRcbLebLsRoLsbRsRebLg
LsLsLgLgLgLsmbLebRgbRiRsRsRsLjmmmbReRsmbRsRsmbReReRsmbRebRsRsRembRhbLo
bLebLcLgLsLsRcReRsmmbReRgRsmbReRsmbReRsRsRsRemmmbLcbLsLebLsLsLsmmbLiLs
bLgLgbRcRsmbRibRgLsbLsbRgbLsRsRsRgRombRsbLcLcbReRsLsRembRsRsRsmmbRhRib
RsRgbRgLsbLeLgRsbLsLsLgLsLeLsLsmmbLibLsbLcLsmbLsLsLsLsLsmmmmbLsbReRsmb
LebLcLsmbLibRcbRsbLgbLiRsbRsRsRsRsmmmbRsRsRsRsLsmmmbRsRgLeRibLoLsmbLeL
cbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsRebRcbRobLcRsRsLsmbRebLsbLhRsRsmbRsbsbLcLoLgLsbLsLsmbRjbLgLibLgLeLs
bRsRsmbLeRoRsmbRsRobRsbLcLeRsRsRsLommbRsLsRsbLsRsRsmbReRsRombLsLsLsmmb
RsRsmbLcbLiLebLcbLsRsbLgLsLsLsLsLsLsmmmmmbRsLgLsbLgLhbLgbLeLebRibLgbLs
b

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bLgLsbLsLsLgmbLsbLsRcbLsRcRsRsRimmbRsbRsbLcbRebRcbLebLsLsLsLsmmmbLsLsL
imbRcRsmbRsbRsRsmbRsbRsLsbRcbLcbLgLsbRsRsmbLjbLgbLsLsmbLgLsbLgLsLsmbLs
LsLgmbLsbRsRsmbsbLsbLsRsLsbRsRsRsRsRsmmmmbRsbRsLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsbRcRsmbRgbLcLobLgbRcLsbRjRibLsRiRsRsRsmmmbRebLebLcLcbLebRebRiRsRsmm
bRgRgRibReRsLcmbLeLobLobLcbRibLjbLebLebRebLgLsLsmbRgbLgbRjbRcbRgRebLsL
sLsmmbRebRcbRgRsmbLsRsbRcbLibLiLobReLobLeLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bLibLiLsbRjbLsbRjbRgRcRibLsbRiLsLsLgLgLoLsLcmmbRsRsLsmbRgLsbRebRsRsLhm
bRgbLsbLibRobRcbRiRsmbRgLsLsLsmmbRsbLeLiLhLsbRjbRsbRobRiRsmbRoLobLhbRo
bLsbsbReLsbReRoLsRsbLgbRebLoLsmbLsLibRsbRcLobRibLoLiLcRiLgbRcbLebLcbLe
bLgRsRgRgbRsRsRsRgmmbRebRgRsLsRsmbRiRsLsLsmmbRgbLiLsLoRoLsbRcbRsbRgRsR
sRsRommmbRcbRsbRgLsRsLsbRhLjbRoRoLebLeLoRsbRhRsmbLiLjbRibLcRcbRoRcRsRi
mbRgRsmbRibRgLsRcLcLoLcLgbLsLeLobRsLsLsmbRgRsmbRiRsReLsLoLiLsLsLgLsLem
mb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bLoLsLsmmbLgRiRsRombRcRgRibRgRgRsmbRgRsRsRsmmmbLsRsLcbRgRgRobLebLeLsbL
iLgLsbLeRsLsbLobLgLeLsLsmbLsLeLsbLhLsbLeLoLhbRoLsbRgbRebRgRsmbLsRsRiRo
LsbLebLeLoLsLeLsmbLgLsLgLsLebLsLeLsbLibLiLsLsmbLsLsLsLimmbLiLgbRebLeRs
bLjbReLsLebRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bRhLsbRibsbLgRsbRgLcbLobLiLsbLsLsmbRoRgbLsRsbRsLsbsbRsbLcLsmbLiLgbLebR
cbLebLgbLibLcbLibRgRsmbRibRgRhbRgRsLsmbRgbLsbRgbRebRibRsRsmbRiLebRsbLi
LsbLibRoRgRibRsRsmbRiRgbRibRgRsRsmmbRgRsmbRiRsmbRgRsmbLjbLobReLiLsbLiL
sbLebLgLsLsmbLsLsRsmbLibLeRibRgbLsRsRsRgmbLcbLsbRjRibRcRsmbRgRsLsLcmbL
gRsbRebRsbLobRebRgRgbRsbRcRgbRgRgRoRgbRgbLsbRiLebLgbLibLgLsbRoRiRsmbRi
bRebRgRsmbLgRiRsmbLgbLsbRcbLsbLgRsRsRsmmbRiRsmbRiRsRsRsmmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bReRcbLcLsmbLeLsbLeLsbRsbLobLebRgLsbRsRsmbRiRsLsmbLcRsbRsbLcLsmbLebLcb
ReRcbLsbRiLsbReRsmbLhbLeLsbsbsbLgbsbsbRebsbsbsbLeLsLcbsbsbRsLsLsmbsbRs
LcLsLsLsmmmbRcbLgbRcbRcbReRgRsRsmmbReRsmbLgbLcLcLsLoLsmmbLhLsbLsbReLsb
RsRebRcRcRsmbRsbRsbLeLsRsbRibReRcLsbsbRibLebReRsRsmmbLgLsbRebLsbLsbReR
ebLsbRcRobLebLsRsbRgbLhbReRcbsbsbsbRebRebRebLiLsRsLgbRhbRcLsbRsbLjLiLs
bLeLobRsbReRcbRsbLsbRsRsmbRebRebLsbReLsbLebLcLcLsmbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bRhbRsbRsbRibRsbRsLcbLsLsRgmbRebLgbRcLsRsRgbRgRgRsRsRommbLsLsmbRsLsbRs
bRsbsbLgbRsRcbRgbRebRiRsRombRibRsbRiRebRebLgbRobLebRiRgbRibLeRsbRgbLsb
RgbRgbLcbLgbLsLsmbRsbRsRsmbRhbLsbLsRsbRcbLcbRebLebRebLibLebLebLsbLebRs
LsRsRsmbLibLiLgbRgbLgLsbLebRcbLjbLebReLobRibLcbRebLsbLebLgLobRebLebRgb
LebRoLobLsbLgLsLsmbLebLiLsbLeLsbRebRsbLjbLjLsLsmmbLsbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bRcRsRsmmbLhRsbRcbLsLobLgbRcbRgbRgbLsbRgRsRsmmbsbsbsbRgLcbLsLsLiLsmbRc
RiRsmbRsLsbLeRsLhbLhRoLsbRiLsbRsbLsbRiLsbsbLcbRjbRoRsRsmmbLjbReRebLebL
sLsLsLoLommbRoLsbLgbLebRobLebLgRsbRjRhRsRgRsmmbRgRsLsRsmbLebLoRsRobsbR
sLsbLgLsbLoRobRebReRsLsmbRsbRsbLjbLcRsbRoRsRsmmbReLsLsLoLsLsRsmmmbRjbR
sbLgbLsbLoRgRsmbRhRsLsmbReRsmbRsRsLsmbReLoLsmbRiLobLibRhRgbLsbRsbLcLsL
gRsmbLsLsmbLoRsLsRsLsbLebRsbLsbsbsbRjbRgbLsbLcLsmbLebLobRgbRgbRgbLeLcR
sbRcRebReReRsmbReRsRimbRgbRsbLjbLebRsbRsbRcbLcbRsbRibRibsbLsbRsRsmbRsL
sbsbRsRsmbLsbRsLebRsRgRsRsmmbLgbRgbRsbRhRsmbRsLsbRgbLsbReLsbLeLsLoRsbR
iRcRsRsmmbRsLsbRcbLoLgbRhbLsbRibLeLsLsmbRgbRcbRgLsbLjbLjRsbLhbRcbRsbRs
LobRsbRcbRsbLcbRebLcbLeRobRsbLsbRsRgRsmbRobLiLsbRjbRiRsRsmmbLebRcbRgbR
gLoLoLsRombLcLsLsRsRsRsmmmmbRibRhRsLsmbLjbRjRiRsmbRebRsbLobLibRcRsmbLj
bRgbLcRsRsmbRcbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bRcLcLgRsRsRsRsRsRsRsRcRsmmmmmmmbLcLeRsRsmbRibRiLsbLcLeLgLsbRsLeRebReR
sRsRhRgLsRcmmbLjLeLsbReLsRsbLsLsmbRcLsRsbRebLebLebReRsRsRgmmbRiRsLjmbL
sbLsbLeLcLsRsmbReLsRhLsbLcLsLcRsRsmmbLeLsLsmbLiRcLiLsLsLhLsmbLiLsRoLsb
RsLsLsmbRgLgbLsbRoRebLeLsLsLcmbRsbLsLeLsLsLsLsmmmbRcRsRsmmbLobRcRsmbLe
bRsLebRsbLgRgbLebRgRobLgbLcLsLsmmbLcReRsRsmmbRsbRcRiReRsRsRsRiReLsmmmb
LsLgLibLeLsReRsmbReLsLgLebLgLsbRsLebRsLsLebRsLsLeLibRgRgRebLsRsRsRsRsR
sRgLsmmmmbLsbLsRsLgbReRibLgbLhbLebRgbLeLsbLiLsLsLgmbRebRsbReRgRsmbLibL
cLsLsLsmmmbRsLhLiLsLsmbRcRsRsRsmmmbLoLsLimbRobRgbLebLibReRgbLcbRsbRibL
ibRcRgbRiRsmbLcLsLsLsLgRcLsLsmmmmbRhRsRsRgRsRsmmmmbLeLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsRsbLgbLgLsbLsbLsbLsLsmbLsLsLsmmbLsbLgbLsbLsLsmbLgbLgbLsbLsLsmbLgbLg
bLgLsbLgbLgRsbLiLsbLsLibLgLsbLgbsbLgbLgLsLgbLsLsmbLsbLobRibRibRgbRsRgL
sRsbRsbRgbRgbRsRgRsmbRgbRgRsmbRsRsRsRsRsmmmmbRsRsmbRsbRsRsmbRsRsmbRibL
oLsmbLsbRcRsmbReLsbRebRgbRgbLsRibRebLibRgbRibRiLsbRgbRgRsRsRsmmmbRsLsb
RsbRgRsmbRsbRgbRsbRgbLjbLgLsbLgbLsbLsbLsbLsLsmbLsbLgLsbLsbLsbLsbLsLsmb
LcbRgbRibRsbRgbLcbLcbLsLsLsLsRiRgmmmbRebLoLsLombRoRsmbLsbLcbRoRsmbLibL
hbRgRsmbReRsmbLsLibRcbLobLiLsbLsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bLcLsmbRjbRsbLebsbsbLsbsbsbRsLjbLgbRsbRsLsbLeRsbLeRsbLsRsRsLsmbLsbRebL
jbRsbsbLsLibRsRiRsmbLsRgbRsLcbLeRsbLgLsLgLebLibLgLcLgbLgbLsLsLgLsLgLem
bLiLsLsLsRsmmbRsLsbRgbRibLibLgbReRsmbLjbRjbLjbRsbRibRsbLsbsbRibRcRsRsm
mbLsLebLebLoLsLsmmbRsbRcbRsRsRimbLibRgRsRsmmbsbsbRsLsbLsLebLjbRcRiRsmb
RgRsRsmmbRsRsRsRsRsmmmmbLjbRhRsmbRibsbLjbRcLsRsRsmbRgLcRsLsRsbLgbLsbRi
RsmbRgbLcLsmbRgbRcbLcLsLiLimbRsbRibLeReRsLsRsmbRgbLgbLcLgLobLjLsRiRsRs
mmmbLsLsRsmbRsbRgRsmbsbRgbRsbLsbRsbLibLsbLsbRsbRsbLebRobLgbRsRsRsmmbLc
LsmbLgLeLsbRibRsRsmbLibRcRsRsmmbLsbLgRsbRjbRebLsLcLsmbLibRjbLiRcbRsRsm
bLsbLcRhRsmbRgLeLsbLsLeLoLgbLeLsbRgbsbLeLsLsmbLcLsmbLgLgLgLeLsbLsbRibR
jRsmbLsbLibRcLcLsmbRcRsRsmmbsbLsRsLsLsmbLcLcbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsLsLsLsmmbRibReRsRsmmbLsRsRsRgmbRibRsRsmbRiRsRsRsLsmmmbRiRsRsmmbRiRs
RsLsmmbRsRgRsRsRsRsmmmmbRsRsmbsbLgLsbRsRgbRcRsRsRsRsmmmmbRgRsRsLsmmbRi
bRgRsmbRsRsRsmmbRsRsRsRgLsmmbRgRsRsRsLsmmmbRsbLsbRsRsRsRsRsRimmmmbLcbR
oLsbRsRgRsmbRgRsRsmmbRgRiRsRsmmbRgRsmbLsbLgbRsRsRgRgmbRsRsmbRgLsbRsRgL
ebRcbRsRsmbRsRsRsRsRsRsmmmmmbRsRsRsRsmmmbLsRsbReRsmbRsRgbRsRsRgRgmbRsR
iRgbLsRiRsmbLcbLsLsLgLgLgmbRsbRsRsRsRemmbRgbRsRsRgmbRgRsRsmmbRgRsRsmmb
RsbReLsbLgLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 153951; End: 154451;
Recording: 12-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsLoLgbLobLsbRiLsbRhLgbLeLsLsLsRsmmbLsLsLsLsLsRcmmmmbLsRsRsRsRsmmmbRs
LsbRjbRiLoRsLsbRjbLhLgLsLsLsmmbLeLgbLgLsLsLsmmbLsLsLsmmbLgLebLoRsbRsLs
RsbRsbRgRsRsmmbLsRsbLeLcbLsbLibLsLsLgmbLibRcbLebRcbLeRsLsRsbLsRsbRsRsR
smmbLcLoRiRsRsmmbRgbLgLgbLsLsLsLsLsLsmmmmmbRjbRebLcLsLsLsmmmbLjbLcLgLs
bLsLibLebLeLjbLgLsLsLsmmbLiLsbLebLiLsLgbLebLcbRobRsReRhbLsbLcbLgLsLgLs
bLiRsLsLgRhbLhLgLgLsbLhLebLsLsRsmbRebLcLgbLgbLhLsbLebLsLsmbLgbLgLgRcbL
gLsbLeLsLsRembLiRsbLgbLebLgbLgLgbRjbLgLsLsmbLeLsRoRsmbLsbRoLsRsbLgbRsR
ebLgbLebRiRsmbRgRgReLsLsmbLoLsmbLsLgRgbLibRsbLsbRcRgRsmbRgLcbLsLsLsmmb
RcRiRsmbRsLsLsmbRgLsbRsRsRsmmbLcbRcbRiLsbLobLiLsbRebRibRibRcLoLgLsLsLs
mmbLgLsbLgLsLsmbRgbLsLebLiLsbLgLebRibLgRsLsbLsbRiRsmbRiLoLsmbLhLsLcLsm
bLcLgbLeRsbLebRsRsmbRgLobLeLgbLiRsLhLiLeLsRsbLgLcLjbRsbRhRsmbRgRsmbReR
ebLsbLsRibRiRiLsLoLsmbLgRob

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 1; Drug: Control PTZ 2.5 mM
bRiRsRsRsRsmmmmbRsLsRsbRsRsRsmmbRsbRsRsmbRgbLsReRsmbRebLgbLgLsLsLsmmbL
eLsbLsbRsbLsLgbLsLsLsLsmmmbLsLsmbLgLgLsRsbLgbLiLsbRgLiRsbRobLeLebLgLsb
LebRebRgbRgbRsRsmbRsbRsLsRsRsRsmmbRsRsRsmmbRsRsRsRsRsmmmmbRsRsRsmmbRsR
sRsRsmmmbLsLsRsRsRsRsmmmmbRgbRsRsRsRsmmmbRsReRsmbRsbLsLebRgLsLsLsmmbLs
LsLimbLgbLibLsLsmbLsbRsLebLgbRgbRsbRgRsRgLsmbRsRsRsRsRsmmmmbRiRsmbRgRs
RsRsmmmbRgbRsRgRsmbRgRsRsmmbRsRsRgmbRsRsRsRsRhRsLeLeLsmmmmbLeLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 2; Drug: Control PTZ 2.5 mM
bLgbLhLcbLgLsLsmbLsbLsbLsbLsLsLsmmbLeLsLsLsmmbLiRoRgRibLgbLgRsLgbLgbLe
bLebLebRobRjbLebLcbLebLhbLebLsbLgLebLebLhLcLebLgLsbLsLsmbLsLsmbLeLebLg
bRcLoLebLebLgbLgLebRebRsbLcLsmbLgbLiLsLsmbLgbRsRsmbLebRsLcLsmbLcLebRiL
sbRiRsRimbRibRgbLebLebRhbRobRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 3; Drug: Control PTZ 2.5 mM
bRsRsRsmmbLeRcbRgbLebRsRsLsRsmbLsLsLcRgmbRcRobRsRsRsmmbLcbRebLsLsmbLeb
LiLibRebRhbLsLsRsRsmmbLcbRcLsLsmbLsLgLsbRcbRebRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 4; Drug: Control PTZ 2.5 mM
bLhRoRsRsmmbRgLgLebLeLcLcRgbReReRebLeLsLsLcmbLgLsLgLibLgbReRsmbLhLsLsL
smmbRhRsRcmbLgbLebLebRgLsbRiRcbLsLsmbLgRebReRsmbRgRibRsbLebLiRcbLiReRs
RsmmbRebRiRsmbRiLsbRiLcbLiLsLgLebLsLebLiRcLjbLcbLgbRcReLcbLebLcLsmbLeb
RobRsRgRsRgRgmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 5; Drug: Control PTZ 2.5 mM
bRobLeLgbRsLeLiLgbLebLgbRsLsRsLsLebLibLhLsbLsLsmbLibLsbRsLebLgbLsLeLgb
LsLsLsmmbLsbLgbLsLsmbRsLsLgbLgbLsLsLembLebLeLsbLebLebLebLiLsbLebLsLsLg
mbLsLgLebLeLsbLibLsLsmbLsLgbRsLsbLsLsLsmmbRsbLsLebLibRgbRebLsLsLombRsb
RgbRgbRsbLjLgLsbRcbLebLebLcLsmbLebLcbLsLgLsLsLsLgLemmbRsRebLebLeRsbLsR
gRsmbRsRsmbLgbLjbLsLibRiRsRsmmbRsLcLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 6; Drug: Control PTZ 2.5 mM
bRiLsbsbLsLsLsLsReLsmmmbLebLoRjbLsbRcLcLsmbRsbRsRcRsRombLeRgLsbRsReLsb
LiLsbRsRibLcbRcbRiReRsmbRsReLsLcLcbLcbRobLeRsbRsRgbRsRebRib

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 7; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsbRgLsLsmbLgLsLebRsRsRsmmbRsRsRsRemmbLcLsmbLsLsRsmbRebRcRsmbRsRebRoR
oRobRsReLsbLgLsLsLgmbLeLsRgbLiLsLcbLgbLcbLsLgbLcbRsbRsbRibRoLsbRebLcLc
bRoLsbLebLhbReRsmbRebRgRoLsRsRobRhbReLsbRcLcLsmbLebLsLcbRcRsRsmmbLsLob
ReRebLcLoRsbLcbRcRsRimbRsRobReRcbRebLeLsbReRcbRsRsReRiLsLsmmbLgbLcbRsL
gRsbRebReRsRsRsmmmbRgRgbLobLcRsbLebRiRsmbReRsRsLsmmbLsLsLcmbRiLhbRebRo
bLcRsbRebRibLcLcbLibRibRobRebReRsmbRsRsRsRiRgRsmmmbLsLcLsLsLsLsRoRsRsL
smmmmmmbRsRiLobRsRsmbReLoLsLsmmbRsLcbRiRoRsmbLgbRobLsRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 8; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsbLsRsbLjbRebRebLsLibRebLcLsLsLsmmmbsbReRobLsLhbRsbLebsbRsbRsbLsbsbR
gRsRsmmbLsbLcLsRsmbRsbRsbRsRsmbRsbRsLsRsbRsbLsbRjRsRsmmbsbLhLsLsLsLgLc
mmbLeLsLsRoRsReRcRsmmmbRgbLsbRsRsmbRsRsmbLjbLsbRsbRgRsRsRsLcRemmmbReLo
LgbRsbLiRsbLgbLgbLeLgRsbLeRsbsbRjbLsLiRsbLiLgLsbsbLsRsbsbRsbRcRsLsRsmb
LgbsbsbsbLsbLsRsbReLeLgLsbRsbRhRsRsRsLcLsRsmmmmbLeLobLcLsmbsbRcRcRoRsm
bLebLsLcbRsRsmbsbsbLsLgRebReRsmbRsRsLsRsmbLeLsLsLsLsmmmbLsLsmbRsRsRsmm
bRebRsRsmbLibLsbRsRsmbLjbRcbRoRsLembLcLobLibLhbRebLeLsbRsbLoLcbRsbLeRs
bRsLsRsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 9; Drug: PCAP2 1 µM PTZ 2.5 mM
bRibLcbLgbRsbRhbRebLeLsLiLsRsbLsbRsbLeRhbLsbLsbLibLeLsbLhbReRsmbLobLeb
LsbRebLsbLebLsbRgbLebRsRcRsmbLjbLcbRibLgbRgRsLsmbRsbRibRgbRibRsbLsLsmb
RiLjbLsLeLhLsbRjbReLeRsbLsbLeLsbRsbRsbLgbLsbRebLebRjbRsRibsbsbRsbRsRsm
bLibsbReLsLsmbLcLcLcRsbLsbLsRsbRcbLcbRebRibLebLsbLsbLcbRgbRiLibRgLebRg
LhbRgbLcbRsbLebRcbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 10; Drug: PCAP2 1 µM PTZ 2.5 mM
bLeRjbLobRoLsRcRebRibRsRsRgmbRsRgbRgReRjReRsmbRebLeLsbRsbLsLebRgbRgbLs
bRibRibRebLiLsbLsbLsLsLsmmbLoLcbLcbRsbLebLcRobRsReRsmbLebRsbRiRobLebRe
bLoLobRcbLebLebLebLebLgLebLebLsbRebRebRebRebRibRebRebRsbLsRsbRiRibRibL
cbRsbLsbRebLcbLeLebRebRebLcRsbLcbRobRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 11; Drug: PCAP2 1 µM PTZ 2.5 mM
bRibLjReLiLoLsmbLebRebLobRsRsRembRibLeLsbLeLeLsbLoRoRgRobRebReRsLimbLe
bLcbRobRsbLiRsRsmbRgbLsRsbRebLobRoRsmbRobRob

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 12; Drug: PCAP2 1 µM PTZ 2.5 mM
bLebLeLsbLeRgbLebLsLsRsLsmbRsbLsbRsRsmbLjbRsbRsbLsbLsbsbLsbLsbLsbLiRib
RsRsRsRsmmmbLgRsRsRsmmbsbRsbReRsmbLcLobRjbRcbRjbRcRcbRsbLeLgbRcRgbReRs
mbRobRoLsbRsLebRgbRebLcbLgbRsbLcLsLsmmbRcbReLiLsLsmbLeRsbReRsRsRsRsmmm
mbLebRebLcRgbLibLsbLcbLsbRebRiRsmbRsRsmbLebReRsmbRgbRgRebRebLcLsmbRebL
oLsmbRjbRebRiLobLsbLibRsbReLsbRobReLcLsmbLeLsLobLcbRgbReLcLsLombLjbLiL
sbLsRcbRiRsmbReLsbReRsmbRcRobRebRebRoRsmbLobReRsRsmmbLebLeRcbRgRgbLjbL
eLsbRgbRcRsRsRsmmmbLcbsbRibRcReLsbLeRsbLcLsRcRgRsmmbReRsmbLsbLobRgbReb
LcbRgRsmbRgLsbRhRsRsRcRsmmmbRgbRgRsReRsRsRcmmmbRsRsRsmmbReRsmbLhRsbLiL
cRcLcbLsbLiRcbRsLsbRcbRebRcRsmbRebReRsmbReRgRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 13; Drug: PCAP2 3 µM PTZ 2.5 mM
bLobLobLsbLsLsRsmbLsRsbRsbRsRsRsRsRsRsmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 14; Drug: PCAP2 3 µM PTZ 2.5 mM
bLjLeLobRhbRcRoRoRsLombLgRsbLgbReRcbRsbRsbLsbRsbLhbRsbRjbRsbLjbLjbRsbL
gbRsbRsLsbRgRsRhmbRsLsRsbLcbRcRcLsbRsbRobLsbRebRsLsbRiRsLsmbRgbRgRsRsR
sRsRsRsmmmmmmbRcRsRsRommbRsLgbRebRebRcbRcbLjbRiRsRsRsmmmbRebLcbRsRsRsR
smmmbLiLcLeRsbLoLhLobRcRsRsLgmmbRsbRhRsLsLsmmbLibLsbRsbRsRsLsmbLsbRcRs
RsmmbLeLsLsmbRsbRsbRsRsmbRsbLiRsbLeLcbLjbRebRobRgbLcbLsLsmbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 15; Drug: PCAP2 3 µM PTZ 2.5 mM
bLjbLeRsRgRcbRhRsmbLsbLebRsbLsbLsbLebReLsLsRsmbLebRcbRjbRoLcbLebLibRjb
LcbLeLebLsbRgLsRsbRsLsbLgbLebRebRiRsmbRibRsLsbRsbsbsbRsbRsbLgRobRgbRjb
RebRsRsmbRgbRibLebLebRsbRsRsmbRjbRgbRgLebLgbRoRcbLgbLjLgbRebRsbLhRsLsb
LgbRibRsbRibRgRsmbsbRgbRebLebLiLsLsmbRsLebLebRgRsRsmmbRgbRjbRibRebLibL
ebLebRcLsbLsLebLeLsbsbLsbLsbLgRcbRiRsmbRsbRebLsbsbsbRsbLiRsbRibReLsbRs
bRgbLgRebRsRibRsRsRsmmbLgLhbsbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 16; Drug: PCAP2 3 µM PTZ 2.5 mM
bLcLsLsmmbsbLsbLeRsbsbRobRgRsRsmmbRoRsRsRgRcmmbLgbLcbRsbRsbLibLgLsbLgR
sLsbsbsbLgbLgLsLsmbLgbLgLibsbRsLsbsbLsbLcLgLeLeLsbRiRsmbLcbRjbLgbRsbLc
bLeLsLgLsLsLsmmbLsRjbRcbLibLiLgLsbLiLiLsbLgLsbLgRibRiRgbLebLcbLgRsRsmb
LebsbLebRsbReRsmbLgbLcbRebLebLgbLsbRcbRebRebRebRebLjbRhRsmbReLcbRcbLsb
LgbLebRcLsLsmbRibLsLsmbLgbLsLsRembRebsbRsbLjbLibRebRsRsRimbRgRsmbLebLe
bRcbRibLjbRebReRsRsRemmbRiRsmbRibRcbReRsRgmbLgRgRibRiRsLcmbLsLsmbLiLsL
smbLsbRjbRcRsRsRsmmmbRsRgbRgbLoLsmbRcRsReLembLsbLebsbLeLsbsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 17; Drug: PCAP2 3 µM PTZ 2.5 mM
bLoReLsbRoRsmbLcbRsbLcbLsRsbLsLebLeLgRsbRsbLobRgbRsRiRsRgRgRsmmbLebLoL
sLsmmbLcbRebRsbReRoLsbRiRsRsRsLsLsLommmmbLsRsbLsbRiRsLjLsmmbsbLsLeLoRs
bRgbRiLoLoRsbRsRsmbRgRsmbLsLebLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 18; Drug: PCAP2 3 µM PTZ 2.5 mM
bRhRsmbRgRsmbRebRsbRhLcbLhbLibRsRsLsmbRjbsbLibLsRsbRgbLgbLeLoLcbLgLsLs
mbLsRsbLsbRsbRsbRsbLsbLsbRsbLeLsLsmbLsbLgRhbRcbRiRcRobRgbLibLjLsmbsbsb
sbsbRgbRsbRhRsRiLsmbLcLjbLsLsmbRgbRsbLjbLibRjbRgRsmbRcbRibLoLibLcRsbLi
LsbLsbLgLsLsmbLgLibLebLsbLebRibLobRiRsRsRsmmmbsbRsRsmbRsRsRsmmbRsLsbsb
RebRsRsmbRebRsRsmbLjbRgbRibReRsmbReRsLsRsRgLeLembRebRebRebLobRibRgRsmb
RebRsbRgRebRsRsmbLiRsbLgRhbRoLsRcbRsbRgLsbRgbRsbRgRsLsmbLiLsLsLsLsLsRs
LsmmmmbRebRoRsmbRsRebLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 19; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsbLgLsRsRsmbRgbReLgbLsRsbRjLsbLjbLsbLsLsLsLsmmmbLsbLsbLsbRcRsmbRsRib
RgRgbLibLsRsbLsLsRsmbLsLsRgRsRsmmmbRsRsRgRsmmbRsRsRsmmbRsRsRgRsmmbRsRs
RsmmbRgLsbRgRsRsRsmmmbRsRsRsmmbRsRsmbRsRsRsRsmmmbRsRsRsmmbRsbRsRsmbLsb
RsRsmbRsRsRsmmbRgbRgbLsRsbRsbRgRsLsRsLsmbRsbRsRsRgLsmbRsRgbRsRsRgmbRsR
sRsRsRgmmmbRsbLsbLsLsRsRsmmbRgbRsbLsbLsbRsbRsRsRsRsRsmmmmbRsbLgbRsbLsL
sRsRsRsmmmbRsLsbLsbLsbLgbLsLsLsmmbLgLsRsRsmbLsLsLsmmbLsLsLsmmbsbLsLsmb
sbLgLsbLsLsmbRsLsLsLsmmbLsLsmbLsRsbLgLsbLgRsbLsLsLsRsLsRsLsmmbLsbsbLsL
smbLsbLsLgLgbsbLsLsmbLsLsLsmmbLsLsmbRsbLsLsLsmmbLsLgbLsLsmbLsLsLsmmbLs
bLsLsLsLsmmmbLsbLsLsLsLsmmmbLsLsmbLsLgbRsRsLsLsmmbRsbsbLgLsLsLsLsLsLsR
sLsmmmmmbLsLsLsLsLsLsmmmmmbLgLsLgLsbRsLsbRsLsbLsbRsLsbsbLsbLsbLsLsLsmm
bRsbLsbLsLsLgLsLsLsmmmbLsbLsbLsLsmbLsLsLsLsmmmbLsLsLsmmbLsLsLsLsmmmbLs
LsLsmmbLsbLsLsRsLimbLsLsLsmmbRsLsLsmbLsRsbLsLsLsLsmmmbLsbLsLsmbRsbLsLs
LsLsLsmmmmbLsLsLsLsLsmmmmbLsLsLsmmbLsLsRsRsmmbsbLsLsmbLsLsLgLsLsLsmmmb
LsbsbLsLsmbLsRsLsbLsbLsLsLsmmbLsLgbLgLsbLgbRsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 20; Drug: PCAP2 10 µM PTZ 2.5 mM
bLsRsbLeRsRcRsmbRcbLeLsLsLsLsLsLsLsLgRsmmmmmmbLsRsbRcbRsbRsbRiRsmbLgbR
gbLgbRsbRgbRsbRgbsbReRsRsmmbLsbReLgbLcbLgbRebLcLsmbLsLgbLsLsLsLsLsLsLs
LsRsmmmmmmmbRjbRsbRjbRcbLjbLsbRcRsRsmmbLgLsbRsLsbRsbLgbRiRsRsmmbRsRsmb
sbsbLsbRgRsRsLsmmbRsbRsRcLiLsbLgLsLgbRsRsmbLsbLsLsmbLsRsLsbReRsRsmmbLj
bLiLsRsbRsLsbRgbRebLibRsbLjbRsbLgRgbRsbReRsLsLjmbLebRcbLcbLiRibLeLsLsm
bRsbReLsbLeLeLsLsLsLsmmmbRsRsmbRgbLibLgbLsbLsbsbRgbRiRsmbLgRsRsmbRiRsR
iLcLsLsRhmmmbLeLgLsbRsbsbRebRsbRhbLgbReRsRsRsLcmmmbRoRsLsLsmmbLcbRsbRg
LsbRebRiRsRsmmbRsLgLsbLgbLsLsmbLsbLsbLsbLsbLgbLgLsLsLsLsLsLsLsLsLsLsLs
LsLsLsLsLsLsmmmmmmmmmmmmmmmmbLsLsLsLsLsLsLsLsLgLgmmmmmmmbsbLsbLsLsmbsb
LsLsLsLsLsLsLsmmmmmmbsbRsLgLsbLgLsbLsRsLsLsLsLsmmmbLsLsLsLsmmmbLsbLsLs
LgLgLsmbLsLsLsLsLcLsLiLgLsmmmmbLiLiLsLsmbLsLsmbLsRsRsRsmmbRsRgbRsRgbRs
bRsbLsRsbRsLsLgLgLsbLsLsLsLiLsmmbLsLcLgLsLiLsbLsLgLiLgLsLsLsLsmmmbLsbL
sLsLsmmbRsRsmbRsRsmbLsbLsbLsLgLsLsLsLgLsLsmmmbLgLsLsLimbLcLsmbsbRsRsRs
mmbRsRsRsRsmmmbRsbRsLsRsRsRsmmbLsbLsbRsbsbRsLsbRsbRsbRsRsRsRgmmbRsRsRs
mmbRsbRsRsmbLsbLibLsbLgLsbLsLsLsLsLsLsmmmmmbLsbLsLsLsmmbLsLsLsmmbLsLsL
sLsLsLsmmmmmbLsLsLsLsLsmmmmbLsLsLsLsLsLsLsmmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 21; Drug: PCAP2 10 µM PTZ 2.5 mM
bRhbLibLsbsbsbRsbRsRgbRibRsRsLombLgbLcbRcRsLsmbReRgbRibLgRgLibLsRsbLsb
LibLsbLebRsbRsbLebRsbRjRibRsbLsbLsRsbRgbLebLhbRsbRibLjbRsbRcbLcLsmbLsb
LsRsLsbRsbLsbRgbLjbRsLsbLebRebLebLgLeLcbRcRsmbRobLebRsbLsbRcRgbRsbLsbR
sbLsbsbLsbsbsbsbRsRibRcbLgbRsLsRsbRgbLibLcbRcbRsRsmbRibRibLgbLsLsLgmbR
jbLebRibRebLiLsbLhbRsLsbLibLiLsRebRsbRsbLcbLsbLhbLebRebLebReLsbRgbRibR
eLgbRgbLsbLcbLsLsmbLgbLeRsLsbRjbLjbRgbLcbLgbRjbRgbLcbsbRjbLsbLsbLiRsbR
iRsmbRibLcbLsbLibRjbRebLeLgbLebLebLebLibRgRsmbRjbRsbLsbLebRibLoLsmbLsb
LgbRoRsmbLebLsbRsbLsbRhLcbRsbLsbRibRcLsRgbLhbRsbRjbLsbRgbLibLsbRsbLsbR
sbRsbRsbLibRsbRgbLebRibLjbLebLibLsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 22; Drug: PCAP2 10 µM PTZ 2.5 mM
bLobLoLgbLcbRsLiLsbRoLgLsbLcLgLsLsRombLhRsLsbRsLebLeRjbLsbLhbRsLsbLgbL
ebLcbLoRcRsmbRoLsLsRhmbLoRsbLibLgbLsLsLsmmbRcbLjbLibLgbRsbLsbRsbRoLgbL
hbRoRebLcLsmbLsLsLsLemmbLeLcbRibLgbRgbRgRsmbLobRjbRhRoRoLsLsLsRsLsmmbL
sbLhbLgRsbLeLsbLebLhbLeLsbLebRibLcLsLsLsLsLommmmbRsbsbLsbRgLsRsbLoLsLs
LsLsmmmmbLeRibsbsbLsbLebLcLsmbLibLibsbRsbRoLoLsmbRgLgbRsbLsbLcLsRiRcLs
RoLsmbLebLeLsLsmbLsLhLsbLibLgbLgLgbRsbLcLsLgmbRobsbsbsbLibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 23; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbLgbLebRsbLibLsLebLoRsbRebRgbRsbRhbRsbRsRsRsRsmmmbRsRsRsmmbLgbRibRi
RsmbReRsRembRgbRgbRiRsmbRibRsbReRsmbRsbLiLgbLebLsRsbLebRobRebRcbRibRgR
gbRibRgbRsbLsbRsbRsbRsRsmbRsRsRsRsRsmmmmbRsRsLsmbRsRsRsLommbRibRsRebLh
RgbsbLsbRiLsRsbRsbLsbRsbLsbRgRsmbsbRsRsRiLsLsRsmmbLeRibLsbRsRgbRiRsmbs
bRebRiRsmbRebRsbLgbRjbLebRebRebLeLhLeLsLsmbLhbLgbLgRoRcbLsRsbRebRibLsL
sLgmbRgbReRsmbRcLgRgbRjbRebRebRiRsmbRibRgbRibRgbRsbsbRsbLsRsbRsRsmbRib
RsRiRsmbRibRebRebRiRhRgRsRsmmbRsLsRsRsmbLsRsbLhLsbRcRsLjmbLebsbLsbRgbs
bRsbRgbLgRgRsmbRebReRsmbRsbRebRsbRsbsbLgbLcbRjbLgbRgbReRsmbRgbRebReRsm
bRiRsmbRgbLsbReRebRsbRsbReRsmbReRibRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 24; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbRgbRsRibLsbRsbLobLobRsbRhRsmbsbLsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbRjb
LebLgbLsLsmbRgbLebRebLsbLebsbLebLiRsbRjbLebRobRibLebsbsbLgbLsLgRsbRsRe
bLebLsbLibRibLebLsbRsbRsbsbsbLsRsbsbsbRsLsRsbLcbLibLcLsmbLeLobRsbRgbLi
RsbLsbLobLibLjbRibRgLsbsbsbLhbLcbRgbLhbLebLebRsbRgbLebRgRsmbLiRsbLsbRs
bRsbLsbLsbsbsbRsRsmbLsLibRobsbsbsbsbsbRsRsmbRsRsRsmmbLsRsbLsbsbsbsbLgR
sbLcbRibLsbRcRiRiLcbLebLobLgbLgbLgbLcbRsbRsbLsRsbLsbLsbLsbLsbLsRsLsLsm
bsbsbRsbRjbLsbLsbRibLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 25; Drug: Control PTZ 2.5 mM
bRsRebLsRsRsmbRsbRsbRcbRsRsmbRsRsmbRsRebLebRgbReRsRsRcLsmmbLsLsLcmbRsR
iLjbRgbLobLebRhbRoLgbRebLgRsbRgbRsRsRsLsmmbLsRsRsRgmbRebRsReRcbRsbRebR
sbRsRsmbRsRsmbRsRsLombLsbLjLsLsLsmmmbLsbRebRsLsRsbRgRsRsmmbRsbRsbReRsm
bRsRsmbLebLcbLeRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 26; Drug: Control PTZ 2.5 mM
bRebRoRsmbReRsmbRibRibRgbRebLcbLebLebLeLebLeLsbLebLebLsLsLsmmbLibLsLsm
bReRoLsbLebLeLsbLgbLiLsbLebRcbRebRebReRsmbRibRebRhRsmbRebReRsmbReRgRgb
ReRsmbRebRebRibRiRsRsmmbRiRsmbRibRibRcRsmbRebRiRsmbRiRsmbRgbReRsmbRiRs
mbRebRebRcbRibRgRgbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 27; Drug: Control PTZ 2.5 mM
bsbRiRsRsmmbLsRsRsmbRgRsmbReRsmbRebReRcbReRcLsLsmbLsLsmbLeLsbRsRsmbLsL
obRsLcbLobLgbsbLsbRcRgRsmbRibLsLsLsmmbLsLsReReRsRimmbReRsReReReRsRsReR
sReRsRgmmmmmbReRsRsRsRsReLsRsmmmmbRiRgRsRsRgRiRcmmbLsbLeLsbRcbRebRebLg
bRjbRebLcbLibLeRebReLsLsLsLsLgLhmmmbLibLgbLsLsmbLsLsRsmbLsRsbRgbLgbLeb
LebRibRcbRsRsReRsmmbRcRsRsmmbLsRibRibRibRcLeRsbLebLeLebLebLsLsmbLgbRsb
LebLoRsbLobRgLjbReRsmbRebRebRsbRiRcbRiLsLsmbRcbLhbReRgbLeRebLsLeLsLsmb
LsLsLsLgLsLsLsmmmmbLiLsRhbLcRsbRsbsbLhLsRsbRiRsRsRcmmbRhLsbLjbReRsLsmb
RsRsmbLjbLibRcRiLsbRgRsRsRsRsmmmmbRsRsmbsbReReRsRsmmbRebsbLcLeLsbLiLsb
LsLeLsLsLsLsLsLeLsLsLsmmmmmmbLgLsLgLsLsmbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 28; Drug: Control PTZ 2.5 mM
bRhbRsbRibRsRsRsmmbReRsmbRcbLsLsmbRebRsbRsRsmbRibRsRebRgbRgbRhbRsRebRg
RsmbRgRsmbRhRsmbRsRiRsRsmmbRsRhbRobRcRsmbRiRibRsRsRsRsmmmbRsRgbRsRgRsR
smmbRsRsRsmmbReLsbLsbRcRsmbRgbRsRsRsRsRsRsRimmmmmbRiRsmbRebRcLsbLsbLeL
sbLhLsLsLgmbLgbRsLeLsbLhLsbLgbLebLebLgbLgbLiLsbLsLsLsLsLsmmmmbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 29; Drug: Control PTZ 2.5 mM
bLeRsLsRsLoLsmbLgLsLcRsbReLsbRhRobLsRsbRgRsRsmmbRsRsmbRcbRsRsRsmmbRsRs
mbReRsRsmmbLgbRcbLeLsRsbLsRebRsbRebLsbRgRgRsRgRsmmbRgRibsbRgbRebLobReb
LebLeRsbLsLsLsmmbLgLsLsLsLsmmmbLgLsLsmbLsbLhbRsRgbRobRgbRjbRcLsLcbRibL
oLsmbLhLsbLsRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 30; Drug: Control PTZ 2.5 mM
bRsLebLsLsmbLsbLsbRcbLgLsbLsLsmbRsRcbRcRcbLeLsbLsLsLsmmbRsLebRobRiLeLs
bLgLsbLeLsLcbLgbLeLsRibLebLebLebRcbRebRcbRgbRsRsmbsbLebRcRebRgbRsRsRgm
bRsRsmbRsLcLsmbLgbLsbRgLebLeLsbRsRsmbRhbLcbLsLibRsbLibLsRgbRebRebRibLs
RsRebRebLgRibRiRsmbRsRiRiRsmbRiRsmbRibRgbRsRsmbLsbRibLgbRhbRibRsbRiRgL
sbRebLeLsbLiLsbLsLsLsmmbLeLsLhbRsRibLeLsLebRsRhLebRcbRebRebRgbLsRsLsbR
sbsbLgRcRgLsbLeLsbRsRsLsRsmbLsLsRcmbRjRcbRgRsRgLcmbLibLsLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 31; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsLgLeLeLsbLiLgLsLsmbRsLebLeLebRebLgbRgbLebLsLsmbLsLgLebLsLeLsbLgLsLs
mbLeLsLgbLibRsLsLiLsLgbLgbLgLsbLsLsLsLsLsLsLgmmmmmbRsLgLsLsLsmmbLeLsbL
ebLgbLsbLsLgbLsLsmbLsLsmbReLsbLiLeLsLebLsLeLgLibLgLsLeLeLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 32; Drug: PCAP2 1 µM PTZ 2.5 mM
bLgbLsLibLsLsLsLsLsLsmmmmmbLgLsLsmbRcbLsbLsLsLsmmbLsLsmbRsLsRoRsRsmmbR
sReLsbLsLsLsLsmmmbLsLcLsLsmmbRgLoLsmbLcbRebRcbRgRsRsRsmmmbRsLcLsmbLebR
sb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 33; Drug: PCAP2 1 µM PTZ 2.5 mM
bRsbRsRsmbRgRsmbRsRgLsbRibRsbRsLsbRgbRiRsRsLsmmbRiRsLsmbReRsRsRgRsmmmb
RiRgRsRgRsmmbRgbRgLsRsbRgRsmbReRgLsbLgbLeLsbRsbLsLsRsmbRcRsmbRgbRsbLeb
LcLsRimbRcbReRiReReRgbRsRsRsRsRsLsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 34; Drug: PCAP2 1 µM PTZ 2.5 mM
bRgLgbLsLiRsLsbLsRsLsLebLebLebLebLgLsLebLobLsLsLsLsmmmbRebRgbReRebRgRe
RsRiRsReRiRsLjmmmbLsbRgReRsmbRebRsReRiRsmbRsRgRsmbRgRsLsmbRcRebRcLobRs
RgbLcbRgLibLcbLgbLebLiLebLsLeLsbLeRsLsbLsLsLsmmbLiLsLgReReRsmbRebRcbRe
RgbLcbLcbLebRebLebRsbRiReRsmbLsbLsRhLgLsbRgbReRsRsmmbRgbRgbRsRgLsbRsbR
sRsRsRsmmmbRsbLeLsbLeLgLsbLeLsbLeLsLgbLsRsRsmbLeLsbLoRgRcLsbLeLsbReRsR
sLiLoLgmmbLebRoLsbLsLsLsLsLsLsLsmmmmmmbLeLgLsLebLeLsLsLsLsmmmbLiLeLsLs
LeLsLimbLibLebReRsmbLsRsbRsLsbLgLcbRsLobLeRsbLsLgbLcbLcbLiLeRsbRgRsmbR
sRsRsReLsmmbLsLgLsbLsLsLsLsmmmbLsLsLsLsLsLsmmmmmbLeLcbLibLsRcRhbRsRsRe
mbRsbRcbReLsLsmbLsLsLsmmbLsLsLeLsmbLsRsLgLsLcbLsRgbLsReb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 35; Drug: PCAP2 1 µM PTZ 2.5 mM
bRiRibRjRcLsLsmbLsbLsLsLgLsLsLsmmmbRsLsLsRsLsmbsbsbsbRsLsRsbsbRsbLsbRs
RgbLgLsLsLsmmbLsRsLsLsLsmmbRjLhLsRobRsRebRsRsRcRsmmbRgRsRsRgRsReLsmmmb
ReRsmbRsRsRsRsRsRsRsmmmmmmbRgRsRsLsmmbLcLcbRcRsRsmmbRgRsRsRsmmmbLoLgLg
LoRebRgLcbRsbLsLcbRebRebRiRsmbRhRibLoRebRobLsbLibRcRsRembLebLcbRsRsRsR
smmmbLcbLgLebLeLibLebLobRsbRcbRiRsmbRjRsLembLobRib

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 36; Drug: PCAP2 1 µM PTZ 2.5 mM
bLsRsRsRsRsmmmbRgbRsbLcLsmbRcbLhLsLsLsmmbLsLsLsmmbRsbLgbRsLsbsbRsbLsLs
LsReRhmmbLsLsLsLsLsmmmmbLsLcRoRgLsRcLsbLgRcRsLembLgLgbRibLcLsLsmmbRcRg
LcbLsbReLoRgRsmbLsRsbRcRsLcLcmbRoLsbRgbRobRiLsLsmbRsbRsbLsLsLsLgLsmmbR
gbRhLcbReRsmbRsRsRembLsLsmbRcRsLcmbRiRgRsmbRsRsRsRemmbLsLcRcbRebRcLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 37; Drug: PCAP2 3 µM PTZ 2.5 mM
bLobLibRobRebRgLoLebRhLcbLgLsLsLsmmbLibLibLcbLsbLebLebLhLsbRibRhRibRsL
sbLgRsbRiLsbRiRobLjLcbRebRiLobLoLsLombRgbRebRebLsRibRgbRiLgbLsbRgbRsbR
sbRgbRgbLcbLgbRgbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 38; Drug: PCAP2 3 µM PTZ 2.5 mM
bRcbRcbRcbRiLgLsbLiRsLsbRcRgRcRsmbRiRsRsmmbRiRiRsmbRsRsRsRsRsmmmmbRhbR
gLsLsLsmmbLibRcRhRsRsmmbRgLsLsmbRhLsRsRoLsbLcLsLsLemmbLgRsLsbLsLebLsLs
LsLsLgLsmmmbRsLsLgRgRsmbRcLgbLgLsLgbLsLsmbLsbRoLsLsmbLoLiReRsRombRiLsb
LibRoLsLgLsbLoLgRcRoRsmbRsLsbRebRgLsbRsbLhbsbLsbRibReLcbLiLgLoRebLsbsb
LsbsbRgbLeLsbLsbRiLsbLhLsbsbsbsbLgLgbRjbRoLsbLebLibLsLsLsmmbLsRsbRsRsL
eLimbLoLiLsLsLsmmbLsLsLembRjbLsLsLsmmbRjbLsbLiLsbLgRsbLsbRsRcbsbLsbRgR
smbLsbLsbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 39; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsLsLsLsLsLsLsLcmmmmmbLsRsbRibLeRsbLeLcbRsLsLcLoRsbLebLiLoRgbRsLsLsmb
LsLcLsmbRebLgbLsRgRcRcLsbRsRgbRsLoRsRsRsmmbLebReRsmbRsRgRsmbLsLiLoRsbR
ebRgRsmbLcLsmbLsbRsbRiRgRsRsmmbRibRsbRoLgRcbRsRgLsbLiLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 40; Drug: PCAP2 3 µM PTZ 2.5 mM
bRiRgRsRsmmbLgbsbRiRsmbRgbRsbLeLiLsbRsLebRiRsmbRiLsbLsbLiRsbsbsbsbLeLc
RsbRcRsRsRgRsmmmbLobLibLebLeLcLebLiLsbLgLgbLiLsLsmbLsLsLsmmbRsbLsbRsbL
sbLibRgbRjRiRsRsRsmmmbRgbRsbLcLsmbLiLsbLiLsbRgbLibRsbRsLcLsmbLgRsbRgbL
oLebLebLiLsLsmbLsbLiLsLibRgbLiLsbLsbRebRgRsLsLsLsmmmbLjbLsbLsbsbRjbRoR
smbRsRsmbRsbRibRsRsmbRiRsRsLsmmbLsbRgRsmbLsbLsbLsRsbRsbRsbRsbRsbRsbRiR
sRsRsmmmbReRsmbLiLsbLiRsbLcbRgRsmbLgbLcbLgLsLibLgLsbLeLsLcLsmbRsbLhRsb
LhLsbsbLebLgbLcLsmbRsbLsRcLeLebReLsbRgRsmbRgbRiRsmbLsbRgbRsbRgbLsbRgRs
mbLebLgLsLsmbRsLsLsLsRsLsRsLsRsLsRsmmbLgLsRsbLebRcbLeLsbLhbLoRsRsRsmmb
RhbRsbReRsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 41; Drug: PCAP2 3 µM PTZ 2.5 mM
bRebReRsRembRiLsbLebLcLsmbLcbRcbReLsLoLcbLiLsRobRibRsRsRimbRsRsRsLsLsm
mmbRsRsmbRgbRgRsReLsmbLebRsbLibRebReRebReLsLsLsmmbLebsbRsbLebRsbRsbReR
cRsRsmmbLjbLjbReRsmbsbsbRcRsReLsmbRsbLgbLsbReLsbLebRobLeLsbLgbLcbLsbRs
bRebLsRsLsbLibReRsmbsbLsbRsbRebReLgbLsbsbLsbLsbReRsLsLsLsmmmbLeRsRsmbs
bLcbLcLsmbLcRsbRsRebReRsmbLsbRgbLsbRebRibLsbReLsbRebsbRsbLgbsbReLcLebL
ebLcbsbRsbRsbRibRebReRcRsmbRsbRcRcLsbLoLhLsbLsbReRsmbLsbLcbRibRhRsmbLj
bLeRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 42; Drug: PCAP2 3 µM PTZ 2.5 mM
bRsbLeLsbLsLgbLgbRebRibRsRgRsLsmbLebLibLiLhbLiLsLgLsLiLgbLsLsmbsbLsbRs
LsLsmbLiLgbLgLsLsmbLebLiLgLsRsbLsbRgbRsbLibLgbLeLsLcLcLgbRsLsLsmbRhbLs
LjbLgbLeLsbLeLsbRoRgLcRsbLebRjbRsbsbsbRsbLcLoLsmbLcRgbRebLgbLhbLgbLhbR
cbRgbLcLsLsmmbRjbRhbLgRsbLsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 43; Drug: PCAP2 10 µM PTZ 2.5 mM
bLiLsbRsbsbRcRsmbLeLsbLibLcbRjbRsbRcbLeLsbRsbsbRcLsRsRsmbRsLcLsmbRjbRe
RsmbLgLsbRgLibLeLoRsRobRcRsmbRsbLsbRsRsmbReLsRobLiLsbRcbRsbLsbLgbLcLoR
oRcRsmbRgbLsbRsbRgRsmbsbLsbRsLcbLsbRcRsmbsbLjbRcRsRoRcmbLsbRgRsRsmmbLc
RsbsbsbRsbLsbsbLsbLeRsRsmbLoLsLsLsmmmbRebRsRsRgRsRsmmmbRgbLibRcbRhLoRs
bRebRsbRebRcbRiRgbLsbLebRibsbsbLjbLgLsbRgbLiLobLibLobsbsbRjbRgbRgRebRg
bLcLsLsmmbLsLsmbRjbRiRhRsLjmbLcRsLsbLsLsLsRsRsRsmmmmbRsbLcLoRobLcLsmbR
ebRibRsbLsRsRsmbLobLgRsRsmbRgbRcRsRsmmbLjbRgbLcRoRsmbsbsbReRcbLeRsbLsR
sbRhRsLsmbLeLsLsLsmmbRjbLgbRcRsmbRoRsmbLsLiLibRobLebLeLoRoRcbRgRsmbRsb
LjbLgbRobsbRgLsbLcbLeRcbRhbLebRcbLhLjLsmbReRgRibLsbLsbLhbRgbLsRsbRebRg
RsRhLoRcmbLjbLcLsRsmbRcRgRgbReLcbLibRsbLiLsLsRombRsbRsbRgbRgLcLsmbReRs
RsRsmmmbLgbReRsRsmmbRsRsRgLjRsRsRsmmmbLsLeLsbRoRsmbLsbLiRobRsbRibReRsL
oLgmbLsLsLgLsmbRsLsLsLsLsmmmbLsbRjbRibRsbLcRsbRsbsbLeLsLsLombsb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 44; Drug: PCAP2 10 µM PTZ 2.5 mM
bsbRsRiLcbLebLgbRiRibRhRebReLsLsLsLsLsmmmmbLcLsLimbLeRsbLsLeLgbRsReRsL
sLsLsmmmbRcLsbRhLsbLjRcLobRhRgRsRsRsRsRsRsmmmmmmbLcLgLsLiRsbsbRgRsRsmm
bRcRsLgLsmbLsLeLsLsLeLsmbLsLebRcRsmbRiLjLiLsbLebLgLsLsReLsmbLiRsbRgLsb
RhRsRsRsRsmmmmbRiRgbRsbRgLgRsbLcLgLsLsRcLsRsmbRsRsmbLgLsLgbRiRsRgRembL
eRsbLeLsLsmbLgRcLsbLeLsLsRcRgRgReLsmbLebReRgRsRsRsmmmbLsLsmbLeRsbRiLsb
ReRsRsmmbLcbLiLgLsbLcRcbLgbLcbLsbLgbReRcRsRsRgRgRgReRsmmmbRgLsbLcLsLgm
bLsLebRsRgRsRsRsLiLsLcRgRsmmmmbRsRsRsReRgmmbRsLsLsLsRsmmbRgLoLebLeLgLg
LeRiRsmbReRsRsmmbRsLgbLhLeRcRsRgReReLcLsmmbLeLgLeLsbLiLiLgRcLsbLgbLeLe
LsbRsLsRsbLiLsbsbLsLibLibLibReLsbReRsLsLgLsmbRebLebRsLgbLsLeLiLsbLhLsb
LgLsRsbRsbRcRsLsmbLsLsmbRibRsLhLsbRebRsLsbLeLiLsbLgRcLsLsmbRoLsbLsbLcb
RjbRcRsRsmmbRhRsRsRsLsmmmbLsRsLcLsLsLsLsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 45; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbRgRsRsmmbRsRibRgbRgbRgbRgRsmbRgbRgRsRsmmbRgRsRgmbRgbRgRgbRiRsmbRsb
RgbRsbRgRsRsmmbRgbRgbRgbRgRsmbRgRsmbRgbRsRsmbRgbRgRgRsmbRgbRgRsmbRgbRg
bRgRsRsRsLsmmmbRgbRgbRsbRgbRsRsmbRsbRsbRgbRsRsmbRiRsmbRgRsLsRsmbRsbRsb
RgbRgbRgbRgRsRsmmbRgbRsRsmbRgbRsbRsRsRsLsmmbRgbRgbRsRgbRgRsmbRgbRgRsmb
RgRsRsmmbRibRsRsmbRibRsRsRsRgmmbRsbRgbRibRgbRgRsRsmmbRsbRibRgRsRsmmbRs
bRsRsmbRgRgRsmbRgbRgbRgbRsbRgbRgRgbRiRsmbRibRgbRsbRgRsmbRibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 46; Drug: PCAP2 10 µM PTZ 2.5 mM
bLgbRhLjbRsbRjbRhbRgLsLsmbLeLsbRgbLcbLeLsLobReRsRsmmbLgLsbsbsbLsbLsbLs
LsmbLsbLsbLgLsbsbsbLcbRgbLsRibLcRsRsmbLcLoReRsmbRsbLsLsmbLsbLsbRsbLcRc
RsmbRsbLgbRsbRsbLsbRcbLjbRgbRhLeRgRebRsbRsbRsbRsbLjbRgLebRgLsLsmbLcLcb
LjbRsRgbLgbLeRcbLibRcbsbsbLjbRcbLgLsbRsRsmbRibRgLjLsmbLcLsmbRsbRebLjbL
sRsbRsbLebRsbLsLcRebLeLgLsbLsLsmbRgbRgLsbLsbRibsbLjbLcbRcRsmbRgLsbLsLs
mbLebLsLsmbsbsbsbLsbsbsbRjbLsRsbLsLsRsmbLsbRcRgLsbRsLsbLeRsbRebLcbLgLs
RsbLiLsLsmbLgLsLsmbLhbsbsbLeLsLcLsLsLsmmmbReRsRsmmbRsLeLsLsLgLsLsRsmmb
LsLsLsLsRcRsmmmmbRsRgRsmbLsbLgbLsRsbLsbRsbLcbsbsbLebsbLsbRjbRsLsbLsbLs
bLsbRebRiLgbLgbLsLebLgLsLebLsbRcbRsbsbLsbRsLsbRsbLsLsmbLsbLibLeLcbLsLe
bRsbReLsbLiLgLsbLiLsLgLsLsLsmmbLgbRgLsbRsLsLebLcLsmbLsLebLebLoLgLsbLsL
iLebsbsbRsbLgbLcRsRsmbLgRgLgLsLsLsRemmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 47; Drug: PCAP2 10 µM PTZ 2.5 mM
bRsbRsbRsLsbLsLeRsbLsbLobRsbRsbReRgRsRsmmbRiRsmbRgRsRsRsLsmmmbRgRsLsmb
RsRsRsRsmmmbRsRsRsLsRsmmbRsRgbRgRsRsmmbRsRsRsRgRsmmmbRgbRgLsbRgRsRsmmb
RgLsRsRsRsmmbRsRiRsmbRsRsRgRgRsmmbRsbLsRsLsbReRsRsmmbRibRiRiLsbLsLsLsL
gLhmmbLgLebRiRsmbRsbRsRsRsmmbReRsmbRsRgbLiRsbRiRsmbRsRsRsRsmmmbRsRsmbR
gRsRsRsmmmbRgbRgRsmbRsRsRsRsRsmmmmbRsRsmbLsbReRsRsRsmmmbRsRsRsRgRsRgmm
mbLsRgRsmbRgbRsbRsRsRsmmbRgbRsRsRsRsmmmbRsRgbRiRsRsRsRsRsRsmmmmmmbRsRs
RsmmbRsRsRsLsRsmmbsbRsRsRsRgRsmmmbRsRsLsRsLsmbRsRgRsReLsRsmbRgbReRsmbR
hbRsRgbLgRsbRsRgRibRgRsRsLsmmbRsRsmbRgbRsRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 154453; End: 154953;
Recording: 13-1; Individual: 48; Drug: PCAP2 10 µM PTZ 2.5 mM
bLcRcLsbRcRsmbRsRsLcmbLgLsLsLsmmbRcbLsRgbLcbRobLeLibLiRobRiRsRsRsmmmbR
sbRgRsRsmmbRgRsRsmmbRgbLgLsbLoLebLgLsLsRsmbLsbLgRoRsLsmbRgbLoLsmbLsRcL
sRsbRiLsbRebLsRhRsmbRsRsRgLoRimbLsLgLsLobLebLiLibRoLsbLsRsbRsbRibRcLsb
LeLsbLeLsLgLsLsmbLeLsRobLeRsbRcLsbRsRgRsmbRsRsmbRgLgbRgRsRsmmbLcbRgLsL
sLsmmbRcLsbRcbLoRcbLeLebLiLsLsmbLebLcRsbRgbLgLsbRgbRibLsbRibLsbLcLsLsm
mbLiLsRcLjbRebRgRhRsmbRebLeLgbLgLsLsmbLeLgbReRsmbRgLsLsRsmbLsbLsbRibLs
bLiLgLebLhLsbLhLsLsmbLgLsLsLsRcRgLcmmbRhbRiLsRsbRibRsRiLeLsLsmbLjbRgLs
bLsLcbLsLsLcLsLsLsmmmmbLiLsLsLsmmbLsLgbRjbLiLsRgbRgLgbLiRsbRoLsbLsLebL
ebLgbRoLsRibRiRsLsmbLsLjbRgbLsLgbRiRsLsmbRsRsLembLsLeLsbLibLgLsLsmbLsL
sRsmbLsLeRsLsbRsRgbRgLcRsLcbLebLebLiLgbLeRsLsbRgRsRgRsRgLsmmbLjRsRgbRs
RgbLgLsbLcRsLsLsmbRcbLcRhbLoLeLsLeLiRsbLsLeLsb

